
<html lang="en"     class="pb-page"  data-request-id="4546adb1-fae6-451a-a669-5c4455cae351"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2011.54.issue-23;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm2007672"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators" /></meta><meta name="dc.Creator" content="Anatoly A.  Mazurov" /></meta><meta name="dc.Creator" content="Jason D.  Speake" /></meta><meta name="dc.Creator" content="Daniel  Yohannes" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 29, 2011" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2007672" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2007672" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2007672" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2007672" /></link>
        
    
    

<title>Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2007672" /></meta><meta property="og:title" content="Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="" /></meta><meta name="twitter:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta name="twitter:title" content="Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2007672"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2007672">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2007672&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2007672&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2007672&amp;href=/doi/10.1021/jm2007672" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 7943-7961</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm200870n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anatoly+A.++Mazurov">Anatoly A. Mazurov</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason+D.++Speake">Jason D. Speake</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Yohannes">Daniel Yohannes</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Targacept, Inc., 200 E. First Street, Winston-Salem, North Carolina 27101-4165, United States</span></div><div class="corresp-info">Phone: (336) 4802179. E-mail: <a href="/cdn-cgi/l/email-protection#5d3c333c2932312473303c27282f322b1d293c2f3a3c3e382d29733e3230"><span class="__cf_email__" data-cfemail="b3d2ddd2c7dcdfca9dded2c9c6c1dcc5f3c7d2c1d4d2d0d6c3c79dd0dcde">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2007672&amp;href=/doi/10.1021%2Fjm2007672" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 7943–7961</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 15, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 June 2011</li><li><span class="item_label"><b>Published</b> online</span>29 September 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 December 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2007672" title="DOI URL">https://doi.org/10.1021/jm2007672</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7943%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnatoly%2BA.%2BMazurov%252C%2BJason%2BD.%2BSpeake%252C%2BDaniel%2BYohannes%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D23%26contentID%3Djm2007672%26title%3DDiscovery%2Band%2BDevelopment%2Bof%2B%25CE%25B17%2BNicotinic%2BAcetylcholine%2BReceptor%2BModulators%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7961%26publicationDate%3DDecember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2007672"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3332</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">46</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2007672" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anatoly&quot;,&quot;last_name&quot;:&quot;A. Mazurov&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;D. Speake&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Yohannes&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;7943-7961&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2007672&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007672&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007672" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007672&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007672" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007672&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007672" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2007672&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007672&amp;href=/doi/10.1021/jm2007672" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2007672" /></input><a href="/doi/pdf/10.1021/jm2007672" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2007672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2007672%26sid%3Dliteratum%253Aachs%26pmid%3D21919481%26genre%3Darticle%26aulast%3DMazurov%26date%3D2011%26atitle%3DDiscovery%2Band%2BDevelopment%2Bof%2B%25CE%25B17%2BNicotinic%2BAcetylcholine%2BReceptor%2BModulators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D23%26spage%3D7943%26epage%3D7961%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291363" title="Schizophrenia">Schizophrenia</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290792" title="Circuits">Circuits</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/23" title="Go to Volume 54, Issue 23"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jmcmar.2011.54.issue-23/production/jmcmar.2011.54.issue-23.largecover.jpg" alt="Go to Volume 54, Issue 23"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div id="ac_i1" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i1"> </h2><div class="NLM_p last">Efforts in the design and discovery of selective α7 nicotinic acetylcholine receptor (nAChR) agonists were both facilitated and hampered by observation that ligands can show dual affinity at both the 5-HT<sub>3</sub> receptor (5-HT<sub>3</sub>R) and nAChR.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The 5-HT<sub>3</sub>R and nAChRs are both part of the Cys-loop superfamily of ligand-gated ion channels. Further, there is significant sequence homology between 5-HT<sub>3</sub>R and α7 nAChR in the ligand recognition domain.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Previously reported potent α7 nAChR agonists lacked selectivity versus 5-HT<sub>3</sub>R,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and antagonist activity at 5-HT<sub>3</sub>R often translated into agonism at α7 nAChR. The crossover in affinity might be explained by pharmacophoric elements common to both 5-HT<sub>3</sub>R and α7 nAChR: a basic amine (protonated at physiological pH) provides for a cation−π interaction; a hydrogen-bond acceptor, e.g., a carbonyl group, forms a hydrogen bond; and aromatic moieties participate in π–π interactions.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In view of reported side effects, i.e., constipation, asymptomatic electrocardiogram changes, and arrhythmias, associated with 5-HT<sub>3</sub>R antagonists,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> efforts of research groups were focused on design of ligands specifically interacting with only the α7 nAChR to maximize the therapeutic effect and minimize the adverse effects. Over the past 10 years, drug discovery efforts significantly expanded the quantity and quality of selective α7 nAChR ligands. Those have been summarized in several excellent reviews.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Despite early skepticism centered around the rapid desensitization of the α7 nAChR and the hypothesis that agonists might not be functional agonists in vivo, 10 of them have already been advanced to clinical trials. In this review, we highlight the most advanced and characterized (especially in vivo) selective α7 nAChR orthosteric and allosteric α7 nAChR modulators.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Agonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25815" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25815" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Spiroquinuclidines</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i4" class="anchor-spacer"></div><h4 class="article-section__title" id="_i4"> (5<i>S</i>)-Spiro[oxazolidine-5,3′-quinuclidin]-2-one (AR-R17779)<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0029.gif" alt="" id="fx1" /></img><div class="NLM_p last">The conformationally restricted carbamate<a onclick="showRef(event, 'ref19 ref10'); return false;" href="javascript:void(0);" class="ref ref19 ref10">(19, 10)</a> was the first agonist with selective affinity for α7 nAChRs described in the literature: α7 <i>K</i><sub>i</sub> = 92 nM ([<sup>125</sup>I]α-bungarotoxin binding assay), EC<sub>50</sub> = 21 μM, <i>E</i><sub>max</sub> = 96% at the rat α7 nAChR subtype in oocytes; <i>K</i><sub>i</sub> = 420 nM ([<sup>3</sup>H]MLA radioligand binding assay), EC<sub>50</sub> = 420 nM, <i>E</i><sub>max</sub> = 93% in human recombinant nAChR subunit combinations expressed in GH4 cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Despite a less than desirable pharmacokinetic profile<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and insufficient efficacy, compound <b>1</b> served as an invaluable tool for in vivo assessment of α7 nAChR function, validating a link between its activation and a variety of biological effects. Compound <b>1</b> has been shown to enhance learning and memory function in rats in a radial arm maze model<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and social recognition test<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> but has failed to improve performance in a model of attention<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and had no effect on auditory gating<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> using a prepulse inhibition of the acoustic startle response (relevant to sensory deficits in schizophrenic patients<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>). Compound <b>1</b> suppressed the clinical and histologic manifestations of collagen-induced arthritis in mice with established disease, suggesting a link between activation of α7 nAChRs and the inflammatory process in the inflamed joint.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> (<i>R</i>)-3′-(3-Methylbenzo[<i>b</i>]thiophen-5-yl)spiro[1-azabicyclo-[2.2.2]octane-3,5′-oxazolidin]-2′-one (W-56203).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></h4><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0030.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>2</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">By modification of the linker between two essential pharmacophoric elements, cationic center (quinuclidine) and aromatic moiety, (+)-3-[2-(benzo[<i>b</i>]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane (<b>3</b>) was identified as an α7 nAChR ligand.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The aromatic function was modified into (<i>S</i>)-3-(benzo[<i>b</i>]thiophen-2-ylmethoxy)-1-azabicyclo[2.2.2]octane (<b>4</b>). Despite its high affinity (<i>K</i><sub>i</sub> = 13 nM), compound <b>4</b> was not detected in plasma following oral administration. The replacement of the metabolically vulnerable oxamethylene spacer between the quinuclidine and benzothiophene in compound <b>4</b> with a more rigid carbamate ring was likely inspired by compound <b>1</b>. Since compound <b>5</b> showed moderate affinity, a library of bicyclic and monocyclic aromatic spiro-carbamates was synthesized. Among monocyclic aromatic derivatives, only compound <b>6</b> retained affinity comparable with that of <b>5</b>. Optimization of substituents in the thiophene ring led to an enhancement of affinity, producing compound <b>7</b> with high oral bioavailability and brain permeability.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Unfortunately, it exhibited potent cytochrome P450 2D6 isozyme (CYP 2D6) inhibition, which is considered a liability for potential drug–drug interactions. This prompted reconsideration of the fused bicyclic aromatic spiro-carbamates, which demonstrated reduced CYP 2D6 inhibitory activity. Benzothiophene <b>8</b> retained relatively high affinity without inhibition of CYP 2D6 isozyme at 30 μM. Investigation of the effect of a substituent on the ring system provided <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which was suitable for in vivo evaluation. Introduction of a methyl group in position 3 of the benzothiophene ring both improved α7 nAChR affinity and diminished the potential to form reactive metabolites through oxidation of the heteroaromatic ring. Compound <b>2</b> (Mitsubishi Pharma) improved cognition in auditory sensory gating and reversed the scopolamine-induced impairment of cognitive performance in an eight-arm radial maze task in rat models. Given its moderate pharmacokinetic profile, <b>2</b> was reported as a promising drug candidate for the treatment of cognitive impairment associated with neurological disorders. Since this compound significantly increased levels of extracellular dopamine in the medial prefrontal cortex, it was proposed that dopaminergic hypofunction in the prefrontal cortex is responsible for functional abnormalities in schizophrenia.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> (2′<i>R</i>)-Spiro-[1-azabicyclo[2.2.2]octane-3,2′(3′<i>H</i>)-furo[2,3-<i>b</i>]pyridine] (AZD0328).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h4><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0031.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>9</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) was designed to circumvent the poor pharmacokinetic profile of <b>1</b> by replacement of the hydrogen bond acceptor carbonyl moiety with a pyridine nitrogen. 3-Pyridyloxyquinuclidines are known as 5HT<sub>3</sub>R antagonists,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and being a rigid quinuclidinylpyridyl ether, <b>9</b> maintained 5HT<sub>3</sub>R antagonism. Compound <b>9</b> improved novel object recognition in mice over a broad range of doses (0.00178–1.78 mg/kg) and working memory (spatial delayed response performance) in rhesus monkeys. The behavioral effects were blocked by pharmacological antagonism of α7 nAChR function or genetic deletion of the gene encoding the α7 subunit, demonstrating that these actions of <b>9</b> are most likely mediated through α7 nAChRs. Interaction with α7 nAChRs by <b>9</b> selectively elevates midbrain dopaminergic neuronal activity, causing an enhancement of cortical dopamine levels; these neurochemical changes might underlie the positive behavioral responses observed in the animal models.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Since <b>9</b> was unlikely to meet AstraZeneca’s target product profile, further development of <b>9</b> was discontinued in 2008.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Incorporation of aromatic substituents improves interaction with the receptor. Specifically, (2′<i>R</i>)-3-(furan-3-yl)spiro-[1-azabicyclo[2.2.2]octane-3,2′(3′<i>H</i>)-furo[2,3-<i>b</i>]pyridine]<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<b>10</b>) has the highest affinity (<i>K</i><sub>i</sub> = 0.03 nM) among known α7 nAChR ligands. However, the aromatic group facilitates the interaction of the molecule with the hERG (human ether-a-go-go-related gene) channel. Optimization resulted in reduction of hERG inhibition by addition of polar substituents. A trade-off of this approach was that the polar substituents converted the series into P-glycoprotein substrates.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Azabicyclic Arylamides</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> <i>N</i>-[(3<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide (PNU-282987)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0032.gif" alt="" id="fx4" /></img></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> <i>N</i>-[(3<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide (PHA-543613)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0033.gif" alt="" id="fx5" /></img></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> <i>N</i>-[3-(<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]-1,4-benzodioxane-6-carboxamide (PHA-568487)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0034.gif" alt="" id="fx6" /></img></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> <i>N</i>-[(3<i>R</i>,5<i>R</i>)-1-Azabicyclo[3.2.1]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide (PHA-709829)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0035.gif" alt="" id="fx7" /></img><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>16</b>, <b>17</b>, and <b>18</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Quinuclidine amides are well explored ligands for nAChR and 5HT<sub>3</sub> receptors. Amide <b>15</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) was primarily identified via high-throughput screening as a weak agonist of a chimera of the α7 (α7-5HT<sub>3</sub>) receptor. Exploration of the substitution pattern around the benzene ring revealed unambiguous SAR for α7 nAChR activity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Ortho-substitution almost eliminates interaction with α7 nAChR, while an <i>o</i>-alkoxy group is essential for high affinity to 5HT<sub>3</sub>R. Compounds with small para-substituents were the most potent α7 nAChR agonists, while meta-substituted benzamides displayed a moderate activity. The α7 nAChR, unlike the 5HT<sub>3</sub>R, appears to stereospecifically prefer (<i>R</i>)-3-aminoquinuclidine aromatic amides for binding. 4-Chlorobenzamide <b>11</b> was identified as a potent selective agonist for α7 nAChRs with low affinity to 5HT<sub>3</sub>R and demonstrated in vivo efficacy in animal models associated with cognitive dysfunction in schizophrenia. However, the compound was not further developed because of significant hERG potassium channel inhibition (11% and 57% at 2 and 20 μM, respectively).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Fused heterocyclic analogues, such as indole <b>16</b>, preserve α7 nAChR functional potency, providing prospects for improvement of the safety profile. While potent α7 nAChR agonist <b>17</b> significantly inhibits the hERG channel, benzofuran <b>18</b> was amenable to further optimization. Although an in vitro pharmacological profile of the quinuclidine amide <b>18</b> was encouraging, the electron-rich furan ring underwent CYP450-catalyzed oxidative bioactivation, generating reactive metabolites and potential hepatotoxicity. A shift of the electron-withdrawing carboxamide group from position 6 of the benzofuran ring in compound <b>18</b> to position 5 in its analogue <b>19</b> enhanced affinity and potency and, most importantly, eliminated bioactivation. The last obstacle, inhibition of enzyme CYP 2D6 by benzofuran carboxamide <b>19</b>, was circumvented by incorporation of nitrogen into the heterocyclic system. Furopyridine <b>12</b> demonstrated efficacy in the reversal of an amphetamine-induced P50 gating deficit and improved performance in a novel object recognition test. Benzodioxane <b>13</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was highly efficacious at 1 mg/kg in the reversal of an amphetamine-induced P50 gating deficit. Both phase I clinical candidates <b>12</b> and <b>13</b> were discontinued because of cardiovascular findings of nonsustained ventricular tachycardia. Modification of <b>12</b> by replacement of (3<i>R</i>)-1-azabicyclo[2.2.2]octane with (3<i>R</i>,5<i>R</i>)-1-azabicyclo[3.2.1]octane resulted in <b>14</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The compound is 2-fold more potent than <b>12</b> in an amphetamine-induced gating model (MEDs are 0.1 and 0.24 mg/kg, respectively), and it is efficacious over a range of doses (0.1–1.0 mg/kg). In the cardiovascular safety study on dogs, the “no observable adverse effect level” for <b>14</b> was established at a dose of 40 mg/kg (<i>C</i><sub>max</sub> = 22 μM), which is 5-fold higher than for <b>12</b> (<i>C</i><sub>max</sub> = 3.8 μM). Taken together, the efficacy and safety data represent a 10-fold improvement in cardiovascular therapeutic index for <b>14</b> compared to <b>12</b>. Additionally, it was shown that <b>14</b> remains efficacious after chronic administration.</div></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> <i>N</i>-[(3<i>S</i>)-1-Azabicyclo[2.2.2]oct-3-yl]-1<i>H</i>-indazole-3-carboxamide (RG3487)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0002.gif" alt="" id="fx8" /></img><div class="NLM_p last">Compound <b>20</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (acquired by Roche from Memory Pharmaceuticals and formerly known as MEM3454) displayed high affinity at rat α7 nAChRs with a <i>K</i><sub>i</sub> of 10 nM, as demonstrated by binding to [<sup>3</sup>H]MLA-labeled sites in rat brain membrane preparation. Assessment of affinity at 5-HT<sub>3</sub>Rs revealed a slight binding preference for this target, with a <i>K</i><sub>i</sub> of 2 nM. The intrinsic activity profile of <b>20</b> (EC<sub>50</sub> = 0.4 μM, <i>E</i><sub>max</sub> = 67%) was determined by whole-cell patch clamp recordings using a cell line stably expressing the monkey wild-type α7 nAChR. Compound <b>20</b> displayed minimal affinities/efficacies at other nicotinic receptors (α4β2, α3β, and α1β1δγ) and showed selectivity against other neurotransmitter and hormone receptor sites in CEREP profiling. Studies using in vitro rat hippocampal CA1 slices demonstrated that <b>20</b> (1–10 μM) enhanced 40 Hz long-term potentiation, which was significantly blocked by MLA, thereby demonstrating nicotinic α7 receptor specificity.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compound <b>20</b> binds potently to the human α7 nAChR (<i>K</i><sub>i</sub> = 6 nM), in which it acts as a partial agonist (63–69% of acetylcholine) as assessed by whole cell patch-clamp recordings in both oocytes and QM7 cell lines, respectively.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compound <b>20</b> activates human α7 nAChRs with EC<sub>50</sub> of 0.8 μM (oocytes) and 7.7 μM (QM7 cells). Compound <b>20</b> also exhibits antagonist properties at the serotonin 3 receptor (5-HT3R; IC<sub>50</sub> = 2.8 nM [oocytes], 32.7 nM [N1E-115 cells]). Procognitive effects of <b>20</b> were demonstrated in behavioral models representing multiple cognitive domains (e.g., episodic, spatial reference, and working memories)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> with a MED of 1.0 mg/kg po (low-nanomolar range at brain and plasma concentrations) in a novel object recognition test and in models predictive of cognitive and sensory gating restoration in schizophrenia<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> with a MED of 0.03 mg/kg ip in a PPI test and phencyclidine-induced impairment of young and aged rats. Compound <b>20</b> showed a significant dose effect on percent hit accuracy performance in rats without any significant alteration on percent correct rejection performance.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In a time-dependent test, <b>20</b> significantly increased the percent hit accuracy performance when animals were injected 60 min before the start of an attentional task. Administration of galanthamine (acetylcholinesterase inhibitor/α7 nAChR allosteric positive modulator) failed to significantly increase percent hit accuracy performance, and increasing the dose of galanthamine produced a decrease in percent correct rejection performance. In 2007, Memory Pharmaceuticals reported positive results from a phase IIa trial of <b>20</b> for the treatment of Alzheimer’s disease, but <b>20</b> did not reverse cognitive impairment in schizophrenics using the MATRICS scale.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> (3<i>R</i>)-<i>N</i>-(1-Azabicyclo[2.2.2]oct-3-yl)-7-(2-methoxyphenyl)-1- benzofuran-2-carboxamide (ABBF)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0003.gif" alt="" id="fx9" /></img><div class="NLM_p last">Compound <b>21</b><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> was developed by Bayer Healthcare and showed equal affinity to α7 nAChRs in rat brain membranes (<i>K</i><sub>i</sub> = 62 nM) and to recombinant human 5-HT<sub>3</sub>Rs (<i>K</i><sub>i</sub> = 60 nM). Compound <b>21</b> was a potent agonist at the recombinant rat and human α7 nAChR expressed in <i>Xenopus</i> oocytes (EC<sub>50</sub> of 3 and 5.5 μM, respectively), but it did not show agonist activity at other nAChR subtypes. Compound <b>21</b> acted as an antagonist of the 5-HT<sub>3</sub>R and α3β4, α4β2, and muscle nAChRs (at higher concentrations). Compound <b>21</b> can improve performance in several learning and memory tests in both rats and mice without producing nicotine-like discriminative stimulus effects. This compound also improved social recognition memory in rats (0.3–1 mg/kg po), and this effect was blocked by intracerebroventricular administration of MLA at 10 μg, indicating that it is mediated by α7 nAChR agonism. In addition, <b>21</b> improved working memory of aged rats in a water maze repeated acquisition paradigm (1 mg/kg po) and object recognition memory in mice (0.3–1 mg/kg po).</div></div><div id="sec2_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (3<i>R</i>)-<i>N</i>-(1-Azabicyclo[2.2.2]oct-3-yl)-7-chlorobenzo[<i>b</i>]thiophene-2-carboxamide (EVP-6124)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0004.gif" alt="" id="fx10" /></img><div class="NLM_p last">In November of 2004, EnVivo Pharmaceuticals licensed from Bayer Healthcare the exclusive rights to its α7 agonist program and identified <b>22</b> as a clinical candidate. Compound <b>22</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> has been reported to have a favorable brain to plasma exposure ratio and has shown efficacy and potency in a number of animal models of cognition.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Compound <b>22</b> appears to be well tolerated for up to 21 days as measured by adverse events, vital signs, continuous cardiac monitoring, physical examination, and clinical laboratory evaluations. In addition, in normal volunteers, <b>22</b> demonstrated procognitive effects (CogState testing) in various cognitive domains, including executive function. Compound <b>22</b> had procognitive effects in two separate clinical trials: one study conducted in Alzheimer’s disease patients already treated with acetylcholine esterase inhibitors (AChEI) and one in Alzheimer’s disease patients not on AChEI therapy (naive patients).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In May of 2011, EnVivo Pharmaceuticals announced positive results of a phase IIb clinical trial of <b>22</b> in patients with schizophrenia when taken in combination with second-generation antipsychotics.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In clinical trials, the free concentration of <b>22</b> in humans administered at daily 1 mg dose was at least an order of magnitude lower than that expected to be required to exert a positive effect on cognitive function or to improve sensory electrophysiological responses that correlate with improved cognitive and functional performance in schizophrenia patients. This phenomenon was explained by a so-called coagonist effect, which purportedly results in a sensitization of α7 nAChRs. Thus, <b>22</b> may produce an environment where smaller amounts of naturally occurring ACh, typically found in individuals with memory disorders such as Alzheimer’s, are required to activate the receptor. A phase IIb study of <b>22</b> in mild to moderate Alzheimer’s disease has also been initiated.</div></div><div id="sec2_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (2<i>S</i>,3<i>R</i>)-<i>N</i>-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]-1-benzofuran-2-carboxamide (TC-5619)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0005.gif" alt="" id="fx11" /></img><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>23</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Quinuclidinylaryl carbamates<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> have been described as one of the first classes of α7 nAChR ligands. Pharmacophore directed diversification around the quinuclidine scaffold through exploration of both positions 2 and 3 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) resulted in the discovery of a critical pharmacophoric element in the form of a hydrogen bond acceptor (pyridin-3-yl) in position 2 of the azabicyclic ring.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Furthermore, incorporation of a pyridine moiety improved α7 nAChR selectivity by essentially eliminating interaction with 5HT<sub>3</sub>Rs. Further exploration of a hydrogen bond acceptor connecting the cationic pharmacophoric element with the aromatic fragment revealed that a carbamoyl group can be replaced with an amide without loss of affinity, agonism, or selectivity. Optimization of π–π interaction between the ligand and the receptor resulted in the discovery of <b>23</b>.</div><div class="NLM_p">Compound <b>23</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> binds to the α7 nAChR both in rat hippocampal membranes and in a HEK293 cell line coexpressing human α7 and RIC3 cDNAs with a <i>K</i><sub>i</sub> of 1 nM. In a broad receptor selectivity battery (NovaScreen), TC-5619 showed positive interactions in a nonselective opioid receptor assay (58% inhibition) and at the sodium site 2 (79% inhibition). Dose-response assessments of these interactions showed that the <i>K</i><sub>i</sub> values for the opioid site and for the sodium site 2 were both 13 μM, providing a greater than 1000-fold separation from the binding affinity at the α7 nAChR. Binding of <b>23</b> (10 μM) to the 5HT<sub>3</sub>R displayed 59% inhibition of radioligand binding at the mouse receptor and 25% inhibition at the human receptor. An investigation of functional activation at the human 5HT<sub>3</sub>R suggested minimal to no activation; a maximal response of 15% was obtained at 100 μM <b>23</b>. At human α7 nAChRs transiently expressed in <i>Xenopus</i> oocytes, <b>23</b> displayed an EC<sub>50</sub> of 33 nM and an <i>E</i><sub>max</sub> of 100% relative to ACh. Compound <b>23</b> demonstrated statistically significant enhancement of short-term working memory in the novel object recognition paradigm (MED = 0.3 mg/kg po), and these effects on memory were seen up to 18 h following oral administration, suggesting a positive effect on long-term memory consolidation as well. Compound <b>23</b> also reversed apomorphine-induced prepulse inhibition (MED 0.3 mg/kg po) in both mice and rats, which may suggest a benefit against the positive symptoms associated with schizophrenia. The effect of <b>23</b> in the social withdrawal model in mice suggests that the compound also has the potential to target negative symptoms of the disease. Taken together, these findings indicate that <b>23</b> may have potential to impact all of the primary domains of schizophrenia, positive symptoms, negative symptoms, and cognitive dysfunction.</div><div class="NLM_p">Another unique feature of <b>23</b> is that its effects appear to be additive or possibly synergistic with those of antipsychotics, further supporting the therapeutic potential of α7 nAChR-selective compounds not only as monotherapy but also together with existing drugs.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The transgenic <i>th(tk−)/th(tk−)</i>mouse model expresses dopaminergic dysfunction similar to that in schizophrenia and reflects many of the developmental, anatomical, and biochemical aspects of the disease. Although clozapine or 0.1 mg/kg <b>23</b> separately had no effect on investigation time, treatment with <b>23</b> and clozapine together increased the investigation time of a female stimulus mice in control and homozygous transgenic <i>th(tk−)/th(tk−)</i>mice; also, treatment with <b>23</b> (0.1 mg/kg) and clozapine together increased the investigation time of a male stimulus animal in <i>th(tk−)/th(tk−)</i> but not in control mice.</div><div class="NLM_p last">Compound <b>23</b> demonstrated encouraging results on measures of negative symptoms and cognitive dysfunction in schizophrenia and was well tolerated in a phase II clinical proof of concept trial in patients with schizophrenia. Targacept, Inc. reported results from the study at the International Congress on Schizophrenia Research in April 2011.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> In a separate phase II clinical trial of <b>23</b> in adults with attention deficit/hyperactivity disorder (ADHD), conducted in nonsmokers, <b>23</b> did not meet the primary efficacy outcome measure. In the study, <b>23</b> did demonstrate activity across the various secondary efficacy outcome measures, performing best on the Conners’ Adult ADHD Rating Scale—Subject Rated. The product candidate is also in development for Alzheimer’s disease.</div></div><div id="sec2_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (2<i>S</i>,3<i>R</i>)-[5-Methyl-<i>N</i>-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]thiophene-2-carboxamide (TC-7020)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0007.gif" alt="" id="fx12" /></img><div class="NLM_p last">Compound <b>27</b><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> binds to α7 nAChR with high affinity (<i>K</i><sub>i</sub> ≈ 2 nM) in displacement studies using [<sup>3</sup>H]MLA in rat hippocampal synaptosomes and exhibits very poor affinity toward other nicotinic receptor subtypes (<i>K</i><sub>i</sub> > 1000 nM). In functional studies, <b>27</b> is an agonist at α7 nAChRs (<i>E</i><sub>max</sub> = 69%), as evidenced by voltage-clamp studies of human α7 nAChRs transiently expressed in <i>Xenopus</i> oocytes. Compound <b>27</b> showed minimal functional activity at muscle (∼7% of nicotine’s <i>E</i><sub>max</sub> at 100 μM) and ganglionic (∼6% of nicotine’s <i>E</i><sub>max</sub> at 100 μM) nAChR subtypes, as shown by measuring calcium flux in TE-671 cells and SH-SY5Y cells, respectively. Compound <b>27</b> does not exhibit selectivity for any other (non-nicotinic) receptor targets (IC<sub>50</sub> > 10 μM), tested at more than 60 targets in a broad receptor selectivity panel. In a model of type 2 diabetes, the homozygous leptin-resistant <i>db</i>/<i>db</i> obese mouse, oral administration of <b>27</b> reduced weight gain and food intake, reduced elevated glucose and glycated hemoglobin levels, and lowered elevated plasma levels of triglycerides and the proinflammatory cytokine tumor necrosis factor-α.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> These changes were reversed by the α7-selective antagonist methyllycaconitine, confirming the involvement of α7 nAChRs. Prevention of weight gain, decreased food intake, and normalization of glucose levels were also blocked by the Janus kinase 2 (JAK2) inhibitor α-cyano-(3,4-dihydroxy)-<i>N</i>-benzylcinnamide (AG-490), suggesting that these effects involve linkage of α7 nAChR to the JAK2-signal transducer and activator of transcription 3 signaling pathway.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The results indicate that α7 nAChRs play a central role in regulating biological parameters associated with diabetes and support the potential of targeting these receptors as a new therapeutic strategy.</div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Azabicyclic Carbamates</h3><div class="NLM_p">Aryl carbamates, e.g., <b>28</b>, as α7 nAChR ligands were originally reported in 1999.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> A carbamate oxygen atom is thought to be an essential pharmacophoric element, presumably interacting with α7 nAChR via formation of a hydrogen bond. Consequent exploration of the series by a few research groups resulted in the identification of promising lead compounds with a carbonyl group attached to an endocyclic (<b>29</b>) or an exocyclic (<b>30</b>) nitrogen.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0008.gif" alt="" id="fx13" /></img></div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (4-Bromophenyl) 1,4-Diazabicyclo[3.2.2]nonane-4-carboxylate (SSR180711)<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0009.gif" alt="" id="fx14" /></img><div class="NLM_p">Compound <b>29</b><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> displayed high affinity for rat and human α7 nAChRs (<i>K</i><sub>i</sub> of 22 and 14 nM, respectively). In functional studies performed with human α7 nAChRs expressed in <i>Xenopus</i> oocytes or GH4C1 cells with ACh as normalizing reference, the compound showed partial agonist effects (intrinsic activity 51% and 36%, EC<sub>50</sub> of 4.4 and 0.9 μM, respectively). In rat cultured hippocampal neurons, <b>29</b> induced large GABA-mediated inhibitory postsynaptic currents and small α-Bgt sensitive currents through the activation of presynaptic and somato-dendritic α7 nAChRs, respectively. In mouse hippocampal slices, the compound increased the amplitude of both glutamatergic (EPSCs) and GABAergic (IPSCs) postsynaptic currents evoked in CA1 pyramidal cells. In rat and mouse hippocampal slices, 0.3 μM <b>29</b> increased long-term potentiation (LTP) in the CA1 field. Null mutation of the α7 nAChR gene totally abolished <b>29</b>-induced modulation of EPSCs, IPSCs, and LTP in mice. Compound <b>29</b> produced a dose- and time-dependent increase in the expression of <i>Arc</i> mRNA in the prefrontal cortex and the ventral orbital cortex. The protein <i>Arc</i> encoded by the effector immediate early gene <i>arc</i> or <i>arg3.1</i> has been shown to be strongly implicated in long-term memory function. Thus, α7 nAChR activates a subset of neurons in the rat prefrontal cortex and this activation likely is important for the attentional effects of this new class of drugs.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p last">Compound <b>29</b> enhanced episodic memory in the object recognition task in rats and mice and reversed MK-801-induced deficits in retention of episodic memory in rats. It reversed selective attention impaired by neonatal phencyclidine (PCP) treatment and restored MK-801- or PCP-induced memory deficits in the Morris or linear maze. In neurochemical and electrophysiological correlates of antipsychotic drug action, <b>29</b> increased extracellular levels of dopamine in the prefrontal cortex and enhanced spontaneous firing of retrosplenial cortex neurons in rats. Compound <b>29</b> was proposed to be beneficial not only for the treatment of cognitive symptoms in schizophrenia but also for the positive symptoms as demonstrated in pharmacological and neurodevelopmental latent inhibition models of schizophrenia; the antidepressant-like properties of <b>29</b> are of added interest, considering the high prevalence of depressive symptoms in schizophrenic patients. In 2007, Sanofi-Aventis suspended development of <b>29</b> for treatment of mild Alzheimer’s disease because of an insufficient expected benefit risk ratio.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>S</i>)-(1-Azabicyclo[2.2.2]oct-3-yl)carbamic Acid (<i>S</i>)-1-(2-Fluorophenyl)ethyl Ester (JN403)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0010.gif" alt="" id="fx15" /></img><div class="NLM_p last">Compound <b>30</b> was evaluated by Novartis in a number of in vitro systems of different species, at recombinant receptors using radioligand binding, signal transduction, and electrophysiological studies.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> When using [<sup>125</sup>I]α-Bgt as a radioligand, <b>30</b> has high affinity for human recombinant α7 nAChR (p<i>K</i><sub>D</sub> = 6.7, <i>K</i><sub>D</sub> = 200 nM). Functionally, <b>30</b> is a partial and potent agonist at human α7 nAChR. The compound stimulates calcium influx in GH3 cells recombinantly expressing the human nAChR with a pEC<sub>50</sub> of 7.0 (EC<sub>50</sub> 100 nM) and an <i>E</i><sub>max</sub> of 85% (compared to the full agonist epibatidine). In <i>Xenopus</i> oocytes expressing human α7 nAChR, <b>30</b> induces inward currents with a pEC<sub>50</sub> of 5.7 (EC<sub>50</sub> = 2 μM) and an <i>E</i><sub>max</sub> of 55%. In functional ion-flux assays, <b>30</b> shows a 200-fold selectivity over other nAChRs like α3β4 or α4β2 as well as 5HT<sub>3</sub>Rs. Similarly, <b>30</b> showed low binding activity at a wide panel of neurotransmitter receptors. Compound <b>30</b> enhances learning and memory performance in the social recognition test in mice, reverses the auditory gating deficit in anesthetized and awake DBA/2 mice, and is effective in animal models of persistent inflammatory and neuropathic pain.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Arylazabicycles</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-(Pyridin-3-yl)-1-azabicyclo[3.2.2]nonane (TC-1698)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0011.gif" alt="" id="fx16" /></img><div class="NLM_p last">Compound <b>31</b><a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> is a selective α7 nAChR agonist (EC<sub>50</sub> = 440 nM, <i>E</i><sub>max</sub> = 100%), as determined in human α7 nAChRs transiently expressed in <i>Xenopus</i> oocytes using ACh as normalizing reference, with a <i>K</i><sub>i</sub> affinity of 11 nM on membranes prepared from rat hippocampus. A binding profile was conducted to evaluate the interaction of <b>31</b> with other receptors, transporters, enzymes, or ion channels. With the exception of nicotinic receptors at which binding was totally displaced, 10 μM <b>31</b> had no or very low affinity for all binding sites examined. No (or very low) activation was observed on α4β2, α3β2, α3β4, and α1β1εδ nAChRs. Compound <b>31</b> exerts neuroprotective effects via activation of the JAK2/PI-3K cascade, which can be neutralized through activation of the angiotensin II AT2 receptor. These results support the hypothesis that JAK2 plays a central role in the α7 nAChR induced activation of the JAK2-PI-3K cascade in PC12 cells, which ultimately contribute to nAChR-mediated neuroprotection.</div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4-(5-Methyloxazolo[4,5-<i>b</i>]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810123)<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0012.gif" alt="" id="fx17" /></img><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>32</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>32</b><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) was discovered by modification of aryl carbamates. Bioisosteric replacement of the carboxy fragment in aryl carbamate <b>33</b> with a benzoxazole ring originated a new series of α7 nAChR ligands. Benzoxazole <b>34</b> was more efficacious as an α7 nAChR agonist than <b>33</b> with ∼33-fold improved affinity toward α7 nAChRs. Conversely, such modification had a more drastic impact on 5HT<sub>3</sub>R binding: 5HT<sub>3</sub>R <i>K</i><sub>i</sub> was reduced by 307-fold, providing the nonselective ligand <b>34</b> for further optimization. Substitutions at the 5- and 6-positions of the benzoxazole ring did not restore the selectivity toward 5HT<sub>3</sub>Rs to the level of aryl carbamates.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> As shown earlier in a benzofuran carboxamide series (optimization of compound <b>12</b>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> replacement of a fused benzene ring with a pyridine ring proved to be a viable option. Among four possible regioisomers resulting in various fusion of an oxazole with a pyridine ring, 4-azabenzoxazole <b>35</b> demonstrated potential for improved selectivity over 5HT<sub>3</sub>Rs, maintaining full α7 nAChR agonist activity. SAR exploration of substituted 4-azabenzoxazoles resulted in identification of chloro analogue <b>36</b>, which displayed the greatest α7 nAChR affinity and selectivity. Potent hERG inhibition of 6-chloro-4-azabenzoxazole <b>36</b> was diminished by addition of a substituent in position 5 of the heterocycle at the expense of selectivity. Nevertheless, compound <b>37</b> demonstrated α7 nAChR potency equal to that of <b>36</b>, being a 5HT<sub>3</sub>R antagonist. The authors<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> postulated that the risk associated with 5HT<sub>3</sub>R antagonism was minimal, since clinical studies suggest that the 5HT<sub>3</sub>R antagonist ondansetron is well tolerated in patients with schizophrenia.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> On the basis of evaluation of in vitro potency and selectivity profiles at α7 nAChR, 5HT<sub>3</sub>R, hERG, and genetic toxicity, <b>32</b> was selected for evaluation in in vivo efficacy models. It demonstrated efficacy in an amphetamine induced P50 gating deficit model and improved performance in the novel object recognition test. Compound <b>32</b> was introduced by Pfizer as a third generation α7 nAChR agonist for treatment of cognitive deficits associated with schizophrenia;<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> to date, there has been no report of its clinical advancement.</div></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 3-(6-Phenylpyridazin-3-yl)-7-methyl-3,7-diazabicyclo[3.3.0]octane (A-582941)<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0014.gif" alt="" id="fx18" /></img><div class="NLM_p">While a π–cation interaction has been established as an essential pharmacophore for binding to both α4β2 and α7 nAChRs, the α7 binding site is more lipophilic and presents a less negative electrostatic surface than that for the α4β2 receptor. An elegant approach that converted an α4β2 nAChR agonist into a selective α7 agonist was demonstrated by Abbott's scientists in the case of <b>38</b>.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> A structure–activity relationship study around the highly potent α4β2 nAChR agonist 3-(pyridine-3-yl)-3,7-diazabicyclo[3.3.0]octane (<b>39</b>)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> revealed that incorporation of a phenyl ring in position 6 of the pyridine resulted in a 6-fold enhancement of potency at the α7 nAChR (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Coupled with the decreased affinity for α4β2, compound <b>40</b> achieved an 11-fold selectivity for binding to the α7 versus α4β2 nAChR. N-Methylation did not change α7 nAChR affinity while practically eliminating α4β2 binding in compound <b>41</b>. Its pyridazine analogue <b>38</b> was evaluated further in vitro and in vivo.</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>38</b>: construction of selective α7 nAChR agonists from an α4β2 nAChR agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>38</b> exhibited high-affinity binding and partial agonism at α7 nAChRs. Similar affinities were observed in rat brain membranes (<i>K</i><sub>i</sub> = 10.8 nM) and in membranes from human frontal cortex (<i>K</i><sub>i</sub> = 17 nM), indicating that cross-species differences appear to be minimal for this α7 ligand. Compound <b>38</b> also displaced the α7-selective antagonist [<sup>3</sup>H]methyllycaconitine (MLA) from rat brain membranes with a <i>K</i><sub>i</sub> of 88 nM. Compound <b>38</b> was screened for activity across a panel of 78 receptor targets including G-protein-coupled receptors, ligand- and voltage-gated ion channels, and neurotransmitter uptake sites. Significant affinity was observed only at the 5HT<sub>3</sub>R. Compound <b>38</b> displaces [<sup>3</sup>H][(endo-<i>N</i>-(9-methyl-9-azabicyclo[3.3.l]non-3-yl-<span class="smallcaps smallerCapital">l</span>-methyl-1<i>H</i>-indazole-3-carboxamide hydrochloride)] ([<sup>3</sup>H]BRL-43694) binding to human 5HT<sub>3</sub>Rs with a <i>K</i><sub>i</sub> of 150 nM, representing approximately 15-fold selectivity for the human α7 nAChR relative to the 5HT<sub>3</sub>R.</div><div class="NLM_p">Metabolic conversion of <b>38</b> by liver microsomes or hepatocytes in vitro was highly species-dependent, with the rate of turnover fastest in dog, intermediate in rodent and monkey, and slowest in human. Compound <b>38</b> exhibits acceptable pharmacokinetic behavior in rodents, dog, and monkey. In mouse and rat, the compound is well absorbed following oral administration, as evidenced by the very high oral bioavailability (100% and 90%, respectively). The much lower bioavailability (22%) in dog is in accord with a much higher rate of metabolism in this species and likely reflects a larger contribution of first-pass metabolism. Consistent with its lipophilic character, <b>38</b> is characterized by very large volumes of distribution (4–11 L/kg) and correspondingly high clearance values.</div><div class="NLM_p">Compound <b>38</b> was evaluated across a battery of behavioral assays in rodent and non-human primate models that assess cognitive performance: social recognition in rats, delayed matching-to-sample (DMTS) test in primates, inhibitory avoidance (one trial) in mice, sensory gating in rats and DBA2 mice, and five-trial passive avoidance in spontaneously hypertensive rat (SHR) pups. These studies demonstrate that <b>38</b> exhibits broad-spectrum efficacy across various domains of cognition including working memory, short-term recognition memory, long-term memory consolidation, and preattentional sensory gating. With respect to cognitive domains, <b>38</b> appears to be especially effective in tasks that involve learning and memory (monkey DMTS at long delay, rat social recognition, and mouse inhibitory avoidance). The procognitive effects of <b>38</b> in these models were manifested at similar plasma exposures, approximately 3–6 ng/mL (10– 20 nM) across several models and species. These plasma levels correspond closely to the binding affinity for <b>38</b> at the α7 nAChR and are approximately 200-fold lower than the EC<sub>50</sub> for ion channel opening in vitro, indicating that signaling can occur at agonist concentrations well below those required for a macroscopic current in oocytes, measured as the synchronous opening of many channels elicited by rapid application of agonist. It was suggested that low concentrations of agonist can elicit a small but sustained current by stimulating the opening of a small percentage of the α7 nAChR. Individual receptors may be stimulated, desensitized, and recovered with normal dynamics, while the size of the pool of open channels remains relatively stable at any one time.</div><div class="NLM_p">Secondary pharmacodynamic and tolerability profiles of <b>38</b><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> were assessed in a battery of assays of cardiovascular, gastrointestinal, and CNS function. In animal experiments, <b>38</b> was well tolerated at exposures greater than those required for efficacy in cognition models. In rats, single oral dosages of 400 mg/kg (1400 μmol/kg) induced clinical signs indicating CNS activity, such as tremor and spasms. A dose of 800 mg/kg, po, was lethal within 10 min. To explore the potential of <b>38</b> to promote tumor growth, the compound was applied to shaved skin patches on the backs of SENCAR (sensitive to carcinogens) mice every 2 days for a period of 2 weeks. Compound <b>38</b> produced only a mild irritation of the skin, with no histologic evidence of epidermal hyperplasia or increased proliferation of basal keratinocytes as assessed by immunohistochemical detection of bromodeoxyuridine reagent.</div><div class="NLM_p">Comprehensive detailed characterization of <b>38</b> in combination with its broad-spectrum efficacy, favorable tolerability, and relatively low potential for toxicity has made it a valuable tool compound for evaluation of the α7 nAChR platform and as a candidate for potential drug development.</div><div class="NLM_p last">Exploration of substitution in the phenyl ring of <b>38</b> and the observation that a hydrogen bond donor in the para-position of the phenyl ring enhanced α7 binding resulted in replacement of the terminal phenyl by an indolyl group to obtain the most potent α7 ligand (<b>42)</b> identified in the series.</div></div><div id="sec2_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 5-(6-[(3<i>R</i>)-1-Azabicyclo[2,2,2]oct-3-yloxy]pyridazin-3-yl)-1<i>H</i>-indole (ABT-107)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0016.gif" alt="" id="fx19" /></img><div class="NLM_p">Clinical drug candidate <b>43</b><a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> was introduced to address the potential issues that are likely to be encountered in the clinical development of an α7 nAChR agonist for the treatment of Alzheimer’s disease. Those issues may include drug–drug interactions in patients already receiving other AD therapeutics, dosing constraints defined by pharmacokinetic–pharmacodynamic (PK–PD) limitations, and adverse events, in particular, nicotine-like abuse liability.</div><div class="NLM_p">Compound <b>43</b> is structurally related to <b>42</b> containing the same hydrophobic aromatic moiety, (indol-5-yl)pyridazin-6-yl, and common for α7 agonists quinuclidine, as a cationic pharmacophoric element. Compound <b>43</b> displayed high affinity binding to α7 nAChRs [rat or human cortex, [<sup>3</sup>H](1<i>S</i>,4<i>S</i>)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane (A-585539, <b>57</b>),<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a><i>K</i><sub>i</sub> = 0.2–0.6 nM, or [<sup>3</sup>H]MLA, 7 nM] that was at least 100-fold selective versus non-α7 nAChRs and other receptors. Functionally, <b>43</b> did not evoke detectible currents in <i>Xenopus</i> oocytes expressing human or non-human α3β4, chimeric (α6/α3)β4, or 5-HT<sub>3A</sub> receptors, and weak or negligible Ca<sup>2+</sup> responses in human neuroblastoma IMR-32 cells (α3* function) and human α4β2 and α4β4 nAChRs expressed in human embryonic kidney 293 cells. Compound <b>43</b> potently evoked human and rat α7 nAChR current responses in oocytes (EC<sub>50</sub> of 50–90 nM total charge, ∼80% normalized to acetylcholine) and enhanced spontaneous inhibitory postsynaptic current activity in dentate gyrus granule cells. Both effects were augmented by the positive allosteric modulator 4-[5-(4-chlorophenyl)-2-methyl-3-propionylpyrrol-1-yl]benzenesulfonamide (A-867744). In rat hippocampus, <b>43</b> evoked α7-like currents in rat hippocampus, which were inhibited by the α7 antagonist MLA. In the presence of <b>11</b>, the addition of <b>43</b> elicited MLA-sensitive α7 nAChR mediated Ca<sup>2+</sup> signals in IMR-32 cells and rat cortical cultures and enhanced extracellular signal-regulated kinase phosphorylation in differentiated PC-12 cells. Compound <b>43</b> was also effective in protecting rat cortical cultures against glutamate-induced toxicity.</div><div class="NLM_p">In in vivo experiments,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a><b>43</b> improved cognition in monkey delayed matching to sample, rat social recognition, and mouse two-trial inhibitory avoidance and continued to improve cognitive performance at times when exposure levels continued to decline. Rats concurrently infused with <b>43</b> and donepezil at steady-state levels consistent with clinical exposure showed improved short-term recognition memory. Compared with nicotine, <b>43</b> did not produce behavioral sensitization in rats or exhibit psychomotor stimulant activity in mice. Repeated (3 days) daily dosing of <b>43</b> increased extracellular cortical acetylcholine in rats, whereas acute administration increased cortical extracellular signal-regulated kinase and cAMP response element-binding protein phosphorylation in mice, neurochemical and biochemical events relevant to cognitive function. Compound <b>43</b> increased cortical phosphorylation of the inhibitory residue (Ser9) of glycogen synthase kinase-3, a primary tau kinase associated with Alzheimer’s disease pathology. In addition, continuous infusion of <b>43</b> in tau/amyloid precursor protein transgenic AD mice reduced spinal tau hyperphosphorylation. Compound <b>43</b> exhibited a preclinical efficacy profile that included (1) PD–PK discordance consistent with prolonged biochemical signaling germane to synaptic plasticity and enhanced cognition, (2) maintenance of efficacy with concurrent use of an AChEI, and (3) lack of nicotine-like abuse liability and CNS stimulatory activity. These findings show that targeting α7 nAChRs may have potential utility for symptomatic alleviation and slowing of disease progression in the treatment of Alzheimer’s disease.</div><div class="NLM_p last">In clinical trials,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a><b>43</b> was well tolerated over the tested single (1–100 mg) and multiple (2–15 mg once daily for 7 days) dose range; however, it exhibited nonlinear pharmacokinetics. Its development was discontinued in 2009.</div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Monocyclic Amines</h3><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5-(Morpholin-4-yl)pentanoic Acid 4-(Pyridin-3-yl)phenyl)amide (WAY-317538)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0017.gif" alt="" id="fx20" /></img></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-[6-(4-Fluorophenyl)pyridin-3-yl]-3-[4-(piperidin-1-yl)butyl]urea (WYE-103914).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></h4><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0018.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>45</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last"><i>N</i>-{4-[4-(2,4-Dimethoxyphenyl)piperazin-1-yl]butyl}-4-pyridin-2-ylbenzamide (<b>46)</b> was identified as a weak partial agonist of α7 nAChRs (EC<sub>50</sub> = 2.8 μM) after high throughput screening. The number of rotatable bonds, hydrogen bond acceptors, and relatively high molecular weight could negatively impact brain permeability of the compound. After extensive exploration, three modifications were accomplished: the amide moiety was reversed providing aromatic amides; the arylpiperazine was replaced with cyclic amines such as piperidine and morpholine; a pyridin-3-yl was incorporated instead of a pyridin-2-yl. Compound <b>44</b><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> was developed within a Siena Biotech–Wyeth collaboration and chosen to be evaluated in in vivo efficacy models based on its generally good in vitro profile, ease of synthesis, and selectivity on a related panel of nicotinic (α1*, α3*, α4β2) and highly homologous 5HT<sub>3A</sub>Rs. When the compound was tested at 10 μM in a panel of ∼70 binding sites including all major classes of neurotransmitter, growth factor, and peptide receptors, no significant activity was observed except at the histamine H<sub>3</sub> receptor, where binding was observed leading to receptor antagonism. In vivo, <b>44</b> improved performance in rodent behavioral assays of cognitive function and perceptual processing, producing enhancement of normal memory performance. The ability to attenuate pharmacologically induced deficits via either the glutamatergic or cholinergic system was demonstrated as well. Treatment with <b>44</b> (3 mg/kg, ip) minimized spontaneous decay of episodic memory in a novel object recognition task in rats; the compound was able to reverse both a scopolamine and MK-801-induced deficit in the pharmacological models for these recognition memory tests.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> To further improve both potency and selectivity, the more basic piperidine was chosen as a cationic center instead of morpholine in compound <b>47</b>, and the chain length between cationic center and hydrogen bond acceptor was increased by the addition of a nitrogen yielding urea <b>48</b>. Compound <b>49</b> containing pyridin-2-yl fragment showed improved selectivity against the homologous ganglionic receptor α3* and reduction of cytochrome P450 2D6 inhibition. Given that lipophilicity tends to be one of the major factors in molecular recognition by the cytochrome family of enzymes,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> a number of analogues, where pyridine replaced the first phenyl ring of the biaryl system, were synthesized. The pyridine nitrogen was maintained, potentially pointing to the same binding area as in compound <b>49</b>. Considering the overall excellent spectrum of activity and selectivity shown, compound <b>45</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>)<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> was selected for further studies. Compound <b>45</b> displayed efficacy in assays of cognitive function and perceptual processing, showing an ability to attenuate pharmacologically induced deficits via the glutamatergic system. It reversed MK-801 induced deficits in both the novel object recognition and prepulse inhibition models with a minimum efficacious dose of 3 mg/kg in spite of the relatively moderate brain to plasma ratio 0.3. Unlike <b>44</b>, for which efficacy was observed after ip administration, activity of <b>45</b> was observed in both models after oral administration.</div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Miscellaneous</h3><div id="sec2_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 8-Methyl 8-Azabicyclo[3.2.1]octan-3-yl)-(1<i>H</i>)-indole-3-carboxylate (Tropisetron)<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></h4><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0019.gif" alt="" id="fx22" /></img><div class="NLM_p">Since both α7 nAChRs and 5HT<sub>3</sub>Rs belong to the ligand-gated ion channel family, there are a number of 5HT<sub>3</sub>R ligands with affinity and functional activity at α7 nAChRs and vice versa. The 5HT<sub>3</sub>R antagonist (<i>K</i><sub>i</sub> = 5.3 nM) <b>50</b>, which is available in Europe for the treatment of emesis, is a potent and selective partial agonist (<i>K</i><sub>i</sub> = 6.9 nM, EC<sub>50</sub> = 1.3 μM, <i>E</i><sub>max</sub> = 36%) for the α7 nAChR.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Its unremarkable safety profile can be interpreted as demonstrating the safety of both 5HT<sub>3</sub>R antagonist and α7 nAChR partial agonist mechanistic approaches. The discovery that <b>50</b> is also a potent partial agonist for α7 nAChRs gives cause for the re-examination of both clinical and preclinical findings with this compound, particularly when <b>50</b> displayed pharmacological effects different from other 5HT<sub>3</sub>R antagonists. It was reported that the 5HT<sub>3</sub>R antagonists <b>50</b> and ondansetron had qualitatively different results in learning and memory paradigms in rats;<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a><b>50</b>, but not the selective 5-HT<sub>3</sub> receptor antagonist ondansetron, attenuated PCP-induced cognitive deficits in mice, and this effect of <b>50</b> was blocked by coadministration of the selective α7 nAChR antagonist MLA.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> By use of [<sup>11</sup>C]CHIBA-1001 and PET imaging techniques, it was found that <b>50</b>, but not ondansetron, after a single oral administration (5, 10, or 20 mg), binds to α7 nAChRs in the intact human brain in a dose-dependent manner. All of these results substantiated a clinical trial of <b>50</b> in patients with cognitive deficits in schizophrenia.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Compound <b>50</b> (10 mg/day for 8 weeks), but not placebo, significantly improved auditory sensory gating P50 deficits in patients with schizophrenia and had a significant impact on the sustained visual attention in nonsmoking patients. Overall, the clinical study suggests that the α7 nAChR agonist <b>50</b> might be a potential therapeutic drug for cognitive deficits in schizophrenia. Some additional clinical trials (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were conducted with <b>50</b> in patients with attention in nonsmoking patients. Overall, the clinical study suggests that the α7 nAChR agonist <b>50</b> might be a potential therapeutic drug for cognitive deficits in schizophrenia. Some additional clinical trials (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) conducted with <b>50</b> in patients with musculoskeletal and connective tissue disorders and fibromyalgia might also indicate an effect of α7 nicotinic partial agonism. Recently, it has been shown that <b>50</b> attenuates place aversion induced by naloxone in single-dose morphine-treated rats via the α7 nAChR, implicating α7 nicotinic receptors as viable therapeutic targets for opiate withdrawal syndrome.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Clinical Trials Conducted with Tropisetron</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">study</th><th class="colsep0 rowsep0" align="center">therapeutic group</th><th class="colsep0 rowsep0" align="center">condition</th><th class="colsep0 rowsep0" align="center">design</th><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">pop no.</th><th class="colsep0 rowsep0" align="center">conclusions/objectives</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b> in osteoarthritis: the Freiburg and Posnan study<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></td><td class="colsep0 rowsep0" align="left">musculoskeletal and connective tissue disorders</td><td class="colsep0 rowsep0" align="left">osteoarthritis</td><td class="colsep0 rowsep0" align="left">open; pooled/meta-analysis</td><td class="colsep0 rowsep0" align="left">Freiburg study: <b>50</b>, 5 mg i.art.; <b>50</b>, 5 mg i.art. on d 1, 3, and 5; Posnan study: <b>50</b>, 5 mg i.art. on d 1 and 3</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"><b>50</b> appeared to provide pain relief in patients with osteoarthritis of the knee with inflammatory reactions.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b> in tendopathies<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></td><td class="colsep0 rowsep0" align="left">musculoskeletal and connective tissue disorders</td><td class="colsep0 rowsep0" align="left">arthropathy</td><td class="colsep0 rowsep0" align="left">double-blind; randomized</td><td class="colsep0 rowsep0" align="left"><b>50</b>, 2 mg i.art.; prilocaine, 10 mg i.art.</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left"><b>50</b> had a longer effect than prilocaine on resting pain and pain on movement in patients with tendopathies or periarthropathies.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b> in tendopathies<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></td><td class="colsep0 rowsep0" align="left">musculoskeletal and connective tissue disorders</td><td class="colsep0 rowsep0" align="left">tendinitis</td><td class="colsep0 rowsep0" align="left">double-blind; randomized</td><td class="colsep0 rowsep0" align="left"><b>50</b>, 2 mg i.art.; prilocaine, 10 mg i.art.</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left"><b>50</b> had a longer effect than prilocaine on resting pain and pain on movement in patients with tendopathies or periarthropathies.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b> vs dexamethasone/lidocaine in periarthritis<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></td><td class="colsep0 rowsep0" align="left">musculoskeletal and connective tissue disorders</td><td class="colsep0 rowsep0" align="left">arthritis</td><td class="colsep0 rowsep0" align="left">comparative; double-blind; multicenter; randomized</td><td class="colsep0 rowsep0" align="left"><b>50</b>, 5 mg by local injection; dexamethasone, 10 mg + lidocaine by local injection</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left"><b>50</b> was as effective as dexamethasone/lidocaine for the treatment of periarthritis.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b> in fibromyalgia<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></td><td class="colsep0 rowsep0" align="left">pain</td><td class="colsep0 rowsep0" align="left">fibromyalgia</td><td class="colsep0 rowsep0" align="left">double-blind; multicenter; placebo-controlled; randomized</td><td class="colsep0 rowsep0" align="left"><b>50</b>, 5 mg iv bolus o.d. × 5 d; placebo</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left"><b>50</b> was well tolerated and effective in relieving pain in patients with fibromyalgia.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b> in fibromyalgia<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td><td class="colsep0 rowsep0" align="left">pain</td><td class="colsep0 rowsep0" align="left">fibromyalgia</td><td class="colsep0 rowsep0" align="left">open</td><td class="colsep0 rowsep0" align="left"><b>50</b>, 5 mg iv bolus × 5 y</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left"><b>50</b> improved fibromyalgia pain in patients with or without depression.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b> in myofascial pain<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></td><td class="colsep0 rowsep0" align="left">pain</td><td class="colsep0 rowsep0" align="left">pain, myofascial syndrome</td><td class="colsep0 rowsep0" align="left">multicenter; open</td><td class="colsep0 rowsep0" align="left"><b>50</b>, 5 mg/d injected into trigger point × 7 d</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">Local injections of <b>50</b> relieved pain in trigger and tender points.</td></tr></tbody></table></div></div><div class="NLM_p">The α7 nAChR agonist AQW051 (Novartis, structure not disclosed) is currently in phase II clinical trials in Alzheimer’s disease and schizophrenia. Targacept has announced separate phase II clinical studies of the α7 nAChR modulator TC-6987 (structure not disclosed) for disorders characterized by inflammation, one in asthma and one in type 2 diabetes. The pharmacological characteristics of these compounds have not been disclosed.</div><div class="NLM_p">Affinities to α7 nAChRs and 5-HT<sub>3</sub>Rs for the advanced compounds are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> to provide a quick guide for their selectivity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Affinities to α7 nAChR and 5-HT<sub>3</sub>R for the Advanced Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>i</sub>, nM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">α7 nAChR</th><th class="colsep0 rowsep0" align="center">5-HT<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">2.5% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">1662</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">511</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">2800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">299 (IC<sub>50</sub>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">25% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">20% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"><50% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">200 (<i>K</i><sub>d</sub>)</td><td class="colsep0 rowsep0" align="left">13000 (<i>K</i><sub>d</sub>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"><50% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">13.5</td><td class="colsep0 rowsep0" align="left">269</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">4% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left"><50% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left"><50% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">5.3</td></tr></tbody></table></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Positive Allosteric Modulators (PAMs)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As an alternative to activation of a receptor with an exogenous orthosteric agonist, positive allosteric modulators (PAMs) enhance receptor function elicited by the endogenous ligand without directly activating or desensitizing the target receptor.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> There are differences in the pharmacological profiles of positive allosteric modulators of the α7 nAChRs versus orthosteric modulators.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a> Type I PAMs increase the apparent peak amplitude agonist-evoked responses with minor effects on current desensitization/deactivation. For type II PAMs, peak current is dramatically increased and there is a significant prolongation of the current decay, suggesting attenuated desensitization/deactivation. The ramification on safety profiles of chronic treatment with agonists (orthosteric modulators) affecting α7 nAChRs is not yet clear; the benefit of this approach may be suboptimal because of the unknown long-term impact of sustained activation and desensitization of the nAChRs. In this context, allosteric modulation of the α7 nAChR was introduced as a novel therapeutic principle for treating cognitive dysfunction associated with various forms of dementia and schizophrenia without the potential downside of sustained orthosteric agonism of nicotinic receptors. However, according to recent studies,<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> repeated administration of α7 nAChR orthosteric agonists leads to significantly increased [<sup>125</sup>I]Bgt binding, not only in the prefrontal regions as seen with acute treatment but also in the parietal cortex and hippocampus. Such up-regulation observed with orthosteric agonists of the α7 nAChRs does not occur with PAMs.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(5-Chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea (PNU-120596)<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0020.gif" alt="" id="fx23" /></img><div class="NLM_p last">Compound <b>51</b>,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> discovered in high-throughput screening, increased peak agonist-evoked currents mediated by human wild-type receptors expressed in <i>Xenopus</i> oocytes and in rat hippocampal neurons. It also demonstrated a pronounced prolongation of the evoked response in the continued presence of agonist. Compound <b>51</b> produced no detectable change in currents mediated by α4β2, α3β4, and α9α10 nAChRs. Compound <b>51</b> increased the channel mean open time of α7 nAChRs but had no effect on ion selectivity and relatively little, if any, effect on unitary conductance. Subsequent application of <b>51</b> on desensitized receptors in the continued presence of nicotine resulted in a reactivation of the agonist-bound receptor. Co-treatment of neurons with both <b>51</b> and the selective α7 nAChR antagonist MLA (10 nM) abolished the ACh-evoked current, indicating that <b>51</b> was acting at α7-containing nAChRs. When applied to acute hippocampal slices, <b>51</b> increased the frequency of ACh-evoked GABAergic postsynaptic currents measured in pyramidal neurons; this effect was suppressed by tetrodotoxin, suggesting that <b>51</b> modulated the function of α7 nAChRs located on the somatodendritic membrane of hippocampal interneurons. Systemic administration of <b>51</b> to rats improved the auditory gating deficit caused by amphetamine. Consistent with its classification as a type II PAM, <b>51</b> affects desensitization and prolongs excitatory synaptic events that could have excitotoxic consequences. Compound <b>51</b> was reported to be neurotoxic in an in vitro model,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> although in vivo toxicity studies have not been reported for the compound.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(5-Fluoro-2,4-dimethoxyphenyl)-3-[3-(trifluoromethyl)isoxazol-5-yl]urea (PHA-758454)<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0021.gif" alt="" id="fx24" /></img><div class="NLM_p last">To establish an initial SAR around <b>51</b>, a library of closely related <i>N</i>-aryl-<i>N</i>′-heteroarylureas were screened and analyzed. Optimization resulted in compounds with enhanced potency and improved physical and ADME properties. Compound <b>52</b><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> maintained selectivity versus other nAChRs and was selected for further characterization. In the presence of ACh, <b>52</b> enhanced evoked calcium currents in rat hippocampal neurons. In a rat model of impaired sensory gating, <b>52</b> reversed amphetamine induced disruption of hippocampal auditory gating at 0.1 and 0.3 mg/kg.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-(5-Chloro-2-hydroxyphenyl)-3-(2-chloro-5-trifluoromethylphenyl)urea (NS1738)<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0022.gif" alt="" id="fx25" /></img><div class="NLM_p last">In the presence of ACh, <b>53</b><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> produced a marked increase in the current flowing through α7 nAChRs, as determined in both oocyte electrophysiology and patch-clamp recordings from mammalian cells. Compound <b>53</b>, a type I PAM, increased the peak amplitude of ACh-evoked currents at all concentrations with only marginal effects on the desensitization kinetics of α7 nAChRs. Mechanistically, <b>53</b> modulates the activity of the α7 nAChR by facilitating the energetic coupling between agonist binding and ion channel gating, thereby increasing the receptor open probability at all ACh concentrations. However, this enhanced efficiency of the binding-gating coupling is dissociated from the energetics of the desensitization process, which proceeds with nearly unaltered kinetics. Compound <b>53</b> (10 and 30 mg/kg) improved performance to the same extent as (−)-nicotine in the social recognition test, a model of short-term memory, and it reversed the cognitive impairment induced by (−)-scopolamine of acquisition of a water-maze learning task (at 30 mg/kg), a model of long-term spatial memory.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(4-Chlorophenyl)-3-(4-chlorophenylamino)-2-(3-methylisoxazol-5-yl)acrylamide (XY4083)<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0023.gif" alt="" id="fx26" /></img><div class="NLM_p last">Compound <b>54</b> was developed on the hypothesis that the GABA<sub>A</sub> and α7 nAChR exhibit sufficient homology to allow the discovery of compounds that simultaneously modulate both receptors. The above compound increased the apparent potency of ACh by 2.7-fold in oocytes expressing the human α7 nAChR, potentiated EC<sub>5</sub> nicotine-evoked currents at α7 nAChRs in oocytes while preserving the rapid activation and deactivation kinetics of the native channel. It did not reverse desensitization evoked by extended exposure to nicotine. Compound <b>54</b> did not induce modulation of EC<sub>5</sub>-evoked currents at human α4β2, rat α3β4, and mouse α1β1γδ nAChR subtypes or human 5-HT<sub>3A</sub> receptors expressed in oocytes and evoked low efficacy concentration dependent positive modulation of submaximal GABA-evoked currents at human GABA<sub>A</sub> α1β2γ2L receptors expressed in oocytes. Compound <b>54</b> was active in three rodent models relevant to cognition and schizophrenia: sensory gating deficits in a DBA2 mouse at 0.3 mg/kg, MK-801-induced hyperlocomotion in NSA mice at 0.3–3 mg/kg, and the eight-arm radial maze in rats at 3 mg/kg ip.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-Methyl-<i>N</i>-(pyridin-3-yl)-2,3-dihydropyrrolo[2,3-<i>f</i>]indole-1-carboxamide (SB-206553)<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0024.gif" alt="" id="fx27" /></img><div class="NLM_p last">The 5-HT<sub>2B/C</sub> receptor antagonist <b>55</b><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> was identified as PAM<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> in a randomized screening effort and was further confirmed and characterized using different functional assays of α7 nAChR activation, both in a recombinant cell line and natively expressed receptors in hippocampal slices. Compound <b>55</b> produced an 8-fold potentiation of the evoked calcium signal in the presence of an EC<sub>20</sub> concentration of nicotine and a corresponding EC<sub>50</sub> of 1.5 μM for potentiation of EC<sub>20</sub> nicotine responses in GH4C1 cells expressing the α7 receptor. Compound <b>55</b> was devoid of direct α7 receptor agonist activity and selective against other nicotinic receptors. Native nicotinic receptors in CA1 stratum radiatum interneurons of rat hippocampal slices were activated by ACh (200 μM), an effect that was entirely blocked by the α7-selective antagonist MLA. Compound <b>55</b> does not share the profound prolongation of desensitization kinetics with <b>51</b> and is closer to a type I PAM. In behavioral assays, <b>55</b> reversed MK-801-disrupted prepulse inhibition, indicating that other α7 nAChR PAMs may be active in a model of sensorimotor gating relevant to schizophrenia pathology. Subsequently, it was demonstrated that the reversal of MK-801-disrupted prepulse inhibition by <b>55</b> was attenuated by MLA. This supports the notion that the in vivo pharmacological activity of <b>55</b> is driven by its α7 PAM profile and not its 5-HT<sub>2B/C</sub> receptor antagonism profile.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4-[5-(4-Chlorophenyl)-2-methyl-3-propionyl-1<i>H</i>-pyrrol-1-yl]benzenesulfonamide (A-867744)<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0025.gif" alt="" id="compd56" /></img><div class="NLM_p last">Compound <b>56</b><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> was discovered by optimization of a hit that was identified in high-throughput screening. In oocytes expressing α7 nAChR, <b>56</b> potentiated ACh-evoked currents, with an EC<sub>50</sub> of 1 μM. In the presence of <b>56</b>, ACh concentration responses were potentiated by increases in potency, Hill slope, and maximal efficacy. The compound, as type II PAM, not only enhances the ACh-evoked currents but also slows the desensitization profile of agonist responses.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> When examined in rat hippocampus CA1 stratum radiatum interneurons or dentate gyrus granule cells, <b>56</b> (10 μM) increased ACh-evoked α7 currents and recovery from inhibition/desensitization and enhanced spontaneous inhibitory postsynaptic current activity. Compound <b>56</b> did not displace the binding of [<sup>3</sup>H]MLA to rat cortex α7* nAChRs but displaced the binding of the agonist <b>57</b> in rat cortex, with a <i>K</i><sub>i</sub> of 23 nM. Compound <b>56</b> neither increased agonist-evoked responses nor displaced the binding of <b>57</b> in an α7/5-HT<sub>3</sub> chimera, suggesting an interaction distinct from the α7 N-terminus or M2–M3 loop. In a panel of receptor binding assays for >70 diverse neurotransmitter receptor and ion channel sites (CEREP), no significant interaction at any of the targets (>50% displacement of test ligand) was observed at the screening concentration of 10 μM. Since <b>56</b> demonstrated acceptable animal pharmacokinetics and safety profiles, it was tested in vivo in the DBA/2 mouse. In a paired auditory stimulus paradigm, <b>56</b> (0.1–10.0 μmol/kg, ip) improved sensory gating deficits, reducing the ratio of the response to test stimulus relative to the preceding response to conditioning stimulus (<i>T</i>/<i>C</i> ratio).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> SLURP-1</h3><div class="NLM_p last">SLURP-1, secreted mammalian Ly-6/uPAR-related protein 1, that is encoded by the SLURP-1 gene and structurally similar to the snake venom toxin α-bungarotoxin has been identified as a modulator of the human α7 nAChR.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> The lack of action of SLURP-1 in the absence of acetylcholine and its important potentiation of the acetylcholine response suggest that SLURP-1 acts as a positive allosteric effector at the α7 receptor. SLURP-1 (200 pM and 20 nM) enhanced the amplitude of Ach-evoked currents in <i>Xenopus</i> oocytes expressing recombinant human α7 nAChRs by 421% and 1214%, respectively. A concentration–response curve of ACh in the presence of 200 pM SLURP-1 indicates that the protein increases both ACh potency and efficacy at the α7 nAChR. Since SLURP-1 potentiates the human α7 nAChRs that are present in keratinocytes, the PAM was identified as a secreted epidermal neuromodulator which is essential for both epidermal homeostasis and inhibition of TNF-α release by macrophages during wound healing.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although extensive efforts have been taken to identify selective α7 nAChR agonists, the development of selective antagonists is limited by comparison. Natural toxins α-bungarotoxin (α-Bgt) and methyllycaconitine (MLA) are two frequently used α7 nAChR selective antagonists. α7 nAChR selective antagonists recently have been explored as potential treatments for non-small-cell lung cancer<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> and for organophosphorus nerve agent intoxication.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> DECCSNPACRLNNPHDCRRR (Amino Acid Sequence) (α-CtxArIB[V11L,V16D]).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></h3><div class="NLM_p last">Cone snails (genus <i>Conus</i>) produce a vast array of peptide toxins that target ion channels, including nAChRs, with exceptional selectivity.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The conopeptide family that targets nAChRs, α-conotoxins (α-Ctxs), consists of small (13–19 residue) peptides, internally cross-linked by a pair of disulfide bridges. α-Conotoxins target narrow ranges of nAChR subtypes, and sometimes individual subtypes, with an unprecedented degree of specificity. Since α-Ctxs are short peptides, they and their analogues may be synthesized by standard peptide synthesis techniques. Optimization of peptide from <i>Conus arenatus</i> resulted in the selective analogue α-CtxArIB[V11L,V16D]) (<b>58</b>),<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> which was 800- to >10000-fold more potent against α7 (IC<sub>50</sub> = 1.09 nM) than all other nAChR subtypes expressed in <i>Xenopus</i> oocyte with minute-scale on-rate and off-rate kinetics. When tested against native nAChR subtypes in displacement binding assays, it also showed low nanomolar affinity for α7 and poor to no affinity for non-α7 nAChR subtypes. Activity of <b>58</b> on native nAChRs was assessed in competition binding studies using mouse brain and <i>Torpedo</i> electroplax homogenates. Compound <b>58</b> displaced [<sup>125</sup>I]α-Bgt binding in mouse hippocampal membranes with a <i>K</i><sub>i</sub> of 7.04 nM. Compound <b>58</b> interacts with five ligand binding sites per α7 receptor, and occupation of a single site is sufficient to block function.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (−)-4-Allyl-1-ethyloctahydroquinolizine (Quinolizidine (−)-1-epi-207I)<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0026.gif" alt="" id="compd59" /></img><div class="NLM_p last">Extracts from the skin of certain poison frogs provide a variety of pharmacologically active alkaloids, and more than 500 alkaloids have been isolated to date.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> The 1,4-disubstituted quinolizidine <b>59</b><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> was discovered by study of amphibian bicyclic alkaloids in <i>Xenopus laevis</i> oocytes expressing major types of neuronal nicotinic receptors (α4β2, α7, α3β2, α3β4, and α4β4). It selectively blocked α7 acetylcholine-elicited currents (IC<sub>50</sub> = 0.6 μM) with an 8.7-fold higher sensitivity than blockade of α4β2 receptor responses (IC<sub>50</sub> = 5.2 μM) and a 14.7-fold higher blockade than that of α3β4 receptor responses (IC<sub>50</sub> = 8.8 μM). (−)-4-allyl-1-ethyloctahydroquinolizine is a noncompetitive inhibitor of α7 nAChRs.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Imidazole and Triazole Carboxamides</h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0027.gif" alt="" id="compd60-62" /></img><div class="NLM_p last">Recently, two series of selective α7 nAChR antagonists were described.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The functional activity of compounds <b>60</b>, <b>61</b>, and <b>62</b> was determined by electrophysiological experiments on <i>Xenopus</i> oocytes expressing human α7 nAChRs. These three compounds inhibited acetylcholine-evoked receptor responses in a dose-dependent manner with IC<sub>50</sub> values of 11.9, 3.7, and 18.9 μM for compounds <b>60</b>, <b>61</b>, and <b>62</b>, respectively. The selectivity of compounds <b>60</b> and <b>62</b> was measured against three receptors: neuronal α4β2 nAChRs, muscle-type nAChRs, and 5HT<sub>3</sub>Rs. At 10 μM, compound <b>60</b> exhibited 82.5% displacement of radioligand to α7 nAChRs and 18.8% and 8.4% to neuronal α4β2 nAChRs and 5HT<sub>3</sub>Rs, respectively. Similarly, compound <b>62</b> showed displacement of 82.5% to α7, 1.3% to α4β2, and 14.3% to 5HT<sub>3</sub>Rs. Both compounds exhibited no detectable binding to the muscle-type nAChRs at 10 μM. Antagonists <b>61</b> and <b>62</b> were tested in a toxicity animal model using the organophosphorus nerve agent diisopropyl fluorophosphate (DFP) to investigate their antiseizure activity. Compared with DFP controls, pretreatment with compounds <b>61</b> and <b>62</b> antagonized DFP-induced seizure-like behaviors over a 2 h period after injection by 93.4% and 91.2%, respectively. The results suggest that these compounds could provide neuroprotection against seizure-like behaviors induced by DFP and therefore may be useful for treatment of organophosphorus nerve agent intoxication.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Intense research of α7 nAChRs for the past decade has revealed their critical roles in cognitive processes, neuroprotection, sensory gating, and cytokine-mediated inflammation. Discovery and development of structurally diverse selective ligands have motivated the initiation of clinical trials in neuropathological conditions and diseases such as AD, schizophrenia, and intractable immune and inflammatory conditions such as type 2 diabetes and asthma (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Therapeutic agents used to treat AD today, such as acetylcholine esterase inhibitors and glutamate-NMDA receptor antagonists, only provide modest symptomatic relief. Therefore, a major challenge in developing improved AD pharmacotherapies is identifying disease-modifying mechanisms, in addition to symptomatic reducton. Recently revealed results indicate that α7 nAChR agonism may provide both symptomatic and disease-modifying efficacy in the treatment of AD. A few α7 nAChR agonists (<b>22</b>, <b>23</b>, <b>50</b>) demonstrated positive results in clinical trials. However, the termination of promising clinical candidates, such as <b>9</b>, <b>12</b>, <b>13</b>, <b>20</b>, reflects the challenges of developing new agents for the treatment of cognitive impairment in AD and in schizophrenia. While the clinical utility of α7 nAChR agonists continues to be evaluated, results of clinical trials appearing in the peer reviewed literature are still anticipated. Continued discovery and evaluation of PAMs with novel areas of chemical space provide an opportunity to improve our understanding of this drug target, whereas further development of pharmaceutically relevant antagonists might expand the therapeutic potential of α7 nAChRs.</div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0028.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. α7 nAChR product development pipeline. Gray bars with black cross indicate that development of the drug candidates was discontinued. White bars designate successful or ongoing clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anatoly A. Mazurov</span> - <span class="hlFld-Affiliation affiliation">Targacept, Inc., 200 E. First Street, Winston-Salem, North Carolina 27101-4165, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0f6e616e7b60637621626e757a7d60794f7b6e7d686e6c6a7f7b216c6062"><span class="__cf_email__" data-cfemail="7d1c131c0912110453101c07080f120b3d091c0f1a1c1e180d09531e1210">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason D. Speake</span> - <span class="hlFld-Affiliation affiliation">Targacept, Inc., 200 E. First Street, Winston-Salem, North Carolina 27101-4165, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Yohannes</span> - <span class="hlFld-Affiliation affiliation">Targacept, Inc., 200 E. First Street, Winston-Salem, North Carolina 27101-4165, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm2007672" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Anatoly A. Mazurov</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Anatoly A. Mazurov</b> is a medicinal chemist based at Targacept, Inc. He earned his Ph.D. at Mechnikov-University, former USSR, under the supervision of Professor S. A. Andronati in the field of chemistry of biologically active compounds. He has worked on CNS and CV drug discovery projects in Alanex, Inc. (later became Pfizer), Astra Hässle (later became AstraZeneca) and joined Targacept, Inc. in 2000. His current research interests include nicotinic acetylcholine receptors as therapeutic targets.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Jason D. Speake</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jason D. Speake</b> is the Group Leader of Medicinal Chemistry at Targacept, Inc. in Winston-Salem, NC. Jason obtained his Ph.D. in 1997 at Indiana University in the laboratories of Paul Grieco, accomplishing the total synthesis of biologically interesting natural products and analogues. He then moved to the medicinal chemistry group at GlaxoWellcome (later GlaxoSmithKline) in North Carolina, where he worked primarily in CNS mediated metabolic disorders. In 2008, Jason transitioned to Targacept to lead the medicinal chemistry group in the discovery of therapeutic agents targeting neuronal nicotinic receptors.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Daniel Yohannes</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniel Yohannes</b>, Ph.D., is the Senior Director of Drug Discovery at Targacept, where he is responsible for the functions of molecular design, medicinal chemistry, research compound management, and chemical process research. Daniel completed his Ph.D. in the synthesis of natural products in 1991 at Purdue University, IN, after which he completed a National Institutes of Health funded postdoctoral position at Yale University, CT. He then spent 8 years with Pfizer in Neuroscience Medicinal Chemistry, the majority of which was spent in drug discovery in ligand-gated ion channels (nicotinic and GABA<sub>A</sub> receptors). He later took positions of increased responsibilities as Director of Medicinal Chemistry at Infinity Pharmaceuticals and then as Director of Chemistry at ArQule, Inc. before coming to Targacept, where he has been for 6 years.</p></figure></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49"> Abbreviations Used</h2><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADHD</td><td class="NLM_def"><p class="first last">attention deficit/hyperactivity disorder</p></td></tr><tr><td class="NLM_term">α-Bgt</td><td class="NLM_def"><p class="first last">α-bungarotoxin</p></td></tr><tr><td class="NLM_term">nAChR</td><td class="NLM_def"><p class="first last">nicotinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P</p></td></tr><tr><td class="NLM_term">DBA/2</td><td class="NLM_def"><p class="first last">dilute brown non-agouti</p></td></tr><tr><td class="NLM_term">DMTS</td><td class="NLM_def"><p class="first last">delayed matching-to-sample test</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal injection</p></td></tr><tr><td class="NLM_term">MATRICS</td><td class="NLM_def"><p class="first last">measurement and treatment research to improve cognition in schizophrenia</p></td></tr><tr><td class="NLM_term">MED</td><td class="NLM_def"><p class="first last">minimally effective dose</p></td></tr><tr><td class="NLM_term">MLA</td><td class="NLM_def"><p class="first last">methyllycaconitine</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral administration</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">prepulse inhibition</p></td></tr><tr><td class="NLM_term">SHR</td><td class="NLM_def"><p class="first last">spontaneously hypertensive rat</p></td></tr><tr><td class="NLM_term">SH-SY5Y</td><td class="NLM_def"><p class="first last">human neuroblastoma cell line</p></td></tr><tr><td class="NLM_term"><i>th(tk−)/th(tk−)</i></td><td class="NLM_def"><p class="first last">homozygous transgenic mouse</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 97 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gurley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanthorn, T. H.</span><span> </span><span class="NLM_article-title">Nicotinic agonists competitively antagonize serotonin at mouse 5HT<sub>3</sub> receptors expressed in <i>Xenopus</i> oocytes</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1998&pages=107-110&author=D.+A.+Gurleyauthor=T.+H.+Lanthorn&title=Nicotinic+agonists+competitively+antagonize+serotonin+at+mouse+5HT3+receptors+expressed+in+Xenopus+oocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurley%26aufirst%3DD.%2BA.%26aulast%3DLanthorn%26aufirst%3DT.%2BH.%26atitle%3DNicotinic%2520agonists%2520competitively%2520antagonize%2520serotonin%2520at%2520mouse%25205HT3%2520receptors%2520expressed%2520in%2520Xenopus%2520oocytes%26jtitle%3DNeurosci.%2520Lett.%26date%3D1998%26volume%3D247%26spage%3D107%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Karlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akabas, M. H.</span><span> </span><span class="NLM_article-title">Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=1231-1244&author=A.+Karlinauthor=M.+H.+Akabas&title=Toward+a+structural+basis+for+the+function+of+nicotinic+acetylcholine+receptors+and+their+cousins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarlin%26aufirst%3DA.%26aulast%3DAkabas%26aufirst%3DM.%2BH.%26atitle%3DToward%2520a%2520structural%2520basis%2520for%2520the%2520function%2520of%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520their%2520cousins%26jtitle%3DNeuron%26date%3D1995%26volume%3D15%26spage%3D1231%26epage%3D1244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunavs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayhurst, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, L.</span><span> </span><span class="NLM_article-title">High affinity ligands for the α7 nicotinic receptor that show no cross-reactivity with the 5HT<sub>3</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4727</span><span class="NLM_x">–</span> <span class="NLM_lpage">4730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4727-4730&author=S.+R.+Bakerauthor=J.+Bootauthor=M.+Brunavsauthor=D.+Dobsonauthor=R.+Greenauthor=L.+Hayhurstauthor=M.+Keenanauthor=L.+Wallace&title=High+affinity+ligands+for+the+%CE%B17+nicotinic+receptor+that+show+no+cross-reactivity+with+the+5HT3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DBoot%26aufirst%3DJ.%26aulast%3DBrunavs%26aufirst%3DM.%26aulast%3DDobson%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DHayhurst%26aufirst%3DL.%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DWallace%26aufirst%3DL.%26atitle%3DHigh%2520affinity%2520ligands%2520for%2520the%2520%25CE%25B17%2520nicotinic%2520receptor%2520that%2520show%2520no%2520cross-reactivity%2520with%2520the%25205HT3%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4727%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanthorn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J. C.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>3</sub> antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=319-321&author=J.+E.+Macorauthor=D.+Gurleyauthor=T.+Lanthornauthor=J.+Lochauthor=R.+A.+Mackauthor=G.+Mullenauthor=O.+Tranauthor=N.+Wrightauthor=J.+C.+Gordon&title=The+5-HT3+antagonist+tropisetron+%28ICS+205-930%29+is+a+potent+and+selective+%CE%B17+nicotinic+receptor+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DLanthorn%26aufirst%3DT.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DMack%26aufirst%3DR.%2BA.%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DO.%26aulast%3DWright%26aufirst%3DN.%26aulast%3DGordon%26aufirst%3DJ.%2BC.%26atitle%3DThe%25205-HT3%2520antagonist%2520tropisetron%2520%2528ICS%2520205-930%2529%2520is%2520a%2520potent%2520and%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520partial%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D319%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_contrib-group">Thompson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lummis, S. C. R.</span><span> </span><span class="NLM_article-title">5-HT<sub>3</sub> Receptors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3615</span><span class="NLM_x">–</span> <span class="NLM_lpage">3630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F138161206778522029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17073663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFalsL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3615-3630&author=A.+J.+Thompsonauthor=S.+C.+R.+Lummis&title=5-HT3+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT3 receptors</span></div><div class="casAuthors">Thompson, A. J.; Lummis, S. C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3615-3630</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 5-HT3 receptor is a member of the Cys-loop family of ligand-gated ion channels.  These receptors are located in both the peripheral and central nervous systems, where functional receptors are constructed from five subunits.  These subunits may be the same (homopentameric 5-HT3A receptors) or different (heteropentameric receptors, usually comprising of 5-HT3A and 5-HT3B receptor subunits), with the latter having a no. of distinct properties.  The 5-HT3 receptor binding site is comprised of six loops from two adjacent subunits, and crit. ligand binding amino acids in these loops have been largely identified.  There are a range of selective agonists and antagonists for these receptors and the pharmacophore is reasonably well understood.  There are also a wide range of compds. that can modulate receptor activity.  Studies have suggested many diverse potential disease targets that might be amenable to alleviation by 5-HT3 receptor selective compds. but to date only two applications have been fully realized in the clinic: the treatment of emesis and irritable-bowel syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH2ZFrHPWO57Vg90H21EOLACvtfcHk0ljG42bwvYr0_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFalsL%252FN&md5=b4422b7916b7d8e99f8b232f4ec14d06</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.2174%2F138161206778522029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778522029%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DLummis%26aufirst%3DS.%2BC.%2BR.%26atitle%3D5-HT3%2520Receptors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D3615%26epage%3D3630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennuni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Benedetti, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menziani, M. C.</span><span> </span><span class="NLM_article-title">The interaction of 5-HT<sub>3</sub> receptors with arylpiperazine, tropane, and quinuclidine Ligands</span> <span class="citation_source-journal">Curr. Top. Med. Chem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F1568026023393813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=12052196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD38Xksl2jt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=599-624&author=A.+Cappelliauthor=M.+Anziniauthor=S.+Vomeroauthor=L.+Mennuniauthor=F.+Makovecauthor=M.+Hamonauthor=P.+G.+De+Benedettiauthor=M.+C.+Menziani&title=The+interaction+of+5-HT3+receptors+with+arylpiperazine%2C+tropane%2C+and+quinuclidine+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The interactions of the 5-HT3 receptor with arylpiperazine, tropane, and quinuclidine ligands</span></div><div class="casAuthors">Cappelli, Andrea; Anzinj, Maurizio; Vomero, Salvatore; Mennuni, Laura; Makovec, Francesco; Hamon, Michel; De Benedetti, Pier G.; Menziani, M. Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-624</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin 5-HT3 receptor subtype is unique among the receptors for this neurotransmitter because it has been demonstrated to be a ligand-gated ion channel capable of mediating rapid intercellular communication.  This review covers the authors' work performed during more than a decade in the development of 5-HT3 receptor ligands belonging to the classes of arylpiperazines, tropanes, and quinuclidine derivs.  The discussion is focused mainly on what the authors have learned about the interaction of these structurally different ligands with their receptor and shows the way their ideas evolved along with the progress of the project.  Furthermore, a summary of the most significant structure-affinity relationships, derived from the original work, is reported to support the discussion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBgDcXvOA1sLVg90H21EOLACvtfcHk0lgd7rfGcmPtzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xksl2jt7Y%253D&md5=780655968bd7c3b030dd6e257422da4c</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.2174%2F1568026023393813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393813%26sid%3Dliteratum%253Aachs%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DVomero%26aufirst%3DS.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DHamon%26aufirst%3DM.%26aulast%3DDe%2BBenedetti%26aufirst%3DP.%2BG.%26aulast%3DMenziani%26aufirst%3DM.%2BC.%26atitle%3DThe%2520interaction%2520of%25205-HT3%2520receptors%2520with%2520arylpiperazine%252C%2520tropane%252C%2520and%2520quinuclidine%2520Ligands%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem%26date%3D2002%26volume%3D2%26spage%3D599%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span> Dolasetron (Anzemet) product information, Aventis. February<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Dolasetron+%28Anzemet%29+product+information%2C+Aventis.+February+2002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span> Granisetron (Kytril) product information, Roche. August<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Granisetron+%28Kytril%29+product+information%2C+Roche.+August+2002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span> Ondansetron (Zofran) product information, GlaxoSmithKline. May<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Ondansetron+%28Zofran%29+product+information%2C+GlaxoSmithKline.+May+2001."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_contrib-group">Lisi, D. M.</span><span> </span><span class="NLM_article-title">Lotronex withdrawal</span> <span class="citation_source-journal">Arch. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2002&pages=101&author=D.+M.+Lisi&title=Lotronex+withdrawal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLisi%26aufirst%3DD.%2BM.%26atitle%3DLotronex%2520withdrawal%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D2002%26volume%3D162%26spage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hajós, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Targeting α7 nicotinic acetylcholine receptors in the treatment of schizophrenia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F138161210790361434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19909231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVKjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=538-554&author=M.+Haj%C3%B3sauthor=B.+N.+Rogers&title=Targeting+%CE%B17+nicotinic+acetylcholine+receptors+in+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting α7 nicotinic acetylcholine receptors in the treatment of schizophrenia</span></div><div class="casAuthors">Hajos, Mihaly; Rogers, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-554</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The most abundant homomeric nicotinic acetylcholine receptors (nAChRs) in the mammalian brain are the pentameric α7 nAChRs which consist of five α7 subunits, and each subunit provides an orthosteric low affinity binding site for its endogenous ligand, acetylcholine.  Distribution and high level expression of α7 nAChRs within the limbic circuitry, including the hippocampus and prefrontal cortical areas are in line with their involvement in various cognitive functions.  Activation of α7 nAChRs generates a conformational change of sub-unit proteins, making the channel permeable to cations, in particular calcium, leading to change in neuronal activity and excitability, and via increased intracellular calcium, modulating transmitter release and neuronal network activity.  Since genetic linkage studies implicated the α7 nAChRs subunit gene CHRNA7 in schizophrenia, there is a considerable interest for developing drug therapies targeting α7 nAChRs.  In this review recent development of selective agonists and pos. allosteric modulators of α7 nAChRs are discussed.  In addn. to summarizing medicinal chem. efforts, both cellular and neuronal network pharmacol. of α7 nAChRs are covered.  The assocn. between CHRNA7 gene and impaired P50 auditory gating has provided an attractive endophenotype, and its use as a potential translational biomarker for α7 nAChRs drug discovery is discussed.  Preliminary clin. findings on α7 nAChRs agonists are also summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp7AwwIMI237Vg90H21EOLACvtfcHk0lgd7rfGcmPtzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVKjtbc%253D&md5=8ea5d5bcaf0d11b63a31725ebf6e2459</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161210790361434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210790361434%26sid%3Dliteratum%253Aachs%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DTargeting%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D538%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lightfood, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skidmore, J.</span><span> </span><span class="NLM_article-title">α7 Nicotinic acetylcholine receptor agonists and positive allosteric modulators</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0079-6468%2807%2900003-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=18381125" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=131-171&author=A.+P.+Lightfoodauthor=J.+N.+C.+Kewauthor=J.+Skidmore&title=%CE%B17+Nicotinic+acetylcholine+receptor+agonists+and+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2807%2900003-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252807%252900003-3%26sid%3Dliteratum%253Aachs%26aulast%3DLightfood%26aufirst%3DA.%2BP.%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3D%25CE%25B17%2520Nicotinic%2520acetylcholine%2520receptor%2520agonists%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D46%26spage%3D131%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mazurov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. H.</span><span> </span><span class="NLM_article-title">Selective α7 nicotinic acetylcholine receptor ligands</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F092986706777442011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=16787204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVGrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1567-1584&author=A.+A.+Mazurovauthor=T.+Hauserauthor=C.+H.+Miller&title=Selective+%CE%B17+nicotinic+acetylcholine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selective α7 nicotinic acetylcholine receptor ligands</span></div><div class="casAuthors">Mazurov, Anatoly; Hauser, Terry; Miller, Craig H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1567-1584</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand gated ion channels of broad distribution and structural heterogeneity.  Their functional diversity demonstrated involvement in a variety of neuronal processes (e.g., sensory gating and cognitive function) and generated great interest in them as targets for therapeutic intervention in a no. of neuropathol. conditions and diseases.  In order to control distinct nicotinic functions pharmacol., it is important to design ligands that selectively interact with distinct receptor subtypes in such a way as to maximize the therapeutic effect and minimize the adverse effects.  The α7 nAChR, a CNS subtype, has been the most intensively studied nAChR in recent years.  Selective α7 nAChR agonists have been developed as potential candidates for the treatment of schizophrenia, cognitive disorders (including Alzheimer's disease), and inflammation.  Despite early concerns that the rapid desensitization property of the α7 nAChR would limit their therapeutic potential, several have already been advanced to clin. trials (e.g., PH-399733, Pfizer; MEM 3454, Memory Pharmaceuticals/Roche).  Further development of allosteric modulators and pharmaceutically relevant antagonists might expand the therapeutic potential of compds. that target α7 nAChRs.  In this review we briefly describe the structure and function of the α7 nAChR and its in vitro and in vivo pharmacol., discuss the clin. relevance of these efforts, and review the current progress in α7 ligand development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDkem3VpTTzrVg90H21EOLACvtfcHk0li1EPUTvxwJfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVGrs7c%253D&md5=a7ce411b57d1e7b704bdce077563eea3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F092986706777442011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777442011%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA.%2BA.%26aulast%3DHauser%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DC.%2BH.%26atitle%3DSelective%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1567%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gordon, J. C.; Griffith, R. C.; Murray, R. J.; Balestra, M.</span><span> </span><span class="NLM_article-title">Spiro-azabicyclic Compounds Useful in Therapy</span>. U.S. Patent 5902814,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=J.+C.+Gordon&author=R.+C.+Griffith&author=R.+J.+Murray&author=M.+Balestra&title=Spiro-azabicyclic+Compounds+Useful+in+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DJ.%2BC.%26atitle%3DSpiro-azabicyclic%2520Compounds%2520Useful%2520in%2520Therapy%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCory, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maco,r, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampognaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blosser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machulskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zongrone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J.</span><span> </span><span class="NLM_article-title">(−)-Spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α7 nicotinic acethylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">–</span> <span class="NLM_lpage">4050</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000249r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4045-4050&author=G.+Mullenauthor=J.+Napierauthor=M.+Balestraauthor=T.+DeCoryauthor=G.+Haleauthor=J.+Maco%2Crauthor=R.+Mackauthor=J.+Lochauthor=E.+Wuauthor=A.+Koverauthor=P.+Verhoestauthor=A.+Sampognaroauthor=E.+Phillipsauthor=Y.+Zhuauthor=R.+Murrayauthor=R.+Griffithauthor=J.+Blosserauthor=D.+Gurleyauthor=A.+Machulskisauthor=J.+Zongroneauthor=A.+Rosenauthor=J.+Gordon&title=%28%E2%88%92%29-Spiro%5B1-azabicyclo%5B2.2.2%5Doctane-3%2C5%E2%80%B2-oxazolidin-2%E2%80%B2-one%5D%2C+a+conformationally+restricted+analogue+of+acetylcholine%2C+is+a+highly+selective+full+agonist+at+the+%CE%B17+nicotinic+acethylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm000249r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000249r%26sid%3Dliteratum%253Aachs%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DNapier%26aufirst%3DJ.%26aulast%3DBalestra%26aufirst%3DM.%26aulast%3DDeCory%26aufirst%3DT.%26aulast%3DHale%26aufirst%3DG.%26aulast%3DMaco%252Cr%26aufirst%3DJ.%26aulast%3DMack%26aufirst%3DR.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DKover%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%26aulast%3DSampognaro%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DE.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DMurray%26aufirst%3DR.%26aulast%3DGriffith%26aufirst%3DR.%26aulast%3DBlosser%26aufirst%3DJ.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DMachulskis%26aufirst%3DA.%26aulast%3DZongrone%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DJ.%26atitle%3D%2528%25E2%2588%2592%2529-Spiro%255B1-azabicyclo%255B2.2.2%255Doctane-3%252C5%25E2%2580%25B2-oxazolidin-2%25E2%2580%25B2-one%255D%252C%2520a%2520conformationally%2520restricted%2520analogue%2520of%2520acetylcholine%252C%2520is%2520a%2520highly%2520selective%2520full%2520agonist%2520at%2520the%2520%25CE%25B17%2520nicotinic%2520acethylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4045%26epage%3D4050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Astles, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broad, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dell, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M.</span><span> </span><span class="NLM_article-title">Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F1568007023339256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=12769608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=337-348&author=P.+C.+Astlesauthor=S.+R.+Bakerauthor=J.+R.+Bootauthor=L.+M.+Broadauthor=C.+P.+Dellauthor=M.+Keenan&title=Recent+progress+in+the+development+of+subtype+selective+nicotinic+acetylcholine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands</span></div><div class="casAuthors">Astles, P. C.; Baker, S. R.; Boot, J. R.; Broad, L. M.; Dell, C. P.; Keenan, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand gated ion channels, which are found at the neuromuscular junction and in the central and peripheral nervous systems.  The channels can be assembled from fourteen known subunits.  The exact combination and function of all the channels are still not detd. but in the CNS certain combinations have been identified which appear to modulate the release of specific neurotransmitters.  Non-specific nAChR agonists like nicotine and epibatidine, have been shown to have interesting pharmacol. but their clin. value is limited by their undesirable side effects.  Selective ligands for different receptor subtypes have been reported and these compds. are probably the best tools for detg. the function of the subtypes.  The expectation is that some receptor subtype selective nAChR ligands will be clin. useful for the treatment of a broad range of CNS disorders.  The development of stable cell lines functionally expressing specific combinations of subunits has greatly improved our understanding of ligand specificity.  There have also been advances in the modeling of the ligand binding site, thanks to the discovery of a homologous snail ACh binding protein the x-ray structure of which was detd. in 2001.  These techniques should lead to rapid advances in the development of truly subtype selective ligands.  In this review we describe recent progress in the area and describe the first 1000 fold selective low mol. wt. ligands from the Astra-Zeneca group.  We also comment on the first subtype specific channel modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW7blv1UIcybVg90H21EOLACvtfcHk0ljWfuqu0ZZNUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmsr4%253D&md5=dc305ccf03024133de5219453a82cb88</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1568007023339256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007023339256%26sid%3Dliteratum%253Aachs%26aulast%3DAstles%26aufirst%3DP.%2BC.%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DBoot%26aufirst%3DJ.%2BR.%26aulast%3DBroad%26aufirst%3DL.%2BM.%26aulast%3DDell%26aufirst%3DC.%2BP.%26aulast%3DKeenan%26aufirst%3DM.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520subtype%2520selective%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2002%26volume%3D1%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Levin, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettegowda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blosser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J.</span><span> </span><span class="NLM_article-title">AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=675-680&author=E.+D.+Levinauthor=C.+Bettegowdaauthor=J.+Blosserauthor=J.+Gordon&title=AR-R+17779%2C+an+%CE%B17+nicotinic+agonist%2C+improves+learning+and+memory+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DE.%2BD.%26aulast%3DBettegowda%26aufirst%3DC.%26aulast%3DBlosser%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DJ.%26atitle%3DAR-R%252017779%252C%2520an%2520%25CE%25B17%2520nicotinic%2520agonist%252C%2520improves%2520learning%2520and%2520memory%2520in%2520rats%26jtitle%3DBehav.%2520Pharmacol.%26date%3D1999%26volume%3D10%26spage%3D675%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Van Kampen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiegel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boess, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R.</span><span> </span><span class="NLM_article-title">AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=375-383&author=M.+Van+Kampenauthor=K.+Selbachauthor=R.+Schneiderauthor=E.+Schiegelauthor=F.+Boessauthor=R.+Schreiber&title=AR-R+17779+improves+social+recognition+in+rats+by+activation+of+nicotinic+%CE%B17+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BKampen%26aufirst%3DM.%26aulast%3DSelbach%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSchiegel%26aufirst%3DE.%26aulast%3DBoess%26aufirst%3DF.%26aulast%3DSchreiber%26aufirst%3DR.%26atitle%3DAR-R%252017779%2520improves%2520social%2520recognition%2520in%2520rats%2520by%2520activation%2520of%2520nicotinic%2520%25CE%25B17%2520receptors%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D172%26spage%3D375%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0166-4328%2800%2900305-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=11099773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlCqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2000&pages=197-208&author=A.+J.+Grottickauthor=G.+A.+Higgins&title=Effect+of+subtype+selective+nicotinic+compounds+on+attention+as+assessed+by+the+five-choice+serial+reaction+time+task"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task</span></div><div class="casAuthors">Grottick, A. J.; Higgins, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">197-208</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Nicotine can improve attentional functioning in humans, and a no. of studies have recently demonstrated that under specific task conditions, nicotine can also improve attention in the rat.  Neuronal nicotinic receptors comprise combinations of α2-9 and β2-4 subunits, arranged to form a pentameric receptor, with the principal CNS subtypes currently believed to be α4β2 and a homomeric α7 receptor.  In the present studies, we attempted to delineate the particular nicotinic receptor subtype(s) contributing to the effects of nicotine on attention by assessing various nicotinic ligands on performance in the five-choice serial reaction time task (5-CSRTT).  In rats performing below criterion (<80% correct, >20% omissions to a 1-s visual stimulus), subchronic dosing with nicotine (0.2 mg/kg s.c.) and the α4β2 agonist SIB 1765F (5 mg/kg s.c.) increased correct responding and decreased response latencies across the treatment week; whereas the α7 agonist AR-R 17779 (20 mg/kg s.c.) was without effect.  In subjects meeting the criterion, the competitive high affinity (including α4β2) nicotine receptor antagonist dihydro-β-erythroidine (DHβE) (1-10 mg/kg s.c.) and the α7 antagonist methyllycaconitine (MLA: 5-10 mg/kg i.p.) did not disrupt performance, whereas at the highest dose, the non-competitive antagonist mecamylamine (0.3-3 mg/kg s.c.) decreased accuracy and increased response latencies.  These changes bore some similarities to those of prefeeding and the non-competitive NMDA antagonist dizocilpine (0.03-0.06 mg/kg s.c.), suggesting that mecamylamine-induced performance disruption may relate to non-nicotinic receptor effects.  In subjects chronically treated with nicotine, acute nicotine challenge (0.4 mg/kg s.c.) significantly increased accuracy while having no effect on any other performance measures.  Finally, in these same nicotine pretreated rats, the decrease in latency and increase in premature responses induced by nicotine (0.2 mg/kg s.c.) to a target stimulus of 150 ms was fully antagonized by DHβE (3 mg/kg s.c.) but not MLA (5 mg/kg i.p.).  These results suggest that α7 receptors do not play a role in any of the behavioral effects of nicotine obsd. in the 5-CSRTT, whereas a high affinity site, perhaps α4β2, is more likely involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpginujPLkBLbVg90H21EOLACvtfcHk0lhUx9roDhWJNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlCqs74%253D&md5=289d293039da15e8112bf12382825247</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0166-4328%2800%2900305-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-4328%252800%252900305-3%26sid%3Dliteratum%253Aachs%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DEffect%2520of%2520subtype%2520selective%2520nicotinic%2520compounds%2520on%2520attention%2520as%2520assessed%2520by%2520the%2520five-choice%2520serial%2520reaction%2520time%2520task%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2000%26volume%3D117%26spage%3D197%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Schreiber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalmus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vry, J.</span><span> </span><span class="NLM_article-title">Effects of α4β2- and α7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2002&pages=248-257&author=R.+Schreiberauthor=M.+Dalmusauthor=J.+De+Vry&title=Effects+of+%CE%B14%CE%B22-+and+%CE%B17-nicotine+acetylcholine+receptor+agonists+on+prepulse+inhibition+of+the+acoustic+startle+response+in+rats+and+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DDalmus%26aufirst%3DM.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520%25CE%25B14%25CE%25B22-%2520and%2520%25CE%25B17-nicotine%2520acetylcholine%2520receptor%2520agonists%2520on%2520prepulse%2520inhibition%2520of%2520the%2520acoustic%2520startle%2520response%2520in%2520rats%2520and%2520mice%26jtitle%3DPsychopharmacology%26date%3D2002%26volume%3D159%26spage%3D248%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Griffith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petty, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, R.</span><span> </span><span class="NLM_article-title">Nicotinic receptor desensitization and sensory gating deficits in schizophrenia</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0006-3223%2897%2900362-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=9646891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADyaK1cXksVSmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=98-106&author=J.+M.+Griffithauthor=J.+E.+O%E2%80%99Neillauthor=F.+Pettyauthor=D.+Garverauthor=D.+Youngauthor=R.+Freedman&title=Nicotinic+receptor+desensitization+and+sensory+gating+deficits+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor desensitization and sensory gating deficits in schizophrenia</span></div><div class="casAuthors">Griffith, Jay M.; O'neill, Jaishri E.; Petty, Frederick; Garver, David; Young, David; Freedman, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">98-106</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Nicotinic receptor dysfunction is a possible mechanism of the abnormal sensory gating obsd. in schizophrenia with the P50 auditory event-related potential.  Although nicotinic receptors normally desensitize after activation by acetylcholine or nicotine, pathol. increased desensitization might cause receptor dysfunction in schizophrenia.  To examine this possibility, central cholinergic neuronal activity was diminished by allowing schizophrenic patients to sleep briefly, after which they experienced a transient period of normal P50 gating, consistent with receptor resensitization during the absence of cholinergic stimulation.  A crit. test of the mechanism is whether this resensitization is blocked by concurrent administration of nicotine, which would provide continuous receptor stimulation.  Six schizophrenic patients repeated the sleep expt. during nicotine exposure from a dermal patch, in a double-blind, placebo-controlled design.  The normalization of P50 gating immediately postsleep was replicated in the placebo arm; but this effect was decreased in all six patients during exposure to nicotine.  The results suggest that nicotinic receptor desensitization is responsible for the loss of P50 gating in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnH2hbKz_BKrVg90H21EOLACvtfcHk0lhUx9roDhWJNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksVSmt7w%253D&md5=ba6f182c88f28021f1cc00d1a4a8be7a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2897%2900362-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252897%252900362-4%26sid%3Dliteratum%253Aachs%26aulast%3DGriffith%26aufirst%3DJ.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BE.%26aulast%3DPetty%26aufirst%3DF.%26aulast%3DGarver%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DD.%26aulast%3DFreedman%26aufirst%3DR.%26atitle%3DNicotinic%2520receptor%2520desensitization%2520and%2520sensory%2520gating%2520deficits%2520in%2520schizophrenia%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D98%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">van Maanen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebre, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRosa, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vervoordeldonk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tak, P. P.</span><span> </span><span class="NLM_article-title">Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1002%2Fart.24177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19116908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFequ7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=114-122&author=M.+A.+van+Maanenauthor=M.+C.+Lebreauthor=T.+van+der+Pollauthor=G.+J.+LaRosaauthor=D.+Elbaumauthor=M.+J.+Vervoordeldonkauthor=P.+P.+Tak&title=Stimulation+of+nicotinic+acetylcholine+receptors+attenuates+collagen-induced+arthritis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice</span></div><div class="casAuthors">van Maanen, Marjolein A.; Lebre, Maria C.; van der Poll, Tom; La Rosa, Gregory J.; Elbaum, Daniel; Vervoordeldonk, Margriet J.; Tak, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-122</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The parasympathetic nervous system, through the vagus nerve, can down-regulate inflammation in vivo by decreasing the release of cytokines, including tumor necrosis factor α (TNFα), by activated macrophages.  The vagus nerve may exert antiinflammatory actions via a specific effect of its principal neurotransmitter, acetylcholine, on the α7 subunit of nicotinic acetylcholine receptors (α7nAChR) on macrophages.  The present study was undertaken to obtain insight into the role of the cholinergic antiinflammatory pathway in arthritis.  To inhibit the cholinergic antiinflammatory pathway, mice were subjected to unilateral cervical vagotomy or sham surgery, after which arthritis was induced with type II collagen.  In a sep. study, nicotine was added to the drinking water of mice with collagen-induced arthritis (CIA).  In addn., we investigated the effects of i.p. (IP)-injected nicotine and the specific α7nAChR agonist AR-R17779.  Clin. arthritis was exacerbated by vagotomy and ameliorated by oral nicotine administration.  Moreover, oral nicotine inhibited bone degrdn. and reduced TNFα expression in synovial tissue.  Both IP-injected nicotine and AR-R17779 ameliorated clin. arthritis and reduced synovial inflammation.  This was accompanied by a redn. of TNFα levels in both plasma and synovial tissue.  The effect of AR-R17779 was more potent compared with that of nicotine and was assocd. with delayed onset of the disease as well as with protection against joint destruction.  These data provide the first evidence of a role of the cholinergic antiinflammatory pathway in the murine CIA model of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3s5iC-YbxFLVg90H21EOLACvtfcHk0liSdWrCiByj4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFequ7w%253D&md5=409abcd4db452578bab75b9a62cf2b04</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fart.24177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24177%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMaanen%26aufirst%3DM.%2BA.%26aulast%3DLebre%26aufirst%3DM.%2BC.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26aulast%3DLaRosa%26aufirst%3DG.%2BJ.%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DVervoordeldonk%26aufirst%3DM.%2BJ.%26aulast%3DTak%26aufirst%3DP.%2BP.%26atitle%3DStimulation%2520of%2520nicotinic%2520acetylcholine%2520receptors%2520attenuates%2520collagen-induced%2520arthritis%2520in%2520mice%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Tatsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">(+)-3-[2-(Benzo[<i>b</i>]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the α7 nicotinic acetylcholine receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3781-3784&author=R.+Tatsumiauthor=K.+Seioauthor=M.+Fujioauthor=J.+Katayamaauthor=T.+Horikawaauthor=K.+Hashimotoauthor=H.+Tanaka&title=%28%2B%29-3-%5B2-%28Benzo%5Bb%5Dthiophen-2-yl%29-2-oxoethyl%5D-1-azabicyclo%5B2.2.2%5Doctane+as+potent+agonists+for+the+%CE%B17+nicotinic+acetylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DR.%26aulast%3DSeio%26aufirst%3DK.%26aulast%3DFujio%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DJ.%26aulast%3DHorikawa%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3D%2528%252B%2529-3-%255B2-%2528Benzo%255Bb%255Dthiophen-2-yl%2529-2-oxoethyl%255D-1-azabicyclo%255B2.2.2%255Doctane%2520as%2520potent%2520agonists%2520for%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3781%26epage%3D3784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Tatsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">Discovery of the α7 nicotinic acetylcholine receptor agonists. (<i>R</i>)-3′-(5 Chlorothiophen-2-yl)spiro-1-azabicyclo-[2.2.2]octane-3,5′-[1′,3′]-oxazolidin-2′-one as a novel, potent, selective and orally bioavailable ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2678</span><span class="NLM_x">–</span> <span class="NLM_lpage">2686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049188d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2678-2686&author=R.+Tatsumiauthor=M.+Fujioauthor=H.+Satohauthor=J.+Katayamaauthor=S.+Takanashiauthor=K.+Hashimotoauthor=H.+Tanaka&title=Discovery+of+the+%CE%B17+nicotinic+acetylcholine+receptor+agonists.+%28R%29-3%E2%80%B2-%285+Chlorothiophen-2-yl%29spiro-1-azabicyclo-%5B2.2.2%5Doctane-3%2C5%E2%80%B2-%5B1%E2%80%B2%2C3%E2%80%B2%5D-oxazolidin-2%E2%80%B2-one+as+a+novel%2C+potent%2C+selective+and+orally+bioavailable+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm049188d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049188d%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DR.%26aulast%3DFujio%26aufirst%3DM.%26aulast%3DSatoh%26aufirst%3DH.%26aulast%3DKatayama%26aufirst%3DJ.%26aulast%3DTakanashi%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonists.%2520%2528R%2529-3%25E2%2580%25B2-%25285%2520Chlorothiophen-2-yl%2529spiro-1-azabicyclo-%255B2.2.2%255Doctane-3%252C5%25E2%2580%25B2-%255B1%25E2%2580%25B2%252C3%25E2%2580%25B2%255D-oxazolidin-2%25E2%2580%25B2-one%2520as%2520a%2520novel%252C%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2678%26epage%3D2686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tatsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiigi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murozono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">(<i>R</i>)-3′-(3-Methylbenzo[<i>b</i>]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5′-oxazolidin]-2′-one, a novel and potent α7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4374</span><span class="NLM_x">–</span> <span class="NLM_lpage">4383</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060249c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4374-4383&author=R.+Tatsumiauthor=M.+Fujioauthor=S.+Takanashiauthor=A.+Numataauthor=J.+Katayamaauthor=H.+Satohauthor=Y.+Shiigiauthor=J.+Maedaauthor=M.+Kuriyamaauthor=T.+Horikawaauthor=T.+Murozonoauthor=K.+Hashimotoauthor=H.+Tanaka&title=%28R%29-3%E2%80%B2-%283-Methylbenzo%5Bb%5Dthiophen-5-yl%29spiro%5B1-azabicyclo%5B2%2C2%2C2%5Doctane-3%2C5%E2%80%B2-oxazolidin%5D-2%E2%80%B2-one%2C+a+novel+and+potent+%CE%B17+nicotinic+acetylcholine+receptor+partial+agonist+displays+cognitive+enhancing+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm060249c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060249c%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DR.%26aulast%3DFujio%26aufirst%3DM.%26aulast%3DTakanashi%26aufirst%3DS.%26aulast%3DNumata%26aufirst%3DA.%26aulast%3DKatayama%26aufirst%3DJ.%26aulast%3DSatoh%26aufirst%3DH.%26aulast%3DShiigi%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DKuriyama%26aufirst%3DM.%26aulast%3DHorikawa%26aufirst%3DT.%26aulast%3DMurozono%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3D%2528R%2529-3%25E2%2580%25B2-%25283-Methylbenzo%255Bb%255Dthiophen-5-yl%2529spiro%255B1-azabicyclo%255B2%252C2%252C2%255Doctane-3%252C5%25E2%2580%25B2-oxazolidin%255D-2%25E2%2580%25B2-one%252C%2520a%2520novel%2520and%2520potent%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%2520displays%2520cognitive%2520enhancing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4374%26epage%3D4383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Phillips, E.; Mack, R.; Macor, J.; Semus, S.</span><span> </span><span class="NLM_article-title">Spiroazabicyclic Heterocyclic Compounds</span>. U.S. Patent 6706878,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=E.+Phillips&author=R.+Mack&author=J.+Macor&author=S.+Semus&title=Spiroazabicyclic+Heterocyclic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DE.%26atitle%3DSpiroazabicyclic%2520Heterocyclic%2520Compounds%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cliffe, I. A.</span><span> </span><span class="NLM_article-title">Quinuclidyl- and Tropanyl-pyridyl Ethers as 5-HT<sub>3</sub> Receptor Antagonists</span>. U.S. Patent 4921860,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>John Wyeth and Brother, Limited.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=I.+A.+Cliffe&title=Quinuclidyl-+and+Tropanyl-pyridyl+Ethers+as+5-HT3+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26atitle%3DQuinuclidyl-%2520and%2520Tropanyl-pyridyl%2520Ethers%2520as%25205-HT3%2520Receptor%2520Antagonists%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sydserff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirk, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerald Jonak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudzik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrzljak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smagin, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widzowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. S.</span><span> </span><span class="NLM_article-title">Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=880-888&author=S.+Sydserffauthor=E.+J.+Suttonauthor=D.+Songauthor=M.+C.+Quirkauthor=C.+Maciagauthor=C.+Liauthor=G.+Gerald+Jonakauthor=D.+Gurleyauthor=J.+C.+Gordonauthor=E.+P.+Christianauthor=J.+J.+Dohertyauthor=T.+Hudzikauthor=E.+Johnsonauthor=L.+Mrzljakauthor=T.+Piserauthor=G.+N.+Smaginauthor=Y.+Wangauthor=D.+Widzowskiauthor=J.+S.+Smith&title=Selective+%CE%B17+nicotinic+receptor+activation+by+AZD0328+enhances+cortical+dopamine+release+and+improves+learning+and+attentional+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydserff%26aufirst%3DS.%26aulast%3DSutton%26aufirst%3DE.%2BJ.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DQuirk%26aufirst%3DM.%2BC.%26aulast%3DMaciag%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DGerald%2BJonak%26aufirst%3DG.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DJ.%2BC.%26aulast%3DChristian%26aufirst%3DE.%2BP.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DHudzik%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DMrzljak%26aufirst%3DL.%26aulast%3DPiser%26aufirst%3DT.%26aulast%3DSmagin%26aufirst%3DG.%2BN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWidzowski%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DJ.%2BS.%26atitle%3DSelective%2520%25CE%25B17%2520nicotinic%2520receptor%2520activation%2520by%2520AZD0328%2520enhances%2520cortical%2520dopamine%2520release%2520and%2520improves%2520learning%2520and%2520attentional%2520processes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D880%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><a href="http://www.astrazenecaclinicaltrials.com/other-drug-products/discontinued-products/AZD0328/" class="extLink">http://www.astrazenecaclinicaltrials.com/other-drug-products/discontinued-products/AZD0328/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.astrazenecaclinicaltrials.com%2Fother-drug-products%2Fdiscontinued-products%2FAZD0328%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Chang, H.-F.; Li, Y.; Phillips, E.</span><span> </span><span class="NLM_article-title">Furyl Compounds</span>. U.S. Patent 7417049,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.-F.+Chang&author=Y.+Li&author=E.+Phillips&title=Furyl+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.-F.%26atitle%3DFuryl%2520Compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ernst, G.</span>; <span class="NLM_etal">et al.</span><span> </span><span class="NLM_article-title">Spirofuropyridines as alpha-7 Neuronal Nicotinic Receptor Agonists</span>. Presented at the 236th National Meeting of the American Chemical Society, Philadelphia, PA, August 17–21,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>MEDI 249.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Ernst&title=Spirofuropyridines+as+alpha-7+Neuronal+Nicotinic+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DG.%26atitle%3DSpirofuropyridines%2520as%2520alpha-7%2520Neuronal%2520Nicotinic%2520Receptor%2520Agonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bodnar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span> </span><span class="NLM_article-title">Discovery and structure–activity relationship of quinuclidine benzamides as agonists of α7 nicotinic acetylcholine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049363q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=905-908&author=A.+L.+Bodnarauthor=L.+A.+Cortes-Burgosauthor=K.+K.+Cookauthor=D.+M.+Dinhauthor=V.+E.+Groppiauthor=M.+Hajosauthor=N.+R.+Higdonauthor=W.+E.+Hoffmannauthor=R.+S.+Hurstauthor=J.+K.+Myersauthor=B.+N.+Rogersauthor=T.+M.+Wallauthor=M.+L.+Wolfeauthor=E.+Wong&title=Discovery+and+structure%E2%80%93activity+relationship+of+quinuclidine+benzamides+as+agonists+of+%CE%B17+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm049363q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049363q%26sid%3Dliteratum%253Aachs%26aulast%3DBodnar%26aufirst%3DA.%2BL.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DWong%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520quinuclidine%2520benzamides%2520as%2520agonists%2520of%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D905%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanchar, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(3<i>R</i>)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure–activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4425</span><span class="NLM_x">–</span> <span class="NLM_lpage">4436</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0602413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4425-4436&author=D.+G.+Wishkaauthor=D.+P.+Walkerauthor=K.+M.+Yatesauthor=S.+C.+Reitzauthor=S.+Jiaauthor=J.+K.+Myersauthor=K.+I.+Olsonauthor=E.+J.+Jacobsenauthor=M.+L.+Wolfeauthor=V.+E.+Groppiauthor=A.+J.+Hancharauthor=B.+A.+Thornburghauthor=B.+Cortesauthor=A.+Luzauthor=E.+H.+F.+Wongauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=N.+R.+Higdonauthor=T.+M.+Wallauthor=R.+S.+Hurstauthor=R.+R.+Waltersauthor=W.+E.+Hoffmannauthor=M.+Haj%C3%B3sauthor=S.+Franklinauthor=G.+Careyauthor=L.+H.+Goldauthor=K.+K.+Cookauthor=S.+B.+Sandsauthor=S.+X.+Zhaoauthor=J.+R.+Sogliaauthor=A.+S.+Kalgutkarauthor=S.+P.+Arnericauthor=B.+N.+Rogers&title=Discovery+of+N-%5B%283R%29-1-azabicyclo%5B2.2.2%5Doct-3-yl%5Dfuro%5B2%2C3-c%5Dpyridine-5-carboxamide%2C+an+agonist+of+the+%CE%B17+nicotinic+acetylcholine+receptor%2C+for+the+potential+treatment+of+cognitive+deficits+in+schizophrenia%3A+synthesis+and+structure%E2%80%93activity+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm0602413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602413%26sid%3Dliteratum%253Aachs%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DOlson%26aufirst%3DK.%2BI.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHanchar%26aufirst%3DA.%2BJ.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DCortes%26aufirst%3DB.%26aulast%3DLuz%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DCarey%26aufirst%3DG.%26aulast%3DGold%26aufirst%3DL.%2BH.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDiscovery%2520of%2520N-%255B%25283R%2529-1-azabicyclo%255B2.2.2%255Doct-3-yl%255Dfuro%255B2%252C3-c%255Dpyridine-5-carboxamide%252C%2520an%2520agonist%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%252C%2520for%2520the%2520potential%2520treatment%2520of%2520cognitive%2520deficits%2520in%2520schizophrenia%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4425%26epage%3D4436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Design, synthesis, structure–activity relationship, and in vivo activity of azabicyclic aryl amides as α7 nicotinic acetylcholine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8219</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8219-8248&author=T.+M.+Wallauthor=R.+S.+Hurstauthor=E.+H.+F.+Wongauthor=B.+N.+Rogers&title=Design%2C+synthesis%2C+structure%E2%80%93activity+relationship%2C+and+in+vivo+activity+of+azabicyclic+aryl+amides+as+%CE%B17+nicotinic+acetylcholine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDesign%252C%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationship%252C%2520and%2520in%2520vivo%2520activity%2520of%2520azabicyclic%2520aryl%2520amides%2520as%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8219%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Acker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinholt, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(3<i>R</i>,5<i>R</i>)-1-azabicyclo[3.2.1]oct-3-yl]furo-[2,3-<i>c</i>]pyridine-5-carboxamide as an agonist of the α7 nicotinic acetylcholine receptor: in vitro and in vivo activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3611</span><span class="NLM_x">–</span> <span class="NLM_lpage">3615</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3611-3615&author=B.+A.+Ackerauthor=E.+J.+Jacobsenauthor=B.+N.+Rogersauthor=D.+G.+Wishkaauthor=S.+C.+Reitzauthor=D.+W.+Piotrowskiauthor=J.+K.+Myersauthor=M.+L.+Wolfeauthor=V.+E.+Groppiauthor=B.+A.+Thornburghauthor=P.+M.+Tinholtauthor=R.+R.+Waltersauthor=B.+A.+Olsonauthor=L.+Fitzgeraldauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=M.+Krauseauthor=K.+S.+Liauthor=W.+E.+Hoffmannauthor=M.+Hajosauthor=R.+S.+Hurstauthor=D.+P.+Walker&title=Discovery+of+N-%5B%283R%2C5R%29-1-azabicyclo%5B3.2.1%5Doct-3-yl%5Dfuro-%5B2%2C3-c%5Dpyridine-5-carboxamide+as+an+agonist+of+the+%CE%B17+nicotinic+acetylcholine+receptor%3A+in+vitro+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DB.%2BA.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DTinholt%26aufirst%3DP.%2BM.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DOlson%26aufirst%3DB.%2BA.%26aulast%3DFitzgerald%26aufirst%3DL.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DKrause%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DK.%2BS.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520of%2520N-%255B%25283R%252C5R%2529-1-azabicyclo%255B3.2.1%255Doct-3-yl%255Dfuro-%255B2%252C3-c%255Dpyridine-5-carboxamide%2520as%2520an%2520agonist%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3611%26epage%3D3615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_contrib-group">Tehim, A.; Herbert, B.; Nguyen, T. M.; Xie, W.; Gauss, C. M.</span><span> </span><span class="NLM_article-title">Indazoles, Benzothiazoles, Benzoisothiazoles, Benzisoxazoles and Preparation and Uses Thereof</span>. WO 2004029050,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=A.+Tehim&author=B.+Herbert&author=T.+M.+Nguyen&author=W.+Xie&author=C.+M.+Gauss&title=Indazoles%2C+Benzothiazoles%2C+Benzoisothiazoles%2C+Benzisoxazoles+and+Preparation+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTehim%26aufirst%3DA.%26atitle%3DIndazoles%252C%2520Benzothiazoles%252C%2520Benzoisothiazoles%252C%2520Benzisoxazoles%2520and%2520Preparation%2520and%2520Uses%2520Thereof%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_contrib-group">Xie, W.; Herbert, B.; Schumacher, R. A.; Ma, J.; Nguyen, T. M.; Gauss, C. M.; Tehim, A.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Indazoles, 1,2-Benzothiazoles, 1,2-Benzoisothiazoles and Chromosomes and Preparation and Uses Thereof</span>. WO 2005111038,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+Xie&author=B.+Herbert&author=R.+A.+Schumacher&author=J.+Ma&author=T.+M.+Nguyen&author=C.+M.+Gauss&author=A.+Tehim&title=1H-Indazoles%2C+1%2C2-Benzothiazoles%2C+1%2C2-Benzoisothiazoles+and+Chromosomes+and+Preparation+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26atitle%3D1H-Indazoles%252C%25201%252C2-Benzothiazoles%252C%25201%252C2-Benzoisothiazoles%2520and%2520Chromosomes%2520and%2520Preparation%2520and%2520Uses%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31c"><span><span class="NLM_contrib-group">Xie, W.; Herbert, B.; Schumacher, R. A.; Ma, J.; Nguyen, T. M.; Gauss, C. M.; Tehim, A.</span><span> </span><span class="NLM_article-title">Indazoles, Benzothiazoles, Benzoisothiazoles and Preparation and Uses Thereof</span>. WO 2005092890,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+Xie&author=B.+Herbert&author=R.+A.+Schumacher&author=J.+Ma&author=T.+M.+Nguyen&author=C.+M.+Gauss&author=A.+Tehim&title=Indazoles%2C+Benzothiazoles%2C+Benzoisothiazoles+and+Preparation+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26atitle%3DIndazoles%252C%2520Benzothiazoles%252C%2520Benzoisothiazoles%2520and%2520Preparation%2520and%2520Uses%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vivo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span> </span><span class="NLM_article-title">MEM 3454, a novel nicotinic alpha7 receptor partial agonist. I. In vitro pharmacological profiling</span> <span class="citation_source-journal">Soc. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">163.2/Z8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=163.2%2FZ8&author=S.+Wangauthor=T.+Michaelauthor=S.+Draganauthor=S.+Sunauthor=Q.+Xiaoauthor=P.+M.+Callahanauthor=W.+Xieauthor=B.+Herbertauthor=E.+Grahamauthor=M.+De+Vivoauthor=A.+Tehim&title=MEM+3454%2C+a+novel+nicotinic+alpha7+receptor+partial+agonist.+I.+In+vitro+pharmacological+profiling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMichael%26aufirst%3DT.%26aulast%3DDragan%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DHerbert%26aufirst%3DB.%26aulast%3DGraham%26aufirst%3DE.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DTehim%26aufirst%3DA.%26atitle%3DMEM%25203454%252C%2520a%2520novel%2520nicotinic%2520alpha7%2520receptor%2520partial%2520agonist.%2520I.%2520In%2520vitro%2520pharmacological%2520profiling%26jtitle%3DSoc.%2520Neurosci.%26date%3D2006%26spage%3D163.2%252FZ8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wallace, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tombaugh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodefer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D. A.</span><span> </span><span class="NLM_article-title">RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">242</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.110.171892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20959364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1eqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=242-253&issue=1&author=T.+L.+Wallaceauthor=P.+M.+Callahanauthor=A.+Tehimauthor=D.+Bertrandauthor=G.+Tombaughauthor=S.+Wangauthor=W.+Xieauthor=W.+B.+Roweauthor=V.+Ongauthor=E.+Grahamauthor=A.+V.+Terryauthor=J.+Rodeferauthor=B.+Herbertauthor=M.+Murrayauthor=R.+Porterauthor=L.+Santarelliauthor=D.+A.+Lowe&title=RG3487%2C+a+novel+nicotinic+%CE%B17+receptor+partial+agonist%2C+improves+cognition+and+sensorimotor+gating+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents</span></div><div class="casAuthors">Wallace, Tanya L.; Callahan, Patrick M.; Tehim, Ashok; Bertrand, Daniel; Tombaugh, Geoffrey; Wang, Shaojie; Xie, Walter; Rowe, Wayne B.; Ong, Voon; Graham, Elizabeth; Terry, Alvin V., Jr.; Rodefer, Joshua S.; Herbert, Brian; Murray, Michael; Porter, Richard; Santarelli, Luca; Lowe, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">242-253</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal nicotinic α7 acetylcholine receptors (α7nAChRs) are expressed primarily in the brain and are implicated in modulating many cognitive functions (e.g., attention, working and episodic memory).  Not surprisingly, much effort has been committed to the development of mols. acting at α7nAChRs as potential therapies for a variety of central nervous system diseases (e.g., Alzheimer's).  N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-1H-indazole-3-carboxamide hydrochloride (RG3487) binds potently to the human α7nAChR (Ki = 6 nM), in which it acts as a partial agonist (63-69% of acetylcholine) as assessed by whole-cell patch-clamp recordings in both oocytes and QM7 cell lines.  RG3487 activates human α7nAChRs with an EC50 of 0.8 μM (oocytes) and 7.7 μM (QM7 cells).  RG3487 also exhibits antagonist properties at the serotonin 3 receptor [IC50 = 2.8 nM (oocytes), 32.7 nM (N1E-115 cells)].  In vivo, RG3487 improved object recognition memory in rats after acute [minimally ED (MED) 1.0 mg/kg p.o.] or repeated (10 day) administration at brain, and plasma concns. in the low-nanomolar range.  Spatial learning deficits in age-impaired rats were reversed after RG3487 administration (MED: 0.03 mg/kg i.p.) as evaluated in the Morris water maze task.  In the prepulse inhibition (PPI) of startle model of sensorimotor gating, RG3487 improved apomorphine-induced deficits in PPI performance (MED: 0.03 mg/kg i.p.) and reversed phencyclidine-induced impairments in an attentional set-shifting model of executive function (MED: ≤0.03 mg/kg i.p.).  Cumulative evidence from these studies indicates RG3487 is a novel and potent α7nAChR partial agonist that improves cognitive performance and sensorimotor gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRwJiQq8hPF7Vg90H21EOLACvtfcHk0lj0z9xM3HHEjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1eqtA%253D%253D&md5=31e2b80ecdf851d25ad3e9856296b7f1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.171892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.171892%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DT.%2BL.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DTehim%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DTombaugh%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DRowe%26aufirst%3DW.%2BB.%26aulast%3DOng%26aufirst%3DV.%26aulast%3DGraham%26aufirst%3DE.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DRodefer%26aufirst%3DJ.%26aulast%3DHerbert%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DM.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DSantarelli%26aufirst%3DL.%26aulast%3DLowe%26aufirst%3DD.%2BA.%26atitle%3DRG3487%252C%2520a%2520novel%2520nicotinic%2520%25CE%25B17%2520receptor%2520partial%2520agonist%252C%2520improves%2520cognition%2520and%2520sensorimotor%2520gating%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26issue%3D1%26spage%3D242%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, J. A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span> </span><span class="NLM_article-title">MEM 3454, a novel nicotinic alpha7 receptor partial agonist: II. Effects in models predictive of cognitive restoration in Alzheimer’s disease</span> <span class="citation_source-journal">Soc. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">163.5/Z11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=163.5%2FZ11&author=P.+M.+Callahanauthor=W.+B.+Roweauthor=W.+Xieauthor=J.+A.+V.+Terryauthor=J.+J.+Buccafuscoauthor=A.+Tehim&title=MEM+3454%2C+a+novel+nicotinic+alpha7+receptor+partial+agonist%3A+II.+Effects+in+models+predictive+of+cognitive+restoration+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DRowe%26aufirst%3DW.%2BB.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DTerry%26aufirst%3DJ.%2BA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DTehim%26aufirst%3DA.%26atitle%3DMEM%25203454%252C%2520a%2520novel%2520nicotinic%2520alpha7%2520receptor%2520partial%2520agonist%253A%2520II.%2520Effects%2520in%2520models%2520predictive%2520of%2520cognitive%2520restoration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSoc.%2520Neurosci.%26date%3D2006%26spage%3D163.5%252FZ11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Rowe, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodefer, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span> </span><span class="NLM_article-title">MEM 3454, a novel nicotinic alpha7 receptor partial agonist. III. Effects in models predictive of cognitive and sensory gating restoration in schizophrenia</span> <span class="citation_source-journal">Soc. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">163.4/Z10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=163.4%2FZ10&author=W.+B.+Roweauthor=P.+M.+Callahanauthor=W.+Xieauthor=J.+S.+Rodeferauthor=A.+V.+Terryauthor=J.+J.+Buccafuscoauthor=C.+R.+Ashbyauthor=A.+Tehim&title=MEM+3454%2C+a+novel+nicotinic+alpha7+receptor+partial+agonist.+III.+Effects+in+models+predictive+of+cognitive+and+sensory+gating+restoration+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DW.%2BB.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DRodefer%26aufirst%3DJ.%2BS.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DTehim%26aufirst%3DA.%26atitle%3DMEM%25203454%252C%2520a%2520novel%2520nicotinic%2520alpha7%2520receptor%2520partial%2520agonist.%2520III.%2520Effects%2520in%2520models%2520predictive%2520of%2520cognitive%2520and%2520sensory%2520gating%2520restoration%2520in%2520schizophrenia%26jtitle%3DSoc.%2520Neurosci.%26date%3D2006%26spage%3D163.4%252FZ10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kholdebarin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricato, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Effect of R3487/MEM3454, a novel nicotinic a7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.pnpbp.2008.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19110025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=269-275&author=A.+H.+Rezvaniauthor=E.+Kholdebarinauthor=F.+H.+Bricatoauthor=P.+M.+Callahanauthor=D.+A.+Loweauthor=E.+D.+Levin&title=Effect+of+R3487%2FMEM3454%2C+a+novel+nicotinic+a7+receptor+partial+agonist+and+5-HT3+antagonist+on+sustained+attention+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of R3487/MEM3454, a novel nicotinic α7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats</span></div><div class="casAuthors">Rezvani, Amir H.; Kholdebarin, Ehsan; Brucato, Frederic H.; Callahan, Patrick M.; Lowe, David A.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It is well established that nicotinic systems in the brain are critically involved in attentional processes in both animals and humans.  The current study assessed the effects of a novel nicotinic α7 receptor partial agonist and 5-HT3 antagonist, R3487/MEM3454 (also referred to as R3487 or MEM 3454) on sustained attention in rats performing an operant visual signal detection task.  The effects of R3487/MEM3454 were compared to those of the acetylcholinesterase inhibitor/nicotinic α7 allosteric pos. modulator galanthamine.  Adult female Sprague-Dawley rats were injected s.c. with R3487/MEM3454 (0.03, 0.1, 0.15, 0.3 and 0.6 mg/kg), galanthamine (0.25, 0.5, 1, 2 mg/kg) or vehicle 30 min before the attentional test.  In the second study, the time-dependent effects of R3487/MEM3454 were assessed by injecting the compd. (0.6 mg/kg, s.c.) at different pretreatment intervals (30, 60 or 90 min) before the start of the attentional task.  Our results show a significant dose-effect for R3487/MEM3454 on percent hit accuracy performance without any significant alteration on percent correct rejection performance.  In the time-dependent test, R3487/MEM3454 significantly increased the percent hit accuracy performance when animals were injected 60 min before the start of the attentional task.  Administration of galanthamine failed to significantly increase percent hit accuracy performance and increasing the dose of galanthamine produced a decrease in percent correct rejection performance.  The present findings with R3487/MEM3454 suggest that nicotinic α7 receptors and/or 5-HT3 receptors may play an important role in modulating sustained attention and that R3487/MEM3454 may have therapeutic potential in improving sustained attention in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGeYeIWDhalrVg90H21EOLACvtfcHk0liMgOtYxPRivA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wqur4%253D&md5=6865683db698c20314d40c5974809bf7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2008.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2008.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DKholdebarin%26aufirst%3DE.%26aulast%3DBricato%26aufirst%3DF.%2BH.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DLowe%26aufirst%3DD.%2BA.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DEffect%2520of%2520R3487%252FMEM3454%252C%2520a%2520novel%2520nicotinic%2520a7%2520receptor%2520partial%2520agonist%2520and%25205-HT3%2520antagonist%2520on%2520sustained%2520attention%2520in%2520rats%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2009%26volume%3D33%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Umbricht, D. M. S.; Lowe, D.; Yoo, K.; Porter, R.; Garibaldi, G.; Santarelli, L.; Keefe, R.</span><span> </span><span class="NLM_article-title">The Effect of the Partial Nicotinic alpha7 Receptor Agonist R3487 on Cognitive Deficits in Schizophrenia</span>. Presented at the 48th Annual Meeting of American College of Neuropsychopharmacology, Hollywood, FL,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+M.+S.+Umbricht&author=D.+Lowe&author=K.+Yoo&author=R.+Porter&author=G.+Garibaldi&author=L.+Santarelli&author=R.+Keefe&title=The+Effect+of+the+Partial+Nicotinic+alpha7+Receptor+Agonist+R3487+on+Cognitive+Deficits+in+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DUmbricht%26aufirst%3DD.%2BM.%2BS.%26atitle%3DThe%2520Effect%2520of%2520the%2520Partial%2520Nicotinic%2520alpha7%2520Receptor%2520Agonist%2520R3487%2520on%2520Cognitive%2520Deficits%2520in%2520Schizophrenia%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Boess, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flessner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luithle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methfessel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnizler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Staay, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kampen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">The novel alpha7 nicotinic acetylcholine receptor agonist <i>N</i>-[(3<i>R</i>)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">716</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.106.118976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17308038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=716-725&author=F.+G.+Boessauthor=J.+De+Vryauthor=C.+Erbauthor=T.+Flessnerauthor=M.+Hendrixauthor=J.+Luithleauthor=C.+Methfesselauthor=B.+Riedlauthor=K.+Schnizlerauthor=F.-J.+van+der+Staayauthor=M.+van+Kampenauthor=W.+B.+Wieseauthor=G.+Koenig&title=The+novel+alpha7+nicotinic+acetylcholine+receptor+agonist+N-%5B%283R%29-1-azabicyclo%5B2.2.2%5Doct-3-yl%5D-7-%5B2-%28methoxy%29phenyl%5D-1-benzofuran-2-carboxamide+improves+working+and+recognition+memory+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents</span></div><div class="casAuthors">Boess, Frank G.; De Vry, Jean; Erb, Christina; Flessner, Timo; Hendrix, Martin; Luithle, Joachim; Methfessel, Christoph; Riedl, Bernd; Schnizler, Katrin; van der Staay, Franz-Josef; van Kampen, Marja; Wiese, Welf Burkhard; Koenig, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">716-725</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The relative contribution of α4β2, α7 and other nicotinic acetylcholine receptor (nAChR) subtypes to the memory enhancing vs. the addictive effects of nicotine is the subject of ongoing debate.  In the present study, we characterized the pharmacol. and behavioral properties of the α7 nAChR agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide (ABBF).  ABBF bound to α7 nAChR in rat brain membranes (Ki = 62 nM) and to recombinant human 5-hydroxytryptamine (5-HT)3 receptors (Ki = 60 nM).  ABBF was a potent agonist at the recombinant rat and human α7 nAChR expressed in Xenopus oocytes, but it did not show agonist activity at other nAChR subtypes.  ABBF acted as an antagonist of the 5-HT3 receptor and α3β4, α4β2, and muscle nAChRs (at higher concns.).  ABBF improved social recognition memory in rats (0.3-1 mg/kg p.o.).  This improvement was blocked by intracerebroventricular administration of the α7 nAChR antagonist methyllycaconitine at 10 μg, indicating that it is mediated by α7 nAChR agonism.  In addn., ABBF improved working memory of aged rats in a water maze repeated acquisition paradigm (1 mg/kg p.o.) and object recognition memory in mice (0.3-1 mg/kg p.o.).  Rats trained to discriminate nicotine (0.4 mg/kg s.c.) from vehicle did not generalize to ABBF (0.3-30 mg/kg p.o.), suggesting that the nicotine cue is not mediated by the α7 nAChR and that selective α7 nAChR agonists may not share the abuse liability of nicotine.  Our results support the hypothesis that α7 nAChR agonists may provide a novel therapeutic strategy for the treatment of cognitive deficits with low abuse potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwy3grI51_3bVg90H21EOLACvtfcHk0liMgOtYxPRivA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehu7w%253D&md5=a047ab00b180954531bb75e2077ac86c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.118976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.118976%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DFlessner%26aufirst%3DT.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3DLuithle%26aufirst%3DJ.%26aulast%3DMethfessel%26aufirst%3DC.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DSchnizler%26aufirst%3DK.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.-J.%26aulast%3Dvan%2BKampen%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DW.%2BB.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DThe%2520novel%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520N-%255B%25283R%2529-1-azabicyclo%255B2.2.2%255Doct-3-yl%255D-7-%255B2-%2528methoxy%2529phenyl%255D-1-benzofuran-2-carboxamide%2520improves%2520working%2520and%2520recognition%2520memory%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D716%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_contrib-group">Koenig, G.; Chesworth, R.; Shapiro, G.; Hilt, D.; Palfreyman, M.; Barbier, A.</span><span> </span><span class="NLM_article-title">Treatment of Cognitive Disorders with (<i>R</i>)-7-Chloro-<i>N</i>-(quinuclidin-3-yl)benzo[<i>b</i>]thiophene-2-carboxamide and Pharmaceutically Acceptable Salts Thereof</span>. WO 2010059844,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+Koenig&author=R.+Chesworth&author=G.+Shapiro&author=D.+Hilt&author=M.+Palfreyman&author=A.+Barbier&title=Treatment+of+Cognitive+Disorders+with+%28R%29-7-Chloro-N-%28quinuclidin-3-yl%29benzo%5Bb%5Dthiophene-2-carboxamide+and+Pharmaceutically+Acceptable+Salts+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DTreatment%2520of%2520Cognitive%2520Disorders%2520with%2520%2528R%2529-7-Chloro-N-%2528quinuclidin-3-yl%2529benzo%255Bb%255Dthiophene-2-carboxamide%2520and%2520Pharmaceutically%2520Acceptable%2520Salts%2520Thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_contrib-group">Koenig, G.; Hilt, D.</span><span> </span><span class="NLM_article-title">Treatment of Cognitive Disorders with Certain alpha-7 Nicotinic Acid Receptors in Combination with Acetylcholinesterase Inhibitors</span>. US 2011/0124631,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Koenig&author=D.+Hilt&title=Treatment+of+Cognitive+Disorders+with+Certain+alpha-7+Nicotinic+Acid+Receptors+in+Combination+with+Acetylcholinesterase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DTreatment%2520of%2520Cognitive%2520Disorders%2520with%2520Certain%2520alpha-7%2520Nicotinic%2520Acid%2520Receptors%2520in%2520Combination%2520with%2520Acetylcholinesterase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hilt, D.; Safirstein, B.; Hassman, D.; Apter, J.; Thein, S.; Maruff, P.; Harrison, J.; Gawryl, M.; Koenig, G.</span><span> </span><span class="NLM_article-title">EVP-6124: Safety, Tolerability and Cognitive Effects of a Novel α7 Nicotinic Receptor Agonist in Alzheimer’s Disease Patients on Stable Donepezil or Rivastigmine Therapy</span>. Presented at the International Conference on Alzheimer’s Disease,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Hilt&author=B.+Safirstein&author=D.+Hassman&author=J.+Apter&author=S.+Thein&author=P.+Maruff&author=J.+Harrison&author=M.+Gawryl&author=G.+Koenig&title=EVP-6124%3A+Safety%2C+Tolerability+and+Cognitive+Effects+of+a+Novel+%CE%B17+Nicotinic+Receptor+Agonist+in+Alzheimer%E2%80%99s+Disease+Patients+on+Stable+Donepezil+or+Rivastigmine+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHilt%26aufirst%3DD.%26atitle%3DEVP-6124%253A%2520Safety%252C%2520Tolerability%2520and%2520Cognitive%2520Effects%2520of%2520a%2520Novel%2520%25CE%25B17%2520Nicotinic%2520Receptor%2520Agonist%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Patients%2520on%2520Stable%2520Donepezil%2520or%2520Rivastigmine%2520Therapy%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Apter, J. T.</span><span> </span><span class="NLM_article-title">EVP-6124 elicits pro-cognitive effects in Alzheimer’s patients</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=328&author=J.+T.+Apter&title=EVP-6124+elicits+pro-cognitive+effects+in+Alzheimer%E2%80%99s+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DApter%26aufirst%3DJ.%2BT.%26atitle%3DEVP-6124%2520elicits%2520pro-cognitive%2520effects%2520in%2520Alzheimer%25E2%2580%2599s%2520patients%26jtitle%3DNeurotherapeutics%26date%3D2010%26volume%3D7%26spage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><a href="http://envivopharma.com/news-item.php?id=32" class="extLink">http://envivopharma.com/news-item.php?id=32</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fenvivopharma.com%2Fnews-item.php%3Fid%3D32."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Mazurov, A, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klucik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seamans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span> </span><span class="NLM_article-title">2-(Arylmethy)l-3-substituted quinuclidines as selective α7 nicotinic receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2073-2077&author=A%2C+A.+Mazurovauthor=J.+Klucikauthor=L.+Miaoauthor=T.+Y.+Phillipsauthor=A.+Seamansauthor=J.+D.+Schmittauthor=T.+A.+Hauserauthor=R.+T.+Johnsonauthor=C.+Miller&title=2-%28Arylmethy%29l-3-substituted+quinuclidines+as+selective+%CE%B17+nicotinic+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA%252C%2BA.%26aulast%3DKlucik%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DT.%2BY.%26aulast%3DSeamans%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%2BD.%26aulast%3DHauser%26aufirst%3DT.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BT.%26aulast%3DMiller%26aufirst%3DC.%26atitle%3D2-%2528Arylmethy%2529l-3-substituted%2520quinuclidines%2520as%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2073%26epage%3D2077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Hauser, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucinski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatto, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersinger, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachowiak, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachowiak, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippiello, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span> </span><span class="NLM_article-title">TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=803-812&author=T.+A.+Hauserauthor=A.+Kucinskiauthor=K.+G.+Jordanauthor=G.+J.+Gattoauthor=S.+R.+Wersingerauthor=R.+A.+Hesseauthor=E.+K.+Stachowiakauthor=M.+K.+Stachowiakauthor=R.+L.+Papkeauthor=P.+M.+Lippielloauthor=M.+Bencherif&title=TC-5619%3A+an+alpha7+neuronal+nicotinic+receptor-selective+agonist+that+demonstrates+efficacy+in+animal+models+of+the+positive+and+negative+symptoms+and+cognitive+dysfunction+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DT.%2BA.%26aulast%3DKucinski%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DK.%2BG.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DWersinger%26aufirst%3DS.%2BR.%26aulast%3DHesse%26aufirst%3DR.%2BA.%26aulast%3DStachowiak%26aufirst%3DE.%2BK.%26aulast%3DStachowiak%26aufirst%3DM.%2BK.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DLippiello%26aufirst%3DP.%2BM.%26aulast%3DBencherif%26aufirst%3DM.%26atitle%3DTC-5619%253A%2520an%2520alpha7%2520neuronal%2520nicotinic%2520receptor-selective%2520agonist%2520that%2520demonstrates%2520efficacy%2520in%2520animal%2520models%2520of%2520the%2520positive%2520and%2520negative%2520symptoms%2520and%2520cognitive%2520dysfunction%2520of%2520schizophrenia%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D803%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><a href="http://www.targacept.com/wt/page/pr_1302179429" class="extLink">http://www.targacept.com/wt/page/pr_1302179429</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.targacept.com%2Fwt%2Fpage%2Fpr_1302179429."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Marrero, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazurov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippiello, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span> </span><span class="NLM_article-title">An α7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.109.154633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19786623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1yqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2010&pages=173-180&author=M.+B.+Marreroauthor=R.+Lucasauthor=C.+Saletauthor=T.+A.+Hauserauthor=A.+Mazurovauthor=P.+M.+Lippielloauthor=M.+Bencherif&title=An+%CE%B17+nicotinic+acetylcholine+receptor-selective+agonist+reduces+weight+gain+and+metabolic+changes+in+a+mouse+model+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">An α7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes</span></div><div class="casAuthors">Marrero, Mario B.; Lucas, Rudolf; Salet, Christina; Hauser, Terry A.; Mazurov, Anatoly; Lippiello, Patrick M.; Bencherif, Merouane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-180</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Type 2 diabetes has become a pervasive public health problem.  The etiol. of the disease has not been fully defined but appears to involve abnormalities in peripheral and central nervous system pathways, as well as prominent inflammatory components.  Because nicotinic acetylcholine receptors (nAChRs) are known to interact with anti-inflammatory pathways and have been implicated in control of appetite and body wt., as well as lipid and energy metab., we examd. their role in modulating biol. parameters assocd. with the disease.  In a model of type 2 diabetes, the homozygous leptin-resistant db/db obese mouse, we measured the effects of a novel α7 nAChR-selective agonist [5-methyl-N-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]thiophene-2-carboxamide (TC-7020)] on body mass, glucose and lipid metab., and proinflammatory cytokines.  Oral administration of TC-7020 reduced wt. gain and food intake, reduced elevated glucose and glycated Hb levels, and lowered elevated plasma levels of triglycerides and the proinflammatory cytokine tumor necrosis factor-α.  These changes were reversed by the α7-selective antagonist methyllycaconitine, confirming the involvement of α7 nAChRs.  Prevention of wt. gain, decreased food intake, and normalization of glucose levels were also blocked by the Janus kinase 2 (JAK2) inhibitor α-cyano-(3,4-dihydroxy)-N-benzylcinnamide (AG-490), suggesting that these effects involve linkage of α7 nAChRs to the JAK2-signal transducer and activator of transcription 3 signaling pathway.  The results show that α7 nAChRs play a central role in regulating biol. parameters assocd. with diabetes and support the potential of targeting these receptors as a new therapeutic strategy for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-s_qoP8YnkLVg90H21EOLACvtfcHk0lgfDJ3ElfN-iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1yqtg%253D%253D&md5=23c40dfaa67643afc0b04f7c692b24cb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.154633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.154633%26sid%3Dliteratum%253Aachs%26aulast%3DMarrero%26aufirst%3DM.%2BB.%26aulast%3DLucas%26aufirst%3DR.%26aulast%3DSalet%26aufirst%3DC.%26aulast%3DHauser%26aufirst%3DT.%2BA.%26aulast%3DMazurov%26aufirst%3DA.%26aulast%3DLippiello%26aufirst%3DP.%2BM.%26aulast%3DBencherif%26aufirst%3DM.%26atitle%3DAn%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor-selective%2520agonist%2520reduces%2520weight%2520gain%2520and%2520metabolic%2520changes%2520in%2520a%2520mouse%2520model%2520of%2520diabetes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D332%26spage%3D173%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Macor, J.; Wu, E.</span><span> </span><span class="NLM_article-title">Azabicyclic Esters of Carbamic Acids Useful in Therapy</span>. U.S. Patent 5998429,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=J.+Macor&author=E.+Wu&title=Azabicyclic+Esters+of+Carbamic+Acids+Useful+in+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMacor%26aufirst%3DJ.%26atitle%3DAzabicyclic%2520Esters%2520of%2520Carbamic%2520Acids%2520Useful%2520in%2520Therapy%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahagi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span> </span><span class="NLM_article-title">Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective α7 nicotinic receptor agonist SSR180711</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.biopsych.2007.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17601496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCgur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2008&pages=92-97&author=K.+Hashimotoauthor=T.+Ishimaauthor=Y.+Fujitaauthor=M.+Matsuoauthor=T.+Kobashiauthor=M.+Takahagiauthor=H.+Tsukadaauthor=M.+Iyo&title=Phencyclidine-induced+cognitive+deficits+in+mice+are+improved+by+subsequent+subchronic+administration+of+the+novel+selective+%CE%B17+nicotinic+receptor+agonist+SSR180711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711</span></div><div class="casAuthors">Hashimoto, Kenji; Ishima, Tamaki; Fujita, Yuko; Matsuo, Masaaki; Kobashi, Tatsuhiro; Takahagi, Makoto; Tsukada, Hideo; Iyo, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-97</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Accumulating evidence suggests that α7 nicotinic receptor (α7 nAChR) agonists could be potential therapeutic drugs for cognitive deficits in schizophrenia.  The present study was undertaken to examine the effects of the novel selective α7 nAChR agonist SSR180711 on cognitive deficits in mice after repeated administration of the N-methyl-D-aspartate receptor antagonist phencyclidine (PCP).  Methods: Saline or PCP (10 mg/kg/day for 10 days) was administered to mice.  Subsequently, vehicle, SSR180711 (.3 or 3.0 mg/kg/day), SSR180711 (3.0 mg/kg/day) + the selective α7 nAChR antagonist methyllycaconitine (MLA; 3.0 mg/kg/day), or MLA (3.0 mg/kg/day) was administered IP for 2 consecutive weeks.  Twenty-four hours after the final administration, a novel object recognition test was performed.  Results: The PCP-induced cognitive deficits were significantly improved by subsequent subchronic (2-wk) administration of SSR180711 (3.0 mg/kg).  The effects of SSR180711 (3.0 mg/kg) were significantly antagonized by co-administration of MLA (3.0 mg/kg).  Furthermore, Western blot anal. and immunohistochem. revealed that levels of α7 nAChRs in the frontal cortex and hippocampus of the PCP (10 mg/kg/day for 10 days)-treated mice were significantly lower than those of saline-treated mice.  Conclusions: These findings suggest that repeated PCP administration significantly decreased the d. of α7 nAChRs in the brain and that the α7 nAChR agonist SSR180711 could ameliorate cognitive deficits in mice after repeated administration of PCP.  Therefore, α7 nAChR agonists including SSR180711 are potential therapeutic drugs for treating cognitive deficits in schizophrenic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg_FkBDNDWubVg90H21EOLACvtfcHk0lgfDJ3ElfN-iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCgur3L&md5=ba5a9a9c67ed1f7406d232a04a22ccaf</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2007.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2007.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DIshima%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DMatsuo%26aufirst%3DM.%26aulast%3DKobashi%26aufirst%3DT.%26aulast%3DTakahagi%26aufirst%3DM.%26aulast%3DTsukada%26aufirst%3DH.%26aulast%3DIyo%26aufirst%3DM.%26atitle%3DPhencyclidine-induced%2520cognitive%2520deficits%2520in%2520mice%2520are%2520improved%2520by%2520subsequent%2520subchronic%2520administration%2520of%2520the%2520novel%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520agonist%2520SSR180711%26jtitle%3DBiol.%2520Psychiatry%26date%3D2008%26volume%3D63%26spage%3D92%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48b"><span><span class="NLM_contrib-group">Barak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Levie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, I.</span><span> </span><span class="NLM_article-title">Pro-cognitive and antipsychotic efficacy of the <i>α</i>7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">–</span> <span class="NLM_lpage">1763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1753-1763&author=S.+Barakauthor=M.+Aradauthor=A.+De+Levieauthor=M.+D.+Blackauthor=G.+Griebelauthor=I.+Weiner&title=Pro-cognitive+and+antipsychotic+efficacy+of+the+%CE%B17+nicotinic+partial+agonist+SSR180711+in+pharmacological+and+neurodevelopmental+latent+inhibition+models+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarak%26aufirst%3DS.%26aulast%3DArad%26aufirst%3DM.%26aulast%3DDe%2BLevie%26aufirst%3DA.%26aulast%3DBlack%26aufirst%3DM.%2BD.%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DI.%26atitle%3DPro-cognitive%2520and%2520antipsychotic%2520efficacy%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520partial%2520agonist%2520SSR180711%2520in%2520pharmacological%2520and%2520neurodevelopmental%2520latent%2520inhibition%2520models%2520of%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D1753%26epage%3D1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48c"><span><span class="NLM_contrib-group">Biton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedelec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jegham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanneau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesney, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debono, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besnard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oblin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vige, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouquie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souilhac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueudet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury-Donat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span> </span><span class="NLM_article-title">SSR180711, a novel selective a7 nicotinic receptor partial agonist: (1) binding and functional profile</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=1-16&author=B.+Bitonauthor=O.+Bergisauthor=F.+Galliauthor=A.+Nedelecauthor=A.+Locheadauthor=S.+Jeghamauthor=D.+Godetauthor=C.+Lanneauauthor=R.+Santamariaauthor=F.+Chesneyauthor=J.+Leonardonauthor=P.+Grangerauthor=M.+W.+Debonoauthor=G.+A.+Bohmeauthor=F.+Sgardauthor=F.+Besnardauthor=D.+Grahamauthor=A.+Costeauthor=A.+Oblinauthor=O.+Curetauthor=X.+Vigeauthor=C.+Voltzauthor=L.+Rouquieauthor=J.+Souilhacauthor=V.+Santucciauthor=C.+Gueudetauthor=D.+Franconauthor=R.+Steinbergauthor=G.+Griebelauthor=F.+Oury-Donatauthor=P.+Georgeauthor=P.+Avenetauthor=B.+Scatton&title=SSR180711%2C+a+novel+selective+a7+nicotinic+receptor+partial+agonist%3A+%281%29+binding+and+functional+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiton%26aufirst%3DB.%26aulast%3DBergis%26aufirst%3DO.%26aulast%3DGalli%26aufirst%3DF.%26aulast%3DNedelec%26aufirst%3DA.%26aulast%3DLochead%26aufirst%3DA.%26aulast%3DJegham%26aufirst%3DS.%26aulast%3DGodet%26aufirst%3DD.%26aulast%3DLanneau%26aufirst%3DC.%26aulast%3DSantamaria%26aufirst%3DR.%26aulast%3DChesney%26aufirst%3DF.%26aulast%3DLeonardon%26aufirst%3DJ.%26aulast%3DGranger%26aufirst%3DP.%26aulast%3DDebono%26aufirst%3DM.%2BW.%26aulast%3DBohme%26aufirst%3DG.%2BA.%26aulast%3DSgard%26aufirst%3DF.%26aulast%3DBesnard%26aufirst%3DF.%26aulast%3DGraham%26aufirst%3DD.%26aulast%3DCoste%26aufirst%3DA.%26aulast%3DOblin%26aufirst%3DA.%26aulast%3DCuret%26aufirst%3DO.%26aulast%3DVige%26aufirst%3DX.%26aulast%3DVoltz%26aufirst%3DC.%26aulast%3DRouquie%26aufirst%3DL.%26aulast%3DSouilhac%26aufirst%3DJ.%26aulast%3DSantucci%26aufirst%3DV.%26aulast%3DGueudet%26aufirst%3DC.%26aulast%3DFrancon%26aufirst%3DD.%26aulast%3DSteinberg%26aufirst%3DR.%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DOury-Donat%26aufirst%3DF.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DSSR180711%252C%2520a%2520novel%2520selective%2520a7%2520nicotinic%2520receptor%2520partial%2520agonist%253A%2520%25281%2529%2520binding%2520and%2520functional%2520profile%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48d"><span><span class="NLM_contrib-group">Pichat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terranova, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueudet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmelin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury-Donat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span> </span><span class="NLM_article-title">SSR180711, a novel selective a7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=17-34&author=P.+Pichatauthor=O.+E.+Bergisauthor=J.-P.+Terranovaauthor=A.+Uraniauthor=C.+Duarteauthor=V.+Santucciauthor=C.+Gueudetauthor=C.+Voltzauthor=R.+Steinbergauthor=J.+Stemmelinauthor=F.+Oury-Donatauthor=P.+Avenetauthor=G.+Griebelauthor=B.+Scatton&title=SSR180711%2C+a+novel+selective+a7+nicotinic+receptor+partial+agonist%3A+%28II%29+efficacy+in+experimental+models+predictive+of+activity+against+cognitive+symptoms+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPichat%26aufirst%3DP.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DTerranova%26aufirst%3DJ.-P.%26aulast%3DUrani%26aufirst%3DA.%26aulast%3DDuarte%26aufirst%3DC.%26aulast%3DSantucci%26aufirst%3DV.%26aulast%3DGueudet%26aufirst%3DC.%26aulast%3DVoltz%26aufirst%3DC.%26aulast%3DSteinberg%26aufirst%3DR.%26aulast%3DStemmelin%26aufirst%3DJ.%26aulast%3DOury-Donat%26aufirst%3DF.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DSSR180711%252C%2520a%2520novel%2520selective%2520a7%2520nicotinic%2520receptor%2520partial%2520agonist%253A%2520%2528II%2529%2520efficacy%2520in%2520experimental%2520models%2520predictive%2520of%2520activity%2520against%2520cognitive%2520symptoms%2520of%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D17%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Kristensen, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermann, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay-Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, J. D.</span><span> </span><span class="NLM_article-title">The α<sub>7</sub> nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">418</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2007&pages=154-158&author=S.+E.+Kristensenauthor=M.+S.+Thomsenauthor=H.+H.+Hansenauthor=D.+B.+Timmermannauthor=A.+Hay-Schmidtauthor=J.+D.+Mikkelsen&title=The+%CE%B17+nicotinic+receptor+agonist+SSR180711+increases+activity+regulated+cytoskeleton+protein+%28Arc%29+gene+expression+in+the+prefrontal+cortex+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKristensen%26aufirst%3DS.%2BE.%26aulast%3DThomsen%26aufirst%3DM.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BH.%26aulast%3DTimmermann%26aufirst%3DD.%2BB.%26aulast%3DHay-Schmidt%26aufirst%3DA.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520%25CE%25B17%2520nicotinic%2520receptor%2520agonist%2520SSR180711%2520increases%2520activity%2520regulated%2520cytoskeleton%2520protein%2520%2528Arc%2529%2520gene%2520expression%2520in%2520the%2520prefrontal%2520cortex%2520of%2520the%2520rat%26jtitle%3DNeurosci.%2520Lett.%26date%3D2007%26volume%3D418%26spage%3D154%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span>Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer’s Disease. <a href="http://clinicaltrials.gov/ct2/show/NCT00602680" class="extLink">http://clinicaltrials.gov/ct2/show/NCT00602680</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Effect+on+Cognitive+Performance+and+Safety%2FTolerability+of+SSR180711C+in+Mild+Alzheimer%E2%80%99s+Disease.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00602680."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Feuerbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingenhohl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosbacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozulak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span> </span><span class="NLM_article-title">JN403, in vitro characterization of a novel nicotinic acetylcholine receptor α7 selective agonist</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2007&pages=61-65&author=D.+Feuerbachauthor=K.+Lingenhohlauthor=P.+Dobbinsauthor=J.+Mosbacherauthor=N.+Corbettauthor=J.+Nozulakauthor=D.+Hoyer&title=JN403%2C+in+vitro+characterization+of+a+novel+nicotinic+acetylcholine+receptor+%CE%B17+selective+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeuerbach%26aufirst%3DD.%26aulast%3DLingenhohl%26aufirst%3DK.%26aulast%3DDobbins%26aufirst%3DP.%26aulast%3DMosbacher%26aufirst%3DJ.%26aulast%3DCorbett%26aufirst%3DN.%26aulast%3DNozulak%26aufirst%3DJ.%26aulast%3DHoyer%26aufirst%3DD.%26atitle%3DJN403%252C%2520in%2520vitro%2520characterization%2520of%2520a%2520novel%2520nicotinic%2520acetylcholine%2520receptor%2520%25CE%25B17%2520selective%2520agonist%26jtitle%3DNeurosci.%2520Lett.%26date%3D2007%26volume%3D416%26spage%3D61%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Feuerbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingenhohl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olpe, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassout, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaperon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozulak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span> </span><span class="NLM_article-title">The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=254-263&author=D.+Feuerbachauthor=K.+Lingenhohlauthor=H.-R.+Olpeauthor=A.+Vassoutauthor=C.+Gentschauthor=F.+Chaperonauthor=J.+Nozulakauthor=A.+Enzauthor=G.+Bilbeauthor=K.+McAllisterauthor=D.+Hoyer&title=The+selective+nicotinic+acetylcholine+receptor+%CE%B17+agonist+JN403+is+active+in+animal+models+of+cognition%2C+sensory+gating%2C+epilepsy+and+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeuerbach%26aufirst%3DD.%26aulast%3DLingenhohl%26aufirst%3DK.%26aulast%3DOlpe%26aufirst%3DH.-R.%26aulast%3DVassout%26aufirst%3DA.%26aulast%3DGentsch%26aufirst%3DC.%26aulast%3DChaperon%26aufirst%3DF.%26aulast%3DNozulak%26aufirst%3DJ.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DMcAllister%26aufirst%3DK.%26aulast%3DHoyer%26aufirst%3DD.%26atitle%3DThe%2520selective%2520nicotinic%2520acetylcholine%2520receptor%2520%25CE%25B17%2520agonist%2520JN403%2520is%2520active%2520in%2520animal%2520models%2520of%2520cognition%252C%2520sensory%2520gating%252C%2520epilepsy%2520and%2520pain%26jtitle%3DNeuropharmacology%26date%3D2009%26volume%3D56%26spage%3D254%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Marrero, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatti, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span> </span><span class="NLM_article-title">The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel α7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.103.061655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=14722323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFamtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=16-27&author=M.+B.+Marreroauthor=R.+L.+Papkeauthor=B.+S.+Bhattiauthor=S.+Shawauthor=M.+Bencherif&title=The+neuroprotective+effect+of+2-%283-pyridyl%29-1-azabicyclo%5B3.2.2%5Dnonane+%28TC-1698%29%2C+a+novel+%CE%B17+ligand%2C+is+prevented+through+angiotensin+II+activation+of+a+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel α7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase</span></div><div class="casAuthors">Marrero, Mario B.; Papke, Roger L.; Bhatti, Balwinder S.; Shaw, Sean; Bencherif, Merouane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-27</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have recently provided evidence for nicotine-induced complex formation between the α7 nicotinic acetylcholine receptor (nAChR) and the tyrosine-phosphorylated enzyme Janus kinase 2 (JAK2) that results in subsequent activation of phosphatidyl-inositol-3-kinase (PI-3-K) and Akt.  Nicotine interaction with the α7 nAChR inhibits Aβ (1-42) interaction with the same receptor, and the Aβ (1-42)-induced apoptosis is prevented through nicotine-induced activation of JAK2.  These effects can be shown by measuring markers of cytotoxicity, including the cleavage of the nuclear protein poly(ADP-ribose) polymerase (PARP), the induction of caspase 3, or cell viability.  In this study, we found that 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel α7-selective agonist, exerts neuroprotective effects via activation of the JAK2/PI-3K cascade, which can be neutralized through activation of the angiotensin II (Ang II) AT2 receptor.  Vanadate not only augmented the TC-1698-induced tyrosine phosphorylation of JAK2 but also blocked the Ang II neutralization of TC-1698-induced neuroprotection against Aβ (1-42)-induced cleavage of PARP.  Furthermore, when SHP-1 was neutralized via antisense transfection, the Ang II inhibition of TC-1698-induced neuroprotection against Aβ (1-42) was prevented.  These results support the main hypothesis that states that JAK2 plays a central role in the nicotinic α7 receptor-induced activation of the JAK2-PI-3K cascade in PC12 cells, which ultimately contribute to nAChR-mediated neuroprotection.  Ang II inhibits this pathway through the AT2 receptor activation of the protein tyrosine phosphatase SHP-1.  This study supports central and opposite roles for JAK2 and SHP-1 in the control of apoptosis and α7-mediated neuroprotection in PC12 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAb6D4X0VRgbVg90H21EOLACvtfcHk0lgMah78Nmt1zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFamtr8%253D&md5=bd5a02ac9b1275210574fe8cbc63946f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.061655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.061655%26sid%3Dliteratum%253Aachs%26aulast%3DMarrero%26aufirst%3DM.%2BB.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DBhatti%26aufirst%3DB.%2BS.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DBencherif%26aufirst%3DM.%26atitle%3DThe%2520neuroprotective%2520effect%2520of%25202-%25283-pyridyl%2529-1-azabicyclo%255B3.2.2%255Dnonane%2520%2528TC-1698%2529%252C%2520a%2520novel%2520%25CE%25B17%2520ligand%252C%2520is%2520prevented%2520through%2520angiotensin%2520II%2520activation%2520of%2520a%2520tyrosine%2520phosphatase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D16%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedza, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottas, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Discovery of 4-(5-methyloxazolo[4,5-<i>b</i>]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel α7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1222-1237&author=C.+J.+O%E2%80%99Donnellauthor=B.+N.+Rogersauthor=B.+S.+Bronkauthor=D.+K.+Bryceauthor=J.+W.+Coeauthor=K.+K.+Cookauthor=A.+J.+Duplantierauthor=E.+Evrardauthor=M.+Haj%C3%B3sauthor=W.+E.+Hoffmannauthor=R.+S.+Hurstauthor=N.+Makladauthor=R.+J.+Matherauthor=S.+McLeanauthor=F.+M.+Nedzaauthor=B.+T.+O%E2%80%99Neillauthor=L.+Pengauthor=W.+Qianauthor=M.+M.+Rottasauthor=S.+B.+Sandsauthor=A.+W.+Schmidtauthor=A.+V.+Shrikhandeauthor=D.+K.+Spracklinauthor=D.+F.+Wongauthor=A.+Zhangauthor=L.+Zhang&title=Discovery+of+4-%285-methyloxazolo%5B4%2C5-b%5Dpyridin-2-yl%29-1%2C4-diazabicyclo%5B3.2.2%5Dnonane+%28CP-810%2C123%29%2C+a+novel+%CE%B17+nicotinic+acetylcholine+receptor+agonist+for+the+treatment+of+cognitive+disorders+in+schizophrenia%3A+synthesis%2C+SAR+development%2C+and+in+vivo+efficacy+in+cognition+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm9015075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015075%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DRottas%26aufirst%3DM.%2BM.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DShrikhande%26aufirst%3DA.%2BV.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25204-%25285-methyloxazolo%255B4%252C5-b%255Dpyridin-2-yl%2529-1%252C4-diazabicyclo%255B3.2.2%255Dnonane%2520%2528CP-810%252C123%2529%252C%2520a%2520novel%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%2520in%2520schizophrenia%253A%2520synthesis%252C%2520SAR%2520development%252C%2520and%2520in%2520vivo%2520efficacy%2520in%2520cognition%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1222%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedza, F. M.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates: subtype selective, high affinity α7 nicotinic acetylcholine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4747</span><span class="NLM_x">–</span> <span class="NLM_lpage">4751</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4747-4751&author=C.+J.+O%E2%80%99Donnellauthor=L.+Pengauthor=B.+T.+O%E2%80%99Neillauthor=E.+P.+Arnoldauthor=R.+J.+Matherauthor=S.+B.+Sandsauthor=A.+V.+Shrikhandeauthor=L.+A.+Lebelauthor=D.+K.+Spracklinauthor=F.+M.+Nedza&title=Synthesis+and+SAR+studies+of+1%2C4-diazabicyclo%5B3.2.2%5Dnonane+phenyl+carbamates%3A+subtype+selective%2C+high+affinity+%CE%B17+nicotinic+acetylcholine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DArnold%26aufirst%3DE.%2BP.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DShrikhande%26aufirst%3DA.%2BV.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%25201%252C4-diazabicyclo%255B3.2.2%255Dnonane%2520phenyl%2520carbamates%253A%2520subtype%2520selective%252C%2520high%2520affinity%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4747%26epage%3D4751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Sirota, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabtay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giladi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korczyn, A. D.</span><span> </span><span class="NLM_article-title">Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1176%2Fappi.ajp.157.2.287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=10671405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BD3c7jslOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2000&pages=287-289&author=P.+Sirotaauthor=T.+Moshevaauthor=H.+Shabtayauthor=N.+Giladiauthor=A.+D.+Korczyn&title=Use+of+the+selective+serotonin+3+receptor+antagonist+ondansetron+in+the+treatment+of+neuroleptic-induced+tardive+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia</span></div><div class="casAuthors">Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn A D</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-9</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  The authors examined the efficacy, tolerability, and safety of ondansetron, a selective serotonin 3 receptor antagonist, in patients with tardive dyskinesia.  METHOD:  Twenty patients with schizophrenia who had neuroleptic-induced tardive dyskinesia were given 12 mg/day of ondansetron for 12 weeks in an open-label study.  RESULTS:  Administration of ondansetron resulted in a statistically significant improvement in tardive dyskinesia and psychotic symptoms.  CONCLUSIONS:  Ondansetron may be an effective and safe therapy to control tardive dyskinesia and psychosis in patients with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlRpAcydzdQFHFYivNCdPRfW6udTcc2eaqwg8OMu1ihLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7jslOjug%253D%253D&md5=1579e3e82f37d414640eeaadf7fc8202</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.157.2.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.157.2.287%26sid%3Dliteratum%253Aachs%26aulast%3DSirota%26aufirst%3DP.%26aulast%3DMosheva%26aufirst%3DT.%26aulast%3DShabtay%26aufirst%3DH.%26aulast%3DGiladi%26aufirst%3DN.%26aulast%3DKorczyn%26aufirst%3DA.%2BD.%26atitle%3DUse%2520of%2520the%2520selective%2520serotonin%25203%2520receptor%2520antagonist%2520ondansetron%2520in%2520the%2520treatment%2520of%2520neuroleptic-induced%2520tardive%2520dyskinesia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2000%26volume%3D157%26spage%3D287%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">CP-810,123, a Third Generation alpha-7 nAChR Agonist for Treatment of Cognitive Deficits Associated with Schizophrenia. Nicotinic Acetylcholine Receptor-Based Therapeutics: Emerging Frontiers in Basic Research & Clinical Science</span>. Presented at the Satellite Meeting to the Society for Neuroscience, Chicago, IL, October 14–16,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+J.+O%E2%80%99Donnell&title=CP-810%2C123%2C+a+Third+Generation+alpha-7+nAChR+Agonist+for+Treatment+of+Cognitive+Deficits+Associated+with+Schizophrenia.+Nicotinic+Acetylcholine+Receptor-Based+Therapeutics%3A+Emerging+Frontiers+in+Basic+Research+%26+Clinical+Science"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DCP-810%252C123%252C%2520a%2520Third%2520Generation%2520alpha-7%2520nAChR%2520Agonist%2520for%2520Treatment%2520of%2520Cognitive%2520Deficits%2520Associated%2520with%2520Schizophrenia.%2520Nicotinic%2520Acetylcholine%2520Receptor-Based%2520Therapeutics%253A%2520Emerging%2520Frontiers%2520in%2520Basic%2520Research%2520%2526%2520Clinical%2520Science%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Tietje, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomme, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackemeyer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bury, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronlien, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfrich, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhaas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molesky, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikkel, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttfarcken, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spies, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waring, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span> </span><span class="NLM_article-title">Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1111%2Fj.1755-5949.2008.00037.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=18482100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVamu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=65-82&author=K.+R.+Tietjeauthor=D.+J.+Andersonauthor=R.+S.+Bitnerauthor=E.+A.+Blommeauthor=P.+J.+Brackemeyerauthor=C.+A.+Briggsauthor=K.+E.+Browmanauthor=D.+Buryauthor=P.+Curzonauthor=K.+U.+Drescherauthor=J.+M.+Frostauthor=R.+H.+Fryerauthor=G.+B.+Foxauthor=G.+H.+Gronlienauthor=M.+H%C3%A5kerudauthor=E.+J.+Gubbinsauthor=S.+Halmauthor=R.+Harrisauthor=R.+J.+Helfrichauthor=K.+L.+Kohlhaasauthor=D.+Lawauthor=J.+Malyszauthor=K.+C.+Marshauthor=R.+L.+Martinauthor=M.+D.+Meyerauthor=A.+L.+Moleskyauthor=A.+L.+Nikkelauthor=S.+Otteauthor=L.+Panauthor=P.+S.+Puttfarckenauthor=R.+J.+Radekauthor=H.+M.+Robbauthor=E.+Spiesauthor=K.+Thorin-Hageneauthor=J.+F.+Waringauthor=H.+Weenauthor=H.+Xuauthor=M.+Gopalakrishnanauthor=W.+H.+Bunnelle&title=Preclinical+characterization+of+A-582941%3A+a+novel+alpha7+neuronal+nicotinic+receptor+agonist+with+broad+spectrum+cognition-enhancing+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of A-582941: a novel α7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties</span></div><div class="casAuthors">Tietje, Karin R.; Anderson, David J.; Bitner, R. Scott; Blomme, Eric A.; Brackemeyer, Paul J.; Briggs, Clark A.; Browman, Kaitlin E.; Bury, Dagmar; Curzon, Peter; Drescher, Karla U.; Frost, Jennifer M.; Fryer, Ryan M.; Fox, Gerard B.; Gronlien, Jens Halvard; Hakerud, Monika; Gubbins, Earl J.; Halm, Sabine; Harris, Richard; Helfrich, Rosalind J.; Kohlhaas, Kathy L.; Law, Devalina; Malysz, John; Marsh, Kennan C.; Martin, Ruth L.; Meyer, Michael D.; Molesky, Angela L.; Nikkel, Arthur L.; Otte, Stephani; Pan, Liping; Puttfarcken, Pamela S.; Radek, Richard J.; Robb, Holly M.; Spies, Eva; Thorin-Hagene, Kirsten; Waring, Jeffrey F.; Ween, Hilde; Xu, Hongyu; Gopalakrishnan, Murali; Bunnelle, William H.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-82</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Among the diverse sets of nicotinic acetylcholine receptors (nAChRs), the α7 subtype is highly expressed in the hippocampus and cortex and is thought to play important roles in a variety of cognitive processes.  In this review, we describe the properties of a novel biaryl diamine α7 nAChR agonist, A-582941.  A-582941 was found to exhibit high-affinity binding and partial agonism at α7 nAChRs, with acceptable pharmacokinetic properties and excellent distribution to the central nervous system (CNS).  In vitro and in vivo studies indicated that A-582941 activates signaling pathways known to be involved in cognitive function such as ERK1/2 and CREB phosphorylation.  A-582941 enhanced cognitive performance in behavioral models that capture domains of working memory, short-term recognition memory, memory consolidation, and sensory gating deficit.  A-582941 exhibited a benign secondary pharmacodynamic and tolerability profile as assessed in a battery of assays of cardiovascular, gastrointestinal, and CNS function.  The studies summarized in this review collectively provide preclin. validation that α7 nAChR agonism offers a mechanism with potential to improve cognitive deficits assocd. with various neurodegenerative and psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojFmrR-kj4_rVg90H21EOLACvtfcHk0lgtXXzcJXlEzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVamu7c%253D&md5=1f00bdb6a843a4386f748754ec65f902</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2008.00037.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2008.00037.x%26sid%3Dliteratum%253Aachs%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DBlomme%26aufirst%3DE.%2BA.%26aulast%3DBrackemeyer%26aufirst%3DP.%2BJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DBury%26aufirst%3DD.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DDrescher%26aufirst%3DK.%2BU.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DFryer%26aufirst%3DR.%2BH.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DGronlien%26aufirst%3DG.%2BH.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DGubbins%26aufirst%3DE.%2BJ.%26aulast%3DHalm%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DHelfrich%26aufirst%3DR.%2BJ.%26aulast%3DKohlhaas%26aufirst%3DK.%2BL.%26aulast%3DLaw%26aufirst%3DD.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DMolesky%26aufirst%3DA.%2BL.%26aulast%3DNikkel%26aufirst%3DA.%2BL.%26aulast%3DOtte%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DPuttfarcken%26aufirst%3DP.%2BS.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DRobb%26aufirst%3DH.%2BM.%26aulast%3DSpies%26aufirst%3DE.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DWaring%26aufirst%3DJ.%2BF.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26atitle%3DPreclinical%2520characterization%2520of%2520A-582941%253A%2520a%2520novel%2520alpha7%2520neuronal%2520nicotinic%2520receptor%2520agonist%2520with%2520broad%2520spectrum%2520cognition-enhancing%2520properties%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2008%26volume%3D14%26spage%3D65%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietje, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanio, M. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Octahydropyrrolo[3,4-<i>c</i>]pyrrole: a diamine scaffold for construction of either α4β2 or α7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4126</span><span class="NLM_x">–</span> <span class="NLM_lpage">4141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900249k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4126-4141&author=W.+H.+Bunnelleauthor=K.+R.+Tietjeauthor=J.+M.+Frostauthor=D.+Petersauthor=J.+Jiauthor=T.+Liauthor=M.+J.+C.+Scanioauthor=L.+Shiauthor=D.+J.+Andersonauthor=T.+Dyhringauthor=J.+H.+Gr%C3%B8nlienauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=M.+D.+Meyer&title=Octahydropyrrolo%5B3%2C4-c%5Dpyrrole%3A+a+diamine+scaffold+for+construction+of+either+%CE%B14%CE%B22+or+%CE%B17-selective+nicotinic+acetylcholine+receptor+%28nAChR%29+ligands.+Substitutions+that+switch+subtype+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm900249k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900249k%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DScanio%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DOctahydropyrrolo%255B3%252C4-c%255Dpyrrole%253A%2520a%2520diamine%2520scaffold%2520for%2520construction%2520of%2520either%2520%25CE%25B14%25CE%25B22%2520or%2520%25CE%25B17-selective%2520nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520ligands.%2520Substitutions%2520that%2520switch%2520subtype%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4126%26epage%3D4141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfrich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttfarcken, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, E. Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermann, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">In vitro pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.110.167072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20504915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyksLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=863-874&author=J.+Malyszauthor=D.+J.+Andersonauthor=J.+H.+Gr%C3%B8nlienauthor=J.+Jiauthor=W.+H.+Bunnelleauthor=M.+H%C3%A5kerudauthor=K.+Thorin-Hageneauthor=H.+Weenauthor=R.+Helfrichauthor=M.+Huauthor=E.+Gubbinsauthor=S.+Gopalakrishnanauthor=P.+S.+Puttfarckenauthor=C.+A.+Briggsauthor=J.+Liauthor=M.+D.+Meyerauthor=T.+Dyhringauthor=P.+K.+Ahringauthor=E.+%C3%98.+Nielsenauthor=D.+Petersauthor=D.+B.+Timmermannauthor=M.+Gopalakrishnan&title=In+vitro+pharmacological+characterization+of+a+novel+selective+%CE%B17+neuronal+nicotinic+acetylcholine+receptor+agonist+ABT-107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107</span></div><div class="casAuthors">Malysz, John; Anderson, David J.; Gronlien, Jens H.; Ji, Jianguo; Bunnelle, William H.; Hakerud, Monika; Thorin-Hagene, Kirten; Ween, Hilde; Helfrich, Rosalind; Hu, Min; Gubbins, Earl; Gopalakrishnan, Sujatha; Puttfarcken, Pamela S.; Briggs, Clark A.; Li, Jinhe; Meyer, Michael D.; Dyhring, Tino; Ahring, Philip K.; Nielsen, Elsebet O.; Peters, Dan; Timmermann, Daniel B.; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">863-874</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Enhancement of α7 nicotinic acetylcholine receptor (nAChR) activity is considered a therapeutic approach for ameliorating cognitive deficits present in Alzheimer's disease and schizophrenia.  In this study, we describe the in vitro profile of a novel selective α7 nAChR agonist, 5-(6-[(3R)-1-azabicyclo[2,2,2]oct-3-yloxy]pyridazin-3-yl)-1H-indole (ABT-107).  ABT-107 displayed high affinity binding to α7 nAChRs [rat or human cortex, [3H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane (A-585539), Ki = 0.2-0.6 nM or [3H]methyllycaconitine (MLA), 7 nM] that was at least 100-fold selective vs. non-α7 nAChRs and other receptors.  Functionally, ABT-107 did not evoke detectable currents in Xenopus oocytes expressing human or nonhuman α3β4, chimeric (α6/α3)β4, or 5-HT3A receptors, and weak or negligible Ca2+ responses in human neuroblastoma IMR-32 cells (α3* function) and human α4β2 and α4β4 nAChRs expressed in human embryonic kidney 293 cells.  ABT-107 potently evoked human and rat α7 nAChR current responses in oocytes (EC50, 50-90 nM total charge, ∼80% normalized to acetylcholine) that were enhanced by the pos. allosteric modulator (PAM) 4-[5-(4-chloro-phenyl)-2-methyl-3-propionyl-pyrrol-1-yl]-benzenesulfonamide (A-867744).  In rat hippocampus, ABT-107 alone evoked α7-like currents, which were inhibited by the α7 antagonist MLA.  In dentate gyrus granule cells, ABT-107 enhanced spontaneous inhibitory postsynaptic current activity when coapplied with A-867744.  In the presence of an α7 PAM [A-867744 or N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride (PNU-120596)], the addn. of ABT-107 elicited MLA-sensitive α7 nAChR-mediated Ca2+ signals in IMR-32 cells and rat cortical cultures and enhanced extracellular signal-regulated kinase phosphorylation in differentiated PC-12 cells.  ABT-107 was also effective in protecting rat cortical cultures against glutamate-induced toxicity.  In summary, ABT-107 is a selective high affinity α7 nAChR agonist suitable for characterizing the roles of this subtype in pharmacol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB9982OSc1h7Vg90H21EOLACvtfcHk0lhoxbmHrvHbgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyksLzO&md5=94a0bd94ac57905c97ac20ee33c20cd2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.167072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.167072%26sid%3Dliteratum%253Aachs%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DHelfrich%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DGubbins%26aufirst%3DE.%26aulast%3DGopalakrishnan%26aufirst%3DS.%26aulast%3DPuttfarcken%26aufirst%3DP.%2BS.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DNielsen%26aufirst%3DE.%2B%25C3%2598.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DTimmermann%26aufirst%3DD.%2BB.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520selective%2520%25CE%25B17%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520ABT-107%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D863%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhaas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markosyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikkel, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">In vivo pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer’s disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.110.167213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20504913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyksLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=875-886&author=R.+S.+Bitnerauthor=W.+H.+Bunnelleauthor=M.+W.+Deckerauthor=K.+U.+Drescherauthor=K.+Kohlhaasauthor=S.+Markosyanauthor=K.+C.+Marshauthor=A.+L.+Nikkelauthor=K.+Browmanauthor=R.+Radekauthor=D.+J.+Andersonauthor=J.+Buccafuscoauthor=M.+Gopalakrishnan&title=In+vivo+pharmacological+characterization+of+a+novel+selective+%CE%B17+neuronal+nicotinic+acetylcholine+receptor+agonist+ABT-107%3A+preclinical+considerations+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease</span></div><div class="casAuthors">Bitner, R. Scott; Bunnelle, William H.; Decker, Michael W.; Drescher, Karla U.; Kohlhaas, Kathy L.; Markosyan, Stella; Marsh, Kennan C.; Nikkel, Arthur L.; Browman, Kaitlin; Radek, Rich; Anderson, David J.; Buccafusco, Jerry; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">875-886</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We previously reported that α7 nicotinic acetylcholine receptor (nAChR) agonism produces efficacy in preclin. cognition models correlating with activation of cognitive and neuroprotective signaling pathways assocd. with Alzheimer's disease (AD) pathol.  In the present studies, the selective and potent α7 nAChR agonist 5-(6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl)-1H-indole (ABT-107) was evaluated in behavioral assays representing distinct cognitive domains.  Studies were also conducted to address potential issues that may be assocd. with the clin. development of an α7 nAChR agonist.  Specifically, ABT-107 improved cognition in monkey delayed matching to sample, rat social recognition, and mouse two-trial inhibitory avoidance, and continued to improve cognitive performance at injection times when exposure levels continued to decline.  Rats concurrently infused with ABT-107 and donepezil at steady-state levels consistent with clin. exposure showed improved short-term recognition memory.  Compared with nicotine, ABT-107 did not produce behavioral sensitization in rats or exhibit psychomotor stimulant activity in mice.  Repeated (3 days) daily dosing of ABT-107 increased extracellular cortical acetylcholine in rats, whereas acute administration increased cortical extracellular signal-regulated kinase and cAMP response element-binding protein phosphorylation in mice, neurochem. and biochem. events germane to cognitive function.  ABT-107 increased cortical phosphorylation of the inhibitory residue (Ser9) of glycogen synthase kinase-3, a primary tau kinase assocd. with AD pathol.  In addn., continuous infusion of ABT-107 in tau/amyloid precursor protein transgenic AD mice reduced spinal tau hyperphosphorylation.  These findings show that targeting α7 nAChRs may have potential utility for symptomatic alleviation and slowing of disease progression in the treatment AD, and expand the understanding of the potential therapeutic viability assocd. with the α7 nAChR approach in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJKfAStEXaJrVg90H21EOLACvtfcHk0lhoxbmHrvHbgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyksLzP&md5=28e7f9761561fe6daf6869cb8fdc8529</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.167213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.167213%26sid%3Dliteratum%253Aachs%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DDrescher%26aufirst%3DK.%2BU.%26aulast%3DKohlhaas%26aufirst%3DK.%26aulast%3DMarkosyan%26aufirst%3DS.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DNikkel%26aufirst%3DA.%2BL.%26aulast%3DBrowman%26aufirst%3DK.%26aulast%3DRadek%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBuccafusco%26aufirst%3DJ.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DIn%2520vivo%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520selective%2520%25CE%25B17%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520ABT-107%253A%2520preclinical%2520considerations%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D875%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marguerat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H] A-585539 [(1<i>S</i>,4<i>S</i>)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2 azoniabicyclo[2.2.1]heptanes], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.107.130062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17959745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsF2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=179-187&author=D.+J.+Andersonauthor=W.+Bunnelleauthor=B.+Surberauthor=J.+Duauthor=C.+Surowyauthor=E.+Tribolletauthor=A.+Margueratauthor=D.+Bertrandauthor=M.+Gopalakrishnan&title=%5B3H%5D+A-585539+%5B%281S%2C4S%29-2%2C2-dimethyl-5-%286-phenylpyridazin-3-yl%29-5-aza-2+azoniabicyclo%5B2.2.1%5Dheptanes%5D%2C+a+novel+high-affinity+%CE%B17+neuronal+nicotinic+receptor+agonist%3A+radioligand+binding+characterization+to+rat+and+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain</span></div><div class="casAuthors">Anderson, David J.; Bunnelle, William; Surber, Bruce; Du, Jia; Surowy, Carol; Tribollet, Eliane; Marguerat, Anouk; Bertrand, Daniel; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-187</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Receptor binding was characterized for [3H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane ([3H]A-585539), a selective high-affinity α7 nicotinic acetylcholine receptor (nAChR) agonist with rapid kinetics, low nonspecific binding, and high specific activity.  At 4, the assocn. was monophasic and rapid (t1/2=8.0 min); dissocn. was slower (t1/2=64.2 min).  The Kd in rat brain at 4 was 0.063 nM, whereas at 22 and 37, the Kd values were 0.188 and 0.95 nM, resp.  In contrast, the Bmax (34 fmol/mg protein) was unaffected by temp.  In human cortex, [3H]A-585539 bound with a Kd of 0.066 nM and a Bmax of 5.8 fmol/mg protein at 4, whereas under similar conditions, specific [3H]methyllycaconitine ([3H]MLA) binding was not measurable.  A no. of agonist and antagonist nAChR ligands displaced binding to rat brain membranes with rank order of affinity similar to that for [3H]MLA, and in general, a 5 to 10-fold higher affinity was obsd. for [3H]A-585539 binding.  There was also a good correlation of Ki values between [3H]A-585539 binding to rat brain and human cortex.  The use of a α7/5-hydroxytryptamine type-3 chimera revealed that the N-terminal domain of α7 nAChR was sufficient to faithfully reproduce the pharmacol. of [3H]A-585539 binding.  Autoradiog. studies comparing [3H]A-585539 and [125I]α-bungarotoxin revealed a similar pattern of labeling in the rat.  In summary, [3H]A-585539 was shown to have excellent binding characteristics in rat and human brain and represents the first high-affinity α7 agonist radioligand with utility in the characterization of this important nAChR subtype that is targeted toward ameliorating cognitive deficits underlying neuropsychiatric and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqji4MU_Eu8BrVg90H21EOLACvtfcHk0lhM78dr7w21fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsF2hsQ%253D%253D&md5=b7ebce829957073aba16e25cb1d4ee63</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.130062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.130062%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBunnelle%26aufirst%3DW.%26aulast%3DSurber%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DMarguerat%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3D%255B3H%255D%2520A-585539%2520%255B%25281S%252C4S%2529-2%252C2-dimethyl-5-%25286-phenylpyridazin-3-yl%2529-5-aza-2%2520azoniabicyclo%255B2.2.1%255Dheptanes%255D%252C%2520a%2520novel%2520high-affinity%2520%25CE%25B17%2520neuronal%2520nicotinic%2520receptor%2520agonist%253A%2520radioligand%2520binding%2520characterization%2520to%2520rat%2520and%2520human%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Othman, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awni, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, S.</span><span> </span><span class="NLM_article-title">Single- and multiple-dose pharmacokinetics, safety and tolerability of the selective α7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1177%2F0091270010370460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20495134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1ans7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=512-526&author=A.+A.+Othmanauthor=R.+A.+Lenzauthor=J.+Zhangauthor=J.+Liauthor=W.+M.+Awniauthor=S.+Dutta&title=Single-+and+multiple-dose+pharmacokinetics%2C+safety+and+tolerability+of+the+selective+%CE%B17+neuronal+nicotinic+receptor+agonist%2C+ABT-107%2C+in+healthy+human+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective α7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers</span></div><div class="casAuthors">Othman, Ahmed A.; Lenz, Robert A.; Zhang, Jun; Li, Jianling; Awni, Walid M.; Dutta, Sandeep</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">512-526</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">ABT-107 is a potent, selective α7 nicotinic receptor agonist under development for treatment of Alzheimer's disease and cognitive deficits assocd. with schizophrenia.  The pharmacokinetics, safety, and tolerability of escalating single oral doses (1, 3, 10, 30, 60, 80, and 100 mg; double-blind, placebo-controlled, randomized, incomplete crossover design) and multiple oral doses (2, 6, and 15 mg once daily for 7 days; double-blind, placebo-controlled, randomized, parallel-group design) of ABT-107 were evaluated.  Addnl., effect of food on ABT-107 pharmacokinetics (20-mg single dose) was evaluated using an open-label, 2-period, fasting and nonfasting, randomized, complete crossover design.  ABT-107 exhibited nonlinear (more than dose-proportional) pharmacokinetics.  ABT-107 half-life ranged from 7 to 10 h, and steady state was achieved by day 6 of dosing.  Food did not have a clin. meaningful effect on ABT-107 exposure.  ABT-107 was safe and well tolerated over the tested dose range.  The most frequently reported adverse events were nausea, headache, and tremor following single dosing and somnolence following multiple dosing.  The pharmacokinetics, safety, and tolerability profiles of ABT-107 pose it as a good candidate for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGyLckX0ur-LVg90H21EOLACvtfcHk0lhM78dr7w21fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1ans7w%253D&md5=a1dc05684f72fbc2a11eb753588e3926</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1177%2F0091270010370460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270010370460%26sid%3Dliteratum%253Aachs%26aulast%3DOthman%26aufirst%3DA.%2BA.%26aulast%3DLenz%26aufirst%3DR.%2BA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DAwni%26aufirst%3DW.%2BM.%26aulast%3DDutta%26aufirst%3DS.%26atitle%3DSingle-%2520and%2520multiple-dose%2520pharmacokinetics%252C%2520safety%2520and%2520tolerability%2520of%2520the%2520selective%2520%25CE%25B17%2520neuronal%2520nicotinic%2520receptor%2520agonist%252C%2520ABT-107%252C%2520in%2520healthy%2520human%2520volunteers%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D51%26spage%3D512%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Haydar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettinetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bothmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncarati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valacchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanaletti, R.</span><span> </span><span class="NLM_article-title">SAR and biological evaluation of SEN12333/WAY-317538: novel alpha 7 nicotinic acetylcholine receptor agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5247</span><span class="NLM_x">–</span> <span class="NLM_lpage">5258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.bmc.2009.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19515567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVyqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=5247-5258&author=S.+N.+Haydarauthor=C.+Ghironauthor=L.+Bettinettiauthor=H.+Bothmannauthor=T.+A.+Comeryauthor=J.+Dunlopauthor=S.+La+Rosaauthor=I.+Miccoauthor=M.+Pollastriniauthor=J.+Quinnauthor=R.+Roncaratiauthor=C.+Scaliauthor=M.+Valacchiauthor=M.+Varroneauthor=R.+Zanaletti&title=SAR+and+biological+evaluation+of+SEN12333%2FWAY-317538%3A+novel+alpha+7+nicotinic+acetylcholine+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist</span></div><div class="casAuthors">Haydar, Simon N.; Ghiron, Chiara; Bettinetti, Laura; Bothmann, Hendrick; Comery, Thomas A.; Dunlop, John; La Rosa, Salvatore; Micco, Iolanda; Pollastrini, Martina; Quinn, Joanna; Roncarati, Renza; Scali, Carla; Valacchi, Michela; Varrone, Maurizio; Zanaletti, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5247-5258</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alpha 7 nicotinic acetylcholine receptor (α7 nAChR) agonists are promising therapeutic candidates for the treatment of cognitive impairment assocd. with a variety of disorders including Alzheimer's disease and schizophrenia.  Alpha 7 nAChRs are expressed in brain regions assocd. with cognitive function, regulate cholinergic neurotransmission and have been shown to be down regulated in both schizophrenia and Alzheimer's disease.  Herein we report a novel, potent small mol. agonist of the alpha 7 nAChR, SEN12333/WAY-317538.  This compd. is a selective agonist of the α7 nAChR with excellent in vitro and in vivo profiles, excellent brain penetration and oral bioavailability, and demonstrates in vivo efficacy in multiple behavioral cognition models.  The SAR and biol. evaluation of this series of compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyFjYGluXw3bVg90H21EOLACvtfcHk0lg_BLd7ZEayrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVyqsrk%253D&md5=293ee7e518e64386330cfde5ca72c584</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DHaydar%26aufirst%3DS.%2BN.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DValacchi%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DZanaletti%26aufirst%3DR.%26atitle%3DSAR%2520and%2520biological%2520evaluation%2520of%2520SEN12333%252FWAY-317538%253A%2520novel%2520alpha%25207%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D5247%26epage%3D5258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Roncarati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bothmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianfriddo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanelli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terstappen, G. C.</span><span> </span><span class="NLM_article-title">Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.108.150094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19223665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Omu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=459-468&author=R.+Roncaratiauthor=C.+Scaliauthor=T.+A.+Comeryauthor=S.+M.+Grauerauthor=S.+Aschmiesauthor=H.+Bothmannauthor=B.+Jowauthor=D.+Kowalauthor=M.+Gianfriddoauthor=C.+Kelleyauthor=U.+Zanelliauthor=C.+Ghironauthor=S.+Haydarauthor=J.+Dunlopauthor=G.+C.+Terstappen&title=Procognitive+and+neuroprotective+activity+of+a+novel+alpha7+nicotinic+acetylcholine+receptor+agonist+for+treatment+of+neurodegenerative+and+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Procognitive and neuroprotective activity of a novel α7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders</span></div><div class="casAuthors">Roncarati, Renza; Scali, Carla; Comery, Thomas A.; Grauer, Steven M.; Aschmi, Suzan; Bothmann, Hendrick; Jow, Brian; Kowal, Dianne; Gianfriddo, Marco; Kelley, Cody; Zanelli, Ugo; Ghiron, Chiara; Haydar, Simon; Dunlop, John; Terstappen, Georg C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">459-468</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The α7 nicotinic acetylcholine receptor (nAChR) is a promising target for treatment of cognitive dysfunction assocd. with Alzheimer's disease and schizophrenia.  Here, we report the pharmacol. properties of 5-morpholin-4-yl-pentanoic acid (4-pyridin-3-yl-phenyl)-amide [SEN12333 (WAY-317538)], a novel selective agonist of α7 nAChR.  SEN12333 shows high affinity for the rat α7 receptor expressed in GH4C1 cells (Ki = 260 nM) and acts as full agonist in functional Ca2+ flux studies (EC50 = 1.6 μM).  In whole-cell patch-clamp recordings, SEN12333 activated peak currents and maximal total charges similar to acetylcholine (EC50 = 12 μM).  The compd. did not show agonist activity at other nicotinic receptors tested and acted as a weak antagonist at α3-contg. receptors.  SEN12333 treatment (3 mg/kg i.p.) improved episodic memory in a novel object recognition task in rats in conditions of spontaneous forgetting as well as cognitive disruptions induced via glutamatergic [5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate); MK-801] or cholinergic (scopolamine) mechanisms.  This improvement was blocked by the α7-selective antagonist methyllycaconitine, indicating that it is mediated by α7 activation.  SEN12333 also prevented a scopolamine-induced deficit in a passive avoidance task.  In models targeting other cognitive domains, including attention and perceptual processing, SEN12333 normalized the apomorphine-induced deficit of prepulse inhibition.  Neuroprotection of SEN12333 was demonstrated in quisqualate-lesioned animals in which treatment with SEN12333 (3 mg/kg/day i.p.) resulted in a significant protection of choline acetyltransferase-pos. neurons in the lesioned hemisphere.  Cumulatively, our results demonstrate that the novel α7 nAChR agonist SEN12333 has procognitive and neuroprotective properties, further demonstrating utility of α7 agonists for treatment of neurodegenerative and cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Bj3oVp7W5bVg90H21EOLACvtfcHk0lg_BLd7ZEayrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Omu74%253D&md5=66ee7b7cc3ff6b926388e960653841de</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.150094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.150094%26sid%3Dliteratum%253Aachs%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DJow%26aufirst%3DB.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DGianfriddo%26aufirst%3DM.%26aulast%3DKelley%26aufirst%3DC.%26aulast%3DZanelli%26aufirst%3DU.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DHaydar%26aufirst%3DS.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26atitle%3DProcognitive%2520and%2520neuroprotective%2520activity%2520of%2520a%2520novel%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520for%2520treatment%2520of%2520neurodegenerative%2520and%2520cognitive%2520disorders%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D459%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. K.</span><span> </span><span class="NLM_article-title">Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1002%2F%28SICI%291098-1128%28199605%2916%3A3%3C243%3A%3AAID-MED2%3E3.0.CO%3B2-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=8727426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADyaK28XivFWktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=243-266&author=D.+A.+Smithauthor=B.+C.+Jonesauthor=D.+K.+Walker&title=Design+of+drugs+involving+the+concepts+and+theories+of+drug+metabolism+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics</span></div><div class="casAuthors">Smith, Dennis A.; Jones, Barry C.; Walker, Donald K.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-266</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review with 53 refs.  Drug metab. input to the discovery process has historically been on an empirical case-by-case basis, since, detailed descriptors of the effect on pharmacokinetics of a change in structure or physicochem. property were not available.  Considerable advances have been made in recent years, such that basic rules can be applied to predict the behavior of a compd. in man based on physicochem. and structure.  This is particularly true in the areas of absorption, distribution, and clearance.  In particular, knowledge of the reactions catalyzed by the enzymes of drug metab., including the cytochrome P 450 super family, can be used in the design of new chem. entities, together with the usual pharmacol.-derived SAR.  The combination of both pharmacokinetics and pharmacodynamics at the discovery stage leads to drugs with optimum performance characteristics.  Such drugs are easier to develop, representing a huge savings in resources.  Moreover, the marketed compd. is much more likely to find high clin. utilization.  This review uses dofetilide, fluconazole, and amlodipine to highlight the multifaceted consequences of changing chem. structure, in terms of drug disposition, and reinforces these principles with examples from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIC1k-4nTJxLVg90H21EOLACvtfcHk0lhlao-iSQPnXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFWktL8%253D&md5=f6ada0fe124832faf614ab7116a31412</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199605%2916%3A3%3C243%3A%3AAID-MED2%3E3.0.CO%3B2-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199605%252916%253A3%253C243%253A%253AAID-MED2%253E3.0.CO%253B2-Z%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DDesign%2520of%2520drugs%2520involving%2520the%2520concepts%2520and%2520theories%2520of%2520drug%2520metabolism%2520and%2520pharmacokinetics%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1996%26volume%3D16%26spage%3D243%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bothmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaldo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocconcelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncarati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terstappen, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turlizzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valacchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanaletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanelli, U.</span><span> </span><span class="NLM_article-title">Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4379</span><span class="NLM_x">–</span> <span class="NLM_lpage">4389</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901692q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFKqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4379-4389&author=C.+Ghironauthor=S.+N.+Haydarauthor=S.+Aschmiesauthor=H.+Bothmannauthor=C.+Castaldoauthor=G.+Cocconcelliauthor=T.+A.+Comeryauthor=L.+Diauthor=J.+Dunlopauthor=T.+Lockauthor=A.+Kramerauthor=D.+Kowalauthor=F.+Jowauthor=S.+Grauerauthor=B.+Harrisonauthor=S.+La+Rosaauthor=L.+Maccariauthor=K.+L.+Marquisauthor=I.+Miccoauthor=A.+Nenciniauthor=J.+Quinnauthor=A.+J.+Robichaudauthor=R.+Roncaratiauthor=C.+Scaliauthor=G.+C.+Terstappenauthor=E.+Turlizziauthor=M.+Valacchiauthor=M.+Varroneauthor=R.+Zanalettiauthor=U.+Zanelli&title=Novel+alpha-7+nicotinic+acetylcholine+receptor+agonists+containing+a+urea+moiety%3A+identification+and+characterization+of+the+potent%2C+selective%2C+and+orally+efficacious+agonist+1-%5B6-%284-fluorophenyl%29pyridin-3-yl%5D-3-%284-piperidin-1-ylbutyl%29+urea+%28SEN34625%2FWYE-103914%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonists Containing a Urea Moiety: Identification and Characterization of the Potent, Selective, and Orally Efficacious Agonist 1-[6-(4-Fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) Urea (SEN34625/WYE-103914)</span></div><div class="casAuthors">Ghiron, Chiara; Haydar, Simon N.; Aschmies, Suzan; Bothmann, Hendrick; Castaldo, Cristiana; Cocconcelli, Giuseppe; Comery, Thomas A.; Di, Li; Dunlop, John; Lock, Tim; Kramer, Angela; Kowal, Dianne; Jow, Flora; Grauer, Steve; Harrison, Boyd; La Rosa, Salvatore; Maccari, Laura; Marquis, Karen L.; Micco, Iolanda; Nencini, Arianna; Quinn, Joanna; Robichaud, Albert J.; Roncarati, Renza; Scali, Carla; Terstappen, Georg C.; Turlizzi, Elisa; Valacchi, Michela; Varrone, Maurizio; Zanaletti, Riccardo; Zanelli, Ugo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4379-4389</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alpha-7 nicotinic acetylcholine receptor (α7 nAChR) agonists are promising therapeutic candidates for the treatment of cognitive impairment.  We report a series of novel, potent small mol. agonists (4-18) of the α7 nAChR deriving from our continuing efforts in the areas of Alzheimer's disease and schizophrenia.  One of the compds. of the series contg. a urea moiety (16)(I) was further shown to be a selective agonist of the α7 nAChR with excellent in vitro and in vivo profiles, brain penetration, and oral bioavailability and demonstrated in vivo efficacy in multiple behavioral cognition models.  Structural modifications leading to the improved selectivity profile and the biol. evaluation of this series of compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlg-l6HJigrrVg90H21EOLACvtfcHk0lhlao-iSQPnXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFKqt70%253D&md5=f15ad80636d6ba345752ce1ddc7be15b</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm901692q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901692q%26sid%3Dliteratum%253Aachs%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DHaydar%26aufirst%3DS.%2BN.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DCastaldo%26aufirst%3DC.%26aulast%3DCocconcelli%26aufirst%3DG.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DJow%26aufirst%3DF.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DMaccari%26aufirst%3DL.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26aulast%3DTurlizzi%26aufirst%3DE.%26aulast%3DValacchi%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DZanaletti%26aufirst%3DR.%26aulast%3DZanelli%26aufirst%3DU.%26atitle%3DNovel%2520alpha-7%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%2520containing%2520a%2520urea%2520moiety%253A%2520identification%2520and%2520characterization%2520of%2520the%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520agonist%25201-%255B6-%25284-fluorophenyl%2529pyridin-3-yl%255D-3-%25284-piperidin-1-ylbutyl%2529%2520urea%2520%2528SEN34625%252FWYE-103914%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4379%26epage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanthorn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J. C.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>3</sub> antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=319-321&author=J.+E.+Macorauthor=D.+Gurleyauthor=T.+Lanthornauthor=J.+Lochauthor=R.+A.+Mackauthor=G.+Mullenauthor=O.+Tranauthor=N.+Wrightauthor=J.+C.+Gordon&title=The+5-HT3+antagonist+tropisetron+%28ICS+205-930%29+is+a+potent+and+selective+%CE%B17+nicotinic+receptor+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DLanthorn%26aufirst%3DT.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DMack%26aufirst%3DR.%2BA.%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DO.%26aulast%3DWright%26aufirst%3DN.%26aulast%3DGordon%26aufirst%3DJ.%2BC.%26atitle%3DThe%25205-HT3%2520antagonist%2520tropisetron%2520%2528ICS%2520205-930%2529%2520is%2520a%2520potent%2520and%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520partial%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D319%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Pitsikas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span> </span><span class="NLM_article-title">Different effects of tropisetron and ondansetron in learning and memory paradigms</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1997&pages=571-576&author=N.+Pitsikasauthor=F.+Borsini&title=Different+effects+of+tropisetron+and+ondansetron+in+learning+and+memory+paradigms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPitsikas%26aufirst%3DN.%26aulast%3DBorsini%26aufirst%3DF.%26atitle%3DDifferent%2520effects%2520of%2520tropisetron%2520and%2520ondansetron%2520in%2520learning%2520and%2520memory%2520paradigms%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1997%26volume%3D56%26spage%3D571%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span> </span><span class="NLM_article-title">Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of α7 nicotinic receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">553</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.ejphar.2006.09.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17094961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2006&pages=191-195&author=K.+Hashimotoauthor=Y.+Fujitaauthor=T.+Ishimaauthor=H.+Hagiwaraauthor=M.+Iyo&title=Phencyclidine-induced+cognitive+deficits+in+mice+are+improved+by+subsequent+subchronic+administration+of+tropisetron%3A+role+of+%CE%B17+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: Role of α7 nicotinic receptors</span></div><div class="casAuthors">Hashimoto, Kenji; Fujita, Yuko; Ishima, Tamaki; Hagiwara, Hiroko; Iyo, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">191-195</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the effects of tropisetron, a 5-hydroxytryptamine (5-HT3) receptor antagonist and α7 nicotinic receptor agonist, on cognitive deficits in mice after repeated administration of the NMDA receptor antagonist phencyclidine (PCP).  PCP (10 mg/kg/day for 10 days)-induced cognitive deficits were significantly improved by subsequent subchronic (2 wk) administration of tropisetron, but not ondansetron.  Effects of tropisetron were significantly antagonized by co-administration of the α7 nicotinic receptor antagonist methyllycaconitine, suggesting the role of α7 nicotinic receptors in the active mechanisms of tropisetron.  These findings suggest that tropisetron could be a potential therapeutic drug for cognitive deficits in schizophrenic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxLAYuAtrF7rVg90H21EOLACvtfcHk0lj0WRXzjAfWYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bI&md5=08620f954d8484fcf2076b7747c5b046</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DIshima%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DH.%26aulast%3DIyo%26aufirst%3DM.%26atitle%3DPhencyclidine-induced%2520cognitive%2520deficits%2520in%2520mice%2520are%2520improved%2520by%2520subsequent%2520subchronic%2520administration%2520of%2520tropisetron%253A%2520role%2520of%2520%25CE%25B17%2520nicotinic%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D553%26spage%3D191%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Shiina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niitsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haraguch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span> </span><span class="NLM_article-title">A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia</span> <span class="citation_source-journal">Ann. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1186%2F1744-859X-9-27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20573264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BC3cnmtFKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=27&author=A.+Shiinaauthor=Y.+Shirayamaauthor=T.+Niitsuauthor=T.+Hashimotoauthor=T.+Yoshidaauthor=T.+Hasegawaauthor=T.+Haraguchauthor=N.+Kanaharaauthor=T.+Shiraishiauthor=M.+Fujisakiauthor=G.+Fukamiauthor=M.+Nakazatoauthor=M.+Iyoauthor=K.+Hashimoto&title=A+randomised%2C+double-blind%2C+placebo-controlled+trial+of+tropisetron+in+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia</span></div><div class="casAuthors">Shiina Akihiro; Shirayama Yukihiko; Niitsu Tomihisa; Hashimoto Tasuku; Yoshida Taisuke; Hasegawa Tadashi; Haraguchi Tadashi; Kanahara Nobuhisa; Shiraishi Tetsuya; Fujisaki Mihisa; Fukami Goro; Nakazato Michiko; Iyo Masaomi; Hashimoto Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Annals of general psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Cognitive deficits in schizophrenia are associated with psychosocial deficits that are primarily responsible for the poor long-term outcome of this disease.  Auditory sensory gating P50 deficits are correlated with neuropsychological deficits in attention, one of the principal cognitive disturbances in schizophrenia.  Our studies suggest that the alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist tropisetron might be a potential therapeutic drug for cognitive deficits in schizophrenia.  Therefore, it is of particular interest to investigate the effects of tropisetron on the cognitive deficits in patients with schizophrenia.  METHODS:  A randomised, placebo-controlled trial of tropisetron in patients with schizophrenia was performed.  A total of 40 patients with chronic schizophrenia who had taken risperidone (2 to 6 mg/day) were enrolled.  Subjects were randomly assigned to a fixed titration of tropisetron (n = 20, 10 mg/day) or placebo (n = 20) in an 8-week double-blind trial.  Auditory sensory gating P50 deficits and Quality of Life Scale (QLS), Cambridge Neuropsychological Test Automated Battery (CANTAB), and Positive and Negative Syndrome Scale (PANSS) scores were measured.  RESULTS:  In all, 33 patients completed the trial.  Tropisetron was well tolerated.  Administration of tropisetron, but not placebo, significantly improved auditory sensory gating P50 deficits in non-smoking patients with schizophrenia.  The score on the rapid visual information processing (sustained visual attention) task of CANTAB was significantly improved by tropisetron treatment.  Total and subscale scores of PANSS were not changed by this trial.  QLS scores in the all patients, but not non-smoking patients, were significantly improved by tropisetron trial.  CONCLUSIONS:  This first randomised, double-blind, placebo-controlled trial supports the safety and efficacy of adjunctive tropisetron for treatment of cognitive deficits in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZVVObPCY7NB0LsK7uFuY7fW6udTcc2eYHr6laLodzX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnmtFKhsw%253D%253D&md5=ba0cf0cbfd6891364378133f24a40c2b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1186%2F1744-859X-9-27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-859X-9-27%26sid%3Dliteratum%253Aachs%26aulast%3DShiina%26aufirst%3DA.%26aulast%3DShirayama%26aufirst%3DY.%26aulast%3DNiitsu%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DHaraguch%26aufirst%3DT.%26aulast%3DKanahara%26aufirst%3DN.%26aulast%3DShiraishi%26aufirst%3DT.%26aulast%3DFujisaki%26aufirst%3DM.%26aulast%3DFukami%26aufirst%3DG.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DIyo%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DA%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520of%2520tropisetron%2520in%2520patients%2520with%2520schizophrenia%26jtitle%3DAnn.%2520Gen.%2520Psychiatry%26date%3D2010%26volume%3D9%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span>Presented at the Congress of the European League against Rheumatism, Stockholm, Sweden, Jun 12–15,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>AB0285.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Presented+at+the+Congress+of+the+European+League+against+Rheumatism%2C+Stockholm%2C+Sweden%2C+Jun+12%E2%80%9315%2C+2002%3B+AB0285."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Stratz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W.</span><span> </span><span class="NLM_article-title">Treatment of tendopathies with tropisetron</span> <span class="citation_source-journal">Rheumatol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1007%2Fs00296-002-0233-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=12426658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFWlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=219-221&author=T.+Stratzauthor=B.+Vargaauthor=W.+Muller&title=Treatment+of+tendopathies+with+tropisetron"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of tendopathies with tropisetron</span></div><div class="casAuthors">Stratz, Thomas; Varga, Boglarka; Mueller, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">219-221</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A comparison between a local anesthetic drug and the 5-hydroxytryptamine 3 (5-HT3) receptor antagonist tropisetron in treating tendopathies or periarthropathies revealed that tropisetron has a longer effect on resting pain and pain on movement than the local anesthetic drug.  The most likely explanation for this effect probably is a blocking of stimulated 5-HT3 receptors at the nociceptors in conjunction with an inhibited release of substance P and other neurokines because of this blockage.  Further studies will have to show whether the action of tropisetron in tendopathies is as favorable as that of corticosteroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ0-OP3htQ6rVg90H21EOLACvtfcHk0lhRjd58OvRCSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFWlsb8%253D&md5=87ab7eca5dd56d64a957b23f6be7e0d1</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1007%2Fs00296-002-0233-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-002-0233-8%26sid%3Dliteratum%253Aachs%26aulast%3DStratz%26aufirst%3DT.%26aulast%3DVarga%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DW.%26atitle%3DTreatment%2520of%2520tendopathies%2520with%2520tropisetron%26jtitle%3DRheumatol.%2520Int.%26date%3D2002%26volume%3D22%26spage%3D219%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span>Presented at the Congress of the European League against Rheumatism, Stockholm, Sweden, Jun 12–15,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>FRI0060.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Presented+at+the+Congress+of+the+European+League+against+Rheumatism%2C+Stockholm%2C+Sweden%2C+Jun+12%E2%80%9315%2C+2002%3B+FRI0060."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Späth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kötter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amberger, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haus, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Färber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, W.</span><span> </span><span class="NLM_article-title">Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia</span> <span class="citation_source-journal">Scand. J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1080%2F03009740410005818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=15370724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BD2crjslWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2004&pages=267-270&author=M.+Sp%C3%A4thauthor=T.+Stratzauthor=G.+Neeckauthor=I.+K%C3%B6tterauthor=B.+Hammelauthor=C.+C.+Ambergerauthor=U.+Hausauthor=L.+F%C3%A4rberauthor=D.+Pongratzauthor=W.+M%C3%BCller&title=Efficacy+and+tolerability+of+intravenous+tropisetron+in+the+treatment+of+fibromyalgia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia</span></div><div class="casAuthors">Spath M; Stratz T; Neeck G; Kotter I; Hammel B; Amberger C C; Haus U; Farber L; Pongratz D; Muller W</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian journal of rheumatology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-70</span>
        ISSN:<span class="NLM_cas:issn">0300-9742</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine the efficacy of a serotonin receptor (5-HT(3)) antagonist in the treatment of fibromyalgia (FM) in a prospective, randomized, double-blind, placebo-controlled, multicentre trial.  METHODS:  Twenty-one female patients (age 21-63 years) with FM according to the American College of Rheumatology classification criteria for FM were assigned randomly to either a placebo group or to receive a daily intravenous bolus injection of 5 mg tropisetron for 5 days.  RESULTS:  In patients receiving tropisetron, the visual analogue scale (VAS) score for pain decreased by 28.9 compared with a decrease of 6.8 in the placebo group [probability (p)=0.063; effect size: 0.794].  Similar results were obtained using a body diagram pain score as a secondary efficacy parameter: mean pain reduction was 27.2 in the tropisetron group, versus 2.8 in the placebo group (p=0.038; effect size: 0.902).  CONCLUSION:  5-HT(3) receptor antagonists provide significant pain relief for a group of FM patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2fWozIaO1lZVVjGoY74BafW6udTcc2eaHfUDQsfppirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crjslWhtg%253D%253D&md5=85495ff408009f1bbf9fe6090cf3ae14</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1080%2F03009740410005818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03009740410005818%26sid%3Dliteratum%253Aachs%26aulast%3DSp%25C3%25A4th%26aufirst%3DM.%26aulast%3DStratz%26aufirst%3DT.%26aulast%3DNeeck%26aufirst%3DG.%26aulast%3DK%25C3%25B6tter%26aufirst%3DI.%26aulast%3DHammel%26aufirst%3DB.%26aulast%3DAmberger%26aufirst%3DC.%2BC.%26aulast%3DHaus%26aufirst%3DU.%26aulast%3DF%25C3%25A4rber%26aufirst%3DL.%26aulast%3DPongratz%26aufirst%3DD.%26aulast%3DM%25C3%25BCller%26aufirst%3DW.%26atitle%3DEfficacy%2520and%2520tolerability%2520of%2520intravenous%2520tropisetron%2520in%2520the%2520treatment%2520of%2520fibromyalgia%26jtitle%3DScand.%2520J.%2520Rheumatol.%26date%3D2004%26volume%3D33%26spage%3D267%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Stratz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W.</span><span> </span><span class="NLM_article-title">Beeinflusst die depressivität den behandlungseffekt von tropisetron bei fibromyalgiepatienten?</span> <span class="citation_source-journal">Z. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1007%2Fs00393-003-0418-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=12624803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BD3s7htFKltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2003&pages=42-45&author=T.+Stratzauthor=B.+Vargaauthor=W.+Muller&title=Beeinflusst+die+depressivit%C3%A4t+den+behandlungseffekt+von+tropisetron+bei+fibromyalgiepatienten%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia</span></div><div class="casAuthors">Stratz T; Varga B; Muller W</div><div class="citationInfo"><span class="NLM_cas:title">Zeitschrift fur Rheumatologie</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-5</span>
        ISSN:<span class="NLM_cas:issn">0340-1855</span>.
    </div><div class="casAbstract">As described elsewhere the oral administration of 5 mg of the 5-HT3-receptor-antagonist Tropisetron in fibromyalgia exhibited less amelioration of pain in patients with a depression in comparison to patients without depression.  Since an intravenous treatment seems to increase the effect of Tropisetron, the question arises whether patients with depression profit from the intravenous therapy.  Methods 68 out patients with fibromyalgia according to ACR-criteria were enrolled in the study.  The patients filled in a VAS pain and the Beck Depression Inventory (BDI) before and after a bolus i.v. injection of 5 mg Tropisetron for 5 days [Beck AT, Steer Ra.  Beck-Depression-Inventory (BDI) In: Hautzinger M (Hrsg der dt.  Ausg.).  Testhandbuch. 1.  Auflage Bern: Verlag Hans Huber, 1994].  In the beginning the patients had to have > or = 40 mm in the VAS pain from 0-100 mm.  The patients were divided into three groups: group 1 = patients with a BDI<19 without experience with antidepressive drugs (n=26); group 2=patients with a BDI > or = 19 (n=22) and negative experience with antidepressive substances, and group 3=patients with a BDI > or = 19 and an accompanying antidepressant drug therapy and some benefit under this therapy (n=20).  Results Before the therapy there was no significant difference in VAS pain in the groups, but in BDI there was a significant difference between group 1 (BDI mean value 11.5) in comparison to group 2 (BDI mean value 26.1) and group 3 (BDI mean value 24.8).  After therapy all three groups had a significant amelioration of pain: group 1: p=0.000023; group 2: p=0.00073; group 3: p=0.0145.  There was a significant difference between the group with BDI<19 and the group with antidepressant drug in amelioration of pain (p=0.044).  A significant correlation was found in group 2 with Beck > or = 19 between amelioration of pain and BDI after therapy (p=0.008, r=0.666).  In this group a pain-reactive depression and in group 3 an endogenous depression must be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXhHpj_bX0ZLxanA7vODO6fW6udTcc2eaHfUDQsfppirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7htFKltg%253D%253D&md5=1f17b5e599847f718959f7e0a8b6abf9</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00393-003-0418-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00393-003-0418-x%26sid%3Dliteratum%253Aachs%26aulast%3DStratz%26aufirst%3DT.%26aulast%3DVarga%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DW.%26atitle%3DBeeinflusst%2520die%2520depressivit%25C3%25A4t%2520den%2520behandlungseffekt%2520von%2520tropisetron%2520bei%2520fibromyalgiepatienten%253F%26jtitle%3DZ.%2520Rheumatol.%26date%3D2003%26volume%3D62%26spage%3D42%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span>Presented at the Congress of the European League against Rheumatism, Stockholm, Sweden, Jun 12–15,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>FRI0032.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Presented+at+the+Congress+of+the+European+League+against+Rheumatism%2C+Stockholm%2C+Sweden%2C+Jun+12%E2%80%9315%2C+2002%3B+FRI0032."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Cui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suemaru, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohnomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, H.</span><span> </span><span class="NLM_article-title">Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">609</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.ejphar.2008.12.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19374878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslyht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=609&publication_year=2009&pages=74-77&author=R.+Cuiauthor=K.+Suemaruauthor=B.+Liauthor=S.+Kohnomiauthor=H.+Araki&title=Tropisetron+attenuates+naloxone-induced+place+aversion+in+single-dose+morphine-treated+rats%3A+role+of+alpha7+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: Role of α7 nicotinic receptors</span></div><div class="casAuthors">Cui, Ranji; Suemaru, Katsuya; Li, Bingjin; Kohnomi, Shuntaro; Araki, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">609</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">74-77</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously reported that acute dependence can occur when naloxone is administered 24 h after even a single dose of morphine, and that nicotine attenuates this naloxone-pptd. withdrawal syndrome.  In the present study, we studied the effect of tropisetron, an α7 nicotinic receptor agonist and 5-hydroxytryptamine 3 (5-HT3) receptor antagonist, on place aversion induced by naloxone in morphine-treated rats.  Place aversion was significantly attenuated by pre-administered tropisetron (1.0 and 2.0 mg/kg, i. p.) in a dose-dependent manner, however tropisetron alone had no effect in a place-conditioning paradigm.  This attenuation was completely antagonized by mecamylamine (1.0 mg/kg, s.c.), which is a central nicotinic receptor antagonist, but not by ondansetron (0.3 and 1.0 mg/kg, s.c.), a 5-HT3 receptor antagonist.  Furthermore, methyllycaconitine (1.0 and 2.0 mg/kg, s.c.), an α7 nicotinic acetylcholine receptor antagonist, but not dihydroxy-β-erithroidine (1.0 and 2.0 mg/kg, s.c.), an α4β2 nicotinic acetylcholine receptor antagonist, also antagonized the inhibitory effect of tropisetron.  These findings suggest that tropisetron attenuates place aversion induced by naloxone in single-dose morphine-treated rats via α7 nicotinic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm_zWF7RxYibVg90H21EOLACvtfcHk0lg12uOGP-EdDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslyht7w%253D&md5=24d6a5f950a95f725be2508205091224</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.12.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.12.051%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DR.%26aulast%3DSuemaru%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKohnomi%26aufirst%3DS.%26aulast%3DAraki%26aufirst%3DH.%26atitle%3DTropisetron%2520attenuates%2520naloxone-induced%2520place%2520aversion%2520in%2520single-dose%2520morphine-treated%2520rats%253A%2520role%2520of%2520alpha7%2520nicotinic%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D609%26spage%3D74%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Lightfoot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skidmore, J.</span><span> </span><span class="NLM_article-title">α7 Nicotinic acetylcholine receptor agonists and positive allosteric modulators</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0079-6468%2807%2900003-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=18381125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1ynsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=131-171&author=A.+P.+Lightfootauthor=J.+N.+C.+Kewauthor=J.+Skidmore&title=%CE%B17+Nicotinic+acetylcholine+receptor+agonists+and+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">α7 nicotinic acetylcholine receptor agonists and positive allosteric modulators</span></div><div class="casAuthors">Lightfoot, Andrew P.; Kew, James N. C.; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-171</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the progress in medicinal chem. of recent α7 nicotinic acetyicholine receptor (nAChR) agonists and, in more detail, the advances in the discovery of α7 nAChR pos. allosteric modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoxo_SwxQsBrVg90H21EOLACvtfcHk0lg12uOGP-EdDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1ynsL0%253D&md5=b892bac8b5f5cec9e543e9d932a3101f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2807%2900003-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252807%252900003-3%26sid%3Dliteratum%253Aachs%26aulast%3DLightfoot%26aufirst%3DA.%2BP.%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3D%25CE%25B17%2520Nicotinic%2520acetylcholine%2520receptor%2520agonists%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D46%26spage%3D131%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Ng, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittemore, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogenkamp, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, K. W.</span><span> </span><span class="NLM_article-title">Nootropic α7 nicotinic receptor allosteric modulator derived from GABA<sub>A</sub> receptor modulators</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">8059</span><span class="NLM_x">–</span> <span class="NLM_lpage">8064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=8059-8064&author=H.+J.+Ngauthor=E.+R.+Whittemoreauthor=M.+B.+Tranauthor=D.+J.+Hogenkampauthor=R.+S.+Broideauthor=T.+B.+Johnstoneauthor=L.+Zhengauthor=K.+E.+Stevensauthor=K.+W.+Gee&title=Nootropic+%CE%B17+nicotinic+receptor+allosteric+modulator+derived+from+GABAA+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DH.%2BJ.%26aulast%3DWhittemore%26aufirst%3DE.%2BR.%26aulast%3DTran%26aufirst%3DM.%2BB.%26aulast%3DHogenkamp%26aufirst%3DD.%2BJ.%26aulast%3DBroide%26aufirst%3DR.%2BS.%26aulast%3DJohnstone%26aufirst%3DT.%2BB.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DStevens%26aufirst%3DK.%2BE.%26aulast%3DGee%26aufirst%3DK.%2BW.%26atitle%3DNootropic%2520%25CE%25B17%2520nicotinic%2520receptor%2520allosteric%2520modulator%2520derived%2520from%2520GABAA%2520receptor%2520modulators%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D8059%26epage%3D8064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span> </span><span class="NLM_article-title">Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2004&pages=715-724&author=J.+H.+Gr%C3%B8nlienauthor=M.+H%C3%A5kerudauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=C.+A.+Briggsauthor=M.+Gopalakrishnanauthor=J.+Malysz&title=Distinct+profiles+of+%CE%B17+nAChR+positive+allosteric+modulation+revealed+by+structurally+diverse+chemotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DMalysz%26aufirst%3DJ.%26atitle%3DDistinct%2520profiles%2520of%2520%25CE%25B17%2520nAChR%2520positive%2520allosteric%2520modulation%2520revealed%2520by%2520structurally%2520diverse%2520chemotypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D72%26spage%3D715%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Christensen, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, M. S.</span><span> </span><span class="NLM_article-title">Repeated administration of α7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases α7 nAChR levels in the brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20533993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWkt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2010&pages=1205-1216&author=D.+Z.+Christensenauthor=J.+D.+Mikkelsenauthor=H.+H.+Hansenauthor=M.+S.+Thomsen&title=Repeated+administration+of+%CE%B17+nicotinic+acetylcholine+receptor+%28nAChR%29+agonists%2C+but+not+positive+allosteric+modulators%2C+increases+%CE%B17+nAChR+levels+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated administration of α7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases α7 nAChR levels in the brain</span></div><div class="casAuthors">Christensen, Ditte Z.; Mikkelsen, Jens D.; Hansen, Henrik H.; Thomsen, Morten S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1205-1216</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The α7 nicotinic acetylcholine receptor (nAChR) is an important target for treatment of cognitive deficits in schizophrenia and Alzheimer's disease.  However, the receptor desensitizes rapidly in vitro, which has led to concern regarding its applicability as a clin. relevant drug target.  Here we investigate the effects of repeated agonism on α7 nAChR receptor levels and responsiveness in vivo in rats.  Using [125I]-α-bungarotoxin (BTX) autoradiog. we show that acute or repeated administration with the selective α7 nAChR agonist A-582941 increases the no. of α7 nAChR binding sites in several brain regions, particularly in the prefrontal cortex.  The α7 nAChR agonists SSR180711 and PNU-282987 also increase [125I]-BTX binding, suggesting that this is a general consequence of α7 nAChR agonism.  Interestingly, the α7 nAChR pos. allosteric modulators PNU-120596 and NS1738 do not increase [125I]-BTX binding.  Furthermore, A-582941-induced increase in Arc and c-fos mRNA expression in the prefrontal cortex is enhanced and unaltered, resp., after repeated administration, demonstrating that the α7 nAChRs remain responsive.  Contrarily, A-582941-induced phosphorylation of Erk2 in the prefrontal cortex occurs following acute, but not repeated administration.  Our results demonstrate that repeated agonist administration increases the no. of α7 nAChRs in the brain, and leads to coupling vs. uncoupling of specific intracellular signaling pathways.  Addnl., our data suggest a fundamental difference between the sequelae of repeated administration with agonists and allosteric modulators of the α7 nAChR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXb-V7CFpzbVg90H21EOLACvtfcHk0liaMHN-AwDDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWkt77J&md5=d2921429bc8350c42d1b6a443c0aca03</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DD.%2BZ.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26aulast%3DHansen%26aufirst%3DH.%2BH.%26aulast%3DThomsen%26aufirst%3DM.%2BS.%26atitle%3DRepeated%2520administration%2520of%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520agonists%252C%2520but%2520not%2520positive%2520allosteric%2520modulators%252C%2520increases%2520%25CE%25B17%2520nAChR%2520levels%2520in%2520the%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D114%26spage%3D1205%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajó s, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggenbass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford-Root, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkenpas, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S.</span><span> </span><span class="NLM_article-title">A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4396</span><span class="NLM_x">–</span> <span class="NLM_lpage">4405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1523%2FJNEUROSCI.5269-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=15858066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFKgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4396-4405&author=R.+S.+Hurstauthor=M.+Haj%C3%B3+sauthor=M.+Raggenbassauthor=T.+M.+Wallauthor=N.+R.+Higdonauthor=J.+A.+Lawsonauthor=K.+L.+Rutherford-Rootauthor=M.+B.+Berkenpasauthor=W.+E.+Hoffmannauthor=D.+W.+Piotrowskiauthor=V.+E.+Groppiauthor=G.+Allamanauthor=R.+Ogierauthor=S.+Bertrandauthor=D.+Bertrandauthor=S.+Arneric&title=A+novel+positive+allosteric+modulator+of+the+%CE%B17+neuronal+nicotinic+acetylcholine+receptor%3A+in+vitro+and+in+vivo+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor: In vitro and in vivo characterization</span></div><div class="casAuthors">Hurst, Raymond S.; Hajos, Mihaly; Raggenbass, Mario; Wall, Theron M.; Higdon, Nicole R.; Lawson, Judy A.; Rutherford-Root, Karen L.; Berkenpas, Mitchell B.; Hoffmann, W. E.; Piotrowski, David W.; Groppi, Vincent E.; Allaman, Geraldine; Ogier, Roch; Bertrand, Sonia; Bertrand, Daniel; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4396-4405</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Several lines of evidence suggest a link between the α7 neuronal nicotinic acetylcholine receptor (nAChR) and brain disorders including schizophrenia, Alzheimer's disease, and traumatic brain injury.  The present work describes a novel mol., 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596), which acts as a powerful pos. allosteric modulator of the α7 nAChR.  Discovered in a high-throughput screen, PNU-120596 increased agonist-evoked calcium flux mediated by an engineered variant of the human α7 nAChR.  Electrophysiol. studies confirmed that PNU-120596 increased peak agonist-evoked currents mediated by wild-type receptors and also demonstrated a pronounced prolongation of the evoked response in the continued presence of agonist.  In contrast, PNU-120596 produced no detectable change in currents mediated by α4β2, α3β4, and α9α10 nAChRs.  PNU-120596 increased the channel mean open time of α7 nAChRs but had no effect on ion selectivity and relatively little, if any, effect on unitary conductance.  When applied to acute hippocampal slices, PNU-120596 increased the frequency of ACh-evoked GABAergic postsynaptic currents measured in pyramidal neurons; this effect was suppressed by TTX, suggesting that PNU-120596 modulated the function of α7 nAChRs located on the somatodendritic membrane of hippocampal interneurons.  Accordingly, PNU-120596 greatly enhanced the ACh-evoked inward currents in these interneurons.  Systemic administration of PNU-120596 to rats improved the auditory gating deficit caused by amphetamine, a model proposed to reflect a circuit level disturbance assocd. with schizophrenia.  Together, these results suggest that PNU-120596 represents a new class of mol. that enhances α7 nAChR function and thus has the potential to treat psychiatric and neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq26WDVJ3sdGLVg90H21EOLACvtfcHk0lhI-wH7YLJrww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFKgtLo%253D&md5=39dd78bcd96ebff54a2beb7d67b68e33</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5269-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5269-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DHaj%25C3%25B3%2Bs%26aufirst%3DM.%26aulast%3DRaggenbass%26aufirst%3DM.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26aulast%3DRutherford-Root%26aufirst%3DK.%2BL.%26aulast%3DBerkenpas%26aufirst%3DM.%2BB.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DAllaman%26aufirst%3DG.%26aulast%3DOgier%26aufirst%3DR.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DArneric%26aufirst%3DS.%26atitle%3DA%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520%25CE%25B17%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D4396%26epage%3D4405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Rogers, B. N.</span>; <span class="NLM_etal">et al.</span><span> </span><span class="NLM_article-title">Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor</span>. Presented at the 236th National Meeting of the American Chemical Society, Philadelphia, PA, Aug 17–21,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>MEDI 248.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+N.+Rogers&title=Positive+Allosteric+Modulators+of+the+%CE%B17+Nicotinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DPositive%2520Allosteric%2520Modulators%2520of%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Timmermann, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhaas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, E. Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jørgensen, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrsitensen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, G. M.</span><span> </span><span class="NLM_article-title">An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.107.120436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17625074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=294-307&author=D.+B.+Timmermannauthor=J.+H.+Gr%C3%B8nlienauthor=K.+L.+Kohlhaasauthor=E.+%C3%98.+Nielsenauthor=E.+Damauthor=T.+D.+J%C3%B8rgensenauthor=P.+K.+Ahringauthor=D.+Petersauthor=D.+Holstauthor=J.+K.+Chrsitensenauthor=J.+Malyszauthor=C.+A.+Briggsauthor=M.+Gopalakrishnanauthor=G.+M.+Olsen&title=An+allosteric+modulator+of+the+%CE%B17+nicotinic+acetylcholine+receptor+possessing+cognition-enhancing+properties+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo</span></div><div class="casAuthors">Timmermann, Daniel B.; Groenlien, Jens Halvard; Kohlhaas, Kathy L.; Nielsen, Elsebet Oe.; Dam, Eva; Joergensen, Tino D.; Ahring, Philip K.; Peters, Dan; Holst, Dorte; Chrsitensen, Jeppe K.; Malysz, John; Briggs, Clark A.; Gopalakrishnan, Murali; Olsen, Gunnar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">294-307</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Augmentation of nicotinic α7 receptor function is considered to be a potential therapeutic strategy aimed at ameliorating cognitive and mnemonic dysfunction in relation to debilitating pathol. conditions, such as Alzheimer's disease and schizophrenia.  In the present report, a novel pos. allosteric modulator of the α7 nicotinic acetylcholine receptor (nAChR), 1-(5-chloro-2-hydroxy-phenyl)-3-(2-chloro-5-trifluoromethyl-phenyl)-urea(NS 1738),is described.  NS 1738 was unable to displace or affect radioligand binding to the agonist binding site of nicotinic receptors, and it was devoid of effect when applied alone in electrophysiol. paradigms.  However, when applied in the presence of acetylcholine (ACh), NS 1738 produced a marked increase in the current flowing through α7 nAChRs, as detd. in both oocyte electrophysiol. and patchclamp recordings from mammalian cells.  NS 1738 acted by increasing the peak amplitude of ACh-evoked currents at all concns.; thus, it increased the maximal efficacy of ACh.  Oocyte expts. indicated an increase in ACh potency as well.  NS 1738 had only marginal effects on the desensitization kinetics of α7 nAChRs, as detd. from patch-clamp studies of both transfected cells and cultured hippocampal neurons.  NS 1738 was modestly brain-penetrant, and it was demonstrated to counteract a (-)-scopolamine-induced deficit in acquisition of a water-maze learning task in rats.  Moreover, NS 1738 improved performance in the rat social recognition test to the same extent as (-)-nicotine, demonstrating that NS 1738 is capable of producing cognitive enhancement in vivo.  These data support the notion that α7 nAChR allosteric modulation may constitute a novel pharmacol. principle for the treatment of cognitive dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PDEOt09g1LVg90H21EOLACvtfcHk0lhI-wH7YLJrww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahsb7K&md5=8d08e8945167c3b75b0d6af7b286c391</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.120436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.120436%26sid%3Dliteratum%253Aachs%26aulast%3DTimmermann%26aufirst%3DD.%2BB.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DKohlhaas%26aufirst%3DK.%2BL.%26aulast%3DNielsen%26aufirst%3DE.%2B%25C3%2598.%26aulast%3DDam%26aufirst%3DE.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DT.%2BD.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DHolst%26aufirst%3DD.%26aulast%3DChrsitensen%26aufirst%3DJ.%2BK.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DOlsen%26aufirst%3DG.%2BM.%26atitle%3DAn%2520allosteric%2520modulator%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520possessing%2520cognition-enhancing%2520properties%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D294%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Kennett, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cilia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. P.</span><span> </span><span class="NLM_article-title">In vitro and in vivo profile of SB-206553, a potent 5-HT<sub>2C</sub>/5-HT<sub>2B</sub> receptor antagonist with anxiolytic properties</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1111%2Fj.1476-5381.1996.tb15208.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=8821530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADyaK28XpsVGgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1996&pages=427-434&author=G.+A.+Kennettauthor=M.+D.+Woodauthor=F.+Brightauthor=J.+Ciliaauthor=D.+C.+Piperauthor=T.+Gagerauthor=D.+Thomasauthor=G.+S.+Baxterauthor=I.+T.+Forbesauthor=P.+Hamauthor=T.+P.+Blackburn&title=In+vitro+and+in+vivo+profile+of+SB-206553%2C+a+potent+5-HT2C%2F5-HT2B+receptor+antagonist+with+anxiolytic+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties</span></div><div class="casAuthors">Kennett, G. a.; Wood, M. D.; Bright, F.; Cilia, J.; Piper, D. C.; Gager, T.; Thomas, D.; Baxter, G. S.; Forbes, I. T.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">427-34</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">SB 206553 (5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole) displays a high affinity (pKI 7.9) for the cloned human 5-HT2C receptor expressed in HEK 293 cells and the 5-HT2B receptor (pA2 8.9) as measured in the rat stomach fundus prepn.  SB 206553 has low affinity for cloned human 5-HT2A receptors expressed in HEK 293 cells (pK1 5.8) and (pKI <6) for a wide variety of other neurotransmitter receptors.  SB 206553 appears to be a surmountable antagonist of 5-HT-stimulated phosphinositide hydrolysis in HEK 293 cells expressing the human 5-HT2C receptor (pKB 9.0).  The compd. potently (ID50 5.5 mg kg-1, p.o., 0.27 mg kg-1, i.v.) inhibited the hypolocomotor response to m-chlorophenylpiperazine (mCPP), a putative model of 5-HT2C/5-HT2B receptor function in vivo.  At similar doses (2-20 mg kg-1, p.o.) SB 206553 increased total interaction scores in a rat social interaction test and increased punished responding in a rat Geller-Seifter conflict test.  These effects are consistent with the possession of anxiolytic properties.  SB 206553 also increased suppressed responding in a marmoset conflict model of anxiety at somewhat higher doses (15 and 20 mg kg-1, p.o.) but also reduced unsuppressed responding.  These results suggest that SB 206553 is a potent mixed 5-HT2C/5-HT2B receptor antagonist with selectivity over the 5-HT2A and all other sites studied and possesses anxiolytic-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGhOi9PL6P5bVg90H21EOLACvtfcHk0lg4EBQ3UL3uwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpsVGgsg%253D%253D&md5=f6faa809154f400759171bfdedb17460</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb15208.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb15208.x%26sid%3Dliteratum%253Aachs%26aulast%3DKennett%26aufirst%3DG.%2BA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DBright%26aufirst%3DF.%26aulast%3DCilia%26aufirst%3DJ.%26aulast%3DPiper%26aufirst%3DD.%2BC.%26aulast%3DGager%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DD.%26aulast%3DBaxter%26aufirst%3DG.%2BS.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DHam%26aufirst%3DP.%26aulast%3DBlackburn%26aufirst%3DT.%2BP.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520profile%2520of%2520SB-206553%252C%2520a%2520potent%25205-HT2C%252F5-HT2B%2520receptor%2520antagonist%2520with%2520anxiolytic%2520properties%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D117%26spage%3D427%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitzia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlby, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRocque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soloveva, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncarati, R.</span><span> </span><span class="NLM_article-title">Old and new pharmacology: positive allosteric modulation of the α7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine<sub>2B/C</sub> receptor antagonist SB-206553 (3,5-dihydro-5-methyl-<i>N</i>-3-pyridinylbenzo[1,2-<i>b</i>:4,5-<i>b</i>′]dipyrrole-1(2<i>H</i>)-carboxamide)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.108.146514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19050173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXislals7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=766-776&author=J.+Dunlopauthor=T.+Lockauthor=B.+Jowauthor=F.+Sitziaauthor=S.+Grauerauthor=F.+Jowauthor=A.+Kramerauthor=M.+R.+Bowlbyauthor=A.+Randallauthor=D.+Kowalauthor=A.+Gilbertauthor=T.+A.+Comeryauthor=J.+LaRocqueauthor=V.+Solovevaauthor=J.+Brownauthor=R.+Roncarati&title=Old+and+new+pharmacology%3A+positive+allosteric+modulation+of+the+%CE%B17+nicotinic+acetylcholine+receptor+by+the+5-hydroxytryptamine2B%2FC+receptor+antagonist+SB-206553+%283%2C5-dihydro-5-methyl-N-3-pyridinylbenzo%5B1%2C2-b%3A4%2C5-b%E2%80%B2%5Ddipyrrole-1%282H%29-carboxamide%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Old and new pharmacology: positive allosteric modulation of the α7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine2B/C receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide)</span></div><div class="casAuthors">Dunlop, John; Lock, Tim; Jow, Brian; Sitzia, Fabrizio; Grauer, Steven; Jow, Flora; Kramer, Angela; Bowlby, Mark R.; Randall, Andrew; Kowal, Dianne; Gilbert, Adam; Comery, Thomas A.; LaRocque, James; Soloveva, Veronica; Brown, Jon; Roncarati, Renza</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">766-776</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The α7 nicotinic acetylcholine receptor (nAChR) has been implicated in Alzheimer's disease and schizophrenia, leading to efforts targeted toward discovering agonists and pos. allosteric modulators (PAMs) of this receptor.  In a Ca2+ flux fluorometric imaging plate reader assay, SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide), a compd. known as a 5-hydroxytryptamine2B/2C receptor antagonist, produced an 8-fold potentiation of the evoked calcium signal in the presence of an EC20 concn. of nicotine and a corresponding EC50 of 1.5 μM for potentiation of EC20 nicotine responses in GH4C1 cells expressing the α7 receptor.  SB-206553 was devoid of direct α7 receptor agonist activity and selective against other nicotinic receptors.  Confirmation of the PAM activity of SB-206553 on the α7 nAChR was obtained in patch-clamp electrophysiol. expts. in GH4C1 cells, where it failed to evoke any detectable currents when applied alone, yet dramatically potentiated the currents evoked by an EC20 (17 μM) and EC100 (124 μM) of acetylcholine (ACh).  Native nicotinic receptors in CA1 stratum radiatum interneurons of rat hippocampal slices could also be activated by ACh (200 μM), an effect that was entirely blocked by the α7-selective antagonist methyllycaconitine (MLA).  These ACh currents were potentiated by SB-206553, which increased the area of the current response significantly, resulting in a 40-fold enhancement at 100 μM.  In behavioral expts. in rats, SB-206553 reversed an MK-801 (dizocilpine maleate)-induced deficit in the prepulse inhibition of acoustic startle response, an effect attenuated in the presence of MLA.  This latter observation provides further evidence in support of the potential therapeutic utility of α7 nAChR PAMs in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomM1BUzvmG6LVg90H21EOLACvtfcHk0lg4EBQ3UL3uwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXislals7w%253D&md5=d1783c43f8d4e58af504614e13126012</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.146514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.146514%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DJow%26aufirst%3DB.%26aulast%3DSitzia%26aufirst%3DF.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DJow%26aufirst%3DF.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DBowlby%26aufirst%3DM.%2BR.%26aulast%3DRandall%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DGilbert%26aufirst%3DA.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DLaRocque%26aufirst%3DJ.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DRoncarati%26aufirst%3DR.%26atitle%3DOld%2520and%2520new%2520pharmacology%253A%2520positive%2520allosteric%2520modulation%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520by%2520the%25205-hydroxytryptamine2B%252FC%2520receptor%2520antagonist%2520SB-206553%2520%25283%252C5-dihydro-5-methyl-N-3-pyridinylbenzo%255B1%252C2-b%253A4%252C5-b%25E2%2580%25B2%255Ddipyrrole-1%25282H%2529-carboxamide%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D766%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterstrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarris, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gfesser, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kouhen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1<i>H</i>-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the α7 nicotinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3377</span><span class="NLM_x">–</span> <span class="NLM_lpage">3384</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9003818" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3377-3384&author=R.+Faghihauthor=S.+M.+Gopalakrishnanauthor=J.+H.+Gr%C3%B8nlienauthor=J.+Malyszauthor=C.+A.+Briggsauthor=C.+Wetterstrandauthor=H.+Weenauthor=M.+P.+Curtisauthor=K.+A.+Sarrisauthor=G.+A.+Gfesserauthor=R.+El-Kouhenauthor=H.+M.+Robbauthor=R.+J.+Radekauthor=K.+C.+Marshauthor=W.+H.+Bunnelleauthor=M.+Gopalakrishnan&title=Discovery+of+4-%285-%284-chlorophenyl%29-2-methyl-3-propionyl-1H-pyrrol-1-yl%29benzenesulfonamide+%28A-867744%29+as+a+novel+positive+allosteric+modulator+of+the+%CE%B17+nicotinic+acetylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm9003818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9003818%26sid%3Dliteratum%253Aachs%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DGopalakrishnan%26aufirst%3DS.%2BM.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DWetterstrand%26aufirst%3DC.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DCurtis%26aufirst%3DM.%2BP.%26aulast%3DSarris%26aufirst%3DK.%2BA.%26aulast%3DGfesser%26aufirst%3DG.%2BA.%26aulast%3DEl-Kouhen%26aufirst%3DR.%26aulast%3DRobb%26aufirst%3DH.%2BM.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25204-%25285-%25284-chlorophenyl%2529-2-methyl-3-propionyl-1H-pyrrol-1-yl%2529benzenesulfonamide%2520%2528A-867744%2529%2520as%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3377%26epage%3D3384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterstrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">In vitro pharmacological characterization of a novel allosteric modulator of α7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1<i>H</i>-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.109.151886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19389923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFelur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=257-267&author=J.+Malyszauthor=J.+H.+Gr%C3%B8nlienauthor=D.+J.+Andersonauthor=M.+H%C3%A5kerudauthor=K.+Thorin-Hageneauthor=H.+Weenauthor=C.+Wetterstrandauthor=C.+A.+Briggsauthor=R.+Faghihauthor=W.+H.+Bunnelleauthor=M.+Gopalakrishnan&title=In+vitro+pharmacological+characterization+of+a+novel+allosteric+modulator+of+%CE%B17+neuronal+acetylcholine+receptor%2C+4-%285-%284-chlorophenyl%29-2-methyl-3-propionyl-1H-pyrrol-1-yl%29benzenesulfonamide+%28A-867744%29%2C+exhibiting+unique+pharmacological+profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro pharmacological characterization of a novel allosteric modulator of α7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile</span></div><div class="casAuthors">Malysz, John; Gronlien, Jens Halvard; Anderson, David J.; Hakerud, Monika; Thorin-Hagene, Kirsten; Ween, Hilde; Wetterstrand, Caroline; Briggs, Clark A.; Faghih, Ramin; Bunnelle, William H.; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">257-267</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Targeting α7 neuronal acetylcholine receptors (nAChRs) with selective agonists and pos. allosteric modulators (PAMs) is considered a therapeutic approach for managing cognitive deficits in schizophrenia and Alzheimer's disease.  In this study, we describe a novel type II α7 PAM, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), that exhibits a unique pharmacol. profile.  In oocytes expressing α7 nAChRs, A-867744 potentiated acetylcholine (ACh)-evoked currents, with an EC50 value of ∼1 μM.  At highest concns. of A-867744 tested, ACh-evoked currents were essentially nondecaying.  At lower concns., no evidence of a distinct secondary component was evident in contrast to 4-naphthalen-1-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonic acid amide (TQS), another type II α7 PAM.  In the presence of A-867744, ACh concn. responses were potentiated by increases in potency, Hill slope, and maximal efficacy.  When examd. in rat hippocampus CA1 stratum radiatum interneurons or dentate gyrus granule cells, A-867744 (10 μM) increased choline-evoked α7 currents and recovery from inhibition/desensitization, and enhanced spontaneous inhibitory postsynaptic current activity.  A-867744, like other α7 PAMs tested [1-(5-chloro-2-hydroxyphenyl)-3-(2-chloro-5-trifluoromethyl-phenyl)urea (NS1738), TQS, and 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596)], did not displace the binding of [3H]methyllycaconitine to rat cortex α7* nAChRs.  However, unlike these PAMs, A-867744 displaced the binding of the agonist [3H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane (A-585539) in rat cortex, with a Ki value of 23 nM.  A-867744 neither increased agonist-evoked responses nor displaced the binding of [3H]A-585539 in an α7/5-hydroxytryptamine3 (α7/5-HT3) chimera, suggesting an interaction distinct from the α7 N terminus or M2-3 loop.  In addn., A-867744 failed to potentiate responses mediated by 5-HT3A or α3β4 and α4β2 nAChRs.  In summary, this study identifies a novel and selective α7 PAM showing activity at recombinant and native α7 nAChRs exhibiting a unique pharmacol. interaction with the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLM5AdS8FvO7Vg90H21EOLACvtfcHk0lgU0VamWshCAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFelur4%253D&md5=31c8e33b9d8bf606a7f11355cb4e9e08</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.151886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.151886%26sid%3Dliteratum%253Aachs%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DWetterstrand%26aufirst%3DC.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520allosteric%2520modulator%2520of%2520%25CE%25B17%2520neuronal%2520acetylcholine%2520receptor%252C%25204-%25285-%25284-chlorophenyl%2529-2-methyl-3-propionyl-1H-pyrrol-1-yl%2529benzenesulfonamide%2520%2528A-867744%2529%252C%2520exhibiting%2520unique%2520pharmacological%2520profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D257%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Chimienti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plantard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brakch, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohl, D.</span><span> </span><span class="NLM_article-title">Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of mal de Meleda</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3017</span><span class="NLM_x">–</span> <span class="NLM_lpage">3024</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1093%2Fhmg%2Fddg320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=14506129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVWqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=3017-3024&author=F.+Chimientiauthor=R.+C.+Hoggauthor=L.+Plantardauthor=C.+Lehmannauthor=N.+Brakchauthor=J.+Fischerauthor=M.+Huberauthor=D.+Bertrandauthor=D.+Hohl&title=Identification+of+SLURP-1+as+an+epidermal+neuromodulator+explains+the+clinical+phenotype+of+mal+de+Meleda"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda</span></div><div class="casAuthors">Chimienti, Fabrice; Hogg, Ronald C.; Plantard, Laure; Lehmann, Caroline; Brakch, Noureddine; Fischer, Judith; Huber, Marcel; Bertrand, Daniel; Hohl, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3017-3024</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mal de Meleda is an autosomal recessive inflammatory and keratotic palmoplantar skin disorder due to mutations in the ARS B gene, encoding for SLURP-1 (secreted mammalian Ly-6/uPAR-related protein 1).  SLURP-1 belongs to the Ly-6/uPAR superfamily of receptor and secreted proteins, which participate in signal transduction, immune cell activation or cellular adhesion.  The high degree of structural similarity between SLURP-1 and the three fingers motif of snake neurotoxins and Lynx1 suggests that this protein interacts with the neuronal acetylcholine receptors.  We found that SLURP-1 potentiates the human α7 nicotinic acetylcholine receptors that are present in keratinocytes.  These results identify SLURP-1 as a secreted epidermal neuromodulator which is likely to be essential for both epidermal homeostasis and inhibition of TNF-alpha release by macrophages during wound healing.  This explains both the hyperproliferative as well as the inflammatory clin. phenotype of Mal de Meleda.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraM-uNE7NmWLVg90H21EOLACvtfcHk0lgU0VamWshCAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVWqtb4%253D&md5=2375520ddf17d75d19088d138c4d96ef</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddg320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddg320%26sid%3Dliteratum%253Aachs%26aulast%3DChimienti%26aufirst%3DF.%26aulast%3DHogg%26aufirst%3DR.%2BC.%26aulast%3DPlantard%26aufirst%3DL.%26aulast%3DLehmann%26aufirst%3DC.%26aulast%3DBrakch%26aufirst%3DN.%26aulast%3DFischer%26aufirst%3DJ.%26aulast%3DHuber%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DHohl%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520SLURP-1%2520as%2520an%2520epidermal%2520neuromodulator%2520explains%2520the%2520clinical%2520phenotype%2520of%2520mal%2520de%2520Meleda%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2003%26volume%3D12%26spage%3D3017%26epage%3D3024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Paleari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, P.</span><span> </span><span class="NLM_article-title">α7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and mesothelioma?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=822-836&author=L.+Paleariauthor=A.+Cesarioauthor=M.+Finiauthor=P.+Russo&title=%CE%B17-Nicotinic+receptor+antagonists+at+the+beginning+of+a+clinical+era+for+NSCLC+and+mesothelioma%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaleari%26aufirst%3DL.%26aulast%3DCesario%26aufirst%3DA.%26aulast%3DFini%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DP.%26atitle%3D%25CE%25B17-Nicotinic%2520receptor%2520antagonists%2520at%2520the%2520beginning%2520of%2520a%2520clinical%2520era%2520for%2520NSCLC%2520and%2520mesothelioma%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D822%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Sheridan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tattersall, J. E.</span><span> </span><span class="NLM_article-title">Nicotinic antagonists in the treatment of nerve agent intoxication</span> <span class="citation_source-journal">J. R. Soc. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1177%2F014107680509800307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=15738554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BD2M7gvVShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2005&pages=114-115&author=R.+D.+Sheridanauthor=A.+P.+Smithauthor=S.+R.+Turnerauthor=J.+E.+Tattersall&title=Nicotinic+antagonists+in+the+treatment+of+nerve+agent+intoxication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic antagonists in the treatment of nerve agent intoxication</span></div><div class="casAuthors">Sheridan Robert D; Smith Andrew P; Turner Simon R; Tattersall John E H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Royal Society of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">114-5</span>
        ISSN:<span class="NLM_cas:issn">0141-0768</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT09LfG1XId50HdcurJClFcfW6udTcc2ebRx650VZpiDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7gvVShtg%253D%253D&md5=aa2f3403af9fcdc698ae16920b5518d6</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1177%2F014107680509800307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F014107680509800307%26sid%3Dliteratum%253Aachs%26aulast%3DSheridan%26aufirst%3DR.%2BD.%26aulast%3DSmith%26aufirst%3DA.%2BP.%26aulast%3DTurner%26aufirst%3DS.%2BR.%26aulast%3DTattersall%26aufirst%3DJ.%2BE.%26atitle%3DNicotinic%2520antagonists%2520in%2520the%2520treatment%2520of%2520nerve%2520agent%2520intoxication%26jtitle%3DJ.%2520R.%2520Soc.%2520Med.%26date%3D2005%26volume%3D98%26spage%3D114%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Terlau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, B. M.</span><span> </span><span class="NLM_article-title"><i>Conus</i> venoms: a rich source of novel ion channel-targeted peptides</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1152%2Fphysrev.00020.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=14715910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotl2rtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=41-68&author=H.+Terlauauthor=B.+M.+Olivera&title=Conus+venoms%3A+a+rich+source+of+novel+ion+channel-targeted+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Conus venoms: a rich source of novel ion channel-targeted peptides</span></div><div class="casAuthors">Terlau, Heinrich; Olivera, Baldomero M.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-68</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The cone snails (genus Conus) are venomous marine mollusks that use small, structured peptide toxins (conotoxins) for prey capture, defense, and competitor deterrence.  Each of the 500 Conus can express ∼100 different conotoxins, with little overlap between species.  An overwhelming majority of these peptides are probably targeted selectively to a specific ion channel.  Because conotoxins discriminate between closely related subtypes of ion channels, they are widely used as pharmacol. agents in ion channel research, and several have direct diagnostic and therapeutic potential.  Large conotoxin families can comprise hundreds or thousands of different peptides; most families have a corresponding ion channel family target (i.e., ω-conotoxins and Ca channels, α-conotoxins and nicotinic receptors).  Different conotoxin families may have different ligand binding sites on the same ion channel target (i.e., μ-conotoxins and δ-conotoxins to sites 1 and 6 of Na channels, resp.).  The individual peptides in a conotoxin family are typically each selectively targeted to a diverse set of different mol. isoforms within the same ion channel family.  This review focuses on the targeting specificity of conotoxins and their differential binding to different states of an ion channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0QX327m4_oLVg90H21EOLACvtfcHk0ljQkqxS5z50Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotl2rtA%253D%253D&md5=ed644caa4b8baa211450239ffc6a8b00</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00020.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00020.2003%26sid%3Dliteratum%253Aachs%26aulast%3DTerlau%26aufirst%3DH.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26atitle%3DConus%2520venoms%253A%2520a%2520rich%2520source%2520of%2520novel%2520ion%2520channel-targeted%2520peptides%26jtitle%3DPhysiol.%2520Rev.%26date%3D2004%26volume%3D84%26spage%3D41%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Whiteaker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikami, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulyas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and structure activity of a highly selective α7 nicotinic acetylcholine receptor antagonist</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">6628</span><span class="NLM_x">–</span> <span class="NLM_lpage">6638</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7004202" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=6628-6638&author=P.+Whiteakerauthor=S.+Christensenauthor=D.+Yoshikamiauthor=C.+Dowellauthor=M.+Watkinsauthor=J.+Gulyasauthor=J.+Rivierauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Discovery%2C+synthesis%2C+and+structure+activity+of+a+highly+selective+%CE%B17+nicotinic+acetylcholine+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fbi7004202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7004202%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DYoshikami%26aufirst%3DD.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DM.%26aulast%3DGulyas%26aufirst%3DJ.%26aulast%3DRivier%26aufirst%3DJ.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520structure%2520activity%2520of%2520a%2520highly%2520selective%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D6628%26epage%3D6638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Daly, J. W.; Garraffo, H. M.; Spande, T. F.</span><span> </span><span class="NLM_article-title">Alkaloids from Amphibian Skins</span>. In  <span class="citation_source-book">Alkaloids: Chemical and Biological Perspectives</span>; <span class="NLM_contrib-group">Pelletier, S. W.</span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">13</span>, pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0735-8210%2899%2980024-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1-161&author=J.+W.+Daly&author=H.+M.+Garraffo&author=T.+F.+Spandeauthor=S.+W.+Pelletier&title=Alkaloids%3A+Chemical+and+Biological+Perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0735-8210%2899%2980024-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0735-8210%252899%252980024-7%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DAlkaloids%2520from%2520Amphibian%2520Skins%26btitle%3DAlkaloids%253A%2520Chemical%2520and%2520Biological%2520Perspectives%26aulast%3DPelletier%26aufirst%3DS.%2BW.%26pub%3DWiley%26date%3D1999%26volume%3D13%26spage%3D1%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Tsuneki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaoka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dani, J.</span><span> </span><span class="NLM_article-title">Alkaloids indolizidine 235B′, quinolizidine 1-epi-207I, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fmol.104.000729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=15258256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlGmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1061-1069&author=H.+Tsunekiauthor=Y.+Youauthor=N.+Toyookaauthor=S.+Kagawaauthor=S.+Kobayashiauthor=T.+Sasaokaauthor=H.+Nemotoauthor=I.+Kimuraauthor=J.+Dani&title=Alkaloids+indolizidine+235B%E2%80%B2%2C+quinolizidine+1-epi-207I%2C+and+the+tricyclic+205B+are+potent+and+selective+noncompetitive+inhibitors+of+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Alkaloids indolizidine 235B', quinolizidine 1-epi-207I, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors</span></div><div class="casAuthors">Tsuneki, Hiroshi; You, Yueren; Toyooka, Naoki; Kagawa, Syota; Kobayashi, Soushi; Sasaoka, Toshiyasu; Nemoto, Hideo; Kimura, Ikuko; Dani, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1061-1069</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors are key mols. in cholinergic transmission in the nervous system.  Because of their structural complexity, only a limited no. of subtype-specific agonists and antagonists are available to study nicotinic receptor functions.  To overcome this limitation, we used voltage-clamp recordings to examine the effects of several frog skin alkaloids on acetylcholine-elicited currents in Xenopus laevis oocytes expressing major types of neuronal nicotinic receptors (α4β2, α7, α3β2, α3β4, and α4β4).  We found that the 5,8-disubstituted indolizidine (-)-235B' acted as a potent noncompetitive blocker of α4β2 nicotinic receptors (IC50 = 74 nM).  This effect was highly selective for α4β2 receptors compared with α3β2, α3β4, and α4β4 receptors.  The inhibition of α4β2 currents by (-)-235B' was more pronounced as the acetylcholine concn. increased (from 10 nM to 100 μM).  Moreover, the blockade of α4β2 currents by (-)-235B' was voltage-dependent (more pronounced at hyperpolarized potentials) and use-dependent, indicating that (-)-235B' behaves as an open-channel blocker of this receptor.  Several other 5,8-disubstituted indolizidines (5-n-propyl-8-n-butylindolizidines), two 5,6,8-trisubstituted indolizidines ((-)-223A and (+)-6-epi-223A), and a 1,4-disubstituted quinolizidine ((+)-207I) were less potent than (-)-235B', and none showed selectivity for α4β2 receptors.  The quinolizidine (-)-1-epi-207I and the tricyclic (+)-205B had 8.7- and 5.4-fold higher sensitivity, resp., for inhibition of the α7 nicotinic receptor than for inhibition of the α4β2 receptor.  These results show that frog alkaloids alter the function of nicotinic receptors in a subtype-selective manner, suggesting that an anal. of these alkaloids may aid in the development of selective drugs to alter nicotinic cholinergic functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOpS5kMyN8lbVg90H21EOLACvtfcHk0ljYLCIjybt43g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlGmurk%253D&md5=a2576d8ab6ced1a2d14f0297a409f833</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.000729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.000729%26sid%3Dliteratum%253Aachs%26aulast%3DTsuneki%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DY.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DKagawa%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DSasaoka%26aufirst%3DT.%26aulast%3DNemoto%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DI.%26aulast%3DDani%26aufirst%3DJ.%26atitle%3DAlkaloids%2520indolizidine%2520235B%25E2%2580%25B2%252C%2520quinolizidine%25201-epi-207I%252C%2520and%2520the%2520tricyclic%2520205B%2520are%2520potent%2520and%2520selective%2520noncompetitive%2520inhibitors%2520of%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1061%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomesch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Callaghan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennogle, L. P.</span><span> </span><span class="NLM_article-title">Discovery of novel α7 nicotinic receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4825</span><span class="NLM_x">–</span> <span class="NLM_lpage">4830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4825-4830&author=Y.+Pengauthor=Q.+Zhangauthor=G.+L.+Snyderauthor=H.+Zhuauthor=W.+Yaoauthor=J.+Tomeschauthor=R.+L.+Papkeauthor=J.+P.+O%E2%80%99Callaghanauthor=W.+J.+Welshauthor=L.+P.+Wennogle&title=Discovery+of+novel+%CE%B17+nicotinic+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DTomesch%26aufirst%3DJ.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DO%25E2%2580%2599Callaghan%26aufirst%3DJ.%2BP.%26aulast%3DWelsh%26aufirst%3DW.%2BJ.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520novel%2520%25CE%25B17%2520nicotinic%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4825%26epage%3D4830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b','cit31c'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48a','cit48b','cit48c','cit48d'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 46 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kang Duan, Xiao-De An, Long-Fei Li, Lian-Lian Sun, Bin Qiu, Xian-Jiang Li, <span class="NLM_string-name hlFld-ContribAuthor">Jian Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Hydride Transfer Initiated Redox-Neutral Cascade Cyclizations of Aurones: Facile Access to [6,5] Spirocycles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (7)
                                     , 2537-2541. <a href="https://doi.org/10.1021/acs.orglett.0c00309" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00309%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DHydride%252BTransfer%252BInitiated%252BRedox-Neutral%252BCascade%252BCyclizations%252Bof%252BAurones%25253A%252BFacile%252BAccess%252Bto%252B%25255B6%25252C5%25255D%252BSpirocycles%26aulast%3DDuan%26aufirst%3DKang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22012020%26date%3D18032020%26volume%3D22%26issue%3D7%26spage%3D2537%26epage%3D2541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiradanai  Sarasamkan</span>, <span class="hlFld-ContribAuthor ">Matthias  Scheunemann</span>, <span class="hlFld-ContribAuthor ">Nattayaporn  Apaijai</span>, <span class="hlFld-ContribAuthor ">Siripong  Palee</span>, <span class="hlFld-ContribAuthor ">Warisara  Parichatikanond</span>, <span class="hlFld-ContribAuthor ">Kuntarat  Arunrungvichian</span>, <span class="hlFld-ContribAuthor ">Steffen  Fischer</span>, <span class="hlFld-ContribAuthor ">Siriporn  Chattipakorn</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Gerrit  Schüürmann</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, and <span class="hlFld-ContribAuthor ">Opa  Vajragupta</span>  . </span><span class="cited-content_cbyCitation_article-title">Varying Chirality Across Nicotinic Acetylcholine Receptor Subtypes: Selective Binding of Quinuclidine Triazole Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (10)
                                     , 890-895. <a href="https://doi.org/10.1021/acsmedchemlett.6b00146" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00146%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVarying%252BChirality%252BAcross%252BNicotinic%252BAcetylcholine%252BReceptor%252BSubtypes%25253A%252BSelective%252BBinding%252Bof%252BQuinuclidine%252BTriazole%252BCompounds%26aulast%3DSarasamkan%26aufirst%3DJiradanai%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07042016%26date%3D09082016%26date%3D15082016%26date%3D13102016%26date%3D09082016%26volume%3D7%26issue%3D10%26spage%3D890%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Criado</span>, <span class="hlFld-ContribAuthor ">José  Mulet</span>, <span class="hlFld-ContribAuthor ">Francisco  Sala</span>, <span class="hlFld-ContribAuthor ">Salvador  Sala</span>, <span class="hlFld-ContribAuthor ">Inés  Colmena</span>, <span class="hlFld-ContribAuthor ">Luis  Gandía</span>, <span class="hlFld-ContribAuthor ">Oscar M.  Bautista-Aguilera</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, and <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>  . </span><span class="cited-content_cbyCitation_article-title">N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (8)
                                     , 1157-1165. <a href="https://doi.org/10.1021/acschemneuro.6b00122" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00122%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DN-Benzylpiperidine%252BDerivatives%252Bas%252B%2525CE%2525B17%252BNicotinic%252BReceptor%252BAntagonists%26aulast%3DCriado%26aufirst%3DManuel%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28042016%26date%3D02062016%26date%3D10062016%26date%3D17082016%26date%3D02062016%26volume%3D7%26issue%3D8%26spage%3D1157%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Grazioso</span>, <span class="hlFld-ContribAuthor ">Jacopo  Sgrignani</span>, <span class="hlFld-ContribAuthor ">Romina  Capelli</span>, <span class="hlFld-ContribAuthor ">Carlo  Matera</span>, <span class="hlFld-ContribAuthor ">Clelia  Dallanoce</span>, <span class="hlFld-ContribAuthor ">Marco  De Amici</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Alpha7 Nicotinic Receptors: Mechanistic Insight through Metadynamics and Essential Dynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (12)
                                     , 2528-2539. <a href="https://doi.org/10.1021/acs.jcim.5b00459" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAllosteric%252BModulation%252Bof%252BAlpha7%252BNicotinic%252BReceptors%25253A%252BMechanistic%252BInsight%252Bthrough%252BMetadynamics%252Band%252BEssential%252BDynamics%26aulast%3DGrazioso%26aufirst%3DGiovanni%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D23072015%26date%3D20112015%26date%3D28122015%26date%3D16112015%26volume%3D55%26issue%3D12%26spage%3D2528%26epage%3D2539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuntarat  Arunrungvichian</span>, <span class="hlFld-ContribAuthor ">Valery V.  Fokin</span>, <span class="hlFld-ContribAuthor ">Opa  Vajragupta</span>, and <span class="hlFld-ContribAuthor ">Palmer  Taylor</span>  . </span><span class="cited-content_cbyCitation_article-title">Selectivity Optimization of Substituted 1,2,3-Triazoles as α7 Nicotinic Acetylcholine Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (8)
                                     , 1317-1330. <a href="https://doi.org/10.1021/acschemneuro.5b00058" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00058%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSelectivity%252BOptimization%252Bof%252BSubstituted%252B1%25252C2%25252C3-Triazoles%252Bas%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptor%252BAgonists%26aulast%3DArunrungvichian%26aufirst%3DKuntarat%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11022015%26date%3D15052015%26date%3D19082015%26date%3D01052015%26volume%3D6%26issue%3D8%26spage%3D1317%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagavaram Narsimha  Rao</span> and <span class="hlFld-ContribAuthor ">Jin Kun  Cha</span>  . </span><span class="cited-content_cbyCitation_article-title">Concise Synthesis of Alkaloid (−)-205B. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2015,</strong> <em>137 </em>
                                    (6)
                                     , 2243-2246. <a href="https://doi.org/10.1021/jacs.5b00243" title="DOI URL">https://doi.org/10.1021/jacs.5b00243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.5b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.5b00243%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DConcise%252BSynthesis%252Bof%252BAlkaloid%252B%252528%2525E2%252588%252592%252529-205B%26aulast%3DRao%26aufirst%3DNagavaram%2BNarsimha%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08012015%26date%3D04022015%26date%3D18022015%26date%3D30012015%26volume%3D137%26issue%3D6%26spage%3D2243%26epage%3D2246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergey V.  Tsukanov</span> and <span class="hlFld-ContribAuthor ">Daniel L.  Comins</span>  . </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Alkaloid 205B. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (19)
                                     , 9074-9085. <a href="https://doi.org/10.1021/jo501415r" title="DOI URL">https://doi.org/10.1021/jo501415r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo501415r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo501415r%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTotal%252BSynthesis%252Bof%252BAlkaloid%252B205B%26aulast%3DTsukanov%26aufirst%3DSergey%2BV.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25062014%26date%3D17092014%26date%3D03102014%26date%3D02092014%26volume%3D79%26issue%3D19%26spage%3D9074%26epage%3D9085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger B.  Clark</span>, <span class="hlFld-ContribAuthor ">Diana  Lamppu</span>, <span class="hlFld-ContribAuthor ">Lyn  Libertine</span>, <span class="hlFld-ContribAuthor ">Amy  McDonough</span>, <span class="hlFld-ContribAuthor ">Anjali  Kumar</span>, <span class="hlFld-ContribAuthor ">Greg  LaRosa</span>, <span class="hlFld-ContribAuthor ">Roger  Rush</span>, and <span class="hlFld-ContribAuthor ">Daniel  Elbaum</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (10)
                                     , 3966-3983. <a href="https://doi.org/10.1021/jm5004599" title="DOI URL">https://doi.org/10.1021/jm5004599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5004599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5004599%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252B2-%252528%252528Pyridin-3-yloxy%252529methyl%252529piperazines%252Bas%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptor%252BModulators%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BDisorders%26aulast%3DClark%26aufirst%3DRoger%2BB.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D13112013%26date%3D09052014%26date%3D22052014%26volume%3D57%26issue%3D10%26spage%3D3966%26epage%3D3983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ganesh A.  Thakur</span>, <span class="hlFld-ContribAuthor ">Abhijit R.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Deschamps</span>, and <span class="hlFld-ContribAuthor ">Roger L.  Papke</span>  . </span><span class="cited-content_cbyCitation_article-title">Expeditious Synthesis, Enantiomeric Resolution, and Enantiomer Functional Characterization of (4-(4-Bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): An Allosteric Agonist-Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (21)
                                     , 8943-8947. <a href="https://doi.org/10.1021/jm401267t" title="DOI URL">https://doi.org/10.1021/jm401267t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401267t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401267t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExpeditious%252BSynthesis%25252C%252BEnantiomeric%252BResolution%25252C%252Band%252BEnantiomer%252BFunctional%252BCharacterization%252Bof%252B%2525284-%2525284-Bromophenyl%252529-3a%25252C4%25252C5%25252C9b-tetrahydro-3H-cyclopenta%25255Bc%25255Dquinoline-8-sulfonamide%252B%2525284BP-TQS%252529%25253A%252BAn%252BAllosteric%252BAgonist-Positive%252BAllosteric%252BModulator%252Bof%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DThakur%26aufirst%3DGanesh%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D29042013%26date%3D25102013%26date%3D14112013%26date%3D03102013%26volume%3D56%26issue%3D21%26spage%3D8943%26epage%3D8947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjun  Gao</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Kellar</span>, <span class="hlFld-ContribAuthor ">Robert P.  Yasuda</span>, <span class="hlFld-ContribAuthor ">Thao  Tran</span>, <span class="hlFld-ContribAuthor ">Yingxian  Xiao</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, and <span class="hlFld-ContribAuthor ">Andrew G.  Horti</span>  . </span><span class="cited-content_cbyCitation_article-title">Derivatives of Dibenzothiophene for Positron Emission Tomography Imaging of α7-Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (19)
                                     , 7574-7589. <a href="https://doi.org/10.1021/jm401184f" title="DOI URL">https://doi.org/10.1021/jm401184f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401184f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401184f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDerivatives%252Bof%252BDibenzothiophene%252Bfor%252BPositron%252BEmission%252BTomography%252BImaging%252Bof%252B%2525CE%2525B17-Nicotinic%252BAcetylcholine%252BReceptors%26aulast%3DGao%26aufirst%3DYongjun%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03052013%26date%3D19092013%26date%3D10102013%26volume%3D56%26issue%3D19%26spage%3D7574%26epage%3D7589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anatoly A.  Mazurov</span>, <span class="hlFld-ContribAuthor ">David C.  Kombo</span>, <span class="hlFld-ContribAuthor ">Terry A.  Hauser</span>, <span class="hlFld-ContribAuthor ">Lan  Miao</span>, <span class="hlFld-ContribAuthor ">Gary  Dull</span>, <span class="hlFld-ContribAuthor ">John F.  Genus</span>, <span class="hlFld-ContribAuthor ">Nikolai B.  Fedorov</span>, <span class="hlFld-ContribAuthor ">Lisa  Benson</span>, <span class="hlFld-ContribAuthor ">Serguei  Sidach</span>, <span class="hlFld-ContribAuthor ">Yunde  Xiao</span>, <span class="hlFld-ContribAuthor ">Philip S.  Hammond</span>, <span class="hlFld-ContribAuthor ">John W.  James</span>, <span class="hlFld-ContribAuthor ">Craig H.  Miller</span>, and <span class="hlFld-ContribAuthor ">Daniel  Yohannes</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (2S,3R)-N-[2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a Selective α7 Nicotinic Acetylcholine Receptor Agonist, for the Treatment of Cognitive Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9793-9809. <a href="https://doi.org/10.1021/jm301048a" title="DOI URL">https://doi.org/10.1021/jm301048a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301048a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301048a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525282S%25252C3R%252529-N-%25255B2-%252528Pyridin-3-ylmethyl%252529-1-azabicyclo%25255B2.2.2%25255Doct-3-yl%25255Dbenzo%25255Bb%25255Dfuran-2-carboxamide%252B%252528TC-5619%252529%25252C%252Ba%252BSelective%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptor%252BAgonist%25252C%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDisorders%26aulast%3DMazurov%26aufirst%3DAnatoly%2BA.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D12072012%26date%3D13112012%26date%3D26112012%26date%3D05112012%26volume%3D55%26issue%3D22%26spage%3D9793%26epage%3D9809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Zanaletti</span>, <span class="hlFld-ContribAuthor ">Laura  Bettinetti</span>, <span class="hlFld-ContribAuthor ">Cristiana  Castaldo</span>, <span class="hlFld-ContribAuthor ">Ilaria  Ceccarelli</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Cocconcelli</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Comery</span>, <span class="hlFld-ContribAuthor ">John  Dunlop</span>, <span class="hlFld-ContribAuthor ">Eva  Genesio</span>, <span class="hlFld-ContribAuthor ">Chiara  Ghiron</span>, <span class="hlFld-ContribAuthor ">Simon N.  Haydar</span>, <span class="hlFld-ContribAuthor ">Flora  Jow</span>, <span class="hlFld-ContribAuthor ">Laura  Maccari</span>, <span class="hlFld-ContribAuthor ">Iolanda  Micco</span>, <span class="hlFld-ContribAuthor ">Arianna  Nencini</span>, <span class="hlFld-ContribAuthor ">Carmela  Pratelli</span>, <span class="hlFld-ContribAuthor ">Carla  Scali</span>, <span class="hlFld-ContribAuthor ">Elisa  Turlizzi</span>, and <span class="hlFld-ContribAuthor ">Michela  Valacchi</span>  . </span><span class="cited-content_cbyCitation_article-title">N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 10277-10281. <a href="https://doi.org/10.1021/jm3013568" title="DOI URL">https://doi.org/10.1021/jm3013568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3013568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3013568%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-%25255B5-%2525285-Fluoropyridin-3-yl%252529-1H-pyrazol-3-yl%25255D-4-piperidin-1-ylbutyramide%252B%252528SEN78702%25252C%252BWYE-308775%252529%25253A%252BA%252BMedicinal%252BChemistry%252BEffort%252Btoward%252Ban%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptor%252BAgonist%252BPreclinical%252BCandidate%26aulast%3DZanaletti%26aufirst%3DRiccardo%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D19062012%26date%3D02112012%26date%3D26112012%26date%3D19102012%26volume%3D55%26issue%3D22%26spage%3D10277%26epage%3D10281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Zanaletti</span>, <span class="hlFld-ContribAuthor ">Laura  Bettinetti</span>, <span class="hlFld-ContribAuthor ">Cristiana  Castaldo</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Cocconcelli</span>, <span class="hlFld-ContribAuthor ">Thomas  Comery</span>, <span class="hlFld-ContribAuthor ">John  Dunlop</span>, <span class="hlFld-ContribAuthor ">Giovanni  Gaviraghi</span>, <span class="hlFld-ContribAuthor ">Chiara  Ghiron</span>, <span class="hlFld-ContribAuthor ">Simon N.  Haydar</span>, <span class="hlFld-ContribAuthor ">Flora  Jow</span>, <span class="hlFld-ContribAuthor ">Laura  Maccari</span>, <span class="hlFld-ContribAuthor ">Iolanda  Micco</span>, <span class="hlFld-ContribAuthor ">Arianna  Nencini</span>, <span class="hlFld-ContribAuthor ">Carla  Scali</span>, <span class="hlFld-ContribAuthor ">Elisa  Turlizzi</span>, and <span class="hlFld-ContribAuthor ">Michela  Valacchi</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (10)
                                     , 4806-4823. <a href="https://doi.org/10.1021/jm300247y" title="DOI URL">https://doi.org/10.1021/jm300247y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300247y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300247y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BAlpha-7%252BNicotinic%252BAcetylcholine%252BReceptor%252BAgonist%252BSeries%252Band%252BCharacterization%252Bof%252Bthe%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BEfficacious%252BAgonist%252B5-%2525284-Acetyl%25255B1%25252C4%25255Ddiazepan-1-yl%252529pentanoic%252BAcid%252B%25255B5-%2525284-Methoxyphenyl%252529-1H-pyrazol-3-yl%25255D%252BAmide%252B%252528SEN15924%25252C%252BWAY-361789%252529%26aulast%3DZanaletti%26aufirst%3DRiccardo%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D23022012%26date%3D03052012%26date%3D24052012%26date%3D02042012%26volume%3D55%26issue%3D10%26spage%3D4806%26epage%3D4823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Christopher Jeyaseelan</span>, <span class="hlFld-ContribAuthor ">A.  Milton Franklin Benial</span>. </span><span class="cited-content_cbyCitation_article-title">Spectroscopic characterization,
              DFT
              studies, molecular docking and cytotoxic evaluation of
              4‐nitro
              ‐indole‐3‐carboxaldehyde: A potent lung cancer agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Recognition</span><span> <strong>2021,</strong> <em>34 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/jmr.2872" title="DOI URL">https://doi.org/10.1002/jmr.2872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmr.2872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmr.2872%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Recognition%26atitle%3DSpectroscopic%252Bcharacterization%25252C%252BDFT%252Bstudies%25252C%252Bmolecular%252Bdocking%252Band%252Bcytotoxic%252Bevaluation%252Bof%252B4%2525E2%252580%252590nitro%252B%2525E2%252580%252590indole%2525E2%252580%2525903%2525E2%252580%252590carboxaldehyde%25253A%252BA%252Bpotent%252Blung%252Bcancer%252Bagent%26aulast%3DChristopher%2BJeyaseelan%26aufirst%3DS.%26date%3D2021%26date%3D2020%26volume%3D34%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaomeng  He</span>, <span class="hlFld-ContribAuthor ">Xintong  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Yu</span>, <span class="hlFld-ContribAuthor ">Siqi  Zhao</span>, <span class="hlFld-ContribAuthor ">Peili  Jiao</span>, <span class="hlFld-ContribAuthor ">Hongwei  Jin</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">KeWei  Wang</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Lihe  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activities of piperidine-spirooxadiazole derivatives as α7 nicotinic receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112774. <a href="https://doi.org/10.1016/j.ejmech.2020.112774" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112774%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bpiperidine-spirooxadiazole%252Bderivatives%252Bas%252B%2525CE%2525B17%252Bnicotinic%252Breceptor%252Bantagonists%26aulast%3DZhang%26aufirst%3DHan%26date%3D2020%26volume%3D207%26spage%3D112774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Alijevic</span>, <span class="hlFld-ContribAuthor ">Damian  McHugh</span>, <span class="hlFld-ContribAuthor ">Lucien  Rufener</span>, <span class="hlFld-ContribAuthor ">Anatoly  Mazurov</span>, <span class="hlFld-ContribAuthor ">Julia  Hoeng</span>, <span class="hlFld-ContribAuthor ">Manuel  Peitsch</span>. </span><span class="cited-content_cbyCitation_article-title">An electrophysiological characterization of naturally occurring tobacco alkaloids and their action on human α4β2 and α7 nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Phytochemistry</span><span> <strong>2020,</strong> <em>170 </em>, 112187. <a href="https://doi.org/10.1016/j.phytochem.2019.112187" title="DOI URL">https://doi.org/10.1016/j.phytochem.2019.112187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phytochem.2019.112187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phytochem.2019.112187%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytochemistry%26atitle%3DAn%252Belectrophysiological%252Bcharacterization%252Bof%252Bnaturally%252Boccurring%252Btobacco%252Balkaloids%252Band%252Btheir%252Baction%252Bon%252Bhuman%252B%2525CE%2525B14%2525CE%2525B22%252Band%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3DAlijevic%26aufirst%3DOmar%26date%3D2020%26volume%3D170%26spage%3D112187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuxia  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Fang</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Hang  Gao</span>, <span class="hlFld-ContribAuthor ">Guohua  Jiang</span>, <span class="hlFld-ContribAuthor ">Jianping  Liu</span>, <span class="hlFld-ContribAuthor ">Qianqian  Xue</span>, <span class="hlFld-ContribAuthor ">Yueheng  Qi</span>, <span class="hlFld-ContribAuthor ">Mengying  Cao</span>, <span class="hlFld-ContribAuthor ">Bingchao  Qiang</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 1,4-Diazobicylco[3.2.2]nonane derivatives as α7-Nicotinic acetylcholine receptor PET/CT imaging agents and agonists for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>159 </em>, 255-266. <a href="https://doi.org/10.1016/j.ejmech.2018.09.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1%25252C4-Diazobicylco%25255B3.2.2%25255Dnonane%252Bderivatives%252Bas%252B%2525CE%2525B17-Nicotinic%252Bacetylcholine%252Breceptor%252BPET%25252FCT%252Bimaging%252Bagents%252Band%252Bagonists%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DWang%26aufirst%3DShuxia%26date%3D2018%26volume%3D159%26spage%3D255%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jhon J.  López</span>, <span class="hlFld-ContribAuthor ">Jesús  García-Colunga</span>, <span class="hlFld-ContribAuthor ">Edwin G.  Pérez</span>, <span class="hlFld-ContribAuthor ">Angélica  Fierro</span>. </span><span class="cited-content_cbyCitation_article-title">Methylpiperidinium Iodides as Novel Antagonists for α7 Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.00744" title="DOI URL">https://doi.org/10.3389/fphar.2018.00744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.00744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.00744%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DMethylpiperidinium%252BIodides%252Bas%252BNovel%252BAntagonists%252Bfor%252B%2525CE%2525B17%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DL%25C3%25B3pez%26aufirst%3DJhon%2BJ.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui Wen  Ng</span>, <span class="hlFld-ContribAuthor ">Carmine  Leggett</span>, <span class="hlFld-ContribAuthor ">Sugunadevi  Sakkiah</span>, <span class="hlFld-ContribAuthor ">Bohu  Pan</span>, <span class="hlFld-ContribAuthor ">Hao  Ye</span>, <span class="hlFld-ContribAuthor ">Leihong  Wu</span>, <span class="hlFld-ContribAuthor ">Chandrabose  Selvaraj</span>, <span class="hlFld-ContribAuthor ">Weida  Tong</span>, <span class="hlFld-ContribAuthor ">Huixiao  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (24)
                                     , 16899-16916. <a href="https://doi.org/10.18632/oncotarget.24458" title="DOI URL">https://doi.org/10.18632/oncotarget.24458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.24458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.24458%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCompetitive%252Bdocking%252Bmodel%252Bfor%252Bprediction%252Bof%252Bthe%252Bhuman%252Bnicotinic%252Bacetylcholine%252Breceptor%252B%2525CE%2525B17%252Bbinding%252Bof%252Btobacco%252Bconstituents%26aulast%3DNg%26aufirst%3DHui%2BWen%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D24%26spage%3D16899%26epage%3D16916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dina  Manetti</span>, <span class="hlFld-ContribAuthor ">Cristina  Bellucci</span>, <span class="hlFld-ContribAuthor ">Niccolò  Chiaramonte</span>, <span class="hlFld-ContribAuthor ">Silvia  Dei</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Teodori</span>, <span class="hlFld-ContribAuthor ">Maria Novella  Romanelli</span>. </span><span class="cited-content_cbyCitation_article-title">Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (4)
                                     , 433-459. <a href="https://doi.org/10.4155/fmc-2017-0169" title="DOI URL">https://doi.org/10.4155/fmc-2017-0169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0169%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252Bselective%252Bmodulators%252Bfor%252Bthe%252Bnicotinic%252Breceptor%252Bsubtypes%25253A%252Bchallenges%252Band%252Bopportunities%26aulast%3DManetti%26aufirst%3DDina%26date%3D2018%26volume%3D10%26issue%3D4%26spage%3D433%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatriz  Balsera</span>, <span class="hlFld-ContribAuthor ">José  Mulet</span>, <span class="hlFld-ContribAuthor ">Salvador  Sala</span>, <span class="hlFld-ContribAuthor ">Francisco  Sala</span>, <span class="hlFld-ContribAuthor ">Roberto  de la Torre-Martínez</span>, <span class="hlFld-ContribAuthor ">Sara  González-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Adrián  Plata</span>, <span class="hlFld-ContribAuthor ">Lieve  Naesens</span>, <span class="hlFld-ContribAuthor ">Asia  Fernández-Carvajal</span>, <span class="hlFld-ContribAuthor ">Antonio  Ferrer-Montiel</span>, <span class="hlFld-ContribAuthor ">Manuel  Criado</span>, <span class="hlFld-ContribAuthor ">María Jesús  Pérez de Vega</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>. </span><span class="cited-content_cbyCitation_article-title">Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of α7 nicotinic receptors with analgesic activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 157-165. <a href="https://doi.org/10.1016/j.ejmech.2017.10.083" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.083%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmino%252Bacid%252Band%252Bpeptide%252Bprodrugs%252Bof%252Bdiphenylpropanones%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252B%2525CE%2525B17%252Bnicotinic%252Breceptors%252Bwith%252Banalgesic%252Bactivity%26aulast%3DBalsera%26aufirst%3DBeatriz%26date%3D2018%26volume%3D143%26spage%3D157%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer M.  Coughlin</span>, <span class="hlFld-ContribAuthor ">Yong  Du</span>, <span class="hlFld-ContribAuthor ">Hailey B.  Rosenthal</span>, <span class="hlFld-ContribAuthor ">Stephanie  Slania</span>, <span class="hlFld-ContribAuthor ">Soo  Min Koo</span>, <span class="hlFld-ContribAuthor ">Andrew  Park</span>, <span class="hlFld-ContribAuthor ">Ghedem  Solomon</span>, <span class="hlFld-ContribAuthor ">Melin  Vranesic</span>, <span class="hlFld-ContribAuthor ">Inga  Antonsdottir</span>, <span class="hlFld-ContribAuthor ">Caroline L.  Speck</span>, <span class="hlFld-ContribAuthor ">Kelly  Rootes-Murdy</span>, <span class="hlFld-ContribAuthor ">Alexandria  Lerner</span>, <span class="hlFld-ContribAuthor ">Steven P.  Rowe</span>, <span class="hlFld-ContribAuthor ">Yuchuan  Wang</span>, <span class="hlFld-ContribAuthor ">Wojciech G.  Lesniak</span>, <span class="hlFld-ContribAuthor ">Il  Minn</span>, <span class="hlFld-ContribAuthor ">Arnold  Bakker</span>, <span class="hlFld-ContribAuthor ">Gwenn S.  Smith</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Hiroto  Kuwabara</span>, <span class="hlFld-ContribAuthor ">Andrew  Horti</span>, <span class="hlFld-ContribAuthor ">Dean F.  Wong</span>, <span class="hlFld-ContribAuthor ">Martin G.  Pomper</span>. </span><span class="cited-content_cbyCitation_article-title">The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [18F]ASEM. </span><span class="cited-content_cbyCitation_journal-name">NeuroImage</span><span> <strong>2018,</strong> <em>165 </em>, 118-124. <a href="https://doi.org/10.1016/j.neuroimage.2017.10.009" title="DOI URL">https://doi.org/10.1016/j.neuroimage.2017.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroimage.2017.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroimage.2017.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroImage%26atitle%3DThe%252Bdistribution%252Bof%252Bthe%252Balpha7%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bin%252Bhealthy%252Baging%25253A%252BAn%252Bin%252Bvivo%252Bpositron%252Bemission%252Btomography%252Bstudy%252Bwith%252B%25255B18F%25255DASEM%26aulast%3DCoughlin%26aufirst%3DJennifer%2BM.%26date%3D2018%26volume%3D165%26spage%3D118%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael R.  Weed</span>, <span class="hlFld-ContribAuthor ">Joseph  Polino</span>, <span class="hlFld-ContribAuthor ">Laura  Signor</span>, <span class="hlFld-ContribAuthor ">Mark  Bookbinder</span>, <span class="hlFld-ContribAuthor ">Deborah  Keavy</span>, <span class="hlFld-ContribAuthor ">Yulia  Benitex</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Morgan</span>, <span class="hlFld-ContribAuthor ">Dalton  King</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Robert  Zaczek</span>, <span class="hlFld-ContribAuthor ">Richard  Olson</span>, <span class="hlFld-ContribAuthor ">Linda J.  Bristow</span>, . </span><span class="cited-content_cbyCitation_article-title">Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2017,</strong> <em>12 </em>
                                    (12)
                                     , e0187609. <a href="https://doi.org/10.1371/journal.pone.0187609" title="DOI URL">https://doi.org/10.1371/journal.pone.0187609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0187609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0187609%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DNicotinic%252Balpha%252B7%252Breceptor%252Bagonists%252BEVP-6124%252Band%252BBMS-933043%25252C%252Battenuate%252Bscopolamine-induced%252Bdeficits%252Bin%252Bvisuo-spatial%252Bpaired%252Bassociates%252Blearning%26aulast%3DWeed%26aufirst%3DMichael%2BR.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D12%26spage%3De0187609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Thompson</span>, <span class="hlFld-ContribAuthor ">Simon  Metzger</span>, <span class="hlFld-ContribAuthor ">Martin  Lochner</span>, <span class="hlFld-ContribAuthor ">Marc-David  Ruepp</span>. </span><span class="cited-content_cbyCitation_article-title">The binding orientation of epibatidine at α7 nACh receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>116 </em>, 421-428. <a href="https://doi.org/10.1016/j.neuropharm.2017.01.008" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.01.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.01.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DThe%252Bbinding%252Borientation%252Bof%252Bepibatidine%252Bat%252B%2525CE%2525B17%252BnACh%252Breceptors%26aulast%3DThompson%26aufirst%3DAndrew%2BJ.%26date%3D2017%26volume%3D116%26spage%3D421%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanglin  Kuang</span>, <span class="hlFld-ContribAuthor ">Yang  Zhou</span>, <span class="hlFld-ContribAuthor ">Rongfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Agneta  Nordberg</span>, <span class="hlFld-ContribAuthor ">Bengt  Långström</span>, <span class="hlFld-ContribAuthor ">Hans  Ågren</span>, <span class="hlFld-ContribAuthor ">Yaoquan  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of the binding mode of the PET tracer [
              18
              F]ASEM to a chimera structure of the α7 nicotinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (32)
                                     , 19787-19793. <a href="https://doi.org/10.1039/C7RA00496F" title="DOI URL">https://doi.org/10.1039/C7RA00496F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA00496F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA00496F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCharacterization%252Bof%252Bthe%252Bbinding%252Bmode%252Bof%252Bthe%252BPET%252Btracer%252B%25255B%252B18%252BF%25255DASEM%252Bto%252Ba%252Bchimera%252Bstructure%252Bof%252Bthe%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptor%26aulast%3DKuang%26aufirst%3DGuanglin%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D32%26spage%3D19787%26epage%3D19793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauriane  Galle-Treger</span>, <span class="hlFld-ContribAuthor ">Yuzo  Suzuki</span>, <span class="hlFld-ContribAuthor ">Nisheel  Patel</span>, <span class="hlFld-ContribAuthor ">Ishwarya  Sankaranarayanan</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Aron</span>, <span class="hlFld-ContribAuthor ">Hadi  Maazi</span>, <span class="hlFld-ContribAuthor ">Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Omid  Akbari</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms13202" title="DOI URL">https://doi.org/10.1038/ncomms13202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms13202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms13202%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DNicotinic%252Bacetylcholine%252Breceptor%252Bagonist%252Battenuates%252BILC2-dependent%252Bairway%252Bhyperreactivity%26aulast%3DGalle-Treger%26aufirst%3DLauriane%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justus J.  Bürgi</span>, <span class="hlFld-ContribAuthor ">Sonia  Bertrand</span>, <span class="hlFld-ContribAuthor ">Fabrice  Marger</span>, <span class="hlFld-ContribAuthor ">Daniel  Bertrand</span>, <span class="hlFld-ContribAuthor ">Jean‐Louis  Reymond</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent Agonists of the
              α
              7 Nicotinic Acetylcholine Receptor Derived from 3‐Amino‐Quinuclidine. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2016,</strong> <em>99 </em>
                                    (10)
                                     , 790-804. <a href="https://doi.org/10.1002/hlca.201600120" title="DOI URL">https://doi.org/10.1002/hlca.201600120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201600120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201600120%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DFluorescent%252BAgonists%252Bof%252Bthe%252B%2525CE%2525B1%252B7%252BNicotinic%252BAcetylcholine%252BReceptor%252BDerived%252Bfrom%252B3%2525E2%252580%252590Amino%2525E2%252580%252590Quinuclidine%26aulast%3DB%25C3%25BCrgi%26aufirst%3DJustus%2BJ.%26date%3D2016%26date%3D2016%26volume%3D99%26issue%3D10%26spage%3D790%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. Adam  Kallel</span>, <span class="hlFld-ContribAuthor ">Colin  Vangel</span>, <span class="hlFld-ContribAuthor ">Daniel  Elbaum</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational analysis of 2-substituted piperazines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (13)
                                     , 3010-3013. <a href="https://doi.org/10.1016/j.bmcl.2016.05.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.05.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.05.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DConformational%252Banalysis%252Bof%252B2-substituted%252Bpiperazines%26aulast%3DKallel%26aufirst%3DE.%2BAdam%26date%3D2016%26volume%3D26%26issue%3D13%26spage%3D3010%26epage%3D3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Criado</span>, <span class="hlFld-ContribAuthor ">Beatriz  Balsera</span>, <span class="hlFld-ContribAuthor ">José  Mulet</span>, <span class="hlFld-ContribAuthor ">Salvador  Sala</span>, <span class="hlFld-ContribAuthor ">Francisco  Sala</span>, <span class="hlFld-ContribAuthor ">Roberto  de la Torre-Martínez</span>, <span class="hlFld-ContribAuthor ">Asia  Fernández-Carvajal</span>, <span class="hlFld-ContribAuthor ">Antonio  Ferrer-Montiel</span>, <span class="hlFld-ContribAuthor ">Silvia  Moreno-Fernández</span>, <span class="hlFld-ContribAuthor ">Marta  Miguel</span>, <span class="hlFld-ContribAuthor ">María Jesús  Pérez de Vega</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-diphenylpropan-1-ones as allosteric modulators of α7 nACh receptors with analgesic and antioxidant properties. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (7)
                                     , 731-749. <a href="https://doi.org/10.4155/fmc-2015-0001" title="DOI URL">https://doi.org/10.4155/fmc-2015-0001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2015-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2015-0001%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3D1%25252C3-diphenylpropan-1-ones%252Bas%252Ballosteric%252Bmodulators%252Bof%252B%2525CE%2525B17%252BnACh%252Breceptors%252Bwith%252Banalgesic%252Band%252Bantioxidant%252Bproperties%26aulast%3DCriado%26aufirst%3DManuel%26date%3D2016%26volume%3D8%26issue%3D7%26spage%3D731%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dina  Manetti</span>, <span class="hlFld-ContribAuthor ">Cristina  Bellucci</span>, <span class="hlFld-ContribAuthor ">Silvia  Dei</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Teodori</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>, <span class="hlFld-ContribAuthor ">Ekaterina  Spirova</span>, <span class="hlFld-ContribAuthor ">Denis  Kudryavtsev</span>, <span class="hlFld-ContribAuthor ">Irina  Shelukhina</span>, <span class="hlFld-ContribAuthor ">Victor  Tsetlin</span>, <span class="hlFld-ContribAuthor ">Maria Novella  Romanelli</span>. </span><span class="cited-content_cbyCitation_article-title">New quinoline derivatives as nicotinic receptor modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>110 </em>, 246-258. <a href="https://doi.org/10.1016/j.ejmech.2016.01.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.01.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.01.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bquinoline%252Bderivatives%252Bas%252Bnicotinic%252Breceptor%252Bmodulators%26aulast%3DManetti%26aufirst%3DDina%26date%3D2016%26volume%3D110%26spage%3D246%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Chatzidaki</span>, <span class="hlFld-ContribAuthor ">Neil S.  Millar</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulation of nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>97 </em>
                                    (4)
                                     , 408-417. <a href="https://doi.org/10.1016/j.bcp.2015.07.028" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.07.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.07.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DAllosteric%252Bmodulation%252Bof%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3DChatzidaki%26aufirst%3DAnna%26date%3D2015%26volume%3D97%26issue%3D4%26spage%3D408%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew G.  Horti</span>. </span><span class="cited-content_cbyCitation_article-title">Development of [ 18 F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>97 </em>
                                    (4)
                                     , 566-575. <a href="https://doi.org/10.1016/j.bcp.2015.07.030" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.07.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.07.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DDevelopment%252Bof%252B%25255B%252B18%252BF%25255DASEM%25252C%252Ba%252Bspecific%252Bradiotracer%252Bfor%252Bquantification%252Bof%252Bthe%252B%2525CE%2525B17-nAChR%252Bwith%252Bpositron-emission%252Btomography%26aulast%3DHorti%26aufirst%3DAndrew%2BG.%26date%3D2015%26volume%3D97%26issue%3D4%26spage%3D566%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Chatzidaki</span>, <span class="hlFld-ContribAuthor ">Jarryl M.  D'Oyley</span>, <span class="hlFld-ContribAuthor ">JasKiran K.  Gill-Thind</span>, <span class="hlFld-ContribAuthor ">Tom D.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Neil S.  Millar</span>. </span><span class="cited-content_cbyCitation_article-title">The influence of allosteric modulators and transmembrane mutations on desensitisation and activation of α7 nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2015,</strong> <em>97 </em>, 75-85. <a href="https://doi.org/10.1016/j.neuropharm.2015.05.006" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2015.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2015.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2015.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DThe%252Binfluence%252Bof%252Ballosteric%252Bmodulators%252Band%252Btransmembrane%252Bmutations%252Bon%252Bdesensitisation%252Band%252Bactivation%252Bof%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3DChatzidaki%26aufirst%3DAnna%26date%3D2015%26volume%3D97%26spage%3D75%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoni  R. Blaazer</span>, <span class="hlFld-ContribAuthor ">Iwan  J. P. de Esch</span>. </span><span class="cited-content_cbyCitation_article-title">From Molecular Understanding to Structure-Thermodynamic Relationships, the Case of Acetylcholine Binding Proteins. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 81-105. <a href="https://doi.org/10.1002/9783527673025.ch5" title="DOI URL">https://doi.org/10.1002/9783527673025.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527673025.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527673025.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BMolecular%252BUnderstanding%252Bto%252BStructure-Thermodynamic%252BRelationships%25252C%252Bthe%252BCase%252Bof%252BAcetylcholine%252BBinding%252BProteins%26aulast%3DR.%2BBlaazer%26aufirst%3DAntoni%26date%3D2015%26date%3D2015%26spage%3D81%26epage%3D105%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DThermodynamics%252Band%252BKinetics%252Bof%252BDrug%252BBinding%26aulast%3DKeser%25C3%25BC%26aufirst%3DGy%25C3%25B6rgy%2BM.%26date%3D2015%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean F.  Wong</span>, <span class="hlFld-ContribAuthor ">Hiroto  Kuwabara</span>, <span class="hlFld-ContribAuthor ">Martin  Pomper</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Holt</span>, <span class="hlFld-ContribAuthor ">James R.  Brasic</span>, <span class="hlFld-ContribAuthor ">Noble  George</span>, <span class="hlFld-ContribAuthor ">Boris  Frolov</span>, <span class="hlFld-ContribAuthor ">William  Willis</span>, <span class="hlFld-ContribAuthor ">Yongjun  Gao</span>, <span class="hlFld-ContribAuthor ">Heather  Valentine</span>, <span class="hlFld-ContribAuthor ">Ayon  Nandi</span>, <span class="hlFld-ContribAuthor ">Lorena  Gapasin</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Horti</span>. </span><span class="cited-content_cbyCitation_article-title">Human Brain Imaging of α7 nAChR with [18F]ASEM: a New PET Radiotracer for Neuropsychiatry and Determination of Drug Occupancy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2014,</strong> <em>16 </em>
                                    (5)
                                     , 730-738. <a href="https://doi.org/10.1007/s11307-014-0779-3" title="DOI URL">https://doi.org/10.1007/s11307-014-0779-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-014-0779-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-014-0779-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DHuman%252BBrain%252BImaging%252Bof%252B%2525CE%2525B17%252BnAChR%252Bwith%252B%25255B18F%25255DASEM%25253A%252Ba%252BNew%252BPET%252BRadiotracer%252Bfor%252BNeuropsychiatry%252Band%252BDetermination%252Bof%252BDrug%252BOccupancy%26aulast%3DWong%26aufirst%3DDean%2BF.%26date%3D2014%26date%3D2014%26volume%3D16%26issue%3D5%26spage%3D730%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">The use of spirocyclic scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3673-3682. <a href="https://doi.org/10.1016/j.bmcl.2014.06.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Buse%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anett K.  Szabo</span>, <span class="hlFld-ContribAuthor ">Krisztina  Pesti</span>, <span class="hlFld-ContribAuthor ">Arpad  Mike</span>, <span class="hlFld-ContribAuthor ">E. Sylvester  Vizi</span>. </span><span class="cited-content_cbyCitation_article-title">Mode of action of the positive modulator PNU-120596 on α7 nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2014,</strong> <em>81 </em>, 42-54. <a href="https://doi.org/10.1016/j.neuropharm.2014.01.033" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2014.01.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2014.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2014.01.033%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DMode%252Bof%252Baction%252Bof%252Bthe%252Bpositive%252Bmodulator%252BPNU-120596%252Bon%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3DSzabo%26aufirst%3DAnett%2BK.%26date%3D2014%26volume%3D81%26spage%3D42%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arianna  Nencini</span>, <span class="hlFld-ContribAuthor ">Cristiana  Castaldo</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Comery</span>, <span class="hlFld-ContribAuthor ">John  Dunlop</span>, <span class="hlFld-ContribAuthor ">Eva  Genesio</span>, <span class="hlFld-ContribAuthor ">Chiara  Ghiron</span>, <span class="hlFld-ContribAuthor ">Simon  Haydar</span>, <span class="hlFld-ContribAuthor ">Laura  Maccari</span>, <span class="hlFld-ContribAuthor ">Iolanda  Micco</span>, <span class="hlFld-ContribAuthor ">Elisa  Turlizzi</span>, <span class="hlFld-ContribAuthor ">Riccardo  Zanaletti</span>, <span class="hlFld-ContribAuthor ">Jean  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>78 </em>, 401-418. <a href="https://doi.org/10.1016/j.ejmech.2014.03.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.03.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.03.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Ba%252Bhybrid%252Bseries%252Bof%252Bpotent%252Band%252Bselective%252Bagonists%252Bof%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptor%26aulast%3DNencini%26aufirst%3DArianna%26date%3D2014%26volume%3D78%26spage%3D401%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anatoly  Mazurov</span>, <span class="hlFld-ContribAuthor ">Daniel  Yohannes</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinic Acetylcholine Receptor Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 213-253. <a href="https://doi.org/10.1007/7355_2014_56" title="DOI URL">https://doi.org/10.1007/7355_2014_56</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_56%26sid%3Dliteratum%253Aachs%26atitle%3DNicotinic%252BAcetylcholine%252BReceptor%252BModulators%26aulast%3DMazurov%26aufirst%3DAnatoly%26date%3D2014%26date%3D2014%26spage%3D213%26epage%3D253%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen’kii</span>, <span class="hlFld-ContribAuthor ">Yu. B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XII, 2010–2011. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 147-274. <a href="https://doi.org/10.1016/B978-0-12-420160-6.00004-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-420160-6.00004-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-420160-6.00004-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-420160-6.00004-5%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXII%25252C%252B2010%2525E2%252580%2525932011%26aulast%3DBelen%25E2%2580%2599kii%26aufirst%3DLeonid%2BI.%26date%3D2014%26spage%3D147%26epage%3D274%26pub%3DElsevier%26date%3D2014%26volume%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ethan B.  Van Arnam</span>, <span class="hlFld-ContribAuthor ">Emily E.  Blythe</span>, <span class="hlFld-ContribAuthor ">Henry A.  Lester</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Dougherty</span>. </span><span class="cited-content_cbyCitation_article-title">An Unusual Pattern of Ligand-Receptor Interactions for the
              α
              7 Nicotinic Acetylcholine Receptor, with Implications for the Binding of Varenicline. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2013,</strong> <em>84 </em>
                                    (2)
                                     , 201-207. <a href="https://doi.org/10.1124/mol.113.085795" title="DOI URL">https://doi.org/10.1124/mol.113.085795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.113.085795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.113.085795%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DAn%252BUnusual%252BPattern%252Bof%252BLigand-Receptor%252BInteractions%252Bfor%252Bthe%252B%2525CE%2525B1%252B7%252BNicotinic%252BAcetylcholine%252BReceptor%25252C%252Bwith%252BImplications%252Bfor%252Bthe%252BBinding%252Bof%252BVarenicline%26aulast%3DVan%2BArnam%26aufirst%3DEthan%2BB.%26date%3D2013%26date%3D2013%26volume%3D84%26issue%3D2%26spage%3D201%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivar M.  McDonald</span>, <span class="hlFld-ContribAuthor ">Robert A.  Mate</span>, <span class="hlFld-ContribAuthor ">F. Christopher  Zusi</span>, <span class="hlFld-ContribAuthor ">Hong  Huang</span>, <span class="hlFld-ContribAuthor ">Debra J.  Post-Munson</span>, <span class="hlFld-ContribAuthor ">Meredith A.  Ferrante</span>, <span class="hlFld-ContribAuthor ">Lizbeth  Gallagher</span>, <span class="hlFld-ContribAuthor ">Robert L.  Bertekap</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Knox</span>, <span class="hlFld-ContribAuthor ">Barbara J.  Robertson</span>, <span class="hlFld-ContribAuthor ">David G.  Harden</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Morgan</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Lodge</span>, <span class="hlFld-ContribAuthor ">Steven I.  Dworetzky</span>, <span class="hlFld-ContribAuthor ">Richard E.  Olson</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (6)
                                     , 1684-1688. <a href="https://doi.org/10.1016/j.bmcl.2013.01.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.01.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.01.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.01.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bquinolone%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bagonists%26aulast%3DMcDonald%26aufirst%3DIvar%2BM.%26date%3D2013%26volume%3D23%26issue%3D6%26spage%3D1684%26epage%3D1688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Gao  Chen</span>, <span class="hlFld-ContribAuthor ">Ruo-Xu  Gu</span>, <span class="hlFld-ContribAuthor ">Hao  Dai</span>, <span class="hlFld-ContribAuthor ">Dong-Qing  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2013,</strong> <em>39 </em>, 98-107. <a href="https://doi.org/10.1016/j.jmgm.2012.11.008" title="DOI URL">https://doi.org/10.1016/j.jmgm.2012.11.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2012.11.008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DVirtual%252Bscreening%252Bfor%252Balpha7%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bfor%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DChen%26aufirst%3DShi-Gao%26date%3D2013%26volume%3D39%26spage%3D98%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JasKiran K.  Gill</span>, <span class="hlFld-ContribAuthor ">Anna  Chatzidaki</span>, <span class="hlFld-ContribAuthor ">Daniel  Ursu</span>, <span class="hlFld-ContribAuthor ">Emanuele  Sher</span>, <span class="hlFld-ContribAuthor ">Neil S.  Millar</span>, . </span><span class="cited-content_cbyCitation_article-title">Contrasting Properties of α7-Selective Orthosteric and Allosteric Agonists Examined on Native Nicotinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (1)
                                     , e55047. <a href="https://doi.org/10.1371/journal.pone.0055047" title="DOI URL">https://doi.org/10.1371/journal.pone.0055047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0055047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0055047%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DContrasting%252BProperties%252Bof%252B%2525CE%2525B17-Selective%252BOrthosteric%252Band%252BAllosteric%252BAgonists%252BExamined%252Bon%252BNative%252BNicotinic%252BAcetylcholine%252BReceptors%26aulast%3DGill%26aufirst%3DJasKiran%2BK.%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D1%26spage%3De55047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwin G.  Pérez</span>, <span class="hlFld-ContribAuthor ">Cristian  Ocampo</span>, <span class="hlFld-ContribAuthor ">Dominik  Feuerbach</span>, <span class="hlFld-ContribAuthor ">Jhon J.  López</span>, <span class="hlFld-ContribAuthor ">Guibeth L.  Morelo</span>, <span class="hlFld-ContribAuthor ">Ricardo A.  Tapia</span>, <span class="hlFld-ContribAuthor ">Hugo R.  Arias</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1-(1-benzyl-1H-indol-3-yl)-N,N,N-trimethylmethanaminium iodides are competitive antagonists for the human α4β2 and α7 nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (8)
                                     , 1166. <a href="https://doi.org/10.1039/c3md00042g" title="DOI URL">https://doi.org/10.1039/c3md00042g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3md00042g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3md00042g%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DNovel%252B1-%2525281-benzyl-1H-indol-3-yl%252529-N%25252CN%25252CN-trimethylmethanaminium%252Biodides%252Bare%252Bcompetitive%252Bantagonists%252Bfor%252Bthe%252Bhuman%252B%2525CE%2525B14%2525CE%2525B22%252Band%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3DP%25C3%25A9rez%26aufirst%3DEdwin%2BG.%26date%3D2013%26volume%3D4%26issue%3D8%26spage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Skidmore</span>, <span class="hlFld-ContribAuthor ">Zeenat  Atcha</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Boucherat</span>, <span class="hlFld-ContribAuthor ">Laura  Castelletti</span>, <span class="hlFld-ContribAuthor ">Deborah W.  Chen</span>, <span class="hlFld-ContribAuthor ">Frank T.  Coppo</span>, <span class="hlFld-ContribAuthor ">Leanne  Cutler</span>, <span class="hlFld-ContribAuthor ">Rachel M.  Dunsdon</span>, <span class="hlFld-ContribAuthor ">Bronagh M.  Heath</span>, <span class="hlFld-ContribAuthor ">Rio  Hutchings</span>, <span class="hlFld-ContribAuthor ">David N.  Hurst</span>, <span class="hlFld-ContribAuthor ">Sahar  Javed</span>, <span class="hlFld-ContribAuthor ">Samuel  Martin</span>, <span class="hlFld-ContribAuthor ">Emma S.L.  Maskell</span>, <span class="hlFld-ContribAuthor ">David  Norton</span>, <span class="hlFld-ContribAuthor ">Darrel J.  Pemberton</span>, <span class="hlFld-ContribAuthor ">Sally  Redshaw</span>, <span class="hlFld-ContribAuthor ">Richard  Rutter</span>, <span class="hlFld-ContribAuthor ">Sanjeet S.  Sehmi</span>, <span class="hlFld-ContribAuthor ">Tiziana  Scoccitti</span>, <span class="hlFld-ContribAuthor ">Hannah E.  Temple</span>, <span class="hlFld-ContribAuthor ">Pam  Theobald</span>, <span class="hlFld-ContribAuthor ">Robert W.  Ward</span>, <span class="hlFld-ContribAuthor ">David M.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (10)
                                     , 3560-3563. <a href="https://doi.org/10.1016/j.bmcl.2012.03.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.03.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.03.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Ba%252Bseries%252Bof%252B1%25252C3%25252C4-oxadiazol-2-amines%252Bas%252Bpotent%252Balpha-7%252Bagonists%252Bwith%252Befficacy%252Bin%252Bthe%252Bnovel%252Bobject%252Brecognition%252Bmodel%252Bof%252Bcognition%26aulast%3DSkidmore%26aufirst%3DJohn%26date%3D2012%26volume%3D22%26issue%3D10%26spage%3D3560%26epage%3D3563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0030.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>2</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0031.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>9</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>16</b>, <b>17</b>, and <b>18</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>23</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>32</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>38</b>: construction of selective α7 nAChR agonists from an α4β2 nAChR agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0018.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>45</b>: hit–lead optimization sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/medium/jm-2011-007672_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0028.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. α7 nAChR product development pipeline. Gray bars with black cross indicate that development of the drug candidates was discontinued. White bars designate successful or ongoing clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2007672/production/images/large/jm-2011-007672_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007672&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03850" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03850" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 97 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gurley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanthorn, T. H.</span><span> </span><span class="NLM_article-title">Nicotinic agonists competitively antagonize serotonin at mouse 5HT<sub>3</sub> receptors expressed in <i>Xenopus</i> oocytes</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1998&pages=107-110&author=D.+A.+Gurleyauthor=T.+H.+Lanthorn&title=Nicotinic+agonists+competitively+antagonize+serotonin+at+mouse+5HT3+receptors+expressed+in+Xenopus+oocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurley%26aufirst%3DD.%2BA.%26aulast%3DLanthorn%26aufirst%3DT.%2BH.%26atitle%3DNicotinic%2520agonists%2520competitively%2520antagonize%2520serotonin%2520at%2520mouse%25205HT3%2520receptors%2520expressed%2520in%2520Xenopus%2520oocytes%26jtitle%3DNeurosci.%2520Lett.%26date%3D1998%26volume%3D247%26spage%3D107%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Karlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akabas, M. H.</span><span> </span><span class="NLM_article-title">Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=1231-1244&author=A.+Karlinauthor=M.+H.+Akabas&title=Toward+a+structural+basis+for+the+function+of+nicotinic+acetylcholine+receptors+and+their+cousins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarlin%26aufirst%3DA.%26aulast%3DAkabas%26aufirst%3DM.%2BH.%26atitle%3DToward%2520a%2520structural%2520basis%2520for%2520the%2520function%2520of%2520nicotinic%2520acetylcholine%2520receptors%2520and%2520their%2520cousins%26jtitle%3DNeuron%26date%3D1995%26volume%3D15%26spage%3D1231%26epage%3D1244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunavs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayhurst, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, L.</span><span> </span><span class="NLM_article-title">High affinity ligands for the α7 nicotinic receptor that show no cross-reactivity with the 5HT<sub>3</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4727</span><span class="NLM_x">–</span> <span class="NLM_lpage">4730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4727-4730&author=S.+R.+Bakerauthor=J.+Bootauthor=M.+Brunavsauthor=D.+Dobsonauthor=R.+Greenauthor=L.+Hayhurstauthor=M.+Keenanauthor=L.+Wallace&title=High+affinity+ligands+for+the+%CE%B17+nicotinic+receptor+that+show+no+cross-reactivity+with+the+5HT3+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DBoot%26aufirst%3DJ.%26aulast%3DBrunavs%26aufirst%3DM.%26aulast%3DDobson%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DHayhurst%26aufirst%3DL.%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DWallace%26aufirst%3DL.%26atitle%3DHigh%2520affinity%2520ligands%2520for%2520the%2520%25CE%25B17%2520nicotinic%2520receptor%2520that%2520show%2520no%2520cross-reactivity%2520with%2520the%25205HT3%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4727%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanthorn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J. C.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>3</sub> antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=319-321&author=J.+E.+Macorauthor=D.+Gurleyauthor=T.+Lanthornauthor=J.+Lochauthor=R.+A.+Mackauthor=G.+Mullenauthor=O.+Tranauthor=N.+Wrightauthor=J.+C.+Gordon&title=The+5-HT3+antagonist+tropisetron+%28ICS+205-930%29+is+a+potent+and+selective+%CE%B17+nicotinic+receptor+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DLanthorn%26aufirst%3DT.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DMack%26aufirst%3DR.%2BA.%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DO.%26aulast%3DWright%26aufirst%3DN.%26aulast%3DGordon%26aufirst%3DJ.%2BC.%26atitle%3DThe%25205-HT3%2520antagonist%2520tropisetron%2520%2528ICS%2520205-930%2529%2520is%2520a%2520potent%2520and%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520partial%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D319%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_contrib-group">Thompson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lummis, S. C. R.</span><span> </span><span class="NLM_article-title">5-HT<sub>3</sub> Receptors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3615</span><span class="NLM_x">–</span> <span class="NLM_lpage">3630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F138161206778522029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17073663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFalsL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3615-3630&author=A.+J.+Thompsonauthor=S.+C.+R.+Lummis&title=5-HT3+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT3 receptors</span></div><div class="casAuthors">Thompson, A. J.; Lummis, S. C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3615-3630</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The 5-HT3 receptor is a member of the Cys-loop family of ligand-gated ion channels.  These receptors are located in both the peripheral and central nervous systems, where functional receptors are constructed from five subunits.  These subunits may be the same (homopentameric 5-HT3A receptors) or different (heteropentameric receptors, usually comprising of 5-HT3A and 5-HT3B receptor subunits), with the latter having a no. of distinct properties.  The 5-HT3 receptor binding site is comprised of six loops from two adjacent subunits, and crit. ligand binding amino acids in these loops have been largely identified.  There are a range of selective agonists and antagonists for these receptors and the pharmacophore is reasonably well understood.  There are also a wide range of compds. that can modulate receptor activity.  Studies have suggested many diverse potential disease targets that might be amenable to alleviation by 5-HT3 receptor selective compds. but to date only two applications have been fully realized in the clinic: the treatment of emesis and irritable-bowel syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH2ZFrHPWO57Vg90H21EOLACvtfcHk0lj8j9fkY8YPJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFalsL%252FN&md5=b4422b7916b7d8e99f8b232f4ec14d06</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.2174%2F138161206778522029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778522029%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DLummis%26aufirst%3DS.%2BC.%2BR.%26atitle%3D5-HT3%2520Receptors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D3615%26epage%3D3630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennuni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Benedetti, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menziani, M. C.</span><span> </span><span class="NLM_article-title">The interaction of 5-HT<sub>3</sub> receptors with arylpiperazine, tropane, and quinuclidine Ligands</span> <span class="citation_source-journal">Curr. Top. Med. Chem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F1568026023393813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=12052196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD38Xksl2jt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=599-624&author=A.+Cappelliauthor=M.+Anziniauthor=S.+Vomeroauthor=L.+Mennuniauthor=F.+Makovecauthor=M.+Hamonauthor=P.+G.+De+Benedettiauthor=M.+C.+Menziani&title=The+interaction+of+5-HT3+receptors+with+arylpiperazine%2C+tropane%2C+and+quinuclidine+Ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The interactions of the 5-HT3 receptor with arylpiperazine, tropane, and quinuclidine ligands</span></div><div class="casAuthors">Cappelli, Andrea; Anzinj, Maurizio; Vomero, Salvatore; Mennuni, Laura; Makovec, Francesco; Hamon, Michel; De Benedetti, Pier G.; Menziani, M. Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-624</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin 5-HT3 receptor subtype is unique among the receptors for this neurotransmitter because it has been demonstrated to be a ligand-gated ion channel capable of mediating rapid intercellular communication.  This review covers the authors' work performed during more than a decade in the development of 5-HT3 receptor ligands belonging to the classes of arylpiperazines, tropanes, and quinuclidine derivs.  The discussion is focused mainly on what the authors have learned about the interaction of these structurally different ligands with their receptor and shows the way their ideas evolved along with the progress of the project.  Furthermore, a summary of the most significant structure-affinity relationships, derived from the original work, is reported to support the discussion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBgDcXvOA1sLVg90H21EOLACvtfcHk0liH4Y1mSZpHlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xksl2jt7Y%253D&md5=780655968bd7c3b030dd6e257422da4c</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.2174%2F1568026023393813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393813%26sid%3Dliteratum%253Aachs%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DVomero%26aufirst%3DS.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DHamon%26aufirst%3DM.%26aulast%3DDe%2BBenedetti%26aufirst%3DP.%2BG.%26aulast%3DMenziani%26aufirst%3DM.%2BC.%26atitle%3DThe%2520interaction%2520of%25205-HT3%2520receptors%2520with%2520arylpiperazine%252C%2520tropane%252C%2520and%2520quinuclidine%2520Ligands%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem%26date%3D2002%26volume%3D2%26spage%3D599%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span> Dolasetron (Anzemet) product information, Aventis. February<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Dolasetron+%28Anzemet%29+product+information%2C+Aventis.+February+2002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span> Granisetron (Kytril) product information, Roche. August<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Granisetron+%28Kytril%29+product+information%2C+Roche.+August+2002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span> Ondansetron (Zofran) product information, GlaxoSmithKline. May<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Ondansetron+%28Zofran%29+product+information%2C+GlaxoSmithKline.+May+2001."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_contrib-group">Lisi, D. M.</span><span> </span><span class="NLM_article-title">Lotronex withdrawal</span> <span class="citation_source-journal">Arch. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2002&pages=101&author=D.+M.+Lisi&title=Lotronex+withdrawal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLisi%26aufirst%3DD.%2BM.%26atitle%3DLotronex%2520withdrawal%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D2002%26volume%3D162%26spage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hajós, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Targeting α7 nicotinic acetylcholine receptors in the treatment of schizophrenia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F138161210790361434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19909231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVKjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=538-554&author=M.+Haj%C3%B3sauthor=B.+N.+Rogers&title=Targeting+%CE%B17+nicotinic+acetylcholine+receptors+in+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting α7 nicotinic acetylcholine receptors in the treatment of schizophrenia</span></div><div class="casAuthors">Hajos, Mihaly; Rogers, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">538-554</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The most abundant homomeric nicotinic acetylcholine receptors (nAChRs) in the mammalian brain are the pentameric α7 nAChRs which consist of five α7 subunits, and each subunit provides an orthosteric low affinity binding site for its endogenous ligand, acetylcholine.  Distribution and high level expression of α7 nAChRs within the limbic circuitry, including the hippocampus and prefrontal cortical areas are in line with their involvement in various cognitive functions.  Activation of α7 nAChRs generates a conformational change of sub-unit proteins, making the channel permeable to cations, in particular calcium, leading to change in neuronal activity and excitability, and via increased intracellular calcium, modulating transmitter release and neuronal network activity.  Since genetic linkage studies implicated the α7 nAChRs subunit gene CHRNA7 in schizophrenia, there is a considerable interest for developing drug therapies targeting α7 nAChRs.  In this review recent development of selective agonists and pos. allosteric modulators of α7 nAChRs are discussed.  In addn. to summarizing medicinal chem. efforts, both cellular and neuronal network pharmacol. of α7 nAChRs are covered.  The assocn. between CHRNA7 gene and impaired P50 auditory gating has provided an attractive endophenotype, and its use as a potential translational biomarker for α7 nAChRs drug discovery is discussed.  Preliminary clin. findings on α7 nAChRs agonists are also summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp7AwwIMI237Vg90H21EOLACvtfcHk0li2SFbV2_fnIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVKjtbc%253D&md5=8ea5d5bcaf0d11b63a31725ebf6e2459</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F138161210790361434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210790361434%26sid%3Dliteratum%253Aachs%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DTargeting%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D538%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lightfood, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skidmore, J.</span><span> </span><span class="NLM_article-title">α7 Nicotinic acetylcholine receptor agonists and positive allosteric modulators</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0079-6468%2807%2900003-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=18381125" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=131-171&author=A.+P.+Lightfoodauthor=J.+N.+C.+Kewauthor=J.+Skidmore&title=%CE%B17+Nicotinic+acetylcholine+receptor+agonists+and+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2807%2900003-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252807%252900003-3%26sid%3Dliteratum%253Aachs%26aulast%3DLightfood%26aufirst%3DA.%2BP.%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3D%25CE%25B17%2520Nicotinic%2520acetylcholine%2520receptor%2520agonists%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D46%26spage%3D131%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mazurov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. H.</span><span> </span><span class="NLM_article-title">Selective α7 nicotinic acetylcholine receptor ligands</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F092986706777442011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=16787204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVGrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1567-1584&author=A.+A.+Mazurovauthor=T.+Hauserauthor=C.+H.+Miller&title=Selective+%CE%B17+nicotinic+acetylcholine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selective α7 nicotinic acetylcholine receptor ligands</span></div><div class="casAuthors">Mazurov, Anatoly; Hauser, Terry; Miller, Craig H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1567-1584</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand gated ion channels of broad distribution and structural heterogeneity.  Their functional diversity demonstrated involvement in a variety of neuronal processes (e.g., sensory gating and cognitive function) and generated great interest in them as targets for therapeutic intervention in a no. of neuropathol. conditions and diseases.  In order to control distinct nicotinic functions pharmacol., it is important to design ligands that selectively interact with distinct receptor subtypes in such a way as to maximize the therapeutic effect and minimize the adverse effects.  The α7 nAChR, a CNS subtype, has been the most intensively studied nAChR in recent years.  Selective α7 nAChR agonists have been developed as potential candidates for the treatment of schizophrenia, cognitive disorders (including Alzheimer's disease), and inflammation.  Despite early concerns that the rapid desensitization property of the α7 nAChR would limit their therapeutic potential, several have already been advanced to clin. trials (e.g., PH-399733, Pfizer; MEM 3454, Memory Pharmaceuticals/Roche).  Further development of allosteric modulators and pharmaceutically relevant antagonists might expand the therapeutic potential of compds. that target α7 nAChRs.  In this review we briefly describe the structure and function of the α7 nAChR and its in vitro and in vivo pharmacol., discuss the clin. relevance of these efforts, and review the current progress in α7 ligand development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDkem3VpTTzrVg90H21EOLACvtfcHk0li2SFbV2_fnIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVGrs7c%253D&md5=a7ce411b57d1e7b704bdce077563eea3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F092986706777442011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777442011%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA.%2BA.%26aulast%3DHauser%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DC.%2BH.%26atitle%3DSelective%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1567%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gordon, J. C.; Griffith, R. C.; Murray, R. J.; Balestra, M.</span><span> </span><span class="NLM_article-title">Spiro-azabicyclic Compounds Useful in Therapy</span>. U.S. Patent 5902814,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=J.+C.+Gordon&author=R.+C.+Griffith&author=R.+J.+Murray&author=M.+Balestra&title=Spiro-azabicyclic+Compounds+Useful+in+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DJ.%2BC.%26atitle%3DSpiro-azabicyclic%2520Compounds%2520Useful%2520in%2520Therapy%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCory, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maco,r, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampognaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blosser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machulskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zongrone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J.</span><span> </span><span class="NLM_article-title">(−)-Spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α7 nicotinic acethylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">–</span> <span class="NLM_lpage">4050</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000249r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4045-4050&author=G.+Mullenauthor=J.+Napierauthor=M.+Balestraauthor=T.+DeCoryauthor=G.+Haleauthor=J.+Maco%2Crauthor=R.+Mackauthor=J.+Lochauthor=E.+Wuauthor=A.+Koverauthor=P.+Verhoestauthor=A.+Sampognaroauthor=E.+Phillipsauthor=Y.+Zhuauthor=R.+Murrayauthor=R.+Griffithauthor=J.+Blosserauthor=D.+Gurleyauthor=A.+Machulskisauthor=J.+Zongroneauthor=A.+Rosenauthor=J.+Gordon&title=%28%E2%88%92%29-Spiro%5B1-azabicyclo%5B2.2.2%5Doctane-3%2C5%E2%80%B2-oxazolidin-2%E2%80%B2-one%5D%2C+a+conformationally+restricted+analogue+of+acetylcholine%2C+is+a+highly+selective+full+agonist+at+the+%CE%B17+nicotinic+acethylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm000249r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000249r%26sid%3Dliteratum%253Aachs%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DNapier%26aufirst%3DJ.%26aulast%3DBalestra%26aufirst%3DM.%26aulast%3DDeCory%26aufirst%3DT.%26aulast%3DHale%26aufirst%3DG.%26aulast%3DMaco%252Cr%26aufirst%3DJ.%26aulast%3DMack%26aufirst%3DR.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DE.%26aulast%3DKover%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%26aulast%3DSampognaro%26aufirst%3DA.%26aulast%3DPhillips%26aufirst%3DE.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DMurray%26aufirst%3DR.%26aulast%3DGriffith%26aufirst%3DR.%26aulast%3DBlosser%26aufirst%3DJ.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DMachulskis%26aufirst%3DA.%26aulast%3DZongrone%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DA.%26aulast%3DGordon%26aufirst%3DJ.%26atitle%3D%2528%25E2%2588%2592%2529-Spiro%255B1-azabicyclo%255B2.2.2%255Doctane-3%252C5%25E2%2580%25B2-oxazolidin-2%25E2%2580%25B2-one%255D%252C%2520a%2520conformationally%2520restricted%2520analogue%2520of%2520acetylcholine%252C%2520is%2520a%2520highly%2520selective%2520full%2520agonist%2520at%2520the%2520%25CE%25B17%2520nicotinic%2520acethylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4045%26epage%3D4050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Astles, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boot, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broad, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dell, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M.</span><span> </span><span class="NLM_article-title">Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.2174%2F1568007023339256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=12769608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFSmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=337-348&author=P.+C.+Astlesauthor=S.+R.+Bakerauthor=J.+R.+Bootauthor=L.+M.+Broadauthor=C.+P.+Dellauthor=M.+Keenan&title=Recent+progress+in+the+development+of+subtype+selective+nicotinic+acetylcholine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands</span></div><div class="casAuthors">Astles, P. C.; Baker, S. R.; Boot, J. R.; Broad, L. M.; Dell, C. P.; Keenan, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-348</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand gated ion channels, which are found at the neuromuscular junction and in the central and peripheral nervous systems.  The channels can be assembled from fourteen known subunits.  The exact combination and function of all the channels are still not detd. but in the CNS certain combinations have been identified which appear to modulate the release of specific neurotransmitters.  Non-specific nAChR agonists like nicotine and epibatidine, have been shown to have interesting pharmacol. but their clin. value is limited by their undesirable side effects.  Selective ligands for different receptor subtypes have been reported and these compds. are probably the best tools for detg. the function of the subtypes.  The expectation is that some receptor subtype selective nAChR ligands will be clin. useful for the treatment of a broad range of CNS disorders.  The development of stable cell lines functionally expressing specific combinations of subunits has greatly improved our understanding of ligand specificity.  There have also been advances in the modeling of the ligand binding site, thanks to the discovery of a homologous snail ACh binding protein the x-ray structure of which was detd. in 2001.  These techniques should lead to rapid advances in the development of truly subtype selective ligands.  In this review we describe recent progress in the area and describe the first 1000 fold selective low mol. wt. ligands from the Astra-Zeneca group.  We also comment on the first subtype specific channel modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW7blv1UIcybVg90H21EOLACvtfcHk0ljCOYK54LFsyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFSmsr4%253D&md5=dc305ccf03024133de5219453a82cb88</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1568007023339256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007023339256%26sid%3Dliteratum%253Aachs%26aulast%3DAstles%26aufirst%3DP.%2BC.%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DBoot%26aufirst%3DJ.%2BR.%26aulast%3DBroad%26aufirst%3DL.%2BM.%26aulast%3DDell%26aufirst%3DC.%2BP.%26aulast%3DKeenan%26aufirst%3DM.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520subtype%2520selective%2520nicotinic%2520acetylcholine%2520receptor%2520ligands%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2002%26volume%3D1%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Levin, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettegowda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blosser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J.</span><span> </span><span class="NLM_article-title">AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=675-680&author=E.+D.+Levinauthor=C.+Bettegowdaauthor=J.+Blosserauthor=J.+Gordon&title=AR-R+17779%2C+an+%CE%B17+nicotinic+agonist%2C+improves+learning+and+memory+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DE.%2BD.%26aulast%3DBettegowda%26aufirst%3DC.%26aulast%3DBlosser%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DJ.%26atitle%3DAR-R%252017779%252C%2520an%2520%25CE%25B17%2520nicotinic%2520agonist%252C%2520improves%2520learning%2520and%2520memory%2520in%2520rats%26jtitle%3DBehav.%2520Pharmacol.%26date%3D1999%26volume%3D10%26spage%3D675%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Van Kampen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiegel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boess, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R.</span><span> </span><span class="NLM_article-title">AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=375-383&author=M.+Van+Kampenauthor=K.+Selbachauthor=R.+Schneiderauthor=E.+Schiegelauthor=F.+Boessauthor=R.+Schreiber&title=AR-R+17779+improves+social+recognition+in+rats+by+activation+of+nicotinic+%CE%B17+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BKampen%26aufirst%3DM.%26aulast%3DSelbach%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DSchiegel%26aufirst%3DE.%26aulast%3DBoess%26aufirst%3DF.%26aulast%3DSchreiber%26aufirst%3DR.%26atitle%3DAR-R%252017779%2520improves%2520social%2520recognition%2520in%2520rats%2520by%2520activation%2520of%2520nicotinic%2520%25CE%25B17%2520receptors%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D172%26spage%3D375%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0166-4328%2800%2900305-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=11099773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlCqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2000&pages=197-208&author=A.+J.+Grottickauthor=G.+A.+Higgins&title=Effect+of+subtype+selective+nicotinic+compounds+on+attention+as+assessed+by+the+five-choice+serial+reaction+time+task"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task</span></div><div class="casAuthors">Grottick, A. J.; Higgins, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">197-208</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Nicotine can improve attentional functioning in humans, and a no. of studies have recently demonstrated that under specific task conditions, nicotine can also improve attention in the rat.  Neuronal nicotinic receptors comprise combinations of α2-9 and β2-4 subunits, arranged to form a pentameric receptor, with the principal CNS subtypes currently believed to be α4β2 and a homomeric α7 receptor.  In the present studies, we attempted to delineate the particular nicotinic receptor subtype(s) contributing to the effects of nicotine on attention by assessing various nicotinic ligands on performance in the five-choice serial reaction time task (5-CSRTT).  In rats performing below criterion (<80% correct, >20% omissions to a 1-s visual stimulus), subchronic dosing with nicotine (0.2 mg/kg s.c.) and the α4β2 agonist SIB 1765F (5 mg/kg s.c.) increased correct responding and decreased response latencies across the treatment week; whereas the α7 agonist AR-R 17779 (20 mg/kg s.c.) was without effect.  In subjects meeting the criterion, the competitive high affinity (including α4β2) nicotine receptor antagonist dihydro-β-erythroidine (DHβE) (1-10 mg/kg s.c.) and the α7 antagonist methyllycaconitine (MLA: 5-10 mg/kg i.p.) did not disrupt performance, whereas at the highest dose, the non-competitive antagonist mecamylamine (0.3-3 mg/kg s.c.) decreased accuracy and increased response latencies.  These changes bore some similarities to those of prefeeding and the non-competitive NMDA antagonist dizocilpine (0.03-0.06 mg/kg s.c.), suggesting that mecamylamine-induced performance disruption may relate to non-nicotinic receptor effects.  In subjects chronically treated with nicotine, acute nicotine challenge (0.4 mg/kg s.c.) significantly increased accuracy while having no effect on any other performance measures.  Finally, in these same nicotine pretreated rats, the decrease in latency and increase in premature responses induced by nicotine (0.2 mg/kg s.c.) to a target stimulus of 150 ms was fully antagonized by DHβE (3 mg/kg s.c.) but not MLA (5 mg/kg i.p.).  These results suggest that α7 receptors do not play a role in any of the behavioral effects of nicotine obsd. in the 5-CSRTT, whereas a high affinity site, perhaps α4β2, is more likely involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpginujPLkBLbVg90H21EOLACvtfcHk0lj38M39mZ4p_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlCqs74%253D&md5=289d293039da15e8112bf12382825247</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0166-4328%2800%2900305-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-4328%252800%252900305-3%26sid%3Dliteratum%253Aachs%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DEffect%2520of%2520subtype%2520selective%2520nicotinic%2520compounds%2520on%2520attention%2520as%2520assessed%2520by%2520the%2520five-choice%2520serial%2520reaction%2520time%2520task%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2000%26volume%3D117%26spage%3D197%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Schreiber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalmus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vry, J.</span><span> </span><span class="NLM_article-title">Effects of α4β2- and α7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2002&pages=248-257&author=R.+Schreiberauthor=M.+Dalmusauthor=J.+De+Vry&title=Effects+of+%CE%B14%CE%B22-+and+%CE%B17-nicotine+acetylcholine+receptor+agonists+on+prepulse+inhibition+of+the+acoustic+startle+response+in+rats+and+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DDalmus%26aufirst%3DM.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520%25CE%25B14%25CE%25B22-%2520and%2520%25CE%25B17-nicotine%2520acetylcholine%2520receptor%2520agonists%2520on%2520prepulse%2520inhibition%2520of%2520the%2520acoustic%2520startle%2520response%2520in%2520rats%2520and%2520mice%26jtitle%3DPsychopharmacology%26date%3D2002%26volume%3D159%26spage%3D248%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Griffith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petty, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, R.</span><span> </span><span class="NLM_article-title">Nicotinic receptor desensitization and sensory gating deficits in schizophrenia</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0006-3223%2897%2900362-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=9646891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADyaK1cXksVSmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=98-106&author=J.+M.+Griffithauthor=J.+E.+O%E2%80%99Neillauthor=F.+Pettyauthor=D.+Garverauthor=D.+Youngauthor=R.+Freedman&title=Nicotinic+receptor+desensitization+and+sensory+gating+deficits+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor desensitization and sensory gating deficits in schizophrenia</span></div><div class="casAuthors">Griffith, Jay M.; O'neill, Jaishri E.; Petty, Frederick; Garver, David; Young, David; Freedman, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">98-106</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Nicotinic receptor dysfunction is a possible mechanism of the abnormal sensory gating obsd. in schizophrenia with the P50 auditory event-related potential.  Although nicotinic receptors normally desensitize after activation by acetylcholine or nicotine, pathol. increased desensitization might cause receptor dysfunction in schizophrenia.  To examine this possibility, central cholinergic neuronal activity was diminished by allowing schizophrenic patients to sleep briefly, after which they experienced a transient period of normal P50 gating, consistent with receptor resensitization during the absence of cholinergic stimulation.  A crit. test of the mechanism is whether this resensitization is blocked by concurrent administration of nicotine, which would provide continuous receptor stimulation.  Six schizophrenic patients repeated the sleep expt. during nicotine exposure from a dermal patch, in a double-blind, placebo-controlled design.  The normalization of P50 gating immediately postsleep was replicated in the placebo arm; but this effect was decreased in all six patients during exposure to nicotine.  The results suggest that nicotinic receptor desensitization is responsible for the loss of P50 gating in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnH2hbKz_BKrVg90H21EOLACvtfcHk0lj38M39mZ4p_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksVSmt7w%253D&md5=ba6f182c88f28021f1cc00d1a4a8be7a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2897%2900362-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252897%252900362-4%26sid%3Dliteratum%253Aachs%26aulast%3DGriffith%26aufirst%3DJ.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DJ.%2BE.%26aulast%3DPetty%26aufirst%3DF.%26aulast%3DGarver%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DD.%26aulast%3DFreedman%26aufirst%3DR.%26atitle%3DNicotinic%2520receptor%2520desensitization%2520and%2520sensory%2520gating%2520deficits%2520in%2520schizophrenia%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D98%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">van Maanen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebre, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Poll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRosa, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vervoordeldonk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tak, P. P.</span><span> </span><span class="NLM_article-title">Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1002%2Fart.24177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19116908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFequ7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=114-122&author=M.+A.+van+Maanenauthor=M.+C.+Lebreauthor=T.+van+der+Pollauthor=G.+J.+LaRosaauthor=D.+Elbaumauthor=M.+J.+Vervoordeldonkauthor=P.+P.+Tak&title=Stimulation+of+nicotinic+acetylcholine+receptors+attenuates+collagen-induced+arthritis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice</span></div><div class="casAuthors">van Maanen, Marjolein A.; Lebre, Maria C.; van der Poll, Tom; La Rosa, Gregory J.; Elbaum, Daniel; Vervoordeldonk, Margriet J.; Tak, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-122</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The parasympathetic nervous system, through the vagus nerve, can down-regulate inflammation in vivo by decreasing the release of cytokines, including tumor necrosis factor α (TNFα), by activated macrophages.  The vagus nerve may exert antiinflammatory actions via a specific effect of its principal neurotransmitter, acetylcholine, on the α7 subunit of nicotinic acetylcholine receptors (α7nAChR) on macrophages.  The present study was undertaken to obtain insight into the role of the cholinergic antiinflammatory pathway in arthritis.  To inhibit the cholinergic antiinflammatory pathway, mice were subjected to unilateral cervical vagotomy or sham surgery, after which arthritis was induced with type II collagen.  In a sep. study, nicotine was added to the drinking water of mice with collagen-induced arthritis (CIA).  In addn., we investigated the effects of i.p. (IP)-injected nicotine and the specific α7nAChR agonist AR-R17779.  Clin. arthritis was exacerbated by vagotomy and ameliorated by oral nicotine administration.  Moreover, oral nicotine inhibited bone degrdn. and reduced TNFα expression in synovial tissue.  Both IP-injected nicotine and AR-R17779 ameliorated clin. arthritis and reduced synovial inflammation.  This was accompanied by a redn. of TNFα levels in both plasma and synovial tissue.  The effect of AR-R17779 was more potent compared with that of nicotine and was assocd. with delayed onset of the disease as well as with protection against joint destruction.  These data provide the first evidence of a role of the cholinergic antiinflammatory pathway in the murine CIA model of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3s5iC-YbxFLVg90H21EOLACvtfcHk0ljt5HKOCobGUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFequ7w%253D&md5=409abcd4db452578bab75b9a62cf2b04</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fart.24177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24177%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMaanen%26aufirst%3DM.%2BA.%26aulast%3DLebre%26aufirst%3DM.%2BC.%26aulast%3Dvan%2Bder%2BPoll%26aufirst%3DT.%26aulast%3DLaRosa%26aufirst%3DG.%2BJ.%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DVervoordeldonk%26aufirst%3DM.%2BJ.%26aulast%3DTak%26aufirst%3DP.%2BP.%26atitle%3DStimulation%2520of%2520nicotinic%2520acetylcholine%2520receptors%2520attenuates%2520collagen-induced%2520arthritis%2520in%2520mice%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Tatsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">(+)-3-[2-(Benzo[<i>b</i>]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the α7 nicotinic acetylcholine receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3781-3784&author=R.+Tatsumiauthor=K.+Seioauthor=M.+Fujioauthor=J.+Katayamaauthor=T.+Horikawaauthor=K.+Hashimotoauthor=H.+Tanaka&title=%28%2B%29-3-%5B2-%28Benzo%5Bb%5Dthiophen-2-yl%29-2-oxoethyl%5D-1-azabicyclo%5B2.2.2%5Doctane+as+potent+agonists+for+the+%CE%B17+nicotinic+acetylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DR.%26aulast%3DSeio%26aufirst%3DK.%26aulast%3DFujio%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DJ.%26aulast%3DHorikawa%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3D%2528%252B%2529-3-%255B2-%2528Benzo%255Bb%255Dthiophen-2-yl%2529-2-oxoethyl%255D-1-azabicyclo%255B2.2.2%255Doctane%2520as%2520potent%2520agonists%2520for%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3781%26epage%3D3784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Tatsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">Discovery of the α7 nicotinic acetylcholine receptor agonists. (<i>R</i>)-3′-(5 Chlorothiophen-2-yl)spiro-1-azabicyclo-[2.2.2]octane-3,5′-[1′,3′]-oxazolidin-2′-one as a novel, potent, selective and orally bioavailable ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2678</span><span class="NLM_x">–</span> <span class="NLM_lpage">2686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049188d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2678-2686&author=R.+Tatsumiauthor=M.+Fujioauthor=H.+Satohauthor=J.+Katayamaauthor=S.+Takanashiauthor=K.+Hashimotoauthor=H.+Tanaka&title=Discovery+of+the+%CE%B17+nicotinic+acetylcholine+receptor+agonists.+%28R%29-3%E2%80%B2-%285+Chlorothiophen-2-yl%29spiro-1-azabicyclo-%5B2.2.2%5Doctane-3%2C5%E2%80%B2-%5B1%E2%80%B2%2C3%E2%80%B2%5D-oxazolidin-2%E2%80%B2-one+as+a+novel%2C+potent%2C+selective+and+orally+bioavailable+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm049188d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049188d%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DR.%26aulast%3DFujio%26aufirst%3DM.%26aulast%3DSatoh%26aufirst%3DH.%26aulast%3DKatayama%26aufirst%3DJ.%26aulast%3DTakanashi%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonists.%2520%2528R%2529-3%25E2%2580%25B2-%25285%2520Chlorothiophen-2-yl%2529spiro-1-azabicyclo-%255B2.2.2%255Doctane-3%252C5%25E2%2580%25B2-%255B1%25E2%2580%25B2%252C3%25E2%2580%25B2%255D-oxazolidin-2%25E2%2580%25B2-one%2520as%2520a%2520novel%252C%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2678%26epage%3D2686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tatsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiigi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murozono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">(<i>R</i>)-3′-(3-Methylbenzo[<i>b</i>]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5′-oxazolidin]-2′-one, a novel and potent α7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4374</span><span class="NLM_x">–</span> <span class="NLM_lpage">4383</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060249c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4374-4383&author=R.+Tatsumiauthor=M.+Fujioauthor=S.+Takanashiauthor=A.+Numataauthor=J.+Katayamaauthor=H.+Satohauthor=Y.+Shiigiauthor=J.+Maedaauthor=M.+Kuriyamaauthor=T.+Horikawaauthor=T.+Murozonoauthor=K.+Hashimotoauthor=H.+Tanaka&title=%28R%29-3%E2%80%B2-%283-Methylbenzo%5Bb%5Dthiophen-5-yl%29spiro%5B1-azabicyclo%5B2%2C2%2C2%5Doctane-3%2C5%E2%80%B2-oxazolidin%5D-2%E2%80%B2-one%2C+a+novel+and+potent+%CE%B17+nicotinic+acetylcholine+receptor+partial+agonist+displays+cognitive+enhancing+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm060249c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060249c%26sid%3Dliteratum%253Aachs%26aulast%3DTatsumi%26aufirst%3DR.%26aulast%3DFujio%26aufirst%3DM.%26aulast%3DTakanashi%26aufirst%3DS.%26aulast%3DNumata%26aufirst%3DA.%26aulast%3DKatayama%26aufirst%3DJ.%26aulast%3DSatoh%26aufirst%3DH.%26aulast%3DShiigi%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DKuriyama%26aufirst%3DM.%26aulast%3DHorikawa%26aufirst%3DT.%26aulast%3DMurozono%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3D%2528R%2529-3%25E2%2580%25B2-%25283-Methylbenzo%255Bb%255Dthiophen-5-yl%2529spiro%255B1-azabicyclo%255B2%252C2%252C2%255Doctane-3%252C5%25E2%2580%25B2-oxazolidin%255D-2%25E2%2580%25B2-one%252C%2520a%2520novel%2520and%2520potent%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%2520displays%2520cognitive%2520enhancing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4374%26epage%3D4383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Phillips, E.; Mack, R.; Macor, J.; Semus, S.</span><span> </span><span class="NLM_article-title">Spiroazabicyclic Heterocyclic Compounds</span>. U.S. Patent 6706878,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=E.+Phillips&author=R.+Mack&author=J.+Macor&author=S.+Semus&title=Spiroazabicyclic+Heterocyclic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DE.%26atitle%3DSpiroazabicyclic%2520Heterocyclic%2520Compounds%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cliffe, I. A.</span><span> </span><span class="NLM_article-title">Quinuclidyl- and Tropanyl-pyridyl Ethers as 5-HT<sub>3</sub> Receptor Antagonists</span>. U.S. Patent 4921860,<span class="NLM_x"> </span><span class="NLM_year">1990</span><span class="NLM_x">; </span>John Wyeth and Brother, Limited.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=I.+A.+Cliffe&title=Quinuclidyl-+and+Tropanyl-pyridyl+Ethers+as+5-HT3+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26atitle%3DQuinuclidyl-%2520and%2520Tropanyl-pyridyl%2520Ethers%2520as%25205-HT3%2520Receptor%2520Antagonists%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sydserff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirk, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerald Jonak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudzik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrzljak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smagin, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widzowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. S.</span><span> </span><span class="NLM_article-title">Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=880-888&author=S.+Sydserffauthor=E.+J.+Suttonauthor=D.+Songauthor=M.+C.+Quirkauthor=C.+Maciagauthor=C.+Liauthor=G.+Gerald+Jonakauthor=D.+Gurleyauthor=J.+C.+Gordonauthor=E.+P.+Christianauthor=J.+J.+Dohertyauthor=T.+Hudzikauthor=E.+Johnsonauthor=L.+Mrzljakauthor=T.+Piserauthor=G.+N.+Smaginauthor=Y.+Wangauthor=D.+Widzowskiauthor=J.+S.+Smith&title=Selective+%CE%B17+nicotinic+receptor+activation+by+AZD0328+enhances+cortical+dopamine+release+and+improves+learning+and+attentional+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydserff%26aufirst%3DS.%26aulast%3DSutton%26aufirst%3DE.%2BJ.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DQuirk%26aufirst%3DM.%2BC.%26aulast%3DMaciag%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DGerald%2BJonak%26aufirst%3DG.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DJ.%2BC.%26aulast%3DChristian%26aufirst%3DE.%2BP.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DHudzik%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DMrzljak%26aufirst%3DL.%26aulast%3DPiser%26aufirst%3DT.%26aulast%3DSmagin%26aufirst%3DG.%2BN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWidzowski%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DJ.%2BS.%26atitle%3DSelective%2520%25CE%25B17%2520nicotinic%2520receptor%2520activation%2520by%2520AZD0328%2520enhances%2520cortical%2520dopamine%2520release%2520and%2520improves%2520learning%2520and%2520attentional%2520processes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D880%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><a href="http://www.astrazenecaclinicaltrials.com/other-drug-products/discontinued-products/AZD0328/" class="extLink">http://www.astrazenecaclinicaltrials.com/other-drug-products/discontinued-products/AZD0328/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.astrazenecaclinicaltrials.com%2Fother-drug-products%2Fdiscontinued-products%2FAZD0328%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Chang, H.-F.; Li, Y.; Phillips, E.</span><span> </span><span class="NLM_article-title">Furyl Compounds</span>. U.S. Patent 7417049,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.-F.+Chang&author=Y.+Li&author=E.+Phillips&title=Furyl+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.-F.%26atitle%3DFuryl%2520Compounds%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ernst, G.</span>; <span class="NLM_etal">et al.</span><span> </span><span class="NLM_article-title">Spirofuropyridines as alpha-7 Neuronal Nicotinic Receptor Agonists</span>. Presented at the 236th National Meeting of the American Chemical Society, Philadelphia, PA, August 17–21,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>MEDI 249.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Ernst&title=Spirofuropyridines+as+alpha-7+Neuronal+Nicotinic+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DG.%26atitle%3DSpirofuropyridines%2520as%2520alpha-7%2520Neuronal%2520Nicotinic%2520Receptor%2520Agonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bodnar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span> </span><span class="NLM_article-title">Discovery and structure–activity relationship of quinuclidine benzamides as agonists of α7 nicotinic acetylcholine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049363q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=905-908&author=A.+L.+Bodnarauthor=L.+A.+Cortes-Burgosauthor=K.+K.+Cookauthor=D.+M.+Dinhauthor=V.+E.+Groppiauthor=M.+Hajosauthor=N.+R.+Higdonauthor=W.+E.+Hoffmannauthor=R.+S.+Hurstauthor=J.+K.+Myersauthor=B.+N.+Rogersauthor=T.+M.+Wallauthor=M.+L.+Wolfeauthor=E.+Wong&title=Discovery+and+structure%E2%80%93activity+relationship+of+quinuclidine+benzamides+as+agonists+of+%CE%B17+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm049363q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049363q%26sid%3Dliteratum%253Aachs%26aulast%3DBodnar%26aufirst%3DA.%2BL.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DWong%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520quinuclidine%2520benzamides%2520as%2520agonists%2520of%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D905%26epage%3D908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanchar, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(3<i>R</i>)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure–activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4425</span><span class="NLM_x">–</span> <span class="NLM_lpage">4436</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0602413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4425-4436&author=D.+G.+Wishkaauthor=D.+P.+Walkerauthor=K.+M.+Yatesauthor=S.+C.+Reitzauthor=S.+Jiaauthor=J.+K.+Myersauthor=K.+I.+Olsonauthor=E.+J.+Jacobsenauthor=M.+L.+Wolfeauthor=V.+E.+Groppiauthor=A.+J.+Hancharauthor=B.+A.+Thornburghauthor=B.+Cortesauthor=A.+Luzauthor=E.+H.+F.+Wongauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=N.+R.+Higdonauthor=T.+M.+Wallauthor=R.+S.+Hurstauthor=R.+R.+Waltersauthor=W.+E.+Hoffmannauthor=M.+Haj%C3%B3sauthor=S.+Franklinauthor=G.+Careyauthor=L.+H.+Goldauthor=K.+K.+Cookauthor=S.+B.+Sandsauthor=S.+X.+Zhaoauthor=J.+R.+Sogliaauthor=A.+S.+Kalgutkarauthor=S.+P.+Arnericauthor=B.+N.+Rogers&title=Discovery+of+N-%5B%283R%29-1-azabicyclo%5B2.2.2%5Doct-3-yl%5Dfuro%5B2%2C3-c%5Dpyridine-5-carboxamide%2C+an+agonist+of+the+%CE%B17+nicotinic+acetylcholine+receptor%2C+for+the+potential+treatment+of+cognitive+deficits+in+schizophrenia%3A+synthesis+and+structure%E2%80%93activity+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm0602413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602413%26sid%3Dliteratum%253Aachs%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DOlson%26aufirst%3DK.%2BI.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHanchar%26aufirst%3DA.%2BJ.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DCortes%26aufirst%3DB.%26aulast%3DLuz%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DCarey%26aufirst%3DG.%26aulast%3DGold%26aufirst%3DL.%2BH.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDiscovery%2520of%2520N-%255B%25283R%2529-1-azabicyclo%255B2.2.2%255Doct-3-yl%255Dfuro%255B2%252C3-c%255Dpyridine-5-carboxamide%252C%2520an%2520agonist%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%252C%2520for%2520the%2520potential%2520treatment%2520of%2520cognitive%2520deficits%2520in%2520schizophrenia%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4425%26epage%3D4436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Design, synthesis, structure–activity relationship, and in vivo activity of azabicyclic aryl amides as α7 nicotinic acetylcholine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8219</span><span class="NLM_x">–</span> <span class="NLM_lpage">8248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8219-8248&author=T.+M.+Wallauthor=R.+S.+Hurstauthor=E.+H.+F.+Wongauthor=B.+N.+Rogers&title=Design%2C+synthesis%2C+structure%E2%80%93activity+relationship%2C+and+in+vivo+activity+of+azabicyclic+aryl+amides+as+%CE%B17+nicotinic+acetylcholine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDesign%252C%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationship%252C%2520and%2520in%2520vivo%2520activity%2520of%2520azabicyclic%2520aryl%2520amides%2520as%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8219%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Acker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinholt, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(3<i>R</i>,5<i>R</i>)-1-azabicyclo[3.2.1]oct-3-yl]furo-[2,3-<i>c</i>]pyridine-5-carboxamide as an agonist of the α7 nicotinic acetylcholine receptor: in vitro and in vivo activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3611</span><span class="NLM_x">–</span> <span class="NLM_lpage">3615</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3611-3615&author=B.+A.+Ackerauthor=E.+J.+Jacobsenauthor=B.+N.+Rogersauthor=D.+G.+Wishkaauthor=S.+C.+Reitzauthor=D.+W.+Piotrowskiauthor=J.+K.+Myersauthor=M.+L.+Wolfeauthor=V.+E.+Groppiauthor=B.+A.+Thornburghauthor=P.+M.+Tinholtauthor=R.+R.+Waltersauthor=B.+A.+Olsonauthor=L.+Fitzgeraldauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=M.+Krauseauthor=K.+S.+Liauthor=W.+E.+Hoffmannauthor=M.+Hajosauthor=R.+S.+Hurstauthor=D.+P.+Walker&title=Discovery+of+N-%5B%283R%2C5R%29-1-azabicyclo%5B3.2.1%5Doct-3-yl%5Dfuro-%5B2%2C3-c%5Dpyridine-5-carboxamide+as+an+agonist+of+the+%CE%B17+nicotinic+acetylcholine+receptor%3A+in+vitro+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DB.%2BA.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DTinholt%26aufirst%3DP.%2BM.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DOlson%26aufirst%3DB.%2BA.%26aulast%3DFitzgerald%26aufirst%3DL.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DKrause%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DK.%2BS.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520of%2520N-%255B%25283R%252C5R%2529-1-azabicyclo%255B3.2.1%255Doct-3-yl%255Dfuro-%255B2%252C3-c%255Dpyridine-5-carboxamide%2520as%2520an%2520agonist%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3611%26epage%3D3615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_contrib-group">Tehim, A.; Herbert, B.; Nguyen, T. M.; Xie, W.; Gauss, C. M.</span><span> </span><span class="NLM_article-title">Indazoles, Benzothiazoles, Benzoisothiazoles, Benzisoxazoles and Preparation and Uses Thereof</span>. WO 2004029050,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=A.+Tehim&author=B.+Herbert&author=T.+M.+Nguyen&author=W.+Xie&author=C.+M.+Gauss&title=Indazoles%2C+Benzothiazoles%2C+Benzoisothiazoles%2C+Benzisoxazoles+and+Preparation+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTehim%26aufirst%3DA.%26atitle%3DIndazoles%252C%2520Benzothiazoles%252C%2520Benzoisothiazoles%252C%2520Benzisoxazoles%2520and%2520Preparation%2520and%2520Uses%2520Thereof%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_contrib-group">Xie, W.; Herbert, B.; Schumacher, R. A.; Ma, J.; Nguyen, T. M.; Gauss, C. M.; Tehim, A.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Indazoles, 1,2-Benzothiazoles, 1,2-Benzoisothiazoles and Chromosomes and Preparation and Uses Thereof</span>. WO 2005111038,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+Xie&author=B.+Herbert&author=R.+A.+Schumacher&author=J.+Ma&author=T.+M.+Nguyen&author=C.+M.+Gauss&author=A.+Tehim&title=1H-Indazoles%2C+1%2C2-Benzothiazoles%2C+1%2C2-Benzoisothiazoles+and+Chromosomes+and+Preparation+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26atitle%3D1H-Indazoles%252C%25201%252C2-Benzothiazoles%252C%25201%252C2-Benzoisothiazoles%2520and%2520Chromosomes%2520and%2520Preparation%2520and%2520Uses%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31c"><span><span class="NLM_contrib-group">Xie, W.; Herbert, B.; Schumacher, R. A.; Ma, J.; Nguyen, T. M.; Gauss, C. M.; Tehim, A.</span><span> </span><span class="NLM_article-title">Indazoles, Benzothiazoles, Benzoisothiazoles and Preparation and Uses Thereof</span>. WO 2005092890,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+Xie&author=B.+Herbert&author=R.+A.+Schumacher&author=J.+Ma&author=T.+M.+Nguyen&author=C.+M.+Gauss&author=A.+Tehim&title=Indazoles%2C+Benzothiazoles%2C+Benzoisothiazoles+and+Preparation+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26atitle%3DIndazoles%252C%2520Benzothiazoles%252C%2520Benzoisothiazoles%2520and%2520Preparation%2520and%2520Uses%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vivo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span> </span><span class="NLM_article-title">MEM 3454, a novel nicotinic alpha7 receptor partial agonist. I. In vitro pharmacological profiling</span> <span class="citation_source-journal">Soc. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">163.2/Z8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=163.2%2FZ8&author=S.+Wangauthor=T.+Michaelauthor=S.+Draganauthor=S.+Sunauthor=Q.+Xiaoauthor=P.+M.+Callahanauthor=W.+Xieauthor=B.+Herbertauthor=E.+Grahamauthor=M.+De+Vivoauthor=A.+Tehim&title=MEM+3454%2C+a+novel+nicotinic+alpha7+receptor+partial+agonist.+I.+In+vitro+pharmacological+profiling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMichael%26aufirst%3DT.%26aulast%3DDragan%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DHerbert%26aufirst%3DB.%26aulast%3DGraham%26aufirst%3DE.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26aulast%3DTehim%26aufirst%3DA.%26atitle%3DMEM%25203454%252C%2520a%2520novel%2520nicotinic%2520alpha7%2520receptor%2520partial%2520agonist.%2520I.%2520In%2520vitro%2520pharmacological%2520profiling%26jtitle%3DSoc.%2520Neurosci.%26date%3D2006%26spage%3D163.2%252FZ8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wallace, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tombaugh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodefer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D. A.</span><span> </span><span class="NLM_article-title">RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">242</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.110.171892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20959364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1eqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=242-253&issue=1&author=T.+L.+Wallaceauthor=P.+M.+Callahanauthor=A.+Tehimauthor=D.+Bertrandauthor=G.+Tombaughauthor=S.+Wangauthor=W.+Xieauthor=W.+B.+Roweauthor=V.+Ongauthor=E.+Grahamauthor=A.+V.+Terryauthor=J.+Rodeferauthor=B.+Herbertauthor=M.+Murrayauthor=R.+Porterauthor=L.+Santarelliauthor=D.+A.+Lowe&title=RG3487%2C+a+novel+nicotinic+%CE%B17+receptor+partial+agonist%2C+improves+cognition+and+sensorimotor+gating+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents</span></div><div class="casAuthors">Wallace, Tanya L.; Callahan, Patrick M.; Tehim, Ashok; Bertrand, Daniel; Tombaugh, Geoffrey; Wang, Shaojie; Xie, Walter; Rowe, Wayne B.; Ong, Voon; Graham, Elizabeth; Terry, Alvin V., Jr.; Rodefer, Joshua S.; Herbert, Brian; Murray, Michael; Porter, Richard; Santarelli, Luca; Lowe, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">242-253</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal nicotinic α7 acetylcholine receptors (α7nAChRs) are expressed primarily in the brain and are implicated in modulating many cognitive functions (e.g., attention, working and episodic memory).  Not surprisingly, much effort has been committed to the development of mols. acting at α7nAChRs as potential therapies for a variety of central nervous system diseases (e.g., Alzheimer's).  N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-1H-indazole-3-carboxamide hydrochloride (RG3487) binds potently to the human α7nAChR (Ki = 6 nM), in which it acts as a partial agonist (63-69% of acetylcholine) as assessed by whole-cell patch-clamp recordings in both oocytes and QM7 cell lines.  RG3487 activates human α7nAChRs with an EC50 of 0.8 μM (oocytes) and 7.7 μM (QM7 cells).  RG3487 also exhibits antagonist properties at the serotonin 3 receptor [IC50 = 2.8 nM (oocytes), 32.7 nM (N1E-115 cells)].  In vivo, RG3487 improved object recognition memory in rats after acute [minimally ED (MED) 1.0 mg/kg p.o.] or repeated (10 day) administration at brain, and plasma concns. in the low-nanomolar range.  Spatial learning deficits in age-impaired rats were reversed after RG3487 administration (MED: 0.03 mg/kg i.p.) as evaluated in the Morris water maze task.  In the prepulse inhibition (PPI) of startle model of sensorimotor gating, RG3487 improved apomorphine-induced deficits in PPI performance (MED: 0.03 mg/kg i.p.) and reversed phencyclidine-induced impairments in an attentional set-shifting model of executive function (MED: ≤0.03 mg/kg i.p.).  Cumulative evidence from these studies indicates RG3487 is a novel and potent α7nAChR partial agonist that improves cognitive performance and sensorimotor gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRwJiQq8hPF7Vg90H21EOLACvtfcHk0liMMH45eoRm0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1eqtA%253D%253D&md5=31e2b80ecdf851d25ad3e9856296b7f1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.171892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.171892%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DT.%2BL.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DTehim%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DTombaugh%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DRowe%26aufirst%3DW.%2BB.%26aulast%3DOng%26aufirst%3DV.%26aulast%3DGraham%26aufirst%3DE.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DRodefer%26aufirst%3DJ.%26aulast%3DHerbert%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DM.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DSantarelli%26aufirst%3DL.%26aulast%3DLowe%26aufirst%3DD.%2BA.%26atitle%3DRG3487%252C%2520a%2520novel%2520nicotinic%2520%25CE%25B17%2520receptor%2520partial%2520agonist%252C%2520improves%2520cognition%2520and%2520sensorimotor%2520gating%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26issue%3D1%26spage%3D242%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, J. A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span> </span><span class="NLM_article-title">MEM 3454, a novel nicotinic alpha7 receptor partial agonist: II. Effects in models predictive of cognitive restoration in Alzheimer’s disease</span> <span class="citation_source-journal">Soc. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">163.5/Z11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=163.5%2FZ11&author=P.+M.+Callahanauthor=W.+B.+Roweauthor=W.+Xieauthor=J.+A.+V.+Terryauthor=J.+J.+Buccafuscoauthor=A.+Tehim&title=MEM+3454%2C+a+novel+nicotinic+alpha7+receptor+partial+agonist%3A+II.+Effects+in+models+predictive+of+cognitive+restoration+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DRowe%26aufirst%3DW.%2BB.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DTerry%26aufirst%3DJ.%2BA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DTehim%26aufirst%3DA.%26atitle%3DMEM%25203454%252C%2520a%2520novel%2520nicotinic%2520alpha7%2520receptor%2520partial%2520agonist%253A%2520II.%2520Effects%2520in%2520models%2520predictive%2520of%2520cognitive%2520restoration%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSoc.%2520Neurosci.%26date%3D2006%26spage%3D163.5%252FZ11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Rowe, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodefer, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span> </span><span class="NLM_article-title">MEM 3454, a novel nicotinic alpha7 receptor partial agonist. III. Effects in models predictive of cognitive and sensory gating restoration in schizophrenia</span> <span class="citation_source-journal">Soc. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">163.4/Z10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=163.4%2FZ10&author=W.+B.+Roweauthor=P.+M.+Callahanauthor=W.+Xieauthor=J.+S.+Rodeferauthor=A.+V.+Terryauthor=J.+J.+Buccafuscoauthor=C.+R.+Ashbyauthor=A.+Tehim&title=MEM+3454%2C+a+novel+nicotinic+alpha7+receptor+partial+agonist.+III.+Effects+in+models+predictive+of+cognitive+and+sensory+gating+restoration+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DW.%2BB.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DRodefer%26aufirst%3DJ.%2BS.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DTehim%26aufirst%3DA.%26atitle%3DMEM%25203454%252C%2520a%2520novel%2520nicotinic%2520alpha7%2520receptor%2520partial%2520agonist.%2520III.%2520Effects%2520in%2520models%2520predictive%2520of%2520cognitive%2520and%2520sensory%2520gating%2520restoration%2520in%2520schizophrenia%26jtitle%3DSoc.%2520Neurosci.%26date%3D2006%26spage%3D163.4%252FZ10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rezvani, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kholdebarin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricato, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, E. D.</span><span> </span><span class="NLM_article-title">Effect of R3487/MEM3454, a novel nicotinic a7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.pnpbp.2008.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19110025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=269-275&author=A.+H.+Rezvaniauthor=E.+Kholdebarinauthor=F.+H.+Bricatoauthor=P.+M.+Callahanauthor=D.+A.+Loweauthor=E.+D.+Levin&title=Effect+of+R3487%2FMEM3454%2C+a+novel+nicotinic+a7+receptor+partial+agonist+and+5-HT3+antagonist+on+sustained+attention+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of R3487/MEM3454, a novel nicotinic α7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats</span></div><div class="casAuthors">Rezvani, Amir H.; Kholdebarin, Ehsan; Brucato, Frederic H.; Callahan, Patrick M.; Lowe, David A.; Levin, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It is well established that nicotinic systems in the brain are critically involved in attentional processes in both animals and humans.  The current study assessed the effects of a novel nicotinic α7 receptor partial agonist and 5-HT3 antagonist, R3487/MEM3454 (also referred to as R3487 or MEM 3454) on sustained attention in rats performing an operant visual signal detection task.  The effects of R3487/MEM3454 were compared to those of the acetylcholinesterase inhibitor/nicotinic α7 allosteric pos. modulator galanthamine.  Adult female Sprague-Dawley rats were injected s.c. with R3487/MEM3454 (0.03, 0.1, 0.15, 0.3 and 0.6 mg/kg), galanthamine (0.25, 0.5, 1, 2 mg/kg) or vehicle 30 min before the attentional test.  In the second study, the time-dependent effects of R3487/MEM3454 were assessed by injecting the compd. (0.6 mg/kg, s.c.) at different pretreatment intervals (30, 60 or 90 min) before the start of the attentional task.  Our results show a significant dose-effect for R3487/MEM3454 on percent hit accuracy performance without any significant alteration on percent correct rejection performance.  In the time-dependent test, R3487/MEM3454 significantly increased the percent hit accuracy performance when animals were injected 60 min before the start of the attentional task.  Administration of galanthamine failed to significantly increase percent hit accuracy performance and increasing the dose of galanthamine produced a decrease in percent correct rejection performance.  The present findings with R3487/MEM3454 suggest that nicotinic α7 receptors and/or 5-HT3 receptors may play an important role in modulating sustained attention and that R3487/MEM3454 may have therapeutic potential in improving sustained attention in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGeYeIWDhalrVg90H21EOLACvtfcHk0lgL2lLtnTsM9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wqur4%253D&md5=6865683db698c20314d40c5974809bf7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2008.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2008.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DRezvani%26aufirst%3DA.%2BH.%26aulast%3DKholdebarin%26aufirst%3DE.%26aulast%3DBricato%26aufirst%3DF.%2BH.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DLowe%26aufirst%3DD.%2BA.%26aulast%3DLevin%26aufirst%3DE.%2BD.%26atitle%3DEffect%2520of%2520R3487%252FMEM3454%252C%2520a%2520novel%2520nicotinic%2520a7%2520receptor%2520partial%2520agonist%2520and%25205-HT3%2520antagonist%2520on%2520sustained%2520attention%2520in%2520rats%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2009%26volume%3D33%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Umbricht, D. M. S.; Lowe, D.; Yoo, K.; Porter, R.; Garibaldi, G.; Santarelli, L.; Keefe, R.</span><span> </span><span class="NLM_article-title">The Effect of the Partial Nicotinic alpha7 Receptor Agonist R3487 on Cognitive Deficits in Schizophrenia</span>. Presented at the 48th Annual Meeting of American College of Neuropsychopharmacology, Hollywood, FL,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+M.+S.+Umbricht&author=D.+Lowe&author=K.+Yoo&author=R.+Porter&author=G.+Garibaldi&author=L.+Santarelli&author=R.+Keefe&title=The+Effect+of+the+Partial+Nicotinic+alpha7+Receptor+Agonist+R3487+on+Cognitive+Deficits+in+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DUmbricht%26aufirst%3DD.%2BM.%2BS.%26atitle%3DThe%2520Effect%2520of%2520the%2520Partial%2520Nicotinic%2520alpha7%2520Receptor%2520Agonist%2520R3487%2520on%2520Cognitive%2520Deficits%2520in%2520Schizophrenia%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Boess, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flessner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luithle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methfessel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnizler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Staay, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kampen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiese, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, G.</span><span> </span><span class="NLM_article-title">The novel alpha7 nicotinic acetylcholine receptor agonist <i>N</i>-[(3<i>R</i>)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">716</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.106.118976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17308038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=716-725&author=F.+G.+Boessauthor=J.+De+Vryauthor=C.+Erbauthor=T.+Flessnerauthor=M.+Hendrixauthor=J.+Luithleauthor=C.+Methfesselauthor=B.+Riedlauthor=K.+Schnizlerauthor=F.-J.+van+der+Staayauthor=M.+van+Kampenauthor=W.+B.+Wieseauthor=G.+Koenig&title=The+novel+alpha7+nicotinic+acetylcholine+receptor+agonist+N-%5B%283R%29-1-azabicyclo%5B2.2.2%5Doct-3-yl%5D-7-%5B2-%28methoxy%29phenyl%5D-1-benzofuran-2-carboxamide+improves+working+and+recognition+memory+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents</span></div><div class="casAuthors">Boess, Frank G.; De Vry, Jean; Erb, Christina; Flessner, Timo; Hendrix, Martin; Luithle, Joachim; Methfessel, Christoph; Riedl, Bernd; Schnizler, Katrin; van der Staay, Franz-Josef; van Kampen, Marja; Wiese, Welf Burkhard; Koenig, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">716-725</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The relative contribution of α4β2, α7 and other nicotinic acetylcholine receptor (nAChR) subtypes to the memory enhancing vs. the addictive effects of nicotine is the subject of ongoing debate.  In the present study, we characterized the pharmacol. and behavioral properties of the α7 nAChR agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide (ABBF).  ABBF bound to α7 nAChR in rat brain membranes (Ki = 62 nM) and to recombinant human 5-hydroxytryptamine (5-HT)3 receptors (Ki = 60 nM).  ABBF was a potent agonist at the recombinant rat and human α7 nAChR expressed in Xenopus oocytes, but it did not show agonist activity at other nAChR subtypes.  ABBF acted as an antagonist of the 5-HT3 receptor and α3β4, α4β2, and muscle nAChRs (at higher concns.).  ABBF improved social recognition memory in rats (0.3-1 mg/kg p.o.).  This improvement was blocked by intracerebroventricular administration of the α7 nAChR antagonist methyllycaconitine at 10 μg, indicating that it is mediated by α7 nAChR agonism.  In addn., ABBF improved working memory of aged rats in a water maze repeated acquisition paradigm (1 mg/kg p.o.) and object recognition memory in mice (0.3-1 mg/kg p.o.).  Rats trained to discriminate nicotine (0.4 mg/kg s.c.) from vehicle did not generalize to ABBF (0.3-30 mg/kg p.o.), suggesting that the nicotine cue is not mediated by the α7 nAChR and that selective α7 nAChR agonists may not share the abuse liability of nicotine.  Our results support the hypothesis that α7 nAChR agonists may provide a novel therapeutic strategy for the treatment of cognitive deficits with low abuse potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwy3grI51_3bVg90H21EOLACvtfcHk0ljdvlKMClKstg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehu7w%253D&md5=a047ab00b180954531bb75e2077ac86c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.118976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.118976%26sid%3Dliteratum%253Aachs%26aulast%3DBoess%26aufirst%3DF.%2BG.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DFlessner%26aufirst%3DT.%26aulast%3DHendrix%26aufirst%3DM.%26aulast%3DLuithle%26aufirst%3DJ.%26aulast%3DMethfessel%26aufirst%3DC.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DSchnizler%26aufirst%3DK.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.-J.%26aulast%3Dvan%2BKampen%26aufirst%3DM.%26aulast%3DWiese%26aufirst%3DW.%2BB.%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DThe%2520novel%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520N-%255B%25283R%2529-1-azabicyclo%255B2.2.2%255Doct-3-yl%255D-7-%255B2-%2528methoxy%2529phenyl%255D-1-benzofuran-2-carboxamide%2520improves%2520working%2520and%2520recognition%2520memory%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D716%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_contrib-group">Koenig, G.; Chesworth, R.; Shapiro, G.; Hilt, D.; Palfreyman, M.; Barbier, A.</span><span> </span><span class="NLM_article-title">Treatment of Cognitive Disorders with (<i>R</i>)-7-Chloro-<i>N</i>-(quinuclidin-3-yl)benzo[<i>b</i>]thiophene-2-carboxamide and Pharmaceutically Acceptable Salts Thereof</span>. WO 2010059844,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+Koenig&author=R.+Chesworth&author=G.+Shapiro&author=D.+Hilt&author=M.+Palfreyman&author=A.+Barbier&title=Treatment+of+Cognitive+Disorders+with+%28R%29-7-Chloro-N-%28quinuclidin-3-yl%29benzo%5Bb%5Dthiophene-2-carboxamide+and+Pharmaceutically+Acceptable+Salts+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DTreatment%2520of%2520Cognitive%2520Disorders%2520with%2520%2528R%2529-7-Chloro-N-%2528quinuclidin-3-yl%2529benzo%255Bb%255Dthiophene-2-carboxamide%2520and%2520Pharmaceutically%2520Acceptable%2520Salts%2520Thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_contrib-group">Koenig, G.; Hilt, D.</span><span> </span><span class="NLM_article-title">Treatment of Cognitive Disorders with Certain alpha-7 Nicotinic Acid Receptors in Combination with Acetylcholinesterase Inhibitors</span>. US 2011/0124631,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Koenig&author=D.+Hilt&title=Treatment+of+Cognitive+Disorders+with+Certain+alpha-7+Nicotinic+Acid+Receptors+in+Combination+with+Acetylcholinesterase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKoenig%26aufirst%3DG.%26atitle%3DTreatment%2520of%2520Cognitive%2520Disorders%2520with%2520Certain%2520alpha-7%2520Nicotinic%2520Acid%2520Receptors%2520in%2520Combination%2520with%2520Acetylcholinesterase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hilt, D.; Safirstein, B.; Hassman, D.; Apter, J.; Thein, S.; Maruff, P.; Harrison, J.; Gawryl, M.; Koenig, G.</span><span> </span><span class="NLM_article-title">EVP-6124: Safety, Tolerability and Cognitive Effects of a Novel α7 Nicotinic Receptor Agonist in Alzheimer’s Disease Patients on Stable Donepezil or Rivastigmine Therapy</span>. Presented at the International Conference on Alzheimer’s Disease,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Hilt&author=B.+Safirstein&author=D.+Hassman&author=J.+Apter&author=S.+Thein&author=P.+Maruff&author=J.+Harrison&author=M.+Gawryl&author=G.+Koenig&title=EVP-6124%3A+Safety%2C+Tolerability+and+Cognitive+Effects+of+a+Novel+%CE%B17+Nicotinic+Receptor+Agonist+in+Alzheimer%E2%80%99s+Disease+Patients+on+Stable+Donepezil+or+Rivastigmine+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHilt%26aufirst%3DD.%26atitle%3DEVP-6124%253A%2520Safety%252C%2520Tolerability%2520and%2520Cognitive%2520Effects%2520of%2520a%2520Novel%2520%25CE%25B17%2520Nicotinic%2520Receptor%2520Agonist%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Patients%2520on%2520Stable%2520Donepezil%2520or%2520Rivastigmine%2520Therapy%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Apter, J. T.</span><span> </span><span class="NLM_article-title">EVP-6124 elicits pro-cognitive effects in Alzheimer’s patients</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=328&author=J.+T.+Apter&title=EVP-6124+elicits+pro-cognitive+effects+in+Alzheimer%E2%80%99s+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DApter%26aufirst%3DJ.%2BT.%26atitle%3DEVP-6124%2520elicits%2520pro-cognitive%2520effects%2520in%2520Alzheimer%25E2%2580%2599s%2520patients%26jtitle%3DNeurotherapeutics%26date%3D2010%26volume%3D7%26spage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><a href="http://envivopharma.com/news-item.php?id=32" class="extLink">http://envivopharma.com/news-item.php?id=32</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fenvivopharma.com%2Fnews-item.php%3Fid%3D32."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Mazurov, A, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klucik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seamans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span> </span><span class="NLM_article-title">2-(Arylmethy)l-3-substituted quinuclidines as selective α7 nicotinic receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2073-2077&author=A%2C+A.+Mazurovauthor=J.+Klucikauthor=L.+Miaoauthor=T.+Y.+Phillipsauthor=A.+Seamansauthor=J.+D.+Schmittauthor=T.+A.+Hauserauthor=R.+T.+Johnsonauthor=C.+Miller&title=2-%28Arylmethy%29l-3-substituted+quinuclidines+as+selective+%CE%B17+nicotinic+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazurov%26aufirst%3DA%252C%2BA.%26aulast%3DKlucik%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DPhillips%26aufirst%3DT.%2BY.%26aulast%3DSeamans%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%2BD.%26aulast%3DHauser%26aufirst%3DT.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BT.%26aulast%3DMiller%26aufirst%3DC.%26atitle%3D2-%2528Arylmethy%2529l-3-substituted%2520quinuclidines%2520as%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2073%26epage%3D2077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Hauser, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucinski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatto, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersinger, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachowiak, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachowiak, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippiello, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span> </span><span class="NLM_article-title">TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=803-812&author=T.+A.+Hauserauthor=A.+Kucinskiauthor=K.+G.+Jordanauthor=G.+J.+Gattoauthor=S.+R.+Wersingerauthor=R.+A.+Hesseauthor=E.+K.+Stachowiakauthor=M.+K.+Stachowiakauthor=R.+L.+Papkeauthor=P.+M.+Lippielloauthor=M.+Bencherif&title=TC-5619%3A+an+alpha7+neuronal+nicotinic+receptor-selective+agonist+that+demonstrates+efficacy+in+animal+models+of+the+positive+and+negative+symptoms+and+cognitive+dysfunction+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DT.%2BA.%26aulast%3DKucinski%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DK.%2BG.%26aulast%3DGatto%26aufirst%3DG.%2BJ.%26aulast%3DWersinger%26aufirst%3DS.%2BR.%26aulast%3DHesse%26aufirst%3DR.%2BA.%26aulast%3DStachowiak%26aufirst%3DE.%2BK.%26aulast%3DStachowiak%26aufirst%3DM.%2BK.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DLippiello%26aufirst%3DP.%2BM.%26aulast%3DBencherif%26aufirst%3DM.%26atitle%3DTC-5619%253A%2520an%2520alpha7%2520neuronal%2520nicotinic%2520receptor-selective%2520agonist%2520that%2520demonstrates%2520efficacy%2520in%2520animal%2520models%2520of%2520the%2520positive%2520and%2520negative%2520symptoms%2520and%2520cognitive%2520dysfunction%2520of%2520schizophrenia%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D803%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><a href="http://www.targacept.com/wt/page/pr_1302179429" class="extLink">http://www.targacept.com/wt/page/pr_1302179429</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.targacept.com%2Fwt%2Fpage%2Fpr_1302179429."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Marrero, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazurov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippiello, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span> </span><span class="NLM_article-title">An α7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.109.154633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19786623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1yqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2010&pages=173-180&author=M.+B.+Marreroauthor=R.+Lucasauthor=C.+Saletauthor=T.+A.+Hauserauthor=A.+Mazurovauthor=P.+M.+Lippielloauthor=M.+Bencherif&title=An+%CE%B17+nicotinic+acetylcholine+receptor-selective+agonist+reduces+weight+gain+and+metabolic+changes+in+a+mouse+model+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">An α7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes</span></div><div class="casAuthors">Marrero, Mario B.; Lucas, Rudolf; Salet, Christina; Hauser, Terry A.; Mazurov, Anatoly; Lippiello, Patrick M.; Bencherif, Merouane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-180</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Type 2 diabetes has become a pervasive public health problem.  The etiol. of the disease has not been fully defined but appears to involve abnormalities in peripheral and central nervous system pathways, as well as prominent inflammatory components.  Because nicotinic acetylcholine receptors (nAChRs) are known to interact with anti-inflammatory pathways and have been implicated in control of appetite and body wt., as well as lipid and energy metab., we examd. their role in modulating biol. parameters assocd. with the disease.  In a model of type 2 diabetes, the homozygous leptin-resistant db/db obese mouse, we measured the effects of a novel α7 nAChR-selective agonist [5-methyl-N-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]thiophene-2-carboxamide (TC-7020)] on body mass, glucose and lipid metab., and proinflammatory cytokines.  Oral administration of TC-7020 reduced wt. gain and food intake, reduced elevated glucose and glycated Hb levels, and lowered elevated plasma levels of triglycerides and the proinflammatory cytokine tumor necrosis factor-α.  These changes were reversed by the α7-selective antagonist methyllycaconitine, confirming the involvement of α7 nAChRs.  Prevention of wt. gain, decreased food intake, and normalization of glucose levels were also blocked by the Janus kinase 2 (JAK2) inhibitor α-cyano-(3,4-dihydroxy)-N-benzylcinnamide (AG-490), suggesting that these effects involve linkage of α7 nAChRs to the JAK2-signal transducer and activator of transcription 3 signaling pathway.  The results show that α7 nAChRs play a central role in regulating biol. parameters assocd. with diabetes and support the potential of targeting these receptors as a new therapeutic strategy for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-s_qoP8YnkLVg90H21EOLACvtfcHk0lgnYXnAEoc5_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1yqtg%253D%253D&md5=23c40dfaa67643afc0b04f7c692b24cb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.154633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.154633%26sid%3Dliteratum%253Aachs%26aulast%3DMarrero%26aufirst%3DM.%2BB.%26aulast%3DLucas%26aufirst%3DR.%26aulast%3DSalet%26aufirst%3DC.%26aulast%3DHauser%26aufirst%3DT.%2BA.%26aulast%3DMazurov%26aufirst%3DA.%26aulast%3DLippiello%26aufirst%3DP.%2BM.%26aulast%3DBencherif%26aufirst%3DM.%26atitle%3DAn%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor-selective%2520agonist%2520reduces%2520weight%2520gain%2520and%2520metabolic%2520changes%2520in%2520a%2520mouse%2520model%2520of%2520diabetes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D332%26spage%3D173%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Macor, J.; Wu, E.</span><span> </span><span class="NLM_article-title">Azabicyclic Esters of Carbamic Acids Useful in Therapy</span>. U.S. Patent 5998429,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=J.+Macor&author=E.+Wu&title=Azabicyclic+Esters+of+Carbamic+Acids+Useful+in+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMacor%26aufirst%3DJ.%26atitle%3DAzabicyclic%2520Esters%2520of%2520Carbamic%2520Acids%2520Useful%2520in%2520Therapy%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahagi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span> </span><span class="NLM_article-title">Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective α7 nicotinic receptor agonist SSR180711</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.biopsych.2007.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17601496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCgur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2008&pages=92-97&author=K.+Hashimotoauthor=T.+Ishimaauthor=Y.+Fujitaauthor=M.+Matsuoauthor=T.+Kobashiauthor=M.+Takahagiauthor=H.+Tsukadaauthor=M.+Iyo&title=Phencyclidine-induced+cognitive+deficits+in+mice+are+improved+by+subsequent+subchronic+administration+of+the+novel+selective+%CE%B17+nicotinic+receptor+agonist+SSR180711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711</span></div><div class="casAuthors">Hashimoto, Kenji; Ishima, Tamaki; Fujita, Yuko; Matsuo, Masaaki; Kobashi, Tatsuhiro; Takahagi, Makoto; Tsukada, Hideo; Iyo, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-97</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Accumulating evidence suggests that α7 nicotinic receptor (α7 nAChR) agonists could be potential therapeutic drugs for cognitive deficits in schizophrenia.  The present study was undertaken to examine the effects of the novel selective α7 nAChR agonist SSR180711 on cognitive deficits in mice after repeated administration of the N-methyl-D-aspartate receptor antagonist phencyclidine (PCP).  Methods: Saline or PCP (10 mg/kg/day for 10 days) was administered to mice.  Subsequently, vehicle, SSR180711 (.3 or 3.0 mg/kg/day), SSR180711 (3.0 mg/kg/day) + the selective α7 nAChR antagonist methyllycaconitine (MLA; 3.0 mg/kg/day), or MLA (3.0 mg/kg/day) was administered IP for 2 consecutive weeks.  Twenty-four hours after the final administration, a novel object recognition test was performed.  Results: The PCP-induced cognitive deficits were significantly improved by subsequent subchronic (2-wk) administration of SSR180711 (3.0 mg/kg).  The effects of SSR180711 (3.0 mg/kg) were significantly antagonized by co-administration of MLA (3.0 mg/kg).  Furthermore, Western blot anal. and immunohistochem. revealed that levels of α7 nAChRs in the frontal cortex and hippocampus of the PCP (10 mg/kg/day for 10 days)-treated mice were significantly lower than those of saline-treated mice.  Conclusions: These findings suggest that repeated PCP administration significantly decreased the d. of α7 nAChRs in the brain and that the α7 nAChR agonist SSR180711 could ameliorate cognitive deficits in mice after repeated administration of PCP.  Therefore, α7 nAChR agonists including SSR180711 are potential therapeutic drugs for treating cognitive deficits in schizophrenic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg_FkBDNDWubVg90H21EOLACvtfcHk0lgZ7Wysi1X4WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCgur3L&md5=ba5a9a9c67ed1f7406d232a04a22ccaf</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2007.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2007.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DIshima%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DMatsuo%26aufirst%3DM.%26aulast%3DKobashi%26aufirst%3DT.%26aulast%3DTakahagi%26aufirst%3DM.%26aulast%3DTsukada%26aufirst%3DH.%26aulast%3DIyo%26aufirst%3DM.%26atitle%3DPhencyclidine-induced%2520cognitive%2520deficits%2520in%2520mice%2520are%2520improved%2520by%2520subsequent%2520subchronic%2520administration%2520of%2520the%2520novel%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520agonist%2520SSR180711%26jtitle%3DBiol.%2520Psychiatry%26date%3D2008%26volume%3D63%26spage%3D92%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_contrib-group">Barak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Levie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, I.</span><span> </span><span class="NLM_article-title">Pro-cognitive and antipsychotic efficacy of the <i>α</i>7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1753</span><span class="NLM_x">–</span> <span class="NLM_lpage">1763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1753-1763&author=S.+Barakauthor=M.+Aradauthor=A.+De+Levieauthor=M.+D.+Blackauthor=G.+Griebelauthor=I.+Weiner&title=Pro-cognitive+and+antipsychotic+efficacy+of+the+%CE%B17+nicotinic+partial+agonist+SSR180711+in+pharmacological+and+neurodevelopmental+latent+inhibition+models+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarak%26aufirst%3DS.%26aulast%3DArad%26aufirst%3DM.%26aulast%3DDe%2BLevie%26aufirst%3DA.%26aulast%3DBlack%26aufirst%3DM.%2BD.%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DI.%26atitle%3DPro-cognitive%2520and%2520antipsychotic%2520efficacy%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520partial%2520agonist%2520SSR180711%2520in%2520pharmacological%2520and%2520neurodevelopmental%2520latent%2520inhibition%2520models%2520of%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D1753%26epage%3D1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48c"><span><span class="NLM_contrib-group">Biton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedelec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lochead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jegham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanneau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santamaria, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesney, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debono, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohme, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besnard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oblin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vige, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouquie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souilhac, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueudet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury-Donat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span> </span><span class="NLM_article-title">SSR180711, a novel selective a7 nicotinic receptor partial agonist: (1) binding and functional profile</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=1-16&author=B.+Bitonauthor=O.+Bergisauthor=F.+Galliauthor=A.+Nedelecauthor=A.+Locheadauthor=S.+Jeghamauthor=D.+Godetauthor=C.+Lanneauauthor=R.+Santamariaauthor=F.+Chesneyauthor=J.+Leonardonauthor=P.+Grangerauthor=M.+W.+Debonoauthor=G.+A.+Bohmeauthor=F.+Sgardauthor=F.+Besnardauthor=D.+Grahamauthor=A.+Costeauthor=A.+Oblinauthor=O.+Curetauthor=X.+Vigeauthor=C.+Voltzauthor=L.+Rouquieauthor=J.+Souilhacauthor=V.+Santucciauthor=C.+Gueudetauthor=D.+Franconauthor=R.+Steinbergauthor=G.+Griebelauthor=F.+Oury-Donatauthor=P.+Georgeauthor=P.+Avenetauthor=B.+Scatton&title=SSR180711%2C+a+novel+selective+a7+nicotinic+receptor+partial+agonist%3A+%281%29+binding+and+functional+profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiton%26aufirst%3DB.%26aulast%3DBergis%26aufirst%3DO.%26aulast%3DGalli%26aufirst%3DF.%26aulast%3DNedelec%26aufirst%3DA.%26aulast%3DLochead%26aufirst%3DA.%26aulast%3DJegham%26aufirst%3DS.%26aulast%3DGodet%26aufirst%3DD.%26aulast%3DLanneau%26aufirst%3DC.%26aulast%3DSantamaria%26aufirst%3DR.%26aulast%3DChesney%26aufirst%3DF.%26aulast%3DLeonardon%26aufirst%3DJ.%26aulast%3DGranger%26aufirst%3DP.%26aulast%3DDebono%26aufirst%3DM.%2BW.%26aulast%3DBohme%26aufirst%3DG.%2BA.%26aulast%3DSgard%26aufirst%3DF.%26aulast%3DBesnard%26aufirst%3DF.%26aulast%3DGraham%26aufirst%3DD.%26aulast%3DCoste%26aufirst%3DA.%26aulast%3DOblin%26aufirst%3DA.%26aulast%3DCuret%26aufirst%3DO.%26aulast%3DVige%26aufirst%3DX.%26aulast%3DVoltz%26aufirst%3DC.%26aulast%3DRouquie%26aufirst%3DL.%26aulast%3DSouilhac%26aufirst%3DJ.%26aulast%3DSantucci%26aufirst%3DV.%26aulast%3DGueudet%26aufirst%3DC.%26aulast%3DFrancon%26aufirst%3DD.%26aulast%3DSteinberg%26aufirst%3DR.%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DOury-Donat%26aufirst%3DF.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DSSR180711%252C%2520a%2520novel%2520selective%2520a7%2520nicotinic%2520receptor%2520partial%2520agonist%253A%2520%25281%2529%2520binding%2520and%2520functional%2520profile%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48d"><span><span class="NLM_contrib-group">Pichat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terranova, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueudet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemmelin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury-Donat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span> </span><span class="NLM_article-title">SSR180711, a novel selective a7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=17-34&author=P.+Pichatauthor=O.+E.+Bergisauthor=J.-P.+Terranovaauthor=A.+Uraniauthor=C.+Duarteauthor=V.+Santucciauthor=C.+Gueudetauthor=C.+Voltzauthor=R.+Steinbergauthor=J.+Stemmelinauthor=F.+Oury-Donatauthor=P.+Avenetauthor=G.+Griebelauthor=B.+Scatton&title=SSR180711%2C+a+novel+selective+a7+nicotinic+receptor+partial+agonist%3A+%28II%29+efficacy+in+experimental+models+predictive+of+activity+against+cognitive+symptoms+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPichat%26aufirst%3DP.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DTerranova%26aufirst%3DJ.-P.%26aulast%3DUrani%26aufirst%3DA.%26aulast%3DDuarte%26aufirst%3DC.%26aulast%3DSantucci%26aufirst%3DV.%26aulast%3DGueudet%26aufirst%3DC.%26aulast%3DVoltz%26aufirst%3DC.%26aulast%3DSteinberg%26aufirst%3DR.%26aulast%3DStemmelin%26aufirst%3DJ.%26aulast%3DOury-Donat%26aufirst%3DF.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DSSR180711%252C%2520a%2520novel%2520selective%2520a7%2520nicotinic%2520receptor%2520partial%2520agonist%253A%2520%2528II%2529%2520efficacy%2520in%2520experimental%2520models%2520predictive%2520of%2520activity%2520against%2520cognitive%2520symptoms%2520of%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D17%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Kristensen, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermann, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay-Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, J. D.</span><span> </span><span class="NLM_article-title">The α<sub>7</sub> nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">418</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2007&pages=154-158&author=S.+E.+Kristensenauthor=M.+S.+Thomsenauthor=H.+H.+Hansenauthor=D.+B.+Timmermannauthor=A.+Hay-Schmidtauthor=J.+D.+Mikkelsen&title=The+%CE%B17+nicotinic+receptor+agonist+SSR180711+increases+activity+regulated+cytoskeleton+protein+%28Arc%29+gene+expression+in+the+prefrontal+cortex+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKristensen%26aufirst%3DS.%2BE.%26aulast%3DThomsen%26aufirst%3DM.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BH.%26aulast%3DTimmermann%26aufirst%3DD.%2BB.%26aulast%3DHay-Schmidt%26aufirst%3DA.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520%25CE%25B17%2520nicotinic%2520receptor%2520agonist%2520SSR180711%2520increases%2520activity%2520regulated%2520cytoskeleton%2520protein%2520%2528Arc%2529%2520gene%2520expression%2520in%2520the%2520prefrontal%2520cortex%2520of%2520the%2520rat%26jtitle%3DNeurosci.%2520Lett.%26date%3D2007%26volume%3D418%26spage%3D154%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span>Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer’s Disease. <a href="http://clinicaltrials.gov/ct2/show/NCT00602680" class="extLink">http://clinicaltrials.gov/ct2/show/NCT00602680</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Effect+on+Cognitive+Performance+and+Safety%2FTolerability+of+SSR180711C+in+Mild+Alzheimer%E2%80%99s+Disease.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00602680."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Feuerbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingenhohl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbins, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosbacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozulak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span> </span><span class="NLM_article-title">JN403, in vitro characterization of a novel nicotinic acetylcholine receptor α7 selective agonist</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2007&pages=61-65&author=D.+Feuerbachauthor=K.+Lingenhohlauthor=P.+Dobbinsauthor=J.+Mosbacherauthor=N.+Corbettauthor=J.+Nozulakauthor=D.+Hoyer&title=JN403%2C+in+vitro+characterization+of+a+novel+nicotinic+acetylcholine+receptor+%CE%B17+selective+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeuerbach%26aufirst%3DD.%26aulast%3DLingenhohl%26aufirst%3DK.%26aulast%3DDobbins%26aufirst%3DP.%26aulast%3DMosbacher%26aufirst%3DJ.%26aulast%3DCorbett%26aufirst%3DN.%26aulast%3DNozulak%26aufirst%3DJ.%26aulast%3DHoyer%26aufirst%3DD.%26atitle%3DJN403%252C%2520in%2520vitro%2520characterization%2520of%2520a%2520novel%2520nicotinic%2520acetylcholine%2520receptor%2520%25CE%25B17%2520selective%2520agonist%26jtitle%3DNeurosci.%2520Lett.%26date%3D2007%26volume%3D416%26spage%3D61%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Feuerbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingenhohl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olpe, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassout, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaperon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozulak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span> </span><span class="NLM_article-title">The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=254-263&author=D.+Feuerbachauthor=K.+Lingenhohlauthor=H.-R.+Olpeauthor=A.+Vassoutauthor=C.+Gentschauthor=F.+Chaperonauthor=J.+Nozulakauthor=A.+Enzauthor=G.+Bilbeauthor=K.+McAllisterauthor=D.+Hoyer&title=The+selective+nicotinic+acetylcholine+receptor+%CE%B17+agonist+JN403+is+active+in+animal+models+of+cognition%2C+sensory+gating%2C+epilepsy+and+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeuerbach%26aufirst%3DD.%26aulast%3DLingenhohl%26aufirst%3DK.%26aulast%3DOlpe%26aufirst%3DH.-R.%26aulast%3DVassout%26aufirst%3DA.%26aulast%3DGentsch%26aufirst%3DC.%26aulast%3DChaperon%26aufirst%3DF.%26aulast%3DNozulak%26aufirst%3DJ.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DMcAllister%26aufirst%3DK.%26aulast%3DHoyer%26aufirst%3DD.%26atitle%3DThe%2520selective%2520nicotinic%2520acetylcholine%2520receptor%2520%25CE%25B17%2520agonist%2520JN403%2520is%2520active%2520in%2520animal%2520models%2520of%2520cognition%252C%2520sensory%2520gating%252C%2520epilepsy%2520and%2520pain%26jtitle%3DNeuropharmacology%26date%3D2009%26volume%3D56%26spage%3D254%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Marrero, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatti, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencherif, M.</span><span> </span><span class="NLM_article-title">The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel α7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.103.061655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=14722323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFamtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=16-27&author=M.+B.+Marreroauthor=R.+L.+Papkeauthor=B.+S.+Bhattiauthor=S.+Shawauthor=M.+Bencherif&title=The+neuroprotective+effect+of+2-%283-pyridyl%29-1-azabicyclo%5B3.2.2%5Dnonane+%28TC-1698%29%2C+a+novel+%CE%B17+ligand%2C+is+prevented+through+angiotensin+II+activation+of+a+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel α7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase</span></div><div class="casAuthors">Marrero, Mario B.; Papke, Roger L.; Bhatti, Balwinder S.; Shaw, Sean; Bencherif, Merouane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-27</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have recently provided evidence for nicotine-induced complex formation between the α7 nicotinic acetylcholine receptor (nAChR) and the tyrosine-phosphorylated enzyme Janus kinase 2 (JAK2) that results in subsequent activation of phosphatidyl-inositol-3-kinase (PI-3-K) and Akt.  Nicotine interaction with the α7 nAChR inhibits Aβ (1-42) interaction with the same receptor, and the Aβ (1-42)-induced apoptosis is prevented through nicotine-induced activation of JAK2.  These effects can be shown by measuring markers of cytotoxicity, including the cleavage of the nuclear protein poly(ADP-ribose) polymerase (PARP), the induction of caspase 3, or cell viability.  In this study, we found that 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel α7-selective agonist, exerts neuroprotective effects via activation of the JAK2/PI-3K cascade, which can be neutralized through activation of the angiotensin II (Ang II) AT2 receptor.  Vanadate not only augmented the TC-1698-induced tyrosine phosphorylation of JAK2 but also blocked the Ang II neutralization of TC-1698-induced neuroprotection against Aβ (1-42)-induced cleavage of PARP.  Furthermore, when SHP-1 was neutralized via antisense transfection, the Ang II inhibition of TC-1698-induced neuroprotection against Aβ (1-42) was prevented.  These results support the main hypothesis that states that JAK2 plays a central role in the nicotinic α7 receptor-induced activation of the JAK2-PI-3K cascade in PC12 cells, which ultimately contribute to nAChR-mediated neuroprotection.  Ang II inhibits this pathway through the AT2 receptor activation of the protein tyrosine phosphatase SHP-1.  This study supports central and opposite roles for JAK2 and SHP-1 in the control of apoptosis and α7-mediated neuroprotection in PC12 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAb6D4X0VRgbVg90H21EOLACvtfcHk0lgMYK8nSWOjnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFamtr8%253D&md5=bd5a02ac9b1275210574fe8cbc63946f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.061655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.061655%26sid%3Dliteratum%253Aachs%26aulast%3DMarrero%26aufirst%3DM.%2BB.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DBhatti%26aufirst%3DB.%2BS.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DBencherif%26aufirst%3DM.%26atitle%3DThe%2520neuroprotective%2520effect%2520of%25202-%25283-pyridyl%2529-1-azabicyclo%255B3.2.2%255Dnonane%2520%2528TC-1698%2529%252C%2520a%2520novel%2520%25CE%25B17%2520ligand%252C%2520is%2520prevented%2520through%2520angiotensin%2520II%2520activation%2520of%2520a%2520tyrosine%2520phosphatase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D16%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedza, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottas, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Discovery of 4-(5-methyloxazolo[4,5-<i>b</i>]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel α7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1222-1237&author=C.+J.+O%E2%80%99Donnellauthor=B.+N.+Rogersauthor=B.+S.+Bronkauthor=D.+K.+Bryceauthor=J.+W.+Coeauthor=K.+K.+Cookauthor=A.+J.+Duplantierauthor=E.+Evrardauthor=M.+Haj%C3%B3sauthor=W.+E.+Hoffmannauthor=R.+S.+Hurstauthor=N.+Makladauthor=R.+J.+Matherauthor=S.+McLeanauthor=F.+M.+Nedzaauthor=B.+T.+O%E2%80%99Neillauthor=L.+Pengauthor=W.+Qianauthor=M.+M.+Rottasauthor=S.+B.+Sandsauthor=A.+W.+Schmidtauthor=A.+V.+Shrikhandeauthor=D.+K.+Spracklinauthor=D.+F.+Wongauthor=A.+Zhangauthor=L.+Zhang&title=Discovery+of+4-%285-methyloxazolo%5B4%2C5-b%5Dpyridin-2-yl%29-1%2C4-diazabicyclo%5B3.2.2%5Dnonane+%28CP-810%2C123%29%2C+a+novel+%CE%B17+nicotinic+acetylcholine+receptor+agonist+for+the+treatment+of+cognitive+disorders+in+schizophrenia%3A+synthesis%2C+SAR+development%2C+and+in+vivo+efficacy+in+cognition+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm9015075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015075%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DRottas%26aufirst%3DM.%2BM.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DShrikhande%26aufirst%3DA.%2BV.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%25204-%25285-methyloxazolo%255B4%252C5-b%255Dpyridin-2-yl%2529-1%252C4-diazabicyclo%255B3.2.2%255Dnonane%2520%2528CP-810%252C123%2529%252C%2520a%2520novel%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%2520in%2520schizophrenia%253A%2520synthesis%252C%2520SAR%2520development%252C%2520and%2520in%2520vivo%2520efficacy%2520in%2520cognition%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1222%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrikhande, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedza, F. M.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates: subtype selective, high affinity α7 nicotinic acetylcholine receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4747</span><span class="NLM_x">–</span> <span class="NLM_lpage">4751</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4747-4751&author=C.+J.+O%E2%80%99Donnellauthor=L.+Pengauthor=B.+T.+O%E2%80%99Neillauthor=E.+P.+Arnoldauthor=R.+J.+Matherauthor=S.+B.+Sandsauthor=A.+V.+Shrikhandeauthor=L.+A.+Lebelauthor=D.+K.+Spracklinauthor=F.+M.+Nedza&title=Synthesis+and+SAR+studies+of+1%2C4-diazabicyclo%5B3.2.2%5Dnonane+phenyl+carbamates%3A+subtype+selective%2C+high+affinity+%CE%B17+nicotinic+acetylcholine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DArnold%26aufirst%3DE.%2BP.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DShrikhande%26aufirst%3DA.%2BV.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%25201%252C4-diazabicyclo%255B3.2.2%255Dnonane%2520phenyl%2520carbamates%253A%2520subtype%2520selective%252C%2520high%2520affinity%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4747%26epage%3D4751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Sirota, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabtay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giladi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korczyn, A. D.</span><span> </span><span class="NLM_article-title">Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1176%2Fappi.ajp.157.2.287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=10671405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BD3c7jslOjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2000&pages=287-289&author=P.+Sirotaauthor=T.+Moshevaauthor=H.+Shabtayauthor=N.+Giladiauthor=A.+D.+Korczyn&title=Use+of+the+selective+serotonin+3+receptor+antagonist+ondansetron+in+the+treatment+of+neuroleptic-induced+tardive+dyskinesia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia</span></div><div class="casAuthors">Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn A D</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">287-9</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  The authors examined the efficacy, tolerability, and safety of ondansetron, a selective serotonin 3 receptor antagonist, in patients with tardive dyskinesia.  METHOD:  Twenty patients with schizophrenia who had neuroleptic-induced tardive dyskinesia were given 12 mg/day of ondansetron for 12 weeks in an open-label study.  RESULTS:  Administration of ondansetron resulted in a statistically significant improvement in tardive dyskinesia and psychotic symptoms.  CONCLUSIONS:  Ondansetron may be an effective and safe therapy to control tardive dyskinesia and psychosis in patients with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlRpAcydzdQFHFYivNCdPRfW6udTcc2ebB74z4-9jI3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7jslOjug%253D%253D&md5=1579e3e82f37d414640eeaadf7fc8202</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.157.2.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.157.2.287%26sid%3Dliteratum%253Aachs%26aulast%3DSirota%26aufirst%3DP.%26aulast%3DMosheva%26aufirst%3DT.%26aulast%3DShabtay%26aufirst%3DH.%26aulast%3DGiladi%26aufirst%3DN.%26aulast%3DKorczyn%26aufirst%3DA.%2BD.%26atitle%3DUse%2520of%2520the%2520selective%2520serotonin%25203%2520receptor%2520antagonist%2520ondansetron%2520in%2520the%2520treatment%2520of%2520neuroleptic-induced%2520tardive%2520dyskinesia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2000%26volume%3D157%26spage%3D287%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">CP-810,123, a Third Generation alpha-7 nAChR Agonist for Treatment of Cognitive Deficits Associated with Schizophrenia. Nicotinic Acetylcholine Receptor-Based Therapeutics: Emerging Frontiers in Basic Research & Clinical Science</span>. Presented at the Satellite Meeting to the Society for Neuroscience, Chicago, IL, October 14–16,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+J.+O%E2%80%99Donnell&title=CP-810%2C123%2C+a+Third+Generation+alpha-7+nAChR+Agonist+for+Treatment+of+Cognitive+Deficits+Associated+with+Schizophrenia.+Nicotinic+Acetylcholine+Receptor-Based+Therapeutics%3A+Emerging+Frontiers+in+Basic+Research+%26+Clinical+Science"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DCP-810%252C123%252C%2520a%2520Third%2520Generation%2520alpha-7%2520nAChR%2520Agonist%2520for%2520Treatment%2520of%2520Cognitive%2520Deficits%2520Associated%2520with%2520Schizophrenia.%2520Nicotinic%2520Acetylcholine%2520Receptor-Based%2520Therapeutics%253A%2520Emerging%2520Frontiers%2520in%2520Basic%2520Research%2520%2526%2520Clinical%2520Science%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Tietje, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomme, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brackemeyer, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bury, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curzon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronlien, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfrich, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhaas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molesky, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikkel, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttfarcken, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spies, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waring, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span> </span><span class="NLM_article-title">Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1111%2Fj.1755-5949.2008.00037.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=18482100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVamu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=65-82&author=K.+R.+Tietjeauthor=D.+J.+Andersonauthor=R.+S.+Bitnerauthor=E.+A.+Blommeauthor=P.+J.+Brackemeyerauthor=C.+A.+Briggsauthor=K.+E.+Browmanauthor=D.+Buryauthor=P.+Curzonauthor=K.+U.+Drescherauthor=J.+M.+Frostauthor=R.+H.+Fryerauthor=G.+B.+Foxauthor=G.+H.+Gronlienauthor=M.+H%C3%A5kerudauthor=E.+J.+Gubbinsauthor=S.+Halmauthor=R.+Harrisauthor=R.+J.+Helfrichauthor=K.+L.+Kohlhaasauthor=D.+Lawauthor=J.+Malyszauthor=K.+C.+Marshauthor=R.+L.+Martinauthor=M.+D.+Meyerauthor=A.+L.+Moleskyauthor=A.+L.+Nikkelauthor=S.+Otteauthor=L.+Panauthor=P.+S.+Puttfarckenauthor=R.+J.+Radekauthor=H.+M.+Robbauthor=E.+Spiesauthor=K.+Thorin-Hageneauthor=J.+F.+Waringauthor=H.+Weenauthor=H.+Xuauthor=M.+Gopalakrishnanauthor=W.+H.+Bunnelle&title=Preclinical+characterization+of+A-582941%3A+a+novel+alpha7+neuronal+nicotinic+receptor+agonist+with+broad+spectrum+cognition-enhancing+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of A-582941: a novel α7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties</span></div><div class="casAuthors">Tietje, Karin R.; Anderson, David J.; Bitner, R. Scott; Blomme, Eric A.; Brackemeyer, Paul J.; Briggs, Clark A.; Browman, Kaitlin E.; Bury, Dagmar; Curzon, Peter; Drescher, Karla U.; Frost, Jennifer M.; Fryer, Ryan M.; Fox, Gerard B.; Gronlien, Jens Halvard; Hakerud, Monika; Gubbins, Earl J.; Halm, Sabine; Harris, Richard; Helfrich, Rosalind J.; Kohlhaas, Kathy L.; Law, Devalina; Malysz, John; Marsh, Kennan C.; Martin, Ruth L.; Meyer, Michael D.; Molesky, Angela L.; Nikkel, Arthur L.; Otte, Stephani; Pan, Liping; Puttfarcken, Pamela S.; Radek, Richard J.; Robb, Holly M.; Spies, Eva; Thorin-Hagene, Kirsten; Waring, Jeffrey F.; Ween, Hilde; Xu, Hongyu; Gopalakrishnan, Murali; Bunnelle, William H.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-82</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Among the diverse sets of nicotinic acetylcholine receptors (nAChRs), the α7 subtype is highly expressed in the hippocampus and cortex and is thought to play important roles in a variety of cognitive processes.  In this review, we describe the properties of a novel biaryl diamine α7 nAChR agonist, A-582941.  A-582941 was found to exhibit high-affinity binding and partial agonism at α7 nAChRs, with acceptable pharmacokinetic properties and excellent distribution to the central nervous system (CNS).  In vitro and in vivo studies indicated that A-582941 activates signaling pathways known to be involved in cognitive function such as ERK1/2 and CREB phosphorylation.  A-582941 enhanced cognitive performance in behavioral models that capture domains of working memory, short-term recognition memory, memory consolidation, and sensory gating deficit.  A-582941 exhibited a benign secondary pharmacodynamic and tolerability profile as assessed in a battery of assays of cardiovascular, gastrointestinal, and CNS function.  The studies summarized in this review collectively provide preclin. validation that α7 nAChR agonism offers a mechanism with potential to improve cognitive deficits assocd. with various neurodegenerative and psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojFmrR-kj4_rVg90H21EOLACvtfcHk0lgQ-AScJSonKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVamu7c%253D&md5=1f00bdb6a843a4386f748754ec65f902</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2008.00037.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2008.00037.x%26sid%3Dliteratum%253Aachs%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DBlomme%26aufirst%3DE.%2BA.%26aulast%3DBrackemeyer%26aufirst%3DP.%2BJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DBrowman%26aufirst%3DK.%2BE.%26aulast%3DBury%26aufirst%3DD.%26aulast%3DCurzon%26aufirst%3DP.%26aulast%3DDrescher%26aufirst%3DK.%2BU.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DFryer%26aufirst%3DR.%2BH.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DGronlien%26aufirst%3DG.%2BH.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DGubbins%26aufirst%3DE.%2BJ.%26aulast%3DHalm%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DHelfrich%26aufirst%3DR.%2BJ.%26aulast%3DKohlhaas%26aufirst%3DK.%2BL.%26aulast%3DLaw%26aufirst%3DD.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DMolesky%26aufirst%3DA.%2BL.%26aulast%3DNikkel%26aufirst%3DA.%2BL.%26aulast%3DOtte%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DPuttfarcken%26aufirst%3DP.%2BS.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DRobb%26aufirst%3DH.%2BM.%26aulast%3DSpies%26aufirst%3DE.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DWaring%26aufirst%3DJ.%2BF.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26atitle%3DPreclinical%2520characterization%2520of%2520A-582941%253A%2520a%2520novel%2520alpha7%2520neuronal%2520nicotinic%2520receptor%2520agonist%2520with%2520broad%2520spectrum%2520cognition-enhancing%2520properties%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2008%26volume%3D14%26spage%3D65%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietje, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scanio, M. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Octahydropyrrolo[3,4-<i>c</i>]pyrrole: a diamine scaffold for construction of either α4β2 or α7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4126</span><span class="NLM_x">–</span> <span class="NLM_lpage">4141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900249k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4126-4141&author=W.+H.+Bunnelleauthor=K.+R.+Tietjeauthor=J.+M.+Frostauthor=D.+Petersauthor=J.+Jiauthor=T.+Liauthor=M.+J.+C.+Scanioauthor=L.+Shiauthor=D.+J.+Andersonauthor=T.+Dyhringauthor=J.+H.+Gr%C3%B8nlienauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=M.+D.+Meyer&title=Octahydropyrrolo%5B3%2C4-c%5Dpyrrole%3A+a+diamine+scaffold+for+construction+of+either+%CE%B14%CE%B22+or+%CE%B17-selective+nicotinic+acetylcholine+receptor+%28nAChR%29+ligands.+Substitutions+that+switch+subtype+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm900249k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900249k%26sid%3Dliteratum%253Aachs%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DScanio%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DOctahydropyrrolo%255B3%252C4-c%255Dpyrrole%253A%2520a%2520diamine%2520scaffold%2520for%2520construction%2520of%2520either%2520%25CE%25B14%25CE%25B22%2520or%2520%25CE%25B17-selective%2520nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520ligands.%2520Substitutions%2520that%2520switch%2520subtype%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4126%26epage%3D4141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helfrich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttfarcken, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyhring, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, E. Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermann, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">In vitro pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.110.167072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20504915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyksLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=863-874&author=J.+Malyszauthor=D.+J.+Andersonauthor=J.+H.+Gr%C3%B8nlienauthor=J.+Jiauthor=W.+H.+Bunnelleauthor=M.+H%C3%A5kerudauthor=K.+Thorin-Hageneauthor=H.+Weenauthor=R.+Helfrichauthor=M.+Huauthor=E.+Gubbinsauthor=S.+Gopalakrishnanauthor=P.+S.+Puttfarckenauthor=C.+A.+Briggsauthor=J.+Liauthor=M.+D.+Meyerauthor=T.+Dyhringauthor=P.+K.+Ahringauthor=E.+%C3%98.+Nielsenauthor=D.+Petersauthor=D.+B.+Timmermannauthor=M.+Gopalakrishnan&title=In+vitro+pharmacological+characterization+of+a+novel+selective+%CE%B17+neuronal+nicotinic+acetylcholine+receptor+agonist+ABT-107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107</span></div><div class="casAuthors">Malysz, John; Anderson, David J.; Gronlien, Jens H.; Ji, Jianguo; Bunnelle, William H.; Hakerud, Monika; Thorin-Hagene, Kirten; Ween, Hilde; Helfrich, Rosalind; Hu, Min; Gubbins, Earl; Gopalakrishnan, Sujatha; Puttfarcken, Pamela S.; Briggs, Clark A.; Li, Jinhe; Meyer, Michael D.; Dyhring, Tino; Ahring, Philip K.; Nielsen, Elsebet O.; Peters, Dan; Timmermann, Daniel B.; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">863-874</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Enhancement of α7 nicotinic acetylcholine receptor (nAChR) activity is considered a therapeutic approach for ameliorating cognitive deficits present in Alzheimer's disease and schizophrenia.  In this study, we describe the in vitro profile of a novel selective α7 nAChR agonist, 5-(6-[(3R)-1-azabicyclo[2,2,2]oct-3-yloxy]pyridazin-3-yl)-1H-indole (ABT-107).  ABT-107 displayed high affinity binding to α7 nAChRs [rat or human cortex, [3H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane (A-585539), Ki = 0.2-0.6 nM or [3H]methyllycaconitine (MLA), 7 nM] that was at least 100-fold selective vs. non-α7 nAChRs and other receptors.  Functionally, ABT-107 did not evoke detectable currents in Xenopus oocytes expressing human or nonhuman α3β4, chimeric (α6/α3)β4, or 5-HT3A receptors, and weak or negligible Ca2+ responses in human neuroblastoma IMR-32 cells (α3* function) and human α4β2 and α4β4 nAChRs expressed in human embryonic kidney 293 cells.  ABT-107 potently evoked human and rat α7 nAChR current responses in oocytes (EC50, 50-90 nM total charge, ∼80% normalized to acetylcholine) that were enhanced by the pos. allosteric modulator (PAM) 4-[5-(4-chloro-phenyl)-2-methyl-3-propionyl-pyrrol-1-yl]-benzenesulfonamide (A-867744).  In rat hippocampus, ABT-107 alone evoked α7-like currents, which were inhibited by the α7 antagonist MLA.  In dentate gyrus granule cells, ABT-107 enhanced spontaneous inhibitory postsynaptic current activity when coapplied with A-867744.  In the presence of an α7 PAM [A-867744 or N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride (PNU-120596)], the addn. of ABT-107 elicited MLA-sensitive α7 nAChR-mediated Ca2+ signals in IMR-32 cells and rat cortical cultures and enhanced extracellular signal-regulated kinase phosphorylation in differentiated PC-12 cells.  ABT-107 was also effective in protecting rat cortical cultures against glutamate-induced toxicity.  In summary, ABT-107 is a selective high affinity α7 nAChR agonist suitable for characterizing the roles of this subtype in pharmacol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB9982OSc1h7Vg90H21EOLACvtfcHk0liRI9mH5oyFlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyksLzO&md5=94a0bd94ac57905c97ac20ee33c20cd2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.167072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.167072%26sid%3Dliteratum%253Aachs%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DJi%26aufirst%3DJ.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DHelfrich%26aufirst%3DR.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DGubbins%26aufirst%3DE.%26aulast%3DGopalakrishnan%26aufirst%3DS.%26aulast%3DPuttfarcken%26aufirst%3DP.%2BS.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DDyhring%26aufirst%3DT.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DNielsen%26aufirst%3DE.%2B%25C3%2598.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DTimmermann%26aufirst%3DD.%2BB.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520selective%2520%25CE%25B17%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520ABT-107%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D863%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Bitner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, K. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhaas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markosyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikkel, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">In vivo pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer’s disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.110.167213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20504913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyksLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2010&pages=875-886&author=R.+S.+Bitnerauthor=W.+H.+Bunnelleauthor=M.+W.+Deckerauthor=K.+U.+Drescherauthor=K.+Kohlhaasauthor=S.+Markosyanauthor=K.+C.+Marshauthor=A.+L.+Nikkelauthor=K.+Browmanauthor=R.+Radekauthor=D.+J.+Andersonauthor=J.+Buccafuscoauthor=M.+Gopalakrishnan&title=In+vivo+pharmacological+characterization+of+a+novel+selective+%CE%B17+neuronal+nicotinic+acetylcholine+receptor+agonist+ABT-107%3A+preclinical+considerations+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease</span></div><div class="casAuthors">Bitner, R. Scott; Bunnelle, William H.; Decker, Michael W.; Drescher, Karla U.; Kohlhaas, Kathy L.; Markosyan, Stella; Marsh, Kennan C.; Nikkel, Arthur L.; Browman, Kaitlin; Radek, Rich; Anderson, David J.; Buccafusco, Jerry; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">875-886</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We previously reported that α7 nicotinic acetylcholine receptor (nAChR) agonism produces efficacy in preclin. cognition models correlating with activation of cognitive and neuroprotective signaling pathways assocd. with Alzheimer's disease (AD) pathol.  In the present studies, the selective and potent α7 nAChR agonist 5-(6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl)-1H-indole (ABT-107) was evaluated in behavioral assays representing distinct cognitive domains.  Studies were also conducted to address potential issues that may be assocd. with the clin. development of an α7 nAChR agonist.  Specifically, ABT-107 improved cognition in monkey delayed matching to sample, rat social recognition, and mouse two-trial inhibitory avoidance, and continued to improve cognitive performance at injection times when exposure levels continued to decline.  Rats concurrently infused with ABT-107 and donepezil at steady-state levels consistent with clin. exposure showed improved short-term recognition memory.  Compared with nicotine, ABT-107 did not produce behavioral sensitization in rats or exhibit psychomotor stimulant activity in mice.  Repeated (3 days) daily dosing of ABT-107 increased extracellular cortical acetylcholine in rats, whereas acute administration increased cortical extracellular signal-regulated kinase and cAMP response element-binding protein phosphorylation in mice, neurochem. and biochem. events germane to cognitive function.  ABT-107 increased cortical phosphorylation of the inhibitory residue (Ser9) of glycogen synthase kinase-3, a primary tau kinase assocd. with AD pathol.  In addn., continuous infusion of ABT-107 in tau/amyloid precursor protein transgenic AD mice reduced spinal tau hyperphosphorylation.  These findings show that targeting α7 nAChRs may have potential utility for symptomatic alleviation and slowing of disease progression in the treatment AD, and expand the understanding of the potential therapeutic viability assocd. with the α7 nAChR approach in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJKfAStEXaJrVg90H21EOLACvtfcHk0ljWZgHnlfdfLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyksLzP&md5=28e7f9761561fe6daf6869cb8fdc8529</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.167213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.167213%26sid%3Dliteratum%253Aachs%26aulast%3DBitner%26aufirst%3DR.%2BS.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DDecker%26aufirst%3DM.%2BW.%26aulast%3DDrescher%26aufirst%3DK.%2BU.%26aulast%3DKohlhaas%26aufirst%3DK.%26aulast%3DMarkosyan%26aufirst%3DS.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DNikkel%26aufirst%3DA.%2BL.%26aulast%3DBrowman%26aufirst%3DK.%26aulast%3DRadek%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBuccafusco%26aufirst%3DJ.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DIn%2520vivo%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520selective%2520%25CE%25B17%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520ABT-107%253A%2520preclinical%2520considerations%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D334%26spage%3D875%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surowy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marguerat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H] A-585539 [(1<i>S</i>,4<i>S</i>)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2 azoniabicyclo[2.2.1]heptanes], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.107.130062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17959745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsF2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=179-187&author=D.+J.+Andersonauthor=W.+Bunnelleauthor=B.+Surberauthor=J.+Duauthor=C.+Surowyauthor=E.+Tribolletauthor=A.+Margueratauthor=D.+Bertrandauthor=M.+Gopalakrishnan&title=%5B3H%5D+A-585539+%5B%281S%2C4S%29-2%2C2-dimethyl-5-%286-phenylpyridazin-3-yl%29-5-aza-2+azoniabicyclo%5B2.2.1%5Dheptanes%5D%2C+a+novel+high-affinity+%CE%B17+neuronal+nicotinic+receptor+agonist%3A+radioligand+binding+characterization+to+rat+and+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity α7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain</span></div><div class="casAuthors">Anderson, David J.; Bunnelle, William; Surber, Bruce; Du, Jia; Surowy, Carol; Tribollet, Eliane; Marguerat, Anouk; Bertrand, Daniel; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-187</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Receptor binding was characterized for [3H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane ([3H]A-585539), a selective high-affinity α7 nicotinic acetylcholine receptor (nAChR) agonist with rapid kinetics, low nonspecific binding, and high specific activity.  At 4, the assocn. was monophasic and rapid (t1/2=8.0 min); dissocn. was slower (t1/2=64.2 min).  The Kd in rat brain at 4 was 0.063 nM, whereas at 22 and 37, the Kd values were 0.188 and 0.95 nM, resp.  In contrast, the Bmax (34 fmol/mg protein) was unaffected by temp.  In human cortex, [3H]A-585539 bound with a Kd of 0.066 nM and a Bmax of 5.8 fmol/mg protein at 4, whereas under similar conditions, specific [3H]methyllycaconitine ([3H]MLA) binding was not measurable.  A no. of agonist and antagonist nAChR ligands displaced binding to rat brain membranes with rank order of affinity similar to that for [3H]MLA, and in general, a 5 to 10-fold higher affinity was obsd. for [3H]A-585539 binding.  There was also a good correlation of Ki values between [3H]A-585539 binding to rat brain and human cortex.  The use of a α7/5-hydroxytryptamine type-3 chimera revealed that the N-terminal domain of α7 nAChR was sufficient to faithfully reproduce the pharmacol. of [3H]A-585539 binding.  Autoradiog. studies comparing [3H]A-585539 and [125I]α-bungarotoxin revealed a similar pattern of labeling in the rat.  In summary, [3H]A-585539 was shown to have excellent binding characteristics in rat and human brain and represents the first high-affinity α7 agonist radioligand with utility in the characterization of this important nAChR subtype that is targeted toward ameliorating cognitive deficits underlying neuropsychiatric and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqji4MU_Eu8BrVg90H21EOLACvtfcHk0ljWZgHnlfdfLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsF2hsQ%253D%253D&md5=b7ebce829957073aba16e25cb1d4ee63</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.130062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.130062%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DBunnelle%26aufirst%3DW.%26aulast%3DSurber%26aufirst%3DB.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DSurowy%26aufirst%3DC.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DMarguerat%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3D%255B3H%255D%2520A-585539%2520%255B%25281S%252C4S%2529-2%252C2-dimethyl-5-%25286-phenylpyridazin-3-yl%2529-5-aza-2%2520azoniabicyclo%255B2.2.1%255Dheptanes%255D%252C%2520a%2520novel%2520high-affinity%2520%25CE%25B17%2520neuronal%2520nicotinic%2520receptor%2520agonist%253A%2520radioligand%2520binding%2520characterization%2520to%2520rat%2520and%2520human%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Othman, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awni, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, S.</span><span> </span><span class="NLM_article-title">Single- and multiple-dose pharmacokinetics, safety and tolerability of the selective α7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1177%2F0091270010370460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20495134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1ans7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=512-526&author=A.+A.+Othmanauthor=R.+A.+Lenzauthor=J.+Zhangauthor=J.+Liauthor=W.+M.+Awniauthor=S.+Dutta&title=Single-+and+multiple-dose+pharmacokinetics%2C+safety+and+tolerability+of+the+selective+%CE%B17+neuronal+nicotinic+receptor+agonist%2C+ABT-107%2C+in+healthy+human+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective α7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers</span></div><div class="casAuthors">Othman, Ahmed A.; Lenz, Robert A.; Zhang, Jun; Li, Jianling; Awni, Walid M.; Dutta, Sandeep</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">512-526</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">ABT-107 is a potent, selective α7 nicotinic receptor agonist under development for treatment of Alzheimer's disease and cognitive deficits assocd. with schizophrenia.  The pharmacokinetics, safety, and tolerability of escalating single oral doses (1, 3, 10, 30, 60, 80, and 100 mg; double-blind, placebo-controlled, randomized, incomplete crossover design) and multiple oral doses (2, 6, and 15 mg once daily for 7 days; double-blind, placebo-controlled, randomized, parallel-group design) of ABT-107 were evaluated.  Addnl., effect of food on ABT-107 pharmacokinetics (20-mg single dose) was evaluated using an open-label, 2-period, fasting and nonfasting, randomized, complete crossover design.  ABT-107 exhibited nonlinear (more than dose-proportional) pharmacokinetics.  ABT-107 half-life ranged from 7 to 10 h, and steady state was achieved by day 6 of dosing.  Food did not have a clin. meaningful effect on ABT-107 exposure.  ABT-107 was safe and well tolerated over the tested dose range.  The most frequently reported adverse events were nausea, headache, and tremor following single dosing and somnolence following multiple dosing.  The pharmacokinetics, safety, and tolerability profiles of ABT-107 pose it as a good candidate for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGyLckX0ur-LVg90H21EOLACvtfcHk0liW7T2NH-wRpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1ans7w%253D&md5=a1dc05684f72fbc2a11eb753588e3926</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1177%2F0091270010370460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270010370460%26sid%3Dliteratum%253Aachs%26aulast%3DOthman%26aufirst%3DA.%2BA.%26aulast%3DLenz%26aufirst%3DR.%2BA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DAwni%26aufirst%3DW.%2BM.%26aulast%3DDutta%26aufirst%3DS.%26atitle%3DSingle-%2520and%2520multiple-dose%2520pharmacokinetics%252C%2520safety%2520and%2520tolerability%2520of%2520the%2520selective%2520%25CE%25B17%2520neuronal%2520nicotinic%2520receptor%2520agonist%252C%2520ABT-107%252C%2520in%2520healthy%2520human%2520volunteers%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D51%26spage%3D512%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Haydar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettinetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bothmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncarati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valacchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanaletti, R.</span><span> </span><span class="NLM_article-title">SAR and biological evaluation of SEN12333/WAY-317538: novel alpha 7 nicotinic acetylcholine receptor agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5247</span><span class="NLM_x">–</span> <span class="NLM_lpage">5258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.bmc.2009.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19515567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVyqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=5247-5258&author=S.+N.+Haydarauthor=C.+Ghironauthor=L.+Bettinettiauthor=H.+Bothmannauthor=T.+A.+Comeryauthor=J.+Dunlopauthor=S.+La+Rosaauthor=I.+Miccoauthor=M.+Pollastriniauthor=J.+Quinnauthor=R.+Roncaratiauthor=C.+Scaliauthor=M.+Valacchiauthor=M.+Varroneauthor=R.+Zanaletti&title=SAR+and+biological+evaluation+of+SEN12333%2FWAY-317538%3A+novel+alpha+7+nicotinic+acetylcholine+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist</span></div><div class="casAuthors">Haydar, Simon N.; Ghiron, Chiara; Bettinetti, Laura; Bothmann, Hendrick; Comery, Thomas A.; Dunlop, John; La Rosa, Salvatore; Micco, Iolanda; Pollastrini, Martina; Quinn, Joanna; Roncarati, Renza; Scali, Carla; Valacchi, Michela; Varrone, Maurizio; Zanaletti, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5247-5258</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alpha 7 nicotinic acetylcholine receptor (α7 nAChR) agonists are promising therapeutic candidates for the treatment of cognitive impairment assocd. with a variety of disorders including Alzheimer's disease and schizophrenia.  Alpha 7 nAChRs are expressed in brain regions assocd. with cognitive function, regulate cholinergic neurotransmission and have been shown to be down regulated in both schizophrenia and Alzheimer's disease.  Herein we report a novel, potent small mol. agonist of the alpha 7 nAChR, SEN12333/WAY-317538.  This compd. is a selective agonist of the α7 nAChR with excellent in vitro and in vivo profiles, excellent brain penetration and oral bioavailability, and demonstrates in vivo efficacy in multiple behavioral cognition models.  The SAR and biol. evaluation of this series of compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyFjYGluXw3bVg90H21EOLACvtfcHk0liW7T2NH-wRpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVyqsrk%253D&md5=293ee7e518e64386330cfde5ca72c584</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DHaydar%26aufirst%3DS.%2BN.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DBettinetti%26aufirst%3DL.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DValacchi%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DZanaletti%26aufirst%3DR.%26atitle%3DSAR%2520and%2520biological%2520evaluation%2520of%2520SEN12333%252FWAY-317538%253A%2520novel%2520alpha%25207%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D5247%26epage%3D5258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Roncarati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bothmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianfriddo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanelli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terstappen, G. C.</span><span> </span><span class="NLM_article-title">Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.108.150094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19223665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Omu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=459-468&author=R.+Roncaratiauthor=C.+Scaliauthor=T.+A.+Comeryauthor=S.+M.+Grauerauthor=S.+Aschmiesauthor=H.+Bothmannauthor=B.+Jowauthor=D.+Kowalauthor=M.+Gianfriddoauthor=C.+Kelleyauthor=U.+Zanelliauthor=C.+Ghironauthor=S.+Haydarauthor=J.+Dunlopauthor=G.+C.+Terstappen&title=Procognitive+and+neuroprotective+activity+of+a+novel+alpha7+nicotinic+acetylcholine+receptor+agonist+for+treatment+of+neurodegenerative+and+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Procognitive and neuroprotective activity of a novel α7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders</span></div><div class="casAuthors">Roncarati, Renza; Scali, Carla; Comery, Thomas A.; Grauer, Steven M.; Aschmi, Suzan; Bothmann, Hendrick; Jow, Brian; Kowal, Dianne; Gianfriddo, Marco; Kelley, Cody; Zanelli, Ugo; Ghiron, Chiara; Haydar, Simon; Dunlop, John; Terstappen, Georg C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">459-468</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The α7 nicotinic acetylcholine receptor (nAChR) is a promising target for treatment of cognitive dysfunction assocd. with Alzheimer's disease and schizophrenia.  Here, we report the pharmacol. properties of 5-morpholin-4-yl-pentanoic acid (4-pyridin-3-yl-phenyl)-amide [SEN12333 (WAY-317538)], a novel selective agonist of α7 nAChR.  SEN12333 shows high affinity for the rat α7 receptor expressed in GH4C1 cells (Ki = 260 nM) and acts as full agonist in functional Ca2+ flux studies (EC50 = 1.6 μM).  In whole-cell patch-clamp recordings, SEN12333 activated peak currents and maximal total charges similar to acetylcholine (EC50 = 12 μM).  The compd. did not show agonist activity at other nicotinic receptors tested and acted as a weak antagonist at α3-contg. receptors.  SEN12333 treatment (3 mg/kg i.p.) improved episodic memory in a novel object recognition task in rats in conditions of spontaneous forgetting as well as cognitive disruptions induced via glutamatergic [5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate); MK-801] or cholinergic (scopolamine) mechanisms.  This improvement was blocked by the α7-selective antagonist methyllycaconitine, indicating that it is mediated by α7 activation.  SEN12333 also prevented a scopolamine-induced deficit in a passive avoidance task.  In models targeting other cognitive domains, including attention and perceptual processing, SEN12333 normalized the apomorphine-induced deficit of prepulse inhibition.  Neuroprotection of SEN12333 was demonstrated in quisqualate-lesioned animals in which treatment with SEN12333 (3 mg/kg/day i.p.) resulted in a significant protection of choline acetyltransferase-pos. neurons in the lesioned hemisphere.  Cumulatively, our results demonstrate that the novel α7 nAChR agonist SEN12333 has procognitive and neuroprotective properties, further demonstrating utility of α7 agonists for treatment of neurodegenerative and cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Bj3oVp7W5bVg90H21EOLACvtfcHk0lgPtHh-OrTN2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Omu74%253D&md5=66ee7b7cc3ff6b926388e960653841de</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.150094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.150094%26sid%3Dliteratum%253Aachs%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DJow%26aufirst%3DB.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DGianfriddo%26aufirst%3DM.%26aulast%3DKelley%26aufirst%3DC.%26aulast%3DZanelli%26aufirst%3DU.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DHaydar%26aufirst%3DS.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26atitle%3DProcognitive%2520and%2520neuroprotective%2520activity%2520of%2520a%2520novel%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%2520agonist%2520for%2520treatment%2520of%2520neurodegenerative%2520and%2520cognitive%2520disorders%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D459%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. K.</span><span> </span><span class="NLM_article-title">Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1002%2F%28SICI%291098-1128%28199605%2916%3A3%3C243%3A%3AAID-MED2%3E3.0.CO%3B2-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=8727426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADyaK28XivFWktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=243-266&author=D.+A.+Smithauthor=B.+C.+Jonesauthor=D.+K.+Walker&title=Design+of+drugs+involving+the+concepts+and+theories+of+drug+metabolism+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics</span></div><div class="casAuthors">Smith, Dennis A.; Jones, Barry C.; Walker, Donald K.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-266</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review with 53 refs.  Drug metab. input to the discovery process has historically been on an empirical case-by-case basis, since, detailed descriptors of the effect on pharmacokinetics of a change in structure or physicochem. property were not available.  Considerable advances have been made in recent years, such that basic rules can be applied to predict the behavior of a compd. in man based on physicochem. and structure.  This is particularly true in the areas of absorption, distribution, and clearance.  In particular, knowledge of the reactions catalyzed by the enzymes of drug metab., including the cytochrome P 450 super family, can be used in the design of new chem. entities, together with the usual pharmacol.-derived SAR.  The combination of both pharmacokinetics and pharmacodynamics at the discovery stage leads to drugs with optimum performance characteristics.  Such drugs are easier to develop, representing a huge savings in resources.  Moreover, the marketed compd. is much more likely to find high clin. utilization.  This review uses dofetilide, fluconazole, and amlodipine to highlight the multifaceted consequences of changing chem. structure, in terms of drug disposition, and reinforces these principles with examples from the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIC1k-4nTJxLVg90H21EOLACvtfcHk0lgPtHh-OrTN2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFWktL8%253D&md5=f6ada0fe124832faf614ab7116a31412</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199605%2916%3A3%3C243%3A%3AAID-MED2%3E3.0.CO%3B2-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199605%252916%253A3%253C243%253A%253AAID-MED2%253E3.0.CO%253B2-Z%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DDesign%2520of%2520drugs%2520involving%2520the%2520concepts%2520and%2520theories%2520of%2520drug%2520metabolism%2520and%2520pharmacokinetics%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1996%26volume%3D16%26spage%3D243%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bothmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaldo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocconcelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nencini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncarati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terstappen, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turlizzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valacchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varrone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanaletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanelli, U.</span><span> </span><span class="NLM_article-title">Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4379</span><span class="NLM_x">–</span> <span class="NLM_lpage">4389</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901692q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFKqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4379-4389&author=C.+Ghironauthor=S.+N.+Haydarauthor=S.+Aschmiesauthor=H.+Bothmannauthor=C.+Castaldoauthor=G.+Cocconcelliauthor=T.+A.+Comeryauthor=L.+Diauthor=J.+Dunlopauthor=T.+Lockauthor=A.+Kramerauthor=D.+Kowalauthor=F.+Jowauthor=S.+Grauerauthor=B.+Harrisonauthor=S.+La+Rosaauthor=L.+Maccariauthor=K.+L.+Marquisauthor=I.+Miccoauthor=A.+Nenciniauthor=J.+Quinnauthor=A.+J.+Robichaudauthor=R.+Roncaratiauthor=C.+Scaliauthor=G.+C.+Terstappenauthor=E.+Turlizziauthor=M.+Valacchiauthor=M.+Varroneauthor=R.+Zanalettiauthor=U.+Zanelli&title=Novel+alpha-7+nicotinic+acetylcholine+receptor+agonists+containing+a+urea+moiety%3A+identification+and+characterization+of+the+potent%2C+selective%2C+and+orally+efficacious+agonist+1-%5B6-%284-fluorophenyl%29pyridin-3-yl%5D-3-%284-piperidin-1-ylbutyl%29+urea+%28SEN34625%2FWYE-103914%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonists Containing a Urea Moiety: Identification and Characterization of the Potent, Selective, and Orally Efficacious Agonist 1-[6-(4-Fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) Urea (SEN34625/WYE-103914)</span></div><div class="casAuthors">Ghiron, Chiara; Haydar, Simon N.; Aschmies, Suzan; Bothmann, Hendrick; Castaldo, Cristiana; Cocconcelli, Giuseppe; Comery, Thomas A.; Di, Li; Dunlop, John; Lock, Tim; Kramer, Angela; Kowal, Dianne; Jow, Flora; Grauer, Steve; Harrison, Boyd; La Rosa, Salvatore; Maccari, Laura; Marquis, Karen L.; Micco, Iolanda; Nencini, Arianna; Quinn, Joanna; Robichaud, Albert J.; Roncarati, Renza; Scali, Carla; Terstappen, Georg C.; Turlizzi, Elisa; Valacchi, Michela; Varrone, Maurizio; Zanaletti, Riccardo; Zanelli, Ugo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4379-4389</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alpha-7 nicotinic acetylcholine receptor (α7 nAChR) agonists are promising therapeutic candidates for the treatment of cognitive impairment.  We report a series of novel, potent small mol. agonists (4-18) of the α7 nAChR deriving from our continuing efforts in the areas of Alzheimer's disease and schizophrenia.  One of the compds. of the series contg. a urea moiety (16)(I) was further shown to be a selective agonist of the α7 nAChR with excellent in vitro and in vivo profiles, brain penetration, and oral bioavailability and demonstrated in vivo efficacy in multiple behavioral cognition models.  Structural modifications leading to the improved selectivity profile and the biol. evaluation of this series of compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlg-l6HJigrrVg90H21EOLACvtfcHk0ljyf9mJ0i1XAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFKqt70%253D&md5=f15ad80636d6ba345752ce1ddc7be15b</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm901692q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901692q%26sid%3Dliteratum%253Aachs%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DHaydar%26aufirst%3DS.%2BN.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DBothmann%26aufirst%3DH.%26aulast%3DCastaldo%26aufirst%3DC.%26aulast%3DCocconcelli%26aufirst%3DG.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DJow%26aufirst%3DF.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DLa%2BRosa%26aufirst%3DS.%26aulast%3DMaccari%26aufirst%3DL.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DMicco%26aufirst%3DI.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DRoncarati%26aufirst%3DR.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26aulast%3DTurlizzi%26aufirst%3DE.%26aulast%3DValacchi%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DM.%26aulast%3DZanaletti%26aufirst%3DR.%26aulast%3DZanelli%26aufirst%3DU.%26atitle%3DNovel%2520alpha-7%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%2520containing%2520a%2520urea%2520moiety%253A%2520identification%2520and%2520characterization%2520of%2520the%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520agonist%25201-%255B6-%25284-fluorophenyl%2529pyridin-3-yl%255D-3-%25284-piperidin-1-ylbutyl%2529%2520urea%2520%2528SEN34625%252FWYE-103914%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4379%26epage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanthorn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J. C.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>3</sub> antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=319-321&author=J.+E.+Macorauthor=D.+Gurleyauthor=T.+Lanthornauthor=J.+Lochauthor=R.+A.+Mackauthor=G.+Mullenauthor=O.+Tranauthor=N.+Wrightauthor=J.+C.+Gordon&title=The+5-HT3+antagonist+tropisetron+%28ICS+205-930%29+is+a+potent+and+selective+%CE%B17+nicotinic+receptor+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DGurley%26aufirst%3DD.%26aulast%3DLanthorn%26aufirst%3DT.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DMack%26aufirst%3DR.%2BA.%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DO.%26aulast%3DWright%26aufirst%3DN.%26aulast%3DGordon%26aufirst%3DJ.%2BC.%26atitle%3DThe%25205-HT3%2520antagonist%2520tropisetron%2520%2528ICS%2520205-930%2529%2520is%2520a%2520potent%2520and%2520selective%2520%25CE%25B17%2520nicotinic%2520receptor%2520partial%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D319%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Pitsikas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span> </span><span class="NLM_article-title">Different effects of tropisetron and ondansetron in learning and memory paradigms</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1997&pages=571-576&author=N.+Pitsikasauthor=F.+Borsini&title=Different+effects+of+tropisetron+and+ondansetron+in+learning+and+memory+paradigms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPitsikas%26aufirst%3DN.%26aulast%3DBorsini%26aufirst%3DF.%26atitle%3DDifferent%2520effects%2520of%2520tropisetron%2520and%2520ondansetron%2520in%2520learning%2520and%2520memory%2520paradigms%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1997%26volume%3D56%26spage%3D571%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span> </span><span class="NLM_article-title">Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of α7 nicotinic receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">553</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.ejphar.2006.09.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17094961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2006&pages=191-195&author=K.+Hashimotoauthor=Y.+Fujitaauthor=T.+Ishimaauthor=H.+Hagiwaraauthor=M.+Iyo&title=Phencyclidine-induced+cognitive+deficits+in+mice+are+improved+by+subsequent+subchronic+administration+of+tropisetron%3A+role+of+%CE%B17+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: Role of α7 nicotinic receptors</span></div><div class="casAuthors">Hashimoto, Kenji; Fujita, Yuko; Ishima, Tamaki; Hagiwara, Hiroko; Iyo, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">191-195</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the effects of tropisetron, a 5-hydroxytryptamine (5-HT3) receptor antagonist and α7 nicotinic receptor agonist, on cognitive deficits in mice after repeated administration of the NMDA receptor antagonist phencyclidine (PCP).  PCP (10 mg/kg/day for 10 days)-induced cognitive deficits were significantly improved by subsequent subchronic (2 wk) administration of tropisetron, but not ondansetron.  Effects of tropisetron were significantly antagonized by co-administration of the α7 nicotinic receptor antagonist methyllycaconitine, suggesting the role of α7 nicotinic receptors in the active mechanisms of tropisetron.  These findings suggest that tropisetron could be a potential therapeutic drug for cognitive deficits in schizophrenic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxLAYuAtrF7rVg90H21EOLACvtfcHk0lgKGDhI2Sw9NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bI&md5=08620f954d8484fcf2076b7747c5b046</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DIshima%26aufirst%3DT.%26aulast%3DHagiwara%26aufirst%3DH.%26aulast%3DIyo%26aufirst%3DM.%26atitle%3DPhencyclidine-induced%2520cognitive%2520deficits%2520in%2520mice%2520are%2520improved%2520by%2520subsequent%2520subchronic%2520administration%2520of%2520tropisetron%253A%2520role%2520of%2520%25CE%25B17%2520nicotinic%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D553%26spage%3D191%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Shiina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niitsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haraguch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span> </span><span class="NLM_article-title">A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia</span> <span class="citation_source-journal">Ann. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1186%2F1744-859X-9-27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20573264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BC3cnmtFKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=27&author=A.+Shiinaauthor=Y.+Shirayamaauthor=T.+Niitsuauthor=T.+Hashimotoauthor=T.+Yoshidaauthor=T.+Hasegawaauthor=T.+Haraguchauthor=N.+Kanaharaauthor=T.+Shiraishiauthor=M.+Fujisakiauthor=G.+Fukamiauthor=M.+Nakazatoauthor=M.+Iyoauthor=K.+Hashimoto&title=A+randomised%2C+double-blind%2C+placebo-controlled+trial+of+tropisetron+in+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia</span></div><div class="casAuthors">Shiina Akihiro; Shirayama Yukihiko; Niitsu Tomihisa; Hashimoto Tasuku; Yoshida Taisuke; Hasegawa Tadashi; Haraguchi Tadashi; Kanahara Nobuhisa; Shiraishi Tetsuya; Fujisaki Mihisa; Fukami Goro; Nakazato Michiko; Iyo Masaomi; Hashimoto Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Annals of general psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Cognitive deficits in schizophrenia are associated with psychosocial deficits that are primarily responsible for the poor long-term outcome of this disease.  Auditory sensory gating P50 deficits are correlated with neuropsychological deficits in attention, one of the principal cognitive disturbances in schizophrenia.  Our studies suggest that the alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist tropisetron might be a potential therapeutic drug for cognitive deficits in schizophrenia.  Therefore, it is of particular interest to investigate the effects of tropisetron on the cognitive deficits in patients with schizophrenia.  METHODS:  A randomised, placebo-controlled trial of tropisetron in patients with schizophrenia was performed.  A total of 40 patients with chronic schizophrenia who had taken risperidone (2 to 6 mg/day) were enrolled.  Subjects were randomly assigned to a fixed titration of tropisetron (n = 20, 10 mg/day) or placebo (n = 20) in an 8-week double-blind trial.  Auditory sensory gating P50 deficits and Quality of Life Scale (QLS), Cambridge Neuropsychological Test Automated Battery (CANTAB), and Positive and Negative Syndrome Scale (PANSS) scores were measured.  RESULTS:  In all, 33 patients completed the trial.  Tropisetron was well tolerated.  Administration of tropisetron, but not placebo, significantly improved auditory sensory gating P50 deficits in non-smoking patients with schizophrenia.  The score on the rapid visual information processing (sustained visual attention) task of CANTAB was significantly improved by tropisetron treatment.  Total and subscale scores of PANSS were not changed by this trial.  QLS scores in the all patients, but not non-smoking patients, were significantly improved by tropisetron trial.  CONCLUSIONS:  This first randomised, double-blind, placebo-controlled trial supports the safety and efficacy of adjunctive tropisetron for treatment of cognitive deficits in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZVVObPCY7NB0LsK7uFuY7fW6udTcc2ebQMGMBMQbkkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnmtFKhsw%253D%253D&md5=ba0cf0cbfd6891364378133f24a40c2b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1186%2F1744-859X-9-27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-859X-9-27%26sid%3Dliteratum%253Aachs%26aulast%3DShiina%26aufirst%3DA.%26aulast%3DShirayama%26aufirst%3DY.%26aulast%3DNiitsu%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DHaraguch%26aufirst%3DT.%26aulast%3DKanahara%26aufirst%3DN.%26aulast%3DShiraishi%26aufirst%3DT.%26aulast%3DFujisaki%26aufirst%3DM.%26aulast%3DFukami%26aufirst%3DG.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DIyo%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DA%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520of%2520tropisetron%2520in%2520patients%2520with%2520schizophrenia%26jtitle%3DAnn.%2520Gen.%2520Psychiatry%26date%3D2010%26volume%3D9%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span>Presented at the Congress of the European League against Rheumatism, Stockholm, Sweden, Jun 12–15,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>AB0285.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Presented+at+the+Congress+of+the+European+League+against+Rheumatism%2C+Stockholm%2C+Sweden%2C+Jun+12%E2%80%9315%2C+2002%3B+AB0285."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Stratz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W.</span><span> </span><span class="NLM_article-title">Treatment of tendopathies with tropisetron</span> <span class="citation_source-journal">Rheumatol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1007%2Fs00296-002-0233-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=12426658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFWlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=219-221&author=T.+Stratzauthor=B.+Vargaauthor=W.+Muller&title=Treatment+of+tendopathies+with+tropisetron"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of tendopathies with tropisetron</span></div><div class="casAuthors">Stratz, Thomas; Varga, Boglarka; Mueller, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">219-221</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A comparison between a local anesthetic drug and the 5-hydroxytryptamine 3 (5-HT3) receptor antagonist tropisetron in treating tendopathies or periarthropathies revealed that tropisetron has a longer effect on resting pain and pain on movement than the local anesthetic drug.  The most likely explanation for this effect probably is a blocking of stimulated 5-HT3 receptors at the nociceptors in conjunction with an inhibited release of substance P and other neurokines because of this blockage.  Further studies will have to show whether the action of tropisetron in tendopathies is as favorable as that of corticosteroids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ0-OP3htQ6rVg90H21EOLACvtfcHk0lhMJYjID0vkfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFWlsb8%253D&md5=87ab7eca5dd56d64a957b23f6be7e0d1</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1007%2Fs00296-002-0233-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-002-0233-8%26sid%3Dliteratum%253Aachs%26aulast%3DStratz%26aufirst%3DT.%26aulast%3DVarga%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DW.%26atitle%3DTreatment%2520of%2520tendopathies%2520with%2520tropisetron%26jtitle%3DRheumatol.%2520Int.%26date%3D2002%26volume%3D22%26spage%3D219%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span>Presented at the Congress of the European League against Rheumatism, Stockholm, Sweden, Jun 12–15,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>FRI0060.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Presented+at+the+Congress+of+the+European+League+against+Rheumatism%2C+Stockholm%2C+Sweden%2C+Jun+12%E2%80%9315%2C+2002%3B+FRI0060."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Späth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kötter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amberger, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haus, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Färber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, W.</span><span> </span><span class="NLM_article-title">Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia</span> <span class="citation_source-journal">Scand. J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1080%2F03009740410005818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=15370724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BD2crjslWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2004&pages=267-270&author=M.+Sp%C3%A4thauthor=T.+Stratzauthor=G.+Neeckauthor=I.+K%C3%B6tterauthor=B.+Hammelauthor=C.+C.+Ambergerauthor=U.+Hausauthor=L.+F%C3%A4rberauthor=D.+Pongratzauthor=W.+M%C3%BCller&title=Efficacy+and+tolerability+of+intravenous+tropisetron+in+the+treatment+of+fibromyalgia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia</span></div><div class="casAuthors">Spath M; Stratz T; Neeck G; Kotter I; Hammel B; Amberger C C; Haus U; Farber L; Pongratz D; Muller W</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian journal of rheumatology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-70</span>
        ISSN:<span class="NLM_cas:issn">0300-9742</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine the efficacy of a serotonin receptor (5-HT(3)) antagonist in the treatment of fibromyalgia (FM) in a prospective, randomized, double-blind, placebo-controlled, multicentre trial.  METHODS:  Twenty-one female patients (age 21-63 years) with FM according to the American College of Rheumatology classification criteria for FM were assigned randomly to either a placebo group or to receive a daily intravenous bolus injection of 5 mg tropisetron for 5 days.  RESULTS:  In patients receiving tropisetron, the visual analogue scale (VAS) score for pain decreased by 28.9 compared with a decrease of 6.8 in the placebo group [probability (p)=0.063; effect size: 0.794].  Similar results were obtained using a body diagram pain score as a secondary efficacy parameter: mean pain reduction was 27.2 in the tropisetron group, versus 2.8 in the placebo group (p=0.038; effect size: 0.902).  CONCLUSION:  5-HT(3) receptor antagonists provide significant pain relief for a group of FM patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2fWozIaO1lZVVjGoY74BafW6udTcc2ea_uYM37WkBvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crjslWhtg%253D%253D&md5=85495ff408009f1bbf9fe6090cf3ae14</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1080%2F03009740410005818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03009740410005818%26sid%3Dliteratum%253Aachs%26aulast%3DSp%25C3%25A4th%26aufirst%3DM.%26aulast%3DStratz%26aufirst%3DT.%26aulast%3DNeeck%26aufirst%3DG.%26aulast%3DK%25C3%25B6tter%26aufirst%3DI.%26aulast%3DHammel%26aufirst%3DB.%26aulast%3DAmberger%26aufirst%3DC.%2BC.%26aulast%3DHaus%26aufirst%3DU.%26aulast%3DF%25C3%25A4rber%26aufirst%3DL.%26aulast%3DPongratz%26aufirst%3DD.%26aulast%3DM%25C3%25BCller%26aufirst%3DW.%26atitle%3DEfficacy%2520and%2520tolerability%2520of%2520intravenous%2520tropisetron%2520in%2520the%2520treatment%2520of%2520fibromyalgia%26jtitle%3DScand.%2520J.%2520Rheumatol.%26date%3D2004%26volume%3D33%26spage%3D267%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Stratz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W.</span><span> </span><span class="NLM_article-title">Beeinflusst die depressivität den behandlungseffekt von tropisetron bei fibromyalgiepatienten?</span> <span class="citation_source-journal">Z. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1007%2Fs00393-003-0418-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=12624803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BD3s7htFKltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2003&pages=42-45&author=T.+Stratzauthor=B.+Vargaauthor=W.+Muller&title=Beeinflusst+die+depressivit%C3%A4t+den+behandlungseffekt+von+tropisetron+bei+fibromyalgiepatienten%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia</span></div><div class="casAuthors">Stratz T; Varga B; Muller W</div><div class="citationInfo"><span class="NLM_cas:title">Zeitschrift fur Rheumatologie</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-5</span>
        ISSN:<span class="NLM_cas:issn">0340-1855</span>.
    </div><div class="casAbstract">As described elsewhere the oral administration of 5 mg of the 5-HT3-receptor-antagonist Tropisetron in fibromyalgia exhibited less amelioration of pain in patients with a depression in comparison to patients without depression.  Since an intravenous treatment seems to increase the effect of Tropisetron, the question arises whether patients with depression profit from the intravenous therapy.  Methods 68 out patients with fibromyalgia according to ACR-criteria were enrolled in the study.  The patients filled in a VAS pain and the Beck Depression Inventory (BDI) before and after a bolus i.v. injection of 5 mg Tropisetron for 5 days [Beck AT, Steer Ra.  Beck-Depression-Inventory (BDI) In: Hautzinger M (Hrsg der dt.  Ausg.).  Testhandbuch. 1.  Auflage Bern: Verlag Hans Huber, 1994].  In the beginning the patients had to have > or = 40 mm in the VAS pain from 0-100 mm.  The patients were divided into three groups: group 1 = patients with a BDI<19 without experience with antidepressive drugs (n=26); group 2=patients with a BDI > or = 19 (n=22) and negative experience with antidepressive substances, and group 3=patients with a BDI > or = 19 and an accompanying antidepressant drug therapy and some benefit under this therapy (n=20).  Results Before the therapy there was no significant difference in VAS pain in the groups, but in BDI there was a significant difference between group 1 (BDI mean value 11.5) in comparison to group 2 (BDI mean value 26.1) and group 3 (BDI mean value 24.8).  After therapy all three groups had a significant amelioration of pain: group 1: p=0.000023; group 2: p=0.00073; group 3: p=0.0145.  There was a significant difference between the group with BDI<19 and the group with antidepressant drug in amelioration of pain (p=0.044).  A significant correlation was found in group 2 with Beck > or = 19 between amelioration of pain and BDI after therapy (p=0.008, r=0.666).  In this group a pain-reactive depression and in group 3 an endogenous depression must be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXhHpj_bX0ZLxanA7vODO6fW6udTcc2eaR6hWYoAI5prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7htFKltg%253D%253D&md5=1f17b5e599847f718959f7e0a8b6abf9</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00393-003-0418-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00393-003-0418-x%26sid%3Dliteratum%253Aachs%26aulast%3DStratz%26aufirst%3DT.%26aulast%3DVarga%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DW.%26atitle%3DBeeinflusst%2520die%2520depressivit%25C3%25A4t%2520den%2520behandlungseffekt%2520von%2520tropisetron%2520bei%2520fibromyalgiepatienten%253F%26jtitle%3DZ.%2520Rheumatol.%26date%3D2003%26volume%3D62%26spage%3D42%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span>Presented at the Congress of the European League against Rheumatism, Stockholm, Sweden, Jun 12–15,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>FRI0032.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Presented+at+the+Congress+of+the+European+League+against+Rheumatism%2C+Stockholm%2C+Sweden%2C+Jun+12%E2%80%9315%2C+2002%3B+FRI0032."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Cui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suemaru, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohnomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, H.</span><span> </span><span class="NLM_article-title">Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">609</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2Fj.ejphar.2008.12.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19374878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslyht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=609&publication_year=2009&pages=74-77&author=R.+Cuiauthor=K.+Suemaruauthor=B.+Liauthor=S.+Kohnomiauthor=H.+Araki&title=Tropisetron+attenuates+naloxone-induced+place+aversion+in+single-dose+morphine-treated+rats%3A+role+of+alpha7+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: Role of α7 nicotinic receptors</span></div><div class="casAuthors">Cui, Ranji; Suemaru, Katsuya; Li, Bingjin; Kohnomi, Shuntaro; Araki, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">609</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">74-77</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously reported that acute dependence can occur when naloxone is administered 24 h after even a single dose of morphine, and that nicotine attenuates this naloxone-pptd. withdrawal syndrome.  In the present study, we studied the effect of tropisetron, an α7 nicotinic receptor agonist and 5-hydroxytryptamine 3 (5-HT3) receptor antagonist, on place aversion induced by naloxone in morphine-treated rats.  Place aversion was significantly attenuated by pre-administered tropisetron (1.0 and 2.0 mg/kg, i. p.) in a dose-dependent manner, however tropisetron alone had no effect in a place-conditioning paradigm.  This attenuation was completely antagonized by mecamylamine (1.0 mg/kg, s.c.), which is a central nicotinic receptor antagonist, but not by ondansetron (0.3 and 1.0 mg/kg, s.c.), a 5-HT3 receptor antagonist.  Furthermore, methyllycaconitine (1.0 and 2.0 mg/kg, s.c.), an α7 nicotinic acetylcholine receptor antagonist, but not dihydroxy-β-erithroidine (1.0 and 2.0 mg/kg, s.c.), an α4β2 nicotinic acetylcholine receptor antagonist, also antagonized the inhibitory effect of tropisetron.  These findings suggest that tropisetron attenuates place aversion induced by naloxone in single-dose morphine-treated rats via α7 nicotinic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm_zWF7RxYibVg90H21EOLACvtfcHk0lh1BXHgCuZoWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslyht7w%253D&md5=24d6a5f950a95f725be2508205091224</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.12.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.12.051%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DR.%26aulast%3DSuemaru%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKohnomi%26aufirst%3DS.%26aulast%3DAraki%26aufirst%3DH.%26atitle%3DTropisetron%2520attenuates%2520naloxone-induced%2520place%2520aversion%2520in%2520single-dose%2520morphine-treated%2520rats%253A%2520role%2520of%2520alpha7%2520nicotinic%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D609%26spage%3D74%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Lightfoot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skidmore, J.</span><span> </span><span class="NLM_article-title">α7 Nicotinic acetylcholine receptor agonists and positive allosteric modulators</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0079-6468%2807%2900003-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=18381125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1ynsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=131-171&author=A.+P.+Lightfootauthor=J.+N.+C.+Kewauthor=J.+Skidmore&title=%CE%B17+Nicotinic+acetylcholine+receptor+agonists+and+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">α7 nicotinic acetylcholine receptor agonists and positive allosteric modulators</span></div><div class="casAuthors">Lightfoot, Andrew P.; Kew, James N. C.; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-171</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the progress in medicinal chem. of recent α7 nicotinic acetyicholine receptor (nAChR) agonists and, in more detail, the advances in the discovery of α7 nAChR pos. allosteric modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoxo_SwxQsBrVg90H21EOLACvtfcHk0li9iAqZx0By-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1ynsL0%253D&md5=b892bac8b5f5cec9e543e9d932a3101f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2807%2900003-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252807%252900003-3%26sid%3Dliteratum%253Aachs%26aulast%3DLightfoot%26aufirst%3DA.%2BP.%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3D%25CE%25B17%2520Nicotinic%2520acetylcholine%2520receptor%2520agonists%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D46%26spage%3D131%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Ng, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittemore, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogenkamp, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, K. W.</span><span> </span><span class="NLM_article-title">Nootropic α7 nicotinic receptor allosteric modulator derived from GABA<sub>A</sub> receptor modulators</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">8059</span><span class="NLM_x">–</span> <span class="NLM_lpage">8064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=8059-8064&author=H.+J.+Ngauthor=E.+R.+Whittemoreauthor=M.+B.+Tranauthor=D.+J.+Hogenkampauthor=R.+S.+Broideauthor=T.+B.+Johnstoneauthor=L.+Zhengauthor=K.+E.+Stevensauthor=K.+W.+Gee&title=Nootropic+%CE%B17+nicotinic+receptor+allosteric+modulator+derived+from+GABAA+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DH.%2BJ.%26aulast%3DWhittemore%26aufirst%3DE.%2BR.%26aulast%3DTran%26aufirst%3DM.%2BB.%26aulast%3DHogenkamp%26aufirst%3DD.%2BJ.%26aulast%3DBroide%26aufirst%3DR.%2BS.%26aulast%3DJohnstone%26aufirst%3DT.%2BB.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DStevens%26aufirst%3DK.%2BE.%26aulast%3DGee%26aufirst%3DK.%2BW.%26atitle%3DNootropic%2520%25CE%25B17%2520nicotinic%2520receptor%2520allosteric%2520modulator%2520derived%2520from%2520GABAA%2520receptor%2520modulators%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D8059%26epage%3D8064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span> </span><span class="NLM_article-title">Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2004&pages=715-724&author=J.+H.+Gr%C3%B8nlienauthor=M.+H%C3%A5kerudauthor=H.+Weenauthor=K.+Thorin-Hageneauthor=C.+A.+Briggsauthor=M.+Gopalakrishnanauthor=J.+Malysz&title=Distinct+profiles+of+%CE%B17+nAChR+positive+allosteric+modulation+revealed+by+structurally+diverse+chemotypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DMalysz%26aufirst%3DJ.%26atitle%3DDistinct%2520profiles%2520of%2520%25CE%25B17%2520nAChR%2520positive%2520allosteric%2520modulation%2520revealed%2520by%2520structurally%2520diverse%2520chemotypes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D72%26spage%3D715%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Christensen, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, M. S.</span><span> </span><span class="NLM_article-title">Repeated administration of α7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases α7 nAChR levels in the brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=20533993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWkt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2010&pages=1205-1216&author=D.+Z.+Christensenauthor=J.+D.+Mikkelsenauthor=H.+H.+Hansenauthor=M.+S.+Thomsen&title=Repeated+administration+of+%CE%B17+nicotinic+acetylcholine+receptor+%28nAChR%29+agonists%2C+but+not+positive+allosteric+modulators%2C+increases+%CE%B17+nAChR+levels+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated administration of α7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases α7 nAChR levels in the brain</span></div><div class="casAuthors">Christensen, Ditte Z.; Mikkelsen, Jens D.; Hansen, Henrik H.; Thomsen, Morten S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1205-1216</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The α7 nicotinic acetylcholine receptor (nAChR) is an important target for treatment of cognitive deficits in schizophrenia and Alzheimer's disease.  However, the receptor desensitizes rapidly in vitro, which has led to concern regarding its applicability as a clin. relevant drug target.  Here we investigate the effects of repeated agonism on α7 nAChR receptor levels and responsiveness in vivo in rats.  Using [125I]-α-bungarotoxin (BTX) autoradiog. we show that acute or repeated administration with the selective α7 nAChR agonist A-582941 increases the no. of α7 nAChR binding sites in several brain regions, particularly in the prefrontal cortex.  The α7 nAChR agonists SSR180711 and PNU-282987 also increase [125I]-BTX binding, suggesting that this is a general consequence of α7 nAChR agonism.  Interestingly, the α7 nAChR pos. allosteric modulators PNU-120596 and NS1738 do not increase [125I]-BTX binding.  Furthermore, A-582941-induced increase in Arc and c-fos mRNA expression in the prefrontal cortex is enhanced and unaltered, resp., after repeated administration, demonstrating that the α7 nAChRs remain responsive.  Contrarily, A-582941-induced phosphorylation of Erk2 in the prefrontal cortex occurs following acute, but not repeated administration.  Our results demonstrate that repeated agonist administration increases the no. of α7 nAChRs in the brain, and leads to coupling vs. uncoupling of specific intracellular signaling pathways.  Addnl., our data suggest a fundamental difference between the sequelae of repeated administration with agonists and allosteric modulators of the α7 nAChR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXb-V7CFpzbVg90H21EOLACvtfcHk0liZG6oQkkDiZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWkt77J&md5=d2921429bc8350c42d1b6a443c0aca03</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DD.%2BZ.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26aulast%3DHansen%26aufirst%3DH.%2BH.%26aulast%3DThomsen%26aufirst%3DM.%2BS.%26atitle%3DRepeated%2520administration%2520of%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520agonists%252C%2520but%2520not%2520positive%2520allosteric%2520modulators%252C%2520increases%2520%25CE%25B17%2520nAChR%2520levels%2520in%2520the%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D114%26spage%3D1205%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajó s, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggenbass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford-Root, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkenpas, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S.</span><span> </span><span class="NLM_article-title">A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4396</span><span class="NLM_x">–</span> <span class="NLM_lpage">4405</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1523%2FJNEUROSCI.5269-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=15858066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFKgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4396-4405&author=R.+S.+Hurstauthor=M.+Haj%C3%B3+sauthor=M.+Raggenbassauthor=T.+M.+Wallauthor=N.+R.+Higdonauthor=J.+A.+Lawsonauthor=K.+L.+Rutherford-Rootauthor=M.+B.+Berkenpasauthor=W.+E.+Hoffmannauthor=D.+W.+Piotrowskiauthor=V.+E.+Groppiauthor=G.+Allamanauthor=R.+Ogierauthor=S.+Bertrandauthor=D.+Bertrandauthor=S.+Arneric&title=A+novel+positive+allosteric+modulator+of+the+%CE%B17+neuronal+nicotinic+acetylcholine+receptor%3A+in+vitro+and+in+vivo+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor: In vitro and in vivo characterization</span></div><div class="casAuthors">Hurst, Raymond S.; Hajos, Mihaly; Raggenbass, Mario; Wall, Theron M.; Higdon, Nicole R.; Lawson, Judy A.; Rutherford-Root, Karen L.; Berkenpas, Mitchell B.; Hoffmann, W. E.; Piotrowski, David W.; Groppi, Vincent E.; Allaman, Geraldine; Ogier, Roch; Bertrand, Sonia; Bertrand, Daniel; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4396-4405</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Several lines of evidence suggest a link between the α7 neuronal nicotinic acetylcholine receptor (nAChR) and brain disorders including schizophrenia, Alzheimer's disease, and traumatic brain injury.  The present work describes a novel mol., 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596), which acts as a powerful pos. allosteric modulator of the α7 nAChR.  Discovered in a high-throughput screen, PNU-120596 increased agonist-evoked calcium flux mediated by an engineered variant of the human α7 nAChR.  Electrophysiol. studies confirmed that PNU-120596 increased peak agonist-evoked currents mediated by wild-type receptors and also demonstrated a pronounced prolongation of the evoked response in the continued presence of agonist.  In contrast, PNU-120596 produced no detectable change in currents mediated by α4β2, α3β4, and α9α10 nAChRs.  PNU-120596 increased the channel mean open time of α7 nAChRs but had no effect on ion selectivity and relatively little, if any, effect on unitary conductance.  When applied to acute hippocampal slices, PNU-120596 increased the frequency of ACh-evoked GABAergic postsynaptic currents measured in pyramidal neurons; this effect was suppressed by TTX, suggesting that PNU-120596 modulated the function of α7 nAChRs located on the somatodendritic membrane of hippocampal interneurons.  Accordingly, PNU-120596 greatly enhanced the ACh-evoked inward currents in these interneurons.  Systemic administration of PNU-120596 to rats improved the auditory gating deficit caused by amphetamine, a model proposed to reflect a circuit level disturbance assocd. with schizophrenia.  Together, these results suggest that PNU-120596 represents a new class of mol. that enhances α7 nAChR function and thus has the potential to treat psychiatric and neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq26WDVJ3sdGLVg90H21EOLACvtfcHk0liZG6oQkkDiZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFKgtLo%253D&md5=39dd78bcd96ebff54a2beb7d67b68e33</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5269-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5269-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DHaj%25C3%25B3%2Bs%26aufirst%3DM.%26aulast%3DRaggenbass%26aufirst%3DM.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26aulast%3DRutherford-Root%26aufirst%3DK.%2BL.%26aulast%3DBerkenpas%26aufirst%3DM.%2BB.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DAllaman%26aufirst%3DG.%26aulast%3DOgier%26aufirst%3DR.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DArneric%26aufirst%3DS.%26atitle%3DA%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520%25CE%25B17%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D4396%26epage%3D4405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Rogers, B. N.</span>; <span class="NLM_etal">et al.</span><span> </span><span class="NLM_article-title">Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor</span>. Presented at the 236th National Meeting of the American Chemical Society, Philadelphia, PA, Aug 17–21,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>MEDI 248.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+N.+Rogers&title=Positive+Allosteric+Modulators+of+the+%CE%B17+Nicotinic+Acetylcholine+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DPositive%2520Allosteric%2520Modulators%2520of%2520the%2520%25CE%25B17%2520Nicotinic%2520Acetylcholine%2520Receptor%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Timmermann, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhaas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, E. Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jørgensen, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahring, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrsitensen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, G. M.</span><span> </span><span class="NLM_article-title">An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.107.120436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=17625074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=294-307&author=D.+B.+Timmermannauthor=J.+H.+Gr%C3%B8nlienauthor=K.+L.+Kohlhaasauthor=E.+%C3%98.+Nielsenauthor=E.+Damauthor=T.+D.+J%C3%B8rgensenauthor=P.+K.+Ahringauthor=D.+Petersauthor=D.+Holstauthor=J.+K.+Chrsitensenauthor=J.+Malyszauthor=C.+A.+Briggsauthor=M.+Gopalakrishnanauthor=G.+M.+Olsen&title=An+allosteric+modulator+of+the+%CE%B17+nicotinic+acetylcholine+receptor+possessing+cognition-enhancing+properties+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo</span></div><div class="casAuthors">Timmermann, Daniel B.; Groenlien, Jens Halvard; Kohlhaas, Kathy L.; Nielsen, Elsebet Oe.; Dam, Eva; Joergensen, Tino D.; Ahring, Philip K.; Peters, Dan; Holst, Dorte; Chrsitensen, Jeppe K.; Malysz, John; Briggs, Clark A.; Gopalakrishnan, Murali; Olsen, Gunnar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">294-307</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Augmentation of nicotinic α7 receptor function is considered to be a potential therapeutic strategy aimed at ameliorating cognitive and mnemonic dysfunction in relation to debilitating pathol. conditions, such as Alzheimer's disease and schizophrenia.  In the present report, a novel pos. allosteric modulator of the α7 nicotinic acetylcholine receptor (nAChR), 1-(5-chloro-2-hydroxy-phenyl)-3-(2-chloro-5-trifluoromethyl-phenyl)-urea(NS 1738),is described.  NS 1738 was unable to displace or affect radioligand binding to the agonist binding site of nicotinic receptors, and it was devoid of effect when applied alone in electrophysiol. paradigms.  However, when applied in the presence of acetylcholine (ACh), NS 1738 produced a marked increase in the current flowing through α7 nAChRs, as detd. in both oocyte electrophysiol. and patchclamp recordings from mammalian cells.  NS 1738 acted by increasing the peak amplitude of ACh-evoked currents at all concns.; thus, it increased the maximal efficacy of ACh.  Oocyte expts. indicated an increase in ACh potency as well.  NS 1738 had only marginal effects on the desensitization kinetics of α7 nAChRs, as detd. from patch-clamp studies of both transfected cells and cultured hippocampal neurons.  NS 1738 was modestly brain-penetrant, and it was demonstrated to counteract a (-)-scopolamine-induced deficit in acquisition of a water-maze learning task in rats.  Moreover, NS 1738 improved performance in the rat social recognition test to the same extent as (-)-nicotine, demonstrating that NS 1738 is capable of producing cognitive enhancement in vivo.  These data support the notion that α7 nAChR allosteric modulation may constitute a novel pharmacol. principle for the treatment of cognitive dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PDEOt09g1LVg90H21EOLACvtfcHk0liIDbbnd24kjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahsb7K&md5=8d08e8945167c3b75b0d6af7b286c391</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.120436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.120436%26sid%3Dliteratum%253Aachs%26aulast%3DTimmermann%26aufirst%3DD.%2BB.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DKohlhaas%26aufirst%3DK.%2BL.%26aulast%3DNielsen%26aufirst%3DE.%2B%25C3%2598.%26aulast%3DDam%26aufirst%3DE.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DT.%2BD.%26aulast%3DAhring%26aufirst%3DP.%2BK.%26aulast%3DPeters%26aufirst%3DD.%26aulast%3DHolst%26aufirst%3DD.%26aulast%3DChrsitensen%26aufirst%3DJ.%2BK.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26aulast%3DOlsen%26aufirst%3DG.%2BM.%26atitle%3DAn%2520allosteric%2520modulator%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520possessing%2520cognition-enhancing%2520properties%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D294%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Kennett, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cilia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, T. P.</span><span> </span><span class="NLM_article-title">In vitro and in vivo profile of SB-206553, a potent 5-HT<sub>2C</sub>/5-HT<sub>2B</sub> receptor antagonist with anxiolytic properties</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1111%2Fj.1476-5381.1996.tb15208.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=8821530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADyaK28XpsVGgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1996&pages=427-434&author=G.+A.+Kennettauthor=M.+D.+Woodauthor=F.+Brightauthor=J.+Ciliaauthor=D.+C.+Piperauthor=T.+Gagerauthor=D.+Thomasauthor=G.+S.+Baxterauthor=I.+T.+Forbesauthor=P.+Hamauthor=T.+P.+Blackburn&title=In+vitro+and+in+vivo+profile+of+SB-206553%2C+a+potent+5-HT2C%2F5-HT2B+receptor+antagonist+with+anxiolytic+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties</span></div><div class="casAuthors">Kennett, G. a.; Wood, M. D.; Bright, F.; Cilia, J.; Piper, D. C.; Gager, T.; Thomas, D.; Baxter, G. S.; Forbes, I. T.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">427-34</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">SB 206553 (5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole) displays a high affinity (pKI 7.9) for the cloned human 5-HT2C receptor expressed in HEK 293 cells and the 5-HT2B receptor (pA2 8.9) as measured in the rat stomach fundus prepn.  SB 206553 has low affinity for cloned human 5-HT2A receptors expressed in HEK 293 cells (pK1 5.8) and (pKI <6) for a wide variety of other neurotransmitter receptors.  SB 206553 appears to be a surmountable antagonist of 5-HT-stimulated phosphinositide hydrolysis in HEK 293 cells expressing the human 5-HT2C receptor (pKB 9.0).  The compd. potently (ID50 5.5 mg kg-1, p.o., 0.27 mg kg-1, i.v.) inhibited the hypolocomotor response to m-chlorophenylpiperazine (mCPP), a putative model of 5-HT2C/5-HT2B receptor function in vivo.  At similar doses (2-20 mg kg-1, p.o.) SB 206553 increased total interaction scores in a rat social interaction test and increased punished responding in a rat Geller-Seifter conflict test.  These effects are consistent with the possession of anxiolytic properties.  SB 206553 also increased suppressed responding in a marmoset conflict model of anxiety at somewhat higher doses (15 and 20 mg kg-1, p.o.) but also reduced unsuppressed responding.  These results suggest that SB 206553 is a potent mixed 5-HT2C/5-HT2B receptor antagonist with selectivity over the 5-HT2A and all other sites studied and possesses anxiolytic-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGhOi9PL6P5bVg90H21EOLACvtfcHk0liIDbbnd24kjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpsVGgsg%253D%253D&md5=f6faa809154f400759171bfdedb17460</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb15208.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb15208.x%26sid%3Dliteratum%253Aachs%26aulast%3DKennett%26aufirst%3DG.%2BA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DBright%26aufirst%3DF.%26aulast%3DCilia%26aufirst%3DJ.%26aulast%3DPiper%26aufirst%3DD.%2BC.%26aulast%3DGager%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DD.%26aulast%3DBaxter%26aufirst%3DG.%2BS.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DHam%26aufirst%3DP.%26aulast%3DBlackburn%26aufirst%3DT.%2BP.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520profile%2520of%2520SB-206553%252C%2520a%2520potent%25205-HT2C%252F5-HT2B%2520receptor%2520antagonist%2520with%2520anxiolytic%2520properties%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D117%26spage%3D427%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitzia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlby, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRocque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soloveva, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncarati, R.</span><span> </span><span class="NLM_article-title">Old and new pharmacology: positive allosteric modulation of the α7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine<sub>2B/C</sub> receptor antagonist SB-206553 (3,5-dihydro-5-methyl-<i>N</i>-3-pyridinylbenzo[1,2-<i>b</i>:4,5-<i>b</i>′]dipyrrole-1(2<i>H</i>)-carboxamide)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.108.146514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19050173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXislals7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=766-776&author=J.+Dunlopauthor=T.+Lockauthor=B.+Jowauthor=F.+Sitziaauthor=S.+Grauerauthor=F.+Jowauthor=A.+Kramerauthor=M.+R.+Bowlbyauthor=A.+Randallauthor=D.+Kowalauthor=A.+Gilbertauthor=T.+A.+Comeryauthor=J.+LaRocqueauthor=V.+Solovevaauthor=J.+Brownauthor=R.+Roncarati&title=Old+and+new+pharmacology%3A+positive+allosteric+modulation+of+the+%CE%B17+nicotinic+acetylcholine+receptor+by+the+5-hydroxytryptamine2B%2FC+receptor+antagonist+SB-206553+%283%2C5-dihydro-5-methyl-N-3-pyridinylbenzo%5B1%2C2-b%3A4%2C5-b%E2%80%B2%5Ddipyrrole-1%282H%29-carboxamide%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Old and new pharmacology: positive allosteric modulation of the α7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine2B/C receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide)</span></div><div class="casAuthors">Dunlop, John; Lock, Tim; Jow, Brian; Sitzia, Fabrizio; Grauer, Steven; Jow, Flora; Kramer, Angela; Bowlby, Mark R.; Randall, Andrew; Kowal, Dianne; Gilbert, Adam; Comery, Thomas A.; LaRocque, James; Soloveva, Veronica; Brown, Jon; Roncarati, Renza</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">766-776</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The α7 nicotinic acetylcholine receptor (nAChR) has been implicated in Alzheimer's disease and schizophrenia, leading to efforts targeted toward discovering agonists and pos. allosteric modulators (PAMs) of this receptor.  In a Ca2+ flux fluorometric imaging plate reader assay, SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide), a compd. known as a 5-hydroxytryptamine2B/2C receptor antagonist, produced an 8-fold potentiation of the evoked calcium signal in the presence of an EC20 concn. of nicotine and a corresponding EC50 of 1.5 μM for potentiation of EC20 nicotine responses in GH4C1 cells expressing the α7 receptor.  SB-206553 was devoid of direct α7 receptor agonist activity and selective against other nicotinic receptors.  Confirmation of the PAM activity of SB-206553 on the α7 nAChR was obtained in patch-clamp electrophysiol. expts. in GH4C1 cells, where it failed to evoke any detectable currents when applied alone, yet dramatically potentiated the currents evoked by an EC20 (17 μM) and EC100 (124 μM) of acetylcholine (ACh).  Native nicotinic receptors in CA1 stratum radiatum interneurons of rat hippocampal slices could also be activated by ACh (200 μM), an effect that was entirely blocked by the α7-selective antagonist methyllycaconitine (MLA).  These ACh currents were potentiated by SB-206553, which increased the area of the current response significantly, resulting in a 40-fold enhancement at 100 μM.  In behavioral expts. in rats, SB-206553 reversed an MK-801 (dizocilpine maleate)-induced deficit in the prepulse inhibition of acoustic startle response, an effect attenuated in the presence of MLA.  This latter observation provides further evidence in support of the potential therapeutic utility of α7 nAChR PAMs in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomM1BUzvmG6LVg90H21EOLACvtfcHk0libj1WvNySG7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXislals7w%253D&md5=d1783c43f8d4e58af504614e13126012</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.146514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.146514%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DLock%26aufirst%3DT.%26aulast%3DJow%26aufirst%3DB.%26aulast%3DSitzia%26aufirst%3DF.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DJow%26aufirst%3DF.%26aulast%3DKramer%26aufirst%3DA.%26aulast%3DBowlby%26aufirst%3DM.%2BR.%26aulast%3DRandall%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DGilbert%26aufirst%3DA.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DLaRocque%26aufirst%3DJ.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DRoncarati%26aufirst%3DR.%26atitle%3DOld%2520and%2520new%2520pharmacology%253A%2520positive%2520allosteric%2520modulation%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520by%2520the%25205-hydroxytryptamine2B%252FC%2520receptor%2520antagonist%2520SB-206553%2520%25283%252C5-dihydro-5-methyl-N-3-pyridinylbenzo%255B1%252C2-b%253A4%252C5-b%25E2%2580%25B2%255Ddipyrrole-1%25282H%2529-carboxamide%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D766%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterstrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarris, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gfesser, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kouhen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1<i>H</i>-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the α7 nicotinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3377</span><span class="NLM_x">–</span> <span class="NLM_lpage">3384</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9003818" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3377-3384&author=R.+Faghihauthor=S.+M.+Gopalakrishnanauthor=J.+H.+Gr%C3%B8nlienauthor=J.+Malyszauthor=C.+A.+Briggsauthor=C.+Wetterstrandauthor=H.+Weenauthor=M.+P.+Curtisauthor=K.+A.+Sarrisauthor=G.+A.+Gfesserauthor=R.+El-Kouhenauthor=H.+M.+Robbauthor=R.+J.+Radekauthor=K.+C.+Marshauthor=W.+H.+Bunnelleauthor=M.+Gopalakrishnan&title=Discovery+of+4-%285-%284-chlorophenyl%29-2-methyl-3-propionyl-1H-pyrrol-1-yl%29benzenesulfonamide+%28A-867744%29+as+a+novel+positive+allosteric+modulator+of+the+%CE%B17+nicotinic+acetylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm9003818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9003818%26sid%3Dliteratum%253Aachs%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DGopalakrishnan%26aufirst%3DS.%2BM.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DWetterstrand%26aufirst%3DC.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DCurtis%26aufirst%3DM.%2BP.%26aulast%3DSarris%26aufirst%3DK.%2BA.%26aulast%3DGfesser%26aufirst%3DG.%2BA.%26aulast%3DEl-Kouhen%26aufirst%3DR.%26aulast%3DRobb%26aufirst%3DH.%2BM.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25204-%25285-%25284-chlorophenyl%2529-2-methyl-3-propionyl-1H-pyrrol-1-yl%2529benzenesulfonamide%2520%2528A-867744%2529%2520as%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3377%26epage%3D3384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grønlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Håkerud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin-Hagene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterstrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">In vitro pharmacological characterization of a novel allosteric modulator of α7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1<i>H</i>-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fjpet.109.151886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=19389923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFelur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=257-267&author=J.+Malyszauthor=J.+H.+Gr%C3%B8nlienauthor=D.+J.+Andersonauthor=M.+H%C3%A5kerudauthor=K.+Thorin-Hageneauthor=H.+Weenauthor=C.+Wetterstrandauthor=C.+A.+Briggsauthor=R.+Faghihauthor=W.+H.+Bunnelleauthor=M.+Gopalakrishnan&title=In+vitro+pharmacological+characterization+of+a+novel+allosteric+modulator+of+%CE%B17+neuronal+acetylcholine+receptor%2C+4-%285-%284-chlorophenyl%29-2-methyl-3-propionyl-1H-pyrrol-1-yl%29benzenesulfonamide+%28A-867744%29%2C+exhibiting+unique+pharmacological+profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro pharmacological characterization of a novel allosteric modulator of α7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile</span></div><div class="casAuthors">Malysz, John; Gronlien, Jens Halvard; Anderson, David J.; Hakerud, Monika; Thorin-Hagene, Kirsten; Ween, Hilde; Wetterstrand, Caroline; Briggs, Clark A.; Faghih, Ramin; Bunnelle, William H.; Gopalakrishnan, Murali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">257-267</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Targeting α7 neuronal acetylcholine receptors (nAChRs) with selective agonists and pos. allosteric modulators (PAMs) is considered a therapeutic approach for managing cognitive deficits in schizophrenia and Alzheimer's disease.  In this study, we describe a novel type II α7 PAM, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), that exhibits a unique pharmacol. profile.  In oocytes expressing α7 nAChRs, A-867744 potentiated acetylcholine (ACh)-evoked currents, with an EC50 value of ∼1 μM.  At highest concns. of A-867744 tested, ACh-evoked currents were essentially nondecaying.  At lower concns., no evidence of a distinct secondary component was evident in contrast to 4-naphthalen-1-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonic acid amide (TQS), another type II α7 PAM.  In the presence of A-867744, ACh concn. responses were potentiated by increases in potency, Hill slope, and maximal efficacy.  When examd. in rat hippocampus CA1 stratum radiatum interneurons or dentate gyrus granule cells, A-867744 (10 μM) increased choline-evoked α7 currents and recovery from inhibition/desensitization, and enhanced spontaneous inhibitory postsynaptic current activity.  A-867744, like other α7 PAMs tested [1-(5-chloro-2-hydroxyphenyl)-3-(2-chloro-5-trifluoromethyl-phenyl)urea (NS1738), TQS, and 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596)], did not displace the binding of [3H]methyllycaconitine to rat cortex α7* nAChRs.  However, unlike these PAMs, A-867744 displaced the binding of the agonist [3H](1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane (A-585539) in rat cortex, with a Ki value of 23 nM.  A-867744 neither increased agonist-evoked responses nor displaced the binding of [3H]A-585539 in an α7/5-hydroxytryptamine3 (α7/5-HT3) chimera, suggesting an interaction distinct from the α7 N terminus or M2-3 loop.  In addn., A-867744 failed to potentiate responses mediated by 5-HT3A or α3β4 and α4β2 nAChRs.  In summary, this study identifies a novel and selective α7 PAM showing activity at recombinant and native α7 nAChRs exhibiting a unique pharmacol. interaction with the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLM5AdS8FvO7Vg90H21EOLACvtfcHk0lhKKqWFv6kx3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFelur4%253D&md5=31c8e33b9d8bf606a7f11355cb4e9e08</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.151886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.151886%26sid%3Dliteratum%253Aachs%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DGr%25C3%25B8nlien%26aufirst%3DJ.%2BH.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DH%25C3%25A5kerud%26aufirst%3DM.%26aulast%3DThorin-Hagene%26aufirst%3DK.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DWetterstrand%26aufirst%3DC.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520allosteric%2520modulator%2520of%2520%25CE%25B17%2520neuronal%2520acetylcholine%2520receptor%252C%25204-%25285-%25284-chlorophenyl%2529-2-methyl-3-propionyl-1H-pyrrol-1-yl%2529benzenesulfonamide%2520%2528A-867744%2529%252C%2520exhibiting%2520unique%2520pharmacological%2520profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D257%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Chimienti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plantard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brakch, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohl, D.</span><span> </span><span class="NLM_article-title">Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of mal de Meleda</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3017</span><span class="NLM_x">–</span> <span class="NLM_lpage">3024</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1093%2Fhmg%2Fddg320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=14506129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVWqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=3017-3024&author=F.+Chimientiauthor=R.+C.+Hoggauthor=L.+Plantardauthor=C.+Lehmannauthor=N.+Brakchauthor=J.+Fischerauthor=M.+Huberauthor=D.+Bertrandauthor=D.+Hohl&title=Identification+of+SLURP-1+as+an+epidermal+neuromodulator+explains+the+clinical+phenotype+of+mal+de+Meleda"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda</span></div><div class="casAuthors">Chimienti, Fabrice; Hogg, Ronald C.; Plantard, Laure; Lehmann, Caroline; Brakch, Noureddine; Fischer, Judith; Huber, Marcel; Bertrand, Daniel; Hohl, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3017-3024</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mal de Meleda is an autosomal recessive inflammatory and keratotic palmoplantar skin disorder due to mutations in the ARS B gene, encoding for SLURP-1 (secreted mammalian Ly-6/uPAR-related protein 1).  SLURP-1 belongs to the Ly-6/uPAR superfamily of receptor and secreted proteins, which participate in signal transduction, immune cell activation or cellular adhesion.  The high degree of structural similarity between SLURP-1 and the three fingers motif of snake neurotoxins and Lynx1 suggests that this protein interacts with the neuronal acetylcholine receptors.  We found that SLURP-1 potentiates the human α7 nicotinic acetylcholine receptors that are present in keratinocytes.  These results identify SLURP-1 as a secreted epidermal neuromodulator which is likely to be essential for both epidermal homeostasis and inhibition of TNF-alpha release by macrophages during wound healing.  This explains both the hyperproliferative as well as the inflammatory clin. phenotype of Mal de Meleda.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraM-uNE7NmWLVg90H21EOLACvtfcHk0lhKKqWFv6kx3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVWqtb4%253D&md5=2375520ddf17d75d19088d138c4d96ef</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddg320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddg320%26sid%3Dliteratum%253Aachs%26aulast%3DChimienti%26aufirst%3DF.%26aulast%3DHogg%26aufirst%3DR.%2BC.%26aulast%3DPlantard%26aufirst%3DL.%26aulast%3DLehmann%26aufirst%3DC.%26aulast%3DBrakch%26aufirst%3DN.%26aulast%3DFischer%26aufirst%3DJ.%26aulast%3DHuber%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DHohl%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520SLURP-1%2520as%2520an%2520epidermal%2520neuromodulator%2520explains%2520the%2520clinical%2520phenotype%2520of%2520mal%2520de%2520Meleda%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2003%26volume%3D12%26spage%3D3017%26epage%3D3024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Paleari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, P.</span><span> </span><span class="NLM_article-title">α7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and mesothelioma?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=822-836&author=L.+Paleariauthor=A.+Cesarioauthor=M.+Finiauthor=P.+Russo&title=%CE%B17-Nicotinic+receptor+antagonists+at+the+beginning+of+a+clinical+era+for+NSCLC+and+mesothelioma%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaleari%26aufirst%3DL.%26aulast%3DCesario%26aufirst%3DA.%26aulast%3DFini%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DP.%26atitle%3D%25CE%25B17-Nicotinic%2520receptor%2520antagonists%2520at%2520the%2520beginning%2520of%2520a%2520clinical%2520era%2520for%2520NSCLC%2520and%2520mesothelioma%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D822%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Sheridan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tattersall, J. E.</span><span> </span><span class="NLM_article-title">Nicotinic antagonists in the treatment of nerve agent intoxication</span> <span class="citation_source-journal">J. R. Soc. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1177%2F014107680509800307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=15738554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A280%3ADC%252BD2M7gvVShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2005&pages=114-115&author=R.+D.+Sheridanauthor=A.+P.+Smithauthor=S.+R.+Turnerauthor=J.+E.+Tattersall&title=Nicotinic+antagonists+in+the+treatment+of+nerve+agent+intoxication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic antagonists in the treatment of nerve agent intoxication</span></div><div class="casAuthors">Sheridan Robert D; Smith Andrew P; Turner Simon R; Tattersall John E H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Royal Society of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">114-5</span>
        ISSN:<span class="NLM_cas:issn">0141-0768</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT09LfG1XId50HdcurJClFcfW6udTcc2ealrWGuLP_3ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7gvVShtg%253D%253D&md5=aa2f3403af9fcdc698ae16920b5518d6</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1177%2F014107680509800307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F014107680509800307%26sid%3Dliteratum%253Aachs%26aulast%3DSheridan%26aufirst%3DR.%2BD.%26aulast%3DSmith%26aufirst%3DA.%2BP.%26aulast%3DTurner%26aufirst%3DS.%2BR.%26aulast%3DTattersall%26aufirst%3DJ.%2BE.%26atitle%3DNicotinic%2520antagonists%2520in%2520the%2520treatment%2520of%2520nerve%2520agent%2520intoxication%26jtitle%3DJ.%2520R.%2520Soc.%2520Med.%26date%3D2005%26volume%3D98%26spage%3D114%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Terlau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, B. M.</span><span> </span><span class="NLM_article-title"><i>Conus</i> venoms: a rich source of novel ion channel-targeted peptides</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1152%2Fphysrev.00020.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=14715910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotl2rtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2004&pages=41-68&author=H.+Terlauauthor=B.+M.+Olivera&title=Conus+venoms%3A+a+rich+source+of+novel+ion+channel-targeted+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Conus venoms: a rich source of novel ion channel-targeted peptides</span></div><div class="casAuthors">Terlau, Heinrich; Olivera, Baldomero M.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-68</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The cone snails (genus Conus) are venomous marine mollusks that use small, structured peptide toxins (conotoxins) for prey capture, defense, and competitor deterrence.  Each of the 500 Conus can express ∼100 different conotoxins, with little overlap between species.  An overwhelming majority of these peptides are probably targeted selectively to a specific ion channel.  Because conotoxins discriminate between closely related subtypes of ion channels, they are widely used as pharmacol. agents in ion channel research, and several have direct diagnostic and therapeutic potential.  Large conotoxin families can comprise hundreds or thousands of different peptides; most families have a corresponding ion channel family target (i.e., ω-conotoxins and Ca channels, α-conotoxins and nicotinic receptors).  Different conotoxin families may have different ligand binding sites on the same ion channel target (i.e., μ-conotoxins and δ-conotoxins to sites 1 and 6 of Na channels, resp.).  The individual peptides in a conotoxin family are typically each selectively targeted to a diverse set of different mol. isoforms within the same ion channel family.  This review focuses on the targeting specificity of conotoxins and their differential binding to different states of an ion channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0QX327m4_oLVg90H21EOLACvtfcHk0lhJsAml66sbAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotl2rtA%253D%253D&md5=ed644caa4b8baa211450239ffc6a8b00</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00020.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00020.2003%26sid%3Dliteratum%253Aachs%26aulast%3DTerlau%26aufirst%3DH.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26atitle%3DConus%2520venoms%253A%2520a%2520rich%2520source%2520of%2520novel%2520ion%2520channel-targeted%2520peptides%26jtitle%3DPhysiol.%2520Rev.%26date%3D2004%26volume%3D84%26spage%3D41%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Whiteaker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikami, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulyas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span> </span><span class="NLM_article-title">Discovery, synthesis, and structure activity of a highly selective α7 nicotinic acetylcholine receptor antagonist</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">6628</span><span class="NLM_x">–</span> <span class="NLM_lpage">6638</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi7004202" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=6628-6638&author=P.+Whiteakerauthor=S.+Christensenauthor=D.+Yoshikamiauthor=C.+Dowellauthor=M.+Watkinsauthor=J.+Gulyasauthor=J.+Rivierauthor=B.+M.+Oliveraauthor=J.+M.+McIntosh&title=Discovery%2C+synthesis%2C+and+structure+activity+of+a+highly+selective+%CE%B17+nicotinic+acetylcholine+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fbi7004202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi7004202%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteaker%26aufirst%3DP.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DYoshikami%26aufirst%3DD.%26aulast%3DDowell%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DM.%26aulast%3DGulyas%26aufirst%3DJ.%26aulast%3DRivier%26aufirst%3DJ.%26aulast%3DOlivera%26aufirst%3DB.%2BM.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%252C%2520synthesis%252C%2520and%2520structure%2520activity%2520of%2520a%2520highly%2520selective%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520antagonist%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D6628%26epage%3D6638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Daly, J. W.; Garraffo, H. M.; Spande, T. F.</span><span> </span><span class="NLM_article-title">Alkaloids from Amphibian Skins</span>. In  <span class="citation_source-book">Alkaloids: Chemical and Biological Perspectives</span>; <span class="NLM_contrib-group">Pelletier, S. W.</span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">13</span>, pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1016%2FS0735-8210%2899%2980024-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1-161&author=J.+W.+Daly&author=H.+M.+Garraffo&author=T.+F.+Spandeauthor=S.+W.+Pelletier&title=Alkaloids%3A+Chemical+and+Biological+Perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2FS0735-8210%2899%2980024-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0735-8210%252899%252980024-7%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DAlkaloids%2520from%2520Amphibian%2520Skins%26btitle%3DAlkaloids%253A%2520Chemical%2520and%2520Biological%2520Perspectives%26aulast%3DPelletier%26aufirst%3DS.%2BW.%26pub%3DWiley%26date%3D1999%26volume%3D13%26spage%3D1%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Tsuneki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaoka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dani, J.</span><span> </span><span class="NLM_article-title">Alkaloids indolizidine 235B′, quinolizidine 1-epi-207I, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm2007672&amp;key=10.1124%2Fmol.104.000729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm2007672&amp;key=15258256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm2007672&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlGmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1061-1069&author=H.+Tsunekiauthor=Y.+Youauthor=N.+Toyookaauthor=S.+Kagawaauthor=S.+Kobayashiauthor=T.+Sasaokaauthor=H.+Nemotoauthor=I.+Kimuraauthor=J.+Dani&title=Alkaloids+indolizidine+235B%E2%80%B2%2C+quinolizidine+1-epi-207I%2C+and+the+tricyclic+205B+are+potent+and+selective+noncompetitive+inhibitors+of+nicotinic+acetylcholine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Alkaloids indolizidine 235B', quinolizidine 1-epi-207I, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors</span></div><div class="casAuthors">Tsuneki, Hiroshi; You, Yueren; Toyooka, Naoki; Kagawa, Syota; Kobayashi, Soushi; Sasaoka, Toshiyasu; Nemoto, Hideo; Kimura, Ikuko; Dani, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1061-1069</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors are key mols. in cholinergic transmission in the nervous system.  Because of their structural complexity, only a limited no. of subtype-specific agonists and antagonists are available to study nicotinic receptor functions.  To overcome this limitation, we used voltage-clamp recordings to examine the effects of several frog skin alkaloids on acetylcholine-elicited currents in Xenopus laevis oocytes expressing major types of neuronal nicotinic receptors (α4β2, α7, α3β2, α3β4, and α4β4).  We found that the 5,8-disubstituted indolizidine (-)-235B' acted as a potent noncompetitive blocker of α4β2 nicotinic receptors (IC50 = 74 nM).  This effect was highly selective for α4β2 receptors compared with α3β2, α3β4, and α4β4 receptors.  The inhibition of α4β2 currents by (-)-235B' was more pronounced as the acetylcholine concn. increased (from 10 nM to 100 μM).  Moreover, the blockade of α4β2 currents by (-)-235B' was voltage-dependent (more pronounced at hyperpolarized potentials) and use-dependent, indicating that (-)-235B' behaves as an open-channel blocker of this receptor.  Several other 5,8-disubstituted indolizidines (5-n-propyl-8-n-butylindolizidines), two 5,6,8-trisubstituted indolizidines ((-)-223A and (+)-6-epi-223A), and a 1,4-disubstituted quinolizidine ((+)-207I) were less potent than (-)-235B', and none showed selectivity for α4β2 receptors.  The quinolizidine (-)-1-epi-207I and the tricyclic (+)-205B had 8.7- and 5.4-fold higher sensitivity, resp., for inhibition of the α7 nicotinic receptor than for inhibition of the α4β2 receptor.  These results show that frog alkaloids alter the function of nicotinic receptors in a subtype-selective manner, suggesting that an anal. of these alkaloids may aid in the development of selective drugs to alter nicotinic cholinergic functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOpS5kMyN8lbVg90H21EOLACvtfcHk0ljbzbeZg2Ol2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlGmurk%253D&md5=a2576d8ab6ced1a2d14f0297a409f833</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.000729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.000729%26sid%3Dliteratum%253Aachs%26aulast%3DTsuneki%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DY.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DKagawa%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DSasaoka%26aufirst%3DT.%26aulast%3DNemoto%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DI.%26aulast%3DDani%26aufirst%3DJ.%26atitle%3DAlkaloids%2520indolizidine%2520235B%25E2%2580%25B2%252C%2520quinolizidine%25201-epi-207I%252C%2520and%2520the%2520tricyclic%2520205B%2520are%2520potent%2520and%2520selective%2520noncompetitive%2520inhibitors%2520of%2520nicotinic%2520acetylcholine%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1061%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomesch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Callaghan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennogle, L. P.</span><span> </span><span class="NLM_article-title">Discovery of novel α7 nicotinic receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4825</span><span class="NLM_x">–</span> <span class="NLM_lpage">4830</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4825-4830&author=Y.+Pengauthor=Q.+Zhangauthor=G.+L.+Snyderauthor=H.+Zhuauthor=W.+Yaoauthor=J.+Tomeschauthor=R.+L.+Papkeauthor=J.+P.+O%E2%80%99Callaghanauthor=W.+J.+Welshauthor=L.+P.+Wennogle&title=Discovery+of+novel+%CE%B17+nicotinic+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DTomesch%26aufirst%3DJ.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26aulast%3DO%25E2%2580%2599Callaghan%26aufirst%3DJ.%2BP.%26aulast%3DWelsh%26aufirst%3DW.%2BJ.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520novel%2520%25CE%25B17%2520nicotinic%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4825%26epage%3D4830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2007672&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-23%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm2007672" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2007672" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667981d2185a2428","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
